<!doctype html>
<html class="">
	<head>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=no" />
		<meta name="description" content="Weâ€™re on a journey to advance and democratize artificial intelligence through open source and open science." />
		<meta property="fb:app_id" content="1321688464574422" />
		<meta name="twitter:card" content="summary_large_image" />
		<meta name="twitter:site" content="@huggingface" />
		<meta name="twitter:image" content="https://cdn-thumbnails.huggingface.co/social-thumbnails/datasets/ChuGyouk/medical-o1-train-kormedmcqa.png" />
		<meta property="og:title" content="ChuGyouk/medical-o1-train-kormedmcqa Â· Datasets at Hugging Face" />
		<meta property="og:type" content="website" />
		<meta property="og:url" content="https://huggingface.co/datasets/ChuGyouk/medical-o1-train-kormedmcqa" />
		<meta property="og:image" content="https://cdn-thumbnails.huggingface.co/social-thumbnails/datasets/ChuGyouk/medical-o1-train-kormedmcqa.png" />

		<link rel="stylesheet" href="/front/build/kube-68d7aa0/style.css" />

		<link rel="preconnect" href="https://fonts.gstatic.com" />
		<link
			href="https://fonts.googleapis.com/css2?family=Source+Sans+Pro:ital,wght@0,200;0,300;0,400;0,600;0,700;0,900;1,200;1,300;1,400;1,600;1,700;1,900&display=swap"
			rel="stylesheet"
		/>
		<link
			href="https://fonts.googleapis.com/css2?family=IBM+Plex+Mono:wght@400;600;700&display=swap"
			rel="stylesheet"
		/>

		<link
			rel="preload"
			href="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.12.0/katex.min.css"
			as="style"
			onload="this.onload=null;this.rel='stylesheet'"
		/>
		<noscript>
			<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.12.0/katex.min.css" />
		</noscript>

		<script>const guestTheme = document.cookie.match(/theme=(\w+)/)?.[1]; document.documentElement.classList.toggle('dark', guestTheme === 'dark' || ( (!guestTheme || guestTheme === 'system') && window.matchMedia('(prefers-color-scheme: dark)').matches));</script>
<link rel="canonical" href="https://huggingface.co/datasets/ChuGyouk/medical-o1-train-kormedmcqa"> <script type="application/ld+json">{
  "@context": {
    "@language": "en",
    "@vocab": "https:\/\/schema.org\/",
    "arrayShape": "cr:arrayShape",
    "citeAs": "cr:citeAs",
    "column": "cr:column",
    "conformsTo": "dct:conformsTo",
    "cr": "http:\/\/mlcommons.org\/croissant\/",
    "data": {
      "@id": "cr:data",
      "@type": "@json"
    },
    "dataBiases": "cr:dataBiases",
    "dataCollection": "cr:dataCollection",
    "dataType": {
      "@id": "cr:dataType",
      "@type": "@vocab"
    },
    "dct": "http:\/\/purl.org\/dc\/terms\/",
    "extract": "cr:extract",
    "field": "cr:field",
    "fileProperty": "cr:fileProperty",
    "fileObject": "cr:fileObject",
    "fileSet": "cr:fileSet",
    "format": "cr:format",
    "includes": "cr:includes",
    "isArray": "cr:isArray",
    "isLiveDataset": "cr:isLiveDataset",
    "jsonPath": "cr:jsonPath",
    "key": "cr:key",
    "md5": "cr:md5",
    "parentField": "cr:parentField",
    "path": "cr:path",
    "personalSensitiveInformation": "cr:personalSensitiveInformation",
    "recordSet": "cr:recordSet",
    "references": "cr:references",
    "regex": "cr:regex",
    "repeated": "cr:repeated",
    "replace": "cr:replace",
    "sc": "https:\/\/schema.org\/",
    "separator": "cr:separator",
    "source": "cr:source",
    "subField": "cr:subField",
    "transform": "cr:transform"
  },
  "@type": "sc:Dataset",
  "distribution": [
    {
      "@type": "cr:FileObject",
      "@id": "repo",
      "name": "repo",
      "description": "The Hugging Face git repository.",
      "contentUrl": "https:\/\/huggingface.co\/datasets\/ChuGyouk\/medical-o1-train-kormedmcqa\/tree\/refs%2Fconvert%2Fparquet",
      "encodingFormat": "git+https",
      "sha256": "https:\/\/github.com\/mlcommons\/croissant\/issues\/80"
    },
    {
      "@type": "cr:FileSet",
      "@id": "parquet-files-for-config-default",
      "containedIn": {
        "@id": "repo"
      },
      "encodingFormat": "application\/x-parquet",
      "includes": "default\/*\/*.parquet"
    }
  ],
  "recordSet": [
    {
      "@type": "cr:RecordSet",
      "dataType": "cr:Split",
      "key": {
        "@id": "default_splits\/split_name"
      },
      "@id": "default_splits",
      "name": "default_splits",
      "description": "Splits for the default config.",
      "field": [
        {
          "@type": "cr:Field",
          "@id": "default_splits\/split_name",
          "dataType": "sc:Text"
        }
      ],
      "data": [
        {
          "default_splits\/split_name": "train"
        }
      ]
    },
    {
      "@type": "cr:RecordSet",
      "@id": "default",
      "description": "ChuGyouk\/medical-o1-train-kormedmcqa - 'default' subset",
      "field": [
        {
          "@type": "cr:Field",
          "@id": "default\/split",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "fileProperty": "fullpath"
            },
            "transform": {
              "regex": "default\/(?:partial-)?(train)\/.+parquet$"
            }
          },
          "references": {
            "field": {
              "@id": "default_splits\/split_name"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/subject",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "subject"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/year",
          "dataType": "cr:Int64",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "year"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/period",
          "dataType": "cr:Int64",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "period"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/q_number",
          "dataType": "cr:Int64",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "q_number"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/question",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "question"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/A",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "A"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/B",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "B"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/C",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "C"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/D",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "D"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/E",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "E"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/answer",
          "dataType": "cr:Int64",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "answer"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/thinking",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "thinking"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/response",
          "dataType": "sc:Text",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "response"
            }
          }
        },
        {
          "@type": "cr:Field",
          "@id": "default\/__index_level_0__",
          "dataType": "cr:Int64",
          "source": {
            "fileSet": {
              "@id": "parquet-files-for-config-default"
            },
            "extract": {
              "column": "__index_level_0__"
            }
          }
        }
      ]
    }
  ],
  "conformsTo": "http:\/\/mlcommons.org\/croissant\/1.1",
  "name": "medical-o1-train-kormedmcqa",
  "description": "\n\t\n\t\t\n\t\tInformation\n\t\n\nThis data includes the training data from KorMedMCQA, as well as a portion of the trainind data from the additional KorMedMCQA support set (private).\nThis dataset is based on the responses generated by gemini-flash-thinking-exp-01-21 model and has undergone MANUAL rejection sampling.\n",
  "alternateName": [
    "ChuGyouk\/medical-o1-train-kormedmcqa"
  ],
  "creator": {
    "@type": "Person",
    "name": "ChuGyouk",
    "url": "https:\/\/huggingface.co\/ChuGyouk"
  },
  "keywords": [
    "1K - 10K",
    "parquet",
    "Tabular",
    "Text",
    "Datasets",
    "pandas",
    "Croissant",
    "Polars",
    "ðŸ‡ºðŸ‡¸ Region: US"
  ],
  "url": "https:\/\/huggingface.co\/datasets\/ChuGyouk\/medical-o1-train-kormedmcqa"
}</script> 

		<title>ChuGyouk/medical-o1-train-kormedmcqa Â· Datasets at Hugging Face</title>

		<script
			defer
			data-domain="huggingface.co"
			event-loggedIn="false"
			src="/js/script.pageview-props.js"
		></script>
		<script>
			window.plausible =
				window.plausible ||
				function () {
					(window.plausible.q = window.plausible.q || []).push(arguments);
				};
		</script>
		<script>
			window.hubConfig = {"features":{"signupDisabled":false},"sshGitUrl":"git@hf.co","moonHttpUrl":"https:\/\/huggingface.co","captchaApiKey":"bd5f2066-93dc-4bdd-a64b-a24646ca3859","captchaDisabledOnSignup":true,"datasetViewerPublicUrl":"https:\/\/datasets-server.huggingface.co","stripePublicKey":"pk_live_x2tdjFXBCvXo2FFmMybezpeM00J6gPCAAc","environment":"production","userAgent":"HuggingFace (production)","spacesIframeDomain":"hf.space","spacesApiUrl":"https:\/\/api.hf.space","docSearchKey":"ece5e02e57300e17d152c08056145326e90c4bff3dd07d7d1ae40cf1c8d39cb6","logoDev":{"apiUrl":"https:\/\/img.logo.dev\/","apiKey":"pk_UHS2HZOeRnaSOdDp7jbd5w"}};
		</script>
		<script type="text/javascript" src="https://de5282c3ca0c.edge.sdk.awswaf.com/de5282c3ca0c/526cf06acb0d/challenge.js" defer></script>
	</head>
	<body class="flex flex-col min-h-dvh bg-white dark:bg-gray-950 text-black DatasetPage">
		<div class="flex min-h-dvh flex-col"><div class="SVELTE_HYDRATER contents" data-target="SystemThemeMonitor" data-props="{&quot;isLoggedIn&quot;:false}"></div>

	<div class="SVELTE_HYDRATER contents" data-target="MainHeader" data-props="{&quot;classNames&quot;:&quot;&quot;,&quot;isWide&quot;:false,&quot;isZh&quot;:false,&quot;isPro&quot;:false}"><header class="border-b border-gray-100 "><div class="w-full px-4 container flex h-16 items-center"><div class="flex flex-1 items-center"><a class="mr-5 flex flex-none items-center lg:mr-6" href="/"><img alt="Hugging Face's logo" class="w-7 md:mr-2" src="/front/assets/huggingface_logo-noborder.svg">
				<span class="hidden whitespace-nowrap text-lg font-bold md:block">Hugging Face</span></a>
			<div class="relative flex-1 lg:max-w-sm mr-2 sm:mr-4 md:mr-3 xl:mr-6"><input autocomplete="off" class="w-full dark:bg-gray-950 pl-8 form-input-alt h-9 pr-3 focus:shadow-xl " name="" placeholder="Search models, datasets, users..."   spellcheck="false" type="text" value="">
	<svg class="absolute left-2.5 text-gray-400 top-1/2 transform -translate-y-1/2" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M30 28.59L22.45 21A11 11 0 1 0 21 22.45L28.59 30zM5 14a9 9 0 1 1 9 9a9 9 0 0 1-9-9z" fill="currentColor"></path></svg>
	</div>
			<div class="flex flex-none items-center justify-center p-0.5 place-self-stretch lg:hidden"><button class="relative z-40 flex h-6 w-8 items-center justify-center" type="button"><svg width="1em" height="1em" viewBox="0 0 10 10" class="text-xl" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" preserveAspectRatio="xMidYMid meet" fill="currentColor"><path fill-rule="evenodd" clip-rule="evenodd" d="M1.65039 2.9999C1.65039 2.8066 1.80709 2.6499 2.00039 2.6499H8.00039C8.19369 2.6499 8.35039 2.8066 8.35039 2.9999C8.35039 3.1932 8.19369 3.3499 8.00039 3.3499H2.00039C1.80709 3.3499 1.65039 3.1932 1.65039 2.9999ZM1.65039 4.9999C1.65039 4.8066 1.80709 4.6499 2.00039 4.6499H8.00039C8.19369 4.6499 8.35039 4.8066 8.35039 4.9999C8.35039 5.1932 8.19369 5.3499 8.00039 5.3499H2.00039C1.80709 5.3499 1.65039 5.1932 1.65039 4.9999ZM2.00039 6.6499C1.80709 6.6499 1.65039 6.8066 1.65039 6.9999C1.65039 7.1932 1.80709 7.3499 2.00039 7.3499H8.00039C8.19369 7.3499 8.35039 7.1932 8.35039 6.9999C8.35039 6.8066 8.19369 6.6499 8.00039 6.6499H2.00039Z"></path></svg>
		</button>

	</div></div>
		<nav aria-label="Main" class="ml-auto hidden lg:block"><ul class="flex items-center space-x-1.5 2xl:space-x-2"><li class="hover:text-indigo-700"><a class="group flex items-center px-2 py-0.5 dark:text-gray-300 dark:hover:text-gray-100" href="/models"><svg class="mr-1.5 text-gray-400 group-hover:text-indigo-500" style="" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 24 24"><path class="uim-quaternary" d="M20.23 7.24L12 12L3.77 7.24a1.98 1.98 0 0 1 .7-.71L11 2.76c.62-.35 1.38-.35 2 0l6.53 3.77c.29.173.531.418.7.71z" opacity=".25" fill="currentColor"></path><path class="uim-tertiary" d="M12 12v9.5a2.09 2.09 0 0 1-.91-.21L4.5 17.48a2.003 2.003 0 0 1-1-1.73v-7.5a2.06 2.06 0 0 1 .27-1.01L12 12z" opacity=".5" fill="currentColor"></path><path class="uim-primary" d="M20.5 8.25v7.5a2.003 2.003 0 0 1-1 1.73l-6.62 3.82c-.275.13-.576.198-.88.2V12l8.23-4.76c.175.308.268.656.27 1.01z" fill="currentColor"></path></svg>
					Models</a>
			</li><li class="hover:text-red-700"><a class="group flex items-center px-2 py-0.5 dark:text-gray-300 dark:hover:text-gray-100" href="/datasets"><svg class="mr-1.5 text-gray-400 group-hover:text-red-500" style="" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 25 25"><ellipse cx="12.5" cy="5" fill="currentColor" fill-opacity="0.25" rx="7.5" ry="2"></ellipse><path d="M12.5 15C16.6421 15 20 14.1046 20 13V20C20 21.1046 16.6421 22 12.5 22C8.35786 22 5 21.1046 5 20V13C5 14.1046 8.35786 15 12.5 15Z" fill="currentColor" opacity="0.5"></path><path d="M12.5 7C16.6421 7 20 6.10457 20 5V11.5C20 12.6046 16.6421 13.5 12.5 13.5C8.35786 13.5 5 12.6046 5 11.5V5C5 6.10457 8.35786 7 12.5 7Z" fill="currentColor" opacity="0.5"></path><path d="M5.23628 12C5.08204 12.1598 5 12.8273 5 13C5 14.1046 8.35786 15 12.5 15C16.6421 15 20 14.1046 20 13C20 12.8273 19.918 12.1598 19.7637 12C18.9311 12.8626 15.9947 13.5 12.5 13.5C9.0053 13.5 6.06886 12.8626 5.23628 12Z" fill="currentColor"></path></svg>
					Datasets</a>
			</li><li class="hover:text-blue-700"><a class="group flex items-center px-2 py-0.5 dark:text-gray-300 dark:hover:text-gray-100" href="/spaces"><svg class="mr-1.5 text-gray-400 group-hover:text-blue-500" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" viewBox="0 0 25 25"><path opacity=".5" d="M6.016 14.674v4.31h4.31v-4.31h-4.31ZM14.674 14.674v4.31h4.31v-4.31h-4.31ZM6.016 6.016v4.31h4.31v-4.31h-4.31Z" fill="currentColor"></path><path opacity=".75" fill-rule="evenodd" clip-rule="evenodd" d="M3 4.914C3 3.857 3.857 3 4.914 3h6.514c.884 0 1.628.6 1.848 1.414a5.171 5.171 0 0 1 7.31 7.31c.815.22 1.414.964 1.414 1.848v6.514A1.914 1.914 0 0 1 20.086 22H4.914A1.914 1.914 0 0 1 3 20.086V4.914Zm3.016 1.102v4.31h4.31v-4.31h-4.31Zm0 12.968v-4.31h4.31v4.31h-4.31Zm8.658 0v-4.31h4.31v4.31h-4.31Zm0-10.813a2.155 2.155 0 1 1 4.31 0 2.155 2.155 0 0 1-4.31 0Z" fill="currentColor"></path><path opacity=".25" d="M16.829 6.016a2.155 2.155 0 1 0 0 4.31 2.155 2.155 0 0 0 0-4.31Z" fill="currentColor"></path></svg>
					Spaces</a>
			</li><li class="hover:text-yellow-700 max-xl:hidden"><a class="group flex items-center px-2 py-0.5 dark:text-gray-300 dark:hover:text-gray-100" href="/posts"><svg class="mr-1.5 text-gray-400 group-hover:text-yellow-500 text-yellow-500!" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" viewBox="0 0 12 12" preserveAspectRatio="xMidYMid meet"><path fill="currentColor" fill-rule="evenodd" d="M3.73 2.4A4.25 4.25 0 1 1 6 10.26H2.17l-.13-.02a.43.43 0 0 1-.3-.43l.01-.06a.43.43 0 0 1 .12-.22l.84-.84A4.26 4.26 0 0 1 3.73 2.4Z" clip-rule="evenodd"></path></svg>
					Posts</a>
			</li><li class="hover:text-yellow-700"><a class="group flex items-center px-2 py-0.5 dark:text-gray-300 dark:hover:text-gray-100" href="/docs"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" class="mr-1.5 text-gray-400 group-hover:text-yellow-500" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 16 16"><path d="m2.28 3.7-.3.16a.67.67 0 0 0-.34.58v8.73l.01.04.02.07.01.04.03.06.02.04.02.03.04.06.05.05.04.04.06.04.06.04.08.04.08.02h.05l.07.02h.11l.04-.01.07-.02.03-.01.07-.03.22-.12a5.33 5.33 0 0 1 5.15.1.67.67 0 0 0 .66 0 5.33 5.33 0 0 1 5.33 0 .67.67 0 0 0 1-.58V4.36a.67.67 0 0 0-.34-.5l-.3-.17v7.78a.63.63 0 0 1-.87.59 4.9 4.9 0 0 0-4.35.35l-.65.39a.29.29 0 0 1-.15.04.29.29 0 0 1-.16-.04l-.65-.4a4.9 4.9 0 0 0-4.34-.34.63.63 0 0 1-.87-.59V3.7Z" fill="currentColor" class="dark:opacity-40"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M8 3.1a5.99 5.99 0 0 0-5.3-.43.66.66 0 0 0-.42.62v8.18c0 .45.46.76.87.59a4.9 4.9 0 0 1 4.34.35l.65.39c.05.03.1.04.16.04.05 0 .1-.01.15-.04l.65-.4a4.9 4.9 0 0 1 4.35-.34.63.63 0 0 0 .86-.59V3.3a.67.67 0 0 0-.41-.62 5.99 5.99 0 0 0-5.3.43l-.3.17L8 3.1Zm.73 1.87a.43.43 0 1 0-.86 0v5.48a.43.43 0 0 0 .86 0V4.97Z" fill="currentColor" class="opacity-40 dark:opacity-100"></path><path d="M8.73 4.97a.43.43 0 1 0-.86 0v5.48a.43.43 0 1 0 .86 0V4.96Z" fill="currentColor" class="dark:opacity-40"></path></svg>
					Docs</a>
			</li><li class="hover:text-black dark:hover:text-white"><a class="group flex items-center px-2 py-0.5 dark:text-gray-300 dark:hover:text-gray-100" href="/enterprise"><svg class="mr-1.5 text-gray-400 group-hover:text-black dark:group-hover:text-white" xmlns="http://www.w3.org/2000/svg" fill="none" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 33 27"><path fill="currentColor" fill-rule="evenodd" d="M13.5.7a8.7 8.7 0 0 0-7.7 5.7L1 20.6c-1 3.1.9 5.7 4.1 5.7h15c3.3 0 6.8-2.6 7.8-5.7l4.6-14.2c1-3.1-.8-5.7-4-5.7h-15Zm1.1 5.7L9.8 20.3h9.8l1-3.1h-5.8l.8-2.5h4.8l1.1-3h-4.8l.8-2.3H23l1-3h-9.5Z" clip-rule="evenodd"></path></svg>
					Enterprise</a>
			</li>

		<li><a class="group flex items-center px-2 py-0.5 dark:text-gray-300 dark:hover:text-gray-100" href="/pricing">Pricing
			</a></li>

		<li><div class="relative group">
	<button class="px-2 py-0.5 hover:text-gray-500 dark:hover:text-gray-600 flex items-center " type="button">
		<svg class=" text-gray-500 w-5 group-hover:text-gray-400 dark:text-gray-300 dark:group-hover:text-gray-100" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" viewBox="0 0 32 18" preserveAspectRatio="xMidYMid meet"><path fill-rule="evenodd" clip-rule="evenodd" d="M14.4504 3.30221C14.4504 2.836 14.8284 2.45807 15.2946 2.45807H28.4933C28.9595 2.45807 29.3374 2.836 29.3374 3.30221C29.3374 3.76842 28.9595 4.14635 28.4933 4.14635H15.2946C14.8284 4.14635 14.4504 3.76842 14.4504 3.30221Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M14.4504 9.00002C14.4504 8.53382 14.8284 8.15588 15.2946 8.15588H28.4933C28.9595 8.15588 29.3374 8.53382 29.3374 9.00002C29.3374 9.46623 28.9595 9.84417 28.4933 9.84417H15.2946C14.8284 9.84417 14.4504 9.46623 14.4504 9.00002Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M14.4504 14.6978C14.4504 14.2316 14.8284 13.8537 15.2946 13.8537H28.4933C28.9595 13.8537 29.3374 14.2316 29.3374 14.6978C29.3374 15.164 28.9595 15.542 28.4933 15.542H15.2946C14.8284 15.542 14.4504 15.164 14.4504 14.6978Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M1.94549 6.87377C2.27514 6.54411 2.80962 6.54411 3.13928 6.87377L6.23458 9.96907L9.32988 6.87377C9.65954 6.54411 10.194 6.54411 10.5237 6.87377C10.8533 7.20343 10.8533 7.73791 10.5237 8.06756L6.23458 12.3567L1.94549 8.06756C1.61583 7.73791 1.61583 7.20343 1.94549 6.87377Z" fill="currentColor"></path></svg>
			
		</button>
	
	
	</div></li>
		<li><hr class="h-5 w-0.5 border-none bg-gray-100 dark:bg-gray-800"></li>
		<li><a class="block cursor-pointer whitespace-nowrap px-2 py-0.5 hover:text-gray-500 dark:text-gray-300 dark:hover:text-gray-100" href="/login">Log In
				</a></li>
			<li><a class="whitespace-nowrap rounded-full border border-transparent bg-gray-900 px-3 py-1 leading-none text-white hover:border-black hover:bg-white hover:text-black" href="/join">Sign Up
					</a></li></ul></nav></div></header></div>
	
	
	
	<div class="SVELTE_HYDRATER contents" data-target="SSOBanner" data-props="{}"></div>
	
	

	<main class="flex flex-1 flex-col">
	<div class="SVELTE_HYDRATER contents" data-target="DatasetHeader" data-props="{&quot;activeTab&quot;:&quot;datasetCard&quot;,&quot;author&quot;:{&quot;_id&quot;:&quot;64ad53921db46d71a5c576e5&quot;,&quot;avatarUrl&quot;:&quot;https://cdn-avatars.huggingface.co/v1/production/uploads/64ad53921db46d71a5c576e5/fH08R-GANVBhZdYCDQjeG.png&quot;,&quot;fullname&quot;:&quot;ChuGyouk&quot;,&quot;name&quot;:&quot;ChuGyouk&quot;,&quot;type&quot;:&quot;user&quot;,&quot;isPro&quot;:true,&quot;isHf&quot;:false,&quot;isHfAdmin&quot;:false,&quot;isMod&quot;:false,&quot;followerCount&quot;:21},&quot;canReadRepoSettings&quot;:false,&quot;dataset&quot;:{&quot;author&quot;:&quot;ChuGyouk&quot;,&quot;cardData&quot;:{&quot;dataset_info&quot;:{&quot;features&quot;:[{&quot;name&quot;:&quot;subject&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;year&quot;,&quot;dtype&quot;:&quot;int64&quot;},{&quot;name&quot;:&quot;period&quot;,&quot;dtype&quot;:&quot;int64&quot;},{&quot;name&quot;:&quot;q_number&quot;,&quot;dtype&quot;:&quot;int64&quot;},{&quot;name&quot;:&quot;question&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;A&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;B&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;C&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;D&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;E&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;answer&quot;,&quot;dtype&quot;:&quot;int64&quot;},{&quot;name&quot;:&quot;thinking&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;response&quot;,&quot;dtype&quot;:&quot;string&quot;},{&quot;name&quot;:&quot;__index_level_0__&quot;,&quot;dtype&quot;:&quot;int64&quot;}],&quot;splits&quot;:[{&quot;name&quot;:&quot;train&quot;,&quot;num_bytes&quot;:76942094,&quot;num_examples&quot;:8751}],&quot;download_size&quot;:38580816,&quot;dataset_size&quot;:76942094},&quot;configs&quot;:[{&quot;config_name&quot;:&quot;default&quot;,&quot;data_files&quot;:[{&quot;split&quot;:&quot;train&quot;,&quot;path&quot;:&quot;data/train-*&quot;}]}]},&quot;cardExists&quot;:true,&quot;createdAt&quot;:&quot;2025-02-17T16:00:27.000Z&quot;,&quot;description&quot;:&quot;\n\t\n\t\t\n\t\tInformation\n\t\n\nThis data includes the training data from KorMedMCQA, as well as a portion of the trainind data from the additional KorMedMCQA support set (private).\nThis dataset is based on the responses generated by gemini-flash-thinking-exp-01-21 model and has undergone MANUAL rejection sampling.\n&quot;,&quot;downloads&quot;:22,&quot;downloadsAllTime&quot;:22,&quot;id&quot;:&quot;ChuGyouk/medical-o1-train-kormedmcqa&quot;,&quot;isLikedByUser&quot;:false,&quot;lastModified&quot;:&quot;2025-03-21T06:06:33.000Z&quot;,&quot;likes&quot;:5,&quot;datasetsServerInfo&quot;:{&quot;viewer&quot;:&quot;viewer&quot;,&quot;numRows&quot;:8751,&quot;libraries&quot;:[&quot;datasets&quot;,&quot;pandas&quot;,&quot;mlcroissant&quot;,&quot;polars&quot;],&quot;formats&quot;:[&quot;parquet&quot;],&quot;modalities&quot;:[&quot;tabular&quot;,&quot;text&quot;]},&quot;discussionsDisabled&quot;:false,&quot;repoType&quot;:&quot;dataset&quot;,&quot;private&quot;:false,&quot;gated&quot;:false,&quot;tags&quot;:[&quot;size_categories:1K<n<10K&quot;,&quot;format:parquet&quot;,&quot;modality:tabular&quot;,&quot;modality:text&quot;,&quot;library:datasets&quot;,&quot;library:pandas&quot;,&quot;library:mlcroissant&quot;,&quot;library:polars&quot;,&quot;region:us&quot;],&quot;tag_objs&quot;:[{&quot;id&quot;:&quot;size_categories:1K<n<10K&quot;,&quot;label&quot;:&quot;1K - 10K&quot;,&quot;type&quot;:&quot;size_categories&quot;},{&quot;id&quot;:&quot;format:parquet&quot;,&quot;label&quot;:&quot;parquet&quot;,&quot;type&quot;:&quot;format&quot;},{&quot;id&quot;:&quot;modality:tabular&quot;,&quot;label&quot;:&quot;Tabular&quot;,&quot;type&quot;:&quot;modality&quot;},{&quot;id&quot;:&quot;modality:text&quot;,&quot;label&quot;:&quot;Text&quot;,&quot;type&quot;:&quot;modality&quot;},{&quot;id&quot;:&quot;library:datasets&quot;,&quot;label&quot;:&quot;Datasets&quot;,&quot;type&quot;:&quot;library&quot;},{&quot;id&quot;:&quot;library:pandas&quot;,&quot;label&quot;:&quot;pandas&quot;,&quot;type&quot;:&quot;library&quot;},{&quot;id&quot;:&quot;library:mlcroissant&quot;,&quot;label&quot;:&quot;Croissant&quot;,&quot;type&quot;:&quot;library&quot;},{&quot;id&quot;:&quot;library:polars&quot;,&quot;label&quot;:&quot;Polars&quot;,&quot;type&quot;:&quot;library&quot;},{&quot;type&quot;:&quot;region&quot;,&quot;label&quot;:&quot;ðŸ‡ºðŸ‡¸ Region: US&quot;,&quot;id&quot;:&quot;region:us&quot;}],&quot;hasBlockedOids&quot;:false,&quot;region&quot;:&quot;us&quot;,&quot;xetEnabled&quot;:false},&quot;discussionsStats&quot;:{&quot;closed&quot;:0,&quot;open&quot;:1,&quot;total&quot;:1}}"><header class="bg-linear-to-t border-b border-gray-100 pt-6 sm:pt-9 from-gray-50-to-white via-white dark:via-gray-950"><div class="container relative "><h1 class="flex flex-wrap items-center max-md:leading-tight mb-3 text-lg max-sm:gap-y-1.5 md:text-xl"><a href="/datasets" class="group flex items-center"><svg class="sm:mr-1.5 -mr-1 text-gray-400" style="" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 25 25"><ellipse cx="12.5" cy="5" fill="currentColor" fill-opacity="0.25" rx="7.5" ry="2"></ellipse><path d="M12.5 15C16.6421 15 20 14.1046 20 13V20C20 21.1046 16.6421 22 12.5 22C8.35786 22 5 21.1046 5 20V13C5 14.1046 8.35786 15 12.5 15Z" fill="currentColor" opacity="0.5"></path><path d="M12.5 7C16.6421 7 20 6.10457 20 5V11.5C20 12.6046 16.6421 13.5 12.5 13.5C8.35786 13.5 5 12.6046 5 11.5V5C5 6.10457 8.35786 7 12.5 7Z" fill="currentColor" opacity="0.5"></path><path d="M5.23628 12C5.08204 12.1598 5 12.8273 5 13C5 14.1046 8.35786 15 12.5 15C16.6421 15 20 14.1046 20 13C20 12.8273 19.918 12.1598 19.7637 12C18.9311 12.8626 15.9947 13.5 12.5 13.5C9.0053 13.5 6.06886 12.8626 5.23628 12Z" fill="currentColor"></path></svg>
					<span class="mr-2.5 font-semibold text-gray-400 group-hover:text-gray-500 max-sm:hidden">Datasets:</span></a>
				<hr class="mx-1.5 h-2 translate-y-px rounded-sm border-r dark:border-gray-600 sm:hidden">
			<div class="group flex flex-none items-center"><div class="relative mr-1 flex items-center">

			

<span class="inline-block "><span class="contents"><a href="/ChuGyouk" class="text-gray-400 hover:text-blue-600"><img alt="" class="w-3.5 h-3.5 rounded-full  flex-none" src="https://cdn-avatars.huggingface.co/v1/production/uploads/64ad53921db46d71a5c576e5/fH08R-GANVBhZdYCDQjeG.png" crossorigin="anonymous"></a></span>
	</span></div>
		

<span class="inline-block "><span class="contents"><a href="/ChuGyouk" class="text-gray-400 hover:text-blue-600">ChuGyouk</a></span>
	</span>
		<div class="mx-0.5 text-gray-300">/</div></div>

<div class="max-w-full "><a class="break-words font-mono font-semibold hover:text-blue-600 " href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa">medical-o1-train-kormedmcqa</a>
	<button class="relative text-sm mr-4 focus:outline-hidden inline-flex cursor-pointer items-center text-sm  mx-0.5   text-gray-600 " title="Copy dataset name to clipboard" type="button"><svg class="" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" fill="currentColor" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M28,10V28H10V10H28m0-2H10a2,2,0,0,0-2,2V28a2,2,0,0,0,2,2H28a2,2,0,0,0,2-2V10a2,2,0,0,0-2-2Z" transform="translate(0)"></path><path d="M4,18H2V4A2,2,0,0,1,4,2H18V4H4Z" transform="translate(0)"></path><rect fill="none" width="32" height="32"></rect></svg>
	
	</button></div>
			<div class="inline-flex items-center overflow-hidden whitespace-nowrap rounded-md border bg-white text-sm leading-none text-gray-500  mr-2"><button class="relative flex items-center overflow-hidden from-red-50 to-transparent dark:from-red-900 px-1.5 py-1 hover:bg-linear-to-t focus:outline-hidden"  title="Like"><svg class="left-1.5 absolute" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32" fill="currentColor"><path d="M22.45,6a5.47,5.47,0,0,1,3.91,1.64,5.7,5.7,0,0,1,0,8L16,26.13,5.64,15.64a5.7,5.7,0,0,1,0-8,5.48,5.48,0,0,1,7.82,0L16,10.24l2.53-2.58A5.44,5.44,0,0,1,22.45,6m0-2a7.47,7.47,0,0,0-5.34,2.24L16,7.36,14.89,6.24a7.49,7.49,0,0,0-10.68,0,7.72,7.72,0,0,0,0,10.82L16,29,27.79,17.06a7.72,7.72,0,0,0,0-10.82A7.49,7.49,0,0,0,22.45,4Z"></path></svg>

		
		<span class="ml-4 pl-0.5 ">like</span></button>
	<button class="focus:outline-hidden flex items-center border-l px-1.5 py-1 text-gray-400 hover:bg-gray-50 focus:bg-gray-100 dark:hover:bg-gray-900 dark:focus:bg-gray-800" title="See users who liked this repository">5</button></div>




			
			
	</h1>
		<div class="mb-3 flex flex-wrap md:mb-4"><div class="mr-1 flex flex-wrap items-center"><span class="mb-1 mr-1 p-1 text-sm leading-tight text-gray-400 md:mb-1.5">Modalities:
	</span>
	<a class="mb-1 mr-1 md:mb-1.5 md:mr-1.5 rounded-lg" href="/datasets?modality=modality%3Atabular"><div class="tag tag-white   ">
		<svg class="" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path fill-rule="evenodd" clip-rule="evenodd" d="M4.619 4.619C2.667 6.572 2.667 9.715 2.667 16s0 9.43 1.952 11.38C6.572 29.333 9.715 29.333 16 29.333s9.43 0 11.38-1.953c1.953-1.952 1.953-5.095 1.953-11.38 0-6.285 0-9.427-1.953-11.381C25.428 2.667 22.285 2.667 16 2.667c-6.285 0-9.427 0-11.381 1.952ZM16.615 10a1 1 0 1 1 0 2h-1.23a1 1 0 1 1 0-2h1.23Zm0 5a1 1 0 1 1 0 2h-1.23a1 1 0 1 1 0-2h1.23Zm3.154 1a1 1 0 0 0 1 1H22a1 1 0 1 0 0-2h-1.23a1 1 0 0 0-1 1Zm-3.154 4a1 1 0 1 1 0 2h-1.23a1 1 0 1 1 0-2h1.23Zm3.154 1a1 1 0 0 0 1 1H22a1 1 0 1 0 0-2h-1.23a1 1 0 0 0-1 1Zm0-10a1 1 0 0 0 1 1H22a1 1 0 1 0 0-2h-1.23a1 1 0 0 0-1 1Zm-8.538-1H10a1 1 0 1 0 0 2h1.23a1 1 0 1 0 0-2Zm0 5H10a1 1 0 1 0 0 2h1.23a1 1 0 1 0 0-2Zm0 5H10a1 1 0 1 0 0 2h1.23a1 1 0 1 0 0-2Z" fill="currentColor"></path></svg>

	

	<span>Tabular</span>
	

	</div></a><a class="mb-1 mr-1 md:mb-1.5 md:mr-1.5 rounded-lg" href="/datasets?modality=modality%3Atext"><div class="tag tag-white   ">
		<svg class="text-red-700 dark:text-red-600" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path fill-rule="evenodd" clip-rule="evenodd" d="M4.619 4.619C2.667 6.573 2.667 9.715 2.667 16s0 9.428 1.952 11.38C6.573 29.333 9.715 29.333 16 29.333s9.428 0 11.38-1.953c1.953-1.95 1.953-5.095 1.953-11.38s0-9.428-1.953-11.381C25.43 2.667 22.285 2.667 16 2.667s-9.428 0-11.381 1.952m8.65 3.714c-.573 0-1.109 0-1.546.066-.495.073-1.003.248-1.41.7-.392.436-.53.956-.59 1.452-.056.464-.056 1.04-.056 1.689V13a1 1 0 1 0 2 0v-.704c0-.724.001-1.176.041-1.505q.015-.15.061-.294a.2.2 0 0 1 .031-.061q0-.003.016-.01a.8.8 0 0 1 .203-.05c.272-.04.654-.043 1.314-.043H15v11.334h-2.333a1 1 0 1 0 0 2H20a1 1 0 0 0 0-2h-3V10.333h1.667c.66 0 1.042.003 1.314.043.123.019.18.04.203.05l.015.009a.2.2 0 0 1 .032.061c.018.05.042.14.061.295.04.329.041.781.041 1.506V13a1 1 0 1 0 2 0v-.76c0-.65 0-1.225-.056-1.69-.06-.495-.198-1.015-.59-1.453-.407-.45-.915-.625-1.41-.698-.437-.067-.973-.067-1.546-.066z" fill="currentColor"></path></svg>

	

	<span>Text</span>
	

	</div></a>

	</div><div class="mr-1 flex flex-wrap items-center"><span class="mb-1 mr-1 p-1 text-sm leading-tight text-gray-400 md:mb-1.5">Formats:
	</span>
	<a class="mb-1 mr-1 md:mb-1.5 md:mr-1.5 rounded-lg" href="/datasets?format=format%3Aparquet"><div class="tag tag-white   ">
		<svg class="" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 34 34"><path fill-rule="evenodd" clip-rule="evenodd" d="m17.97 18.44-3.98-2.3-7.1 3.78 3.98 2.3 7.1-3.78Zm15.1-1.4-3.99-2.3-16.22 8.63 3.98 2.3 16.22-8.63Zm-5.98-3.45-3.97-2.3-7.1 3.78 3.98 2.3 7.1-3.78Zm-9.94-5.74 3.98 2.3-11.16 5.93L6 13.78l11.16-5.93Zm-13.19 7 3.98 2.3-3.04 1.62-3.98-2.3 3.04-1.61Z" fill="currentColor"></path></svg>

	

	<span>parquet</span>
	

	</div></a>

	</div><div class="mr-1 flex flex-wrap items-center"><span class="mb-1 mr-1 p-1 text-sm leading-tight text-gray-400 md:mb-1.5">Size:
	</span>
	<a class="mb-1 mr-1 md:mb-1.5 md:mr-1.5 rounded-lg" href="/datasets?size_categories=size_categories%3A1K%3Cn%3C10K"><div class="tag tag-white   ">

	

	<span>1K - 10K</span>
	

	</div></a>

	</div><div class="mr-1 flex flex-wrap items-center"><span class="mb-1 mr-1 p-1 text-sm leading-tight text-gray-400 md:mb-1.5">Libraries:
	</span>
	<a class="mb-1 mr-1 md:mb-1.5 md:mr-1.5 rounded-lg" href="/datasets?library=library%3Adatasets"><div class="tag tag-white   "><svg class="text-black inline-block text-sm" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" preserveAspectRatio="xMidYMid meet" width="1em" height="1em" viewBox="0 0 95 88"><path fill="#fff" d="M94.25 70.08a8.28 8.28 0 0 1-.43 6.46 10.57 10.57 0 0 1-3 3.6 25.18 25.18 0 0 1-5.7 3.2 65.74 65.74 0 0 1-7.56 2.65 46.67 46.67 0 0 1-11.42 1.68c-5.42.05-10.09-1.23-13.4-4.5a40.4 40.4 0 0 1-10.14.03c-3.34 3.25-7.99 4.52-13.39 4.47a46.82 46.82 0 0 1-11.43-1.68 66.37 66.37 0 0 1-7.55-2.65c-2.28-.98-4.17-2-5.68-3.2a10.5 10.5 0 0 1-3.02-3.6c-.99-2-1.18-4.3-.42-6.46a8.54 8.54 0 0 1-.33-5.63c.25-.95.66-1.83 1.18-2.61a8.67 8.67 0 0 1 2.1-8.47 8.23 8.23 0 0 1 2.82-2.07 41.75 41.75 0 1 1 81.3-.12 8.27 8.27 0 0 1 3.11 2.19 8.7 8.7 0 0 1 2.1 8.47c.52.78.93 1.66 1.18 2.61a8.61 8.61 0 0 1-.32 5.63Z"></path><path fill="#FFD21E" d="M47.21 76.5a34.75 34.75 0 1 0 0-69.5 34.75 34.75 0 0 0 0 69.5Z"></path><path fill="#FF9D0B" d="M81.96 41.75a34.75 34.75 0 1 0-69.5 0 34.75 34.75 0 0 0 69.5 0Zm-73.5 0a38.75 38.75 0 1 1 77.5 0 38.75 38.75 0 0 1-77.5 0Z"></path><path fill="#3A3B45" d="M58.5 32.3c1.28.44 1.78 3.06 3.07 2.38a5 5 0 1 0-6.76-2.07c.61 1.15 2.55-.72 3.7-.32ZM34.95 32.3c-1.28.44-1.79 3.06-3.07 2.38a5 5 0 1 1 6.76-2.07c-.61 1.15-2.56-.72-3.7-.32Z"></path><path fill="#FF323D" d="M46.96 56.29c9.83 0 13-8.76 13-13.26 0-2.34-1.57-1.6-4.09-.36-2.33 1.15-5.46 2.74-8.9 2.74-7.19 0-13-6.88-13-2.38s3.16 13.26 13 13.26Z"></path><path fill="#3A3B45" fill-rule="evenodd" d="M39.43 54a8.7 8.7 0 0 1 5.3-4.49c.4-.12.81.57 1.24 1.28.4.68.82 1.37 1.24 1.37.45 0 .9-.68 1.33-1.35.45-.7.89-1.38 1.32-1.25a8.61 8.61 0 0 1 5 4.17c3.73-2.94 5.1-7.74 5.1-10.7 0-2.34-1.57-1.6-4.09-.36l-.14.07c-2.31 1.15-5.39 2.67-8.77 2.67s-6.45-1.52-8.77-2.67c-2.6-1.29-4.23-2.1-4.23.29 0 3.05 1.46 8.06 5.47 10.97Z" clip-rule="evenodd"></path><path fill="#FF9D0B" d="M70.71 37a3.25 3.25 0 1 0 0-6.5 3.25 3.25 0 0 0 0 6.5ZM24.21 37a3.25 3.25 0 1 0 0-6.5 3.25 3.25 0 0 0 0 6.5ZM17.52 48c-1.62 0-3.06.66-4.07 1.87a5.97 5.97 0 0 0-1.33 3.76 7.1 7.1 0 0 0-1.94-.3c-1.55 0-2.95.59-3.94 1.66a5.8 5.8 0 0 0-.8 7 5.3 5.3 0 0 0-1.79 2.82c-.24.9-.48 2.8.8 4.74a5.22 5.22 0 0 0-.37 5.02c1.02 2.32 3.57 4.14 8.52 6.1 3.07 1.22 5.89 2 5.91 2.01a44.33 44.33 0 0 0 10.93 1.6c5.86 0 10.05-1.8 12.46-5.34 3.88-5.69 3.33-10.9-1.7-15.92-2.77-2.78-4.62-6.87-5-7.77-.78-2.66-2.84-5.62-6.25-5.62a5.7 5.7 0 0 0-4.6 2.46c-1-1.26-1.98-2.25-2.86-2.82A7.4 7.4 0 0 0 17.52 48Zm0 4c.51 0 1.14.22 1.82.65 2.14 1.36 6.25 8.43 7.76 11.18.5.92 1.37 1.31 2.14 1.31 1.55 0 2.75-1.53.15-3.48-3.92-2.93-2.55-7.72-.68-8.01.08-.02.17-.02.24-.02 1.7 0 2.45 2.93 2.45 2.93s2.2 5.52 5.98 9.3c3.77 3.77 3.97 6.8 1.22 10.83-1.88 2.75-5.47 3.58-9.16 3.58-3.81 0-7.73-.9-9.92-1.46-.11-.03-13.45-3.8-11.76-7 .28-.54.75-.76 1.34-.76 2.38 0 6.7 3.54 8.57 3.54.41 0 .7-.17.83-.6.79-2.85-12.06-4.05-10.98-8.17.2-.73.71-1.02 1.44-1.02 3.14 0 10.2 5.53 11.68 5.53.11 0 .2-.03.24-.1.74-1.2.33-2.04-4.9-5.2-5.21-3.16-8.88-5.06-6.8-7.33.24-.26.58-.38 1-.38 3.17 0 10.66 6.82 10.66 6.82s2.02 2.1 3.25 2.1c.28 0 .52-.1.68-.38.86-1.46-8.06-8.22-8.56-11.01-.34-1.9.24-2.85 1.31-2.85Z"></path><path fill="#FFD21E" d="M38.6 76.69c2.75-4.04 2.55-7.07-1.22-10.84-3.78-3.77-5.98-9.3-5.98-9.3s-.82-3.2-2.69-2.9c-1.87.3-3.24 5.08.68 8.01 3.91 2.93-.78 4.92-2.29 2.17-1.5-2.75-5.62-9.82-7.76-11.18-2.13-1.35-3.63-.6-3.13 2.2.5 2.79 9.43 9.55 8.56 11-.87 1.47-3.93-1.71-3.93-1.71s-9.57-8.71-11.66-6.44c-2.08 2.27 1.59 4.17 6.8 7.33 5.23 3.16 5.64 4 4.9 5.2-.75 1.2-12.28-8.53-13.36-4.4-1.08 4.11 11.77 5.3 10.98 8.15-.8 2.85-9.06-5.38-10.74-2.18-1.7 3.21 11.65 6.98 11.76 7.01 4.3 1.12 15.25 3.49 19.08-2.12Z"></path><path fill="#FF9D0B" d="M77.4 48c1.62 0 3.07.66 4.07 1.87a5.97 5.97 0 0 1 1.33 3.76 7.1 7.1 0 0 1 1.95-.3c1.55 0 2.95.59 3.94 1.66a5.8 5.8 0 0 1 .8 7 5.3 5.3 0 0 1 1.78 2.82c.24.9.48 2.8-.8 4.74a5.22 5.22 0 0 1 .37 5.02c-1.02 2.32-3.57 4.14-8.51 6.1-3.08 1.22-5.9 2-5.92 2.01a44.33 44.33 0 0 1-10.93 1.6c-5.86 0-10.05-1.8-12.46-5.34-3.88-5.69-3.33-10.9 1.7-15.92 2.78-2.78 4.63-6.87 5.01-7.77.78-2.66 2.83-5.62 6.24-5.62a5.7 5.7 0 0 1 4.6 2.46c1-1.26 1.98-2.25 2.87-2.82A7.4 7.4 0 0 1 77.4 48Zm0 4c-.51 0-1.13.22-1.82.65-2.13 1.36-6.25 8.43-7.76 11.18a2.43 2.43 0 0 1-2.14 1.31c-1.54 0-2.75-1.53-.14-3.48 3.91-2.93 2.54-7.72.67-8.01a1.54 1.54 0 0 0-.24-.02c-1.7 0-2.45 2.93-2.45 2.93s-2.2 5.52-5.97 9.3c-3.78 3.77-3.98 6.8-1.22 10.83 1.87 2.75 5.47 3.58 9.15 3.58 3.82 0 7.73-.9 9.93-1.46.1-.03 13.45-3.8 11.76-7-.29-.54-.75-.76-1.34-.76-2.38 0-6.71 3.54-8.57 3.54-.42 0-.71-.17-.83-.6-.8-2.85 12.05-4.05 10.97-8.17-.19-.73-.7-1.02-1.44-1.02-3.14 0-10.2 5.53-11.68 5.53-.1 0-.19-.03-.23-.1-.74-1.2-.34-2.04 4.88-5.2 5.23-3.16 8.9-5.06 6.8-7.33-.23-.26-.57-.38-.98-.38-3.18 0-10.67 6.82-10.67 6.82s-2.02 2.1-3.24 2.1a.74.74 0 0 1-.68-.38c-.87-1.46 8.05-8.22 8.55-11.01.34-1.9-.24-2.85-1.31-2.85Z"></path><path fill="#FFD21E" d="M56.33 76.69c-2.75-4.04-2.56-7.07 1.22-10.84 3.77-3.77 5.97-9.3 5.97-9.3s.82-3.2 2.7-2.9c1.86.3 3.23 5.08-.68 8.01-3.92 2.93.78 4.92 2.28 2.17 1.51-2.75 5.63-9.82 7.76-11.18 2.13-1.35 3.64-.6 3.13 2.2-.5 2.79-9.42 9.55-8.55 11 .86 1.47 3.92-1.71 3.92-1.71s9.58-8.71 11.66-6.44c2.08 2.27-1.58 4.17-6.8 7.33-5.23 3.16-5.63 4-4.9 5.2.75 1.2 12.28-8.53 13.36-4.4 1.08 4.11-11.76 5.3-10.97 8.15.8 2.85 9.05-5.38 10.74-2.18 1.69 3.21-11.65 6.98-11.76 7.01-4.31 1.12-15.26 3.49-19.08-2.12Z"></path></svg>

	

	<span>Datasets</span>
	

	</div></a><a class="mb-1 mr-1 md:mb-1.5 md:mr-1.5 rounded-lg" href="/datasets?library=library%3Apandas"><div class="tag tag-white   "><svg class="text-black inline-block text-sm text-[#130754] dark:text-gray-200" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" fill="currentColor" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid slice" viewBox="0 0 210.21 280.43"><rect fill="currentColor" x="74.51" y="43.03" width="24.09" height="50.02"></rect><rect fill="currentColor" x="74.51" y="145.78" width="24.09" height="50.02"></rect><rect fill="#ffca00" x="74.51" y="107.65" width="24.09" height="23.6"></rect><rect fill="currentColor" x="35.81" y="84.15" width="24.09" height="166.27"></rect><rect fill="currentColor" x="112.41" y="187.05" width="24.09" height="50.02"></rect><rect fill="currentColor" x="112.41" y="84.21" width="24.09" height="50.02"></rect><rect fill="#e70488" x="112.41" y="148.84" width="24.09" height="23.6"></rect><rect fill="currentColor" x="150.3" y="30" width="24.09" height="166.27"></rect></svg>

	

	<span>pandas</span>
	

	</div></a><div class="relative inline-block ">
	<button class="group mr-1 mb-1 md:mr-1.5 md:mb-1.5  rounded-lg rounded-br-none " type="button">
		<div class="tag tag-white   relative rounded-br-none pr-2.5"><svg class="text-black inline-block text-sm" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" fill="none" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M22.2812 12.2656L25.9532 15.7187C26.8932 16.6587 28.0913 17.3931 29.0313 16.4531C29.8594 15.7812 29.9332 14.1 29.9532 13.5C29.9532 11.5625 28.9219 8.375 27.25 6.71875C25.5604 5.04493 23.3782 3.91692 22.7032 3.78125L22.2812 12.2656Z" fill="#F5AB6A"></path><path d="M22.2812 12.2656L25.9532 15.7187C26.8932 16.6587 28.0913 17.3931 29.0313 16.4531C29.8594 15.7812 29.9332 14.1 29.9532 13.5C29.9532 11.5625 28.9219 8.375 27.25 6.71875C25.5604 5.04493 23.3782 3.91692 22.7032 3.78125L22.2812 12.2656Z" fill="url(#paint0_radial_18_31665)"></path><g filter="url(#filter0_f_18_31665)"><path d="M22.2849 12.1817L23.4375 13.2656L24.4375 4.70312C23.5121 4.1242 23.0198 3.96369 22.6563 3.89062L22.2849 12.1817Z" fill="url(#paint1_linear_18_31665)"></path></g><path d="M22.7969 3.05741L21.8437 2.65269C19.6421 1.96765 17.2344 1.81208 14.6719 2.23236C12.1094 2.65264 11.5156 3.2442 11.5156 3.2442C10.896 3.3674 10.8671 3.88898 11.1718 4.45363C13.0797 6.72576 15.176 13.4043 18.0469 14.2506C18.89 14.4662 21.3791 14.4776 22.2019 14.1593L22.3238 14.108C22.6692 13.9745 23.1672 13.2814 23.1875 12.9118L23.4219 4.03043C23.4523 3.59924 23.1484 3.25204 22.7969 3.05741Z" fill="url(#paint2_radial_18_31665)"></path><path d="M22.7969 3.05741L21.8437 2.65269C19.6421 1.96765 17.2344 1.81208 14.6719 2.23236C12.1094 2.65264 11.5156 3.2442 11.5156 3.2442C10.896 3.3674 10.8671 3.88898 11.1718 4.45363C13.0797 6.72576 15.176 13.4043 18.0469 14.2506C18.89 14.4662 21.3791 14.4776 22.2019 14.1593L22.3238 14.108C22.6692 13.9745 23.1672 13.2814 23.1875 12.9118L23.4219 4.03043C23.4523 3.59924 23.1484 3.25204 22.7969 3.05741Z" fill="url(#paint3_radial_18_31665)"></path><path d="M22.7969 3.05741L21.8437 2.65269C19.6421 1.96765 17.2344 1.81208 14.6719 2.23236C12.1094 2.65264 11.5156 3.2442 11.5156 3.2442C10.896 3.3674 10.8671 3.88898 11.1718 4.45363C13.0797 6.72576 15.176 13.4043 18.0469 14.2506C18.89 14.4662 21.3791 14.4776 22.2019 14.1593L22.3238 14.108C22.6692 13.9745 23.1672 13.2814 23.1875 12.9118L23.4219 4.03043C23.4523 3.59924 23.1484 3.25204 22.7969 3.05741Z" fill="url(#paint4_radial_18_31665)"></path><path d="M22.7969 3.05741L21.8437 2.65269C19.6421 1.96765 17.2344 1.81208 14.6719 2.23236C12.1094 2.65264 11.5156 3.2442 11.5156 3.2442C10.896 3.3674 10.8671 3.88898 11.1718 4.45363C13.0797 6.72576 15.176 13.4043 18.0469 14.2506C18.89 14.4662 21.3791 14.4776 22.2019 14.1593L22.3238 14.108C22.6692 13.9745 23.1672 13.2814 23.1875 12.9118L23.4219 4.03043C23.4523 3.59924 23.1484 3.25204 22.7969 3.05741Z" fill="url(#paint5_radial_18_31665)"></path><path d="M22.7969 3.05741L21.8437 2.65269C19.6421 1.96765 17.2344 1.81208 14.6719 2.23236C12.1094 2.65264 11.5156 3.2442 11.5156 3.2442C10.896 3.3674 10.8671 3.88898 11.1718 4.45363C13.0797 6.72576 15.176 13.4043 18.0469 14.2506C18.89 14.4662 21.3791 14.4776 22.2019 14.1593L22.3238 14.108C22.6692 13.9745 23.1672 13.2814 23.1875 12.9118L23.4219 4.03043C23.4523 3.59924 23.1484 3.25204 22.7969 3.05741Z" fill="url(#paint6_linear_18_31665)"></path><g filter="url(#filter1_f_18_31665)"><path d="M13.1016 2.72656C11.862 3.06924 11.5298 3.40016 11.5298 3.40016C10.9102 3.52335 10.936 4.11525 11.2408 4.6799C13.1487 6.95202 15.1361 13.2496 18.007 14.0958C18.2707 14.1633 18.6953 14.2107 19.1797 14.2344L13.1016 2.72656Z" fill="url(#paint7_linear_18_31665)"></path></g><path d="M12.2187 22.7187L15.7656 26.2031C16.7332 27.1171 17.3334 28.2487 16.4219 29.2188C15.7749 30.0687 14.2241 29.9933 13.625 30.0313C11.6883 30.0891 9.09014 29.5622 6.84373 27.5313C5.07737 25.9343 4.09321 23.688 3.93751 23.0156L12.2187 22.7187Z" fill="url(#paint8_radial_18_31665)"></path><path d="M12.2187 22.7187L15.7656 26.2031C16.7332 27.1171 17.3334 28.2487 16.4219 29.2188C15.7749 30.0687 14.2241 29.9933 13.625 30.0313C11.6883 30.0891 9.09014 29.5622 6.84373 27.5313C5.07737 25.9343 4.09321 23.688 3.93751 23.0156L12.2187 22.7187Z" fill="url(#paint9_radial_18_31665)"></path><g filter="url(#filter2_f_18_31665)"><path d="M12.0523 22.7916L13.2187 23.9375L4.81018 24.5721C4.4328 23.8671 4.20835 23.2768 4.14062 22.9844L12.0523 22.7916Z" fill="url(#paint10_linear_18_31665)"></path><path d="M12.0523 22.7916L13.2187 23.9375L4.81018 24.5721C4.4328 23.8671 4.20835 23.2768 4.14062 22.9844L12.0523 22.7916Z" fill="url(#paint11_radial_18_31665)"></path></g><path d="M2.99219 22.6484C2.07068 20.538 1.78913 17.4452 2.21096 15.0703C2.63279 12.6953 3.20759 11.951 3.20759 11.951C3.31231 11.3264 3.83281 11.2818 4.40626 11.5703C6.73409 13.4144 13.3119 15.2264 14.2432 18.0781C14.5947 19.3034 14.6279 21.3125 14.1641 22.5156C14.0409 22.8657 13.5 23.3516 13.0625 23.4141C12.625 23.4765 9.47656 23.3516 8.61719 23.3516C7.75781 23.3516 4.64844 23.6719 4.14062 23.6172C3.63281 23.5625 3.23437 23.2031 2.99219 22.6484Z" fill="#EC9F6A"></path><path d="M2.99219 22.6484C2.07068 20.538 1.78913 17.4452 2.21096 15.0703C2.63279 12.6953 3.20759 11.951 3.20759 11.951C3.31231 11.3264 3.83281 11.2818 4.40626 11.5703C6.73409 13.4144 13.3119 15.2264 14.2432 18.0781C14.5947 19.3034 14.6279 21.3125 14.1641 22.5156C14.0409 22.8657 13.5 23.3516 13.0625 23.4141C12.625 23.4765 9.47656 23.3516 8.61719 23.3516C7.75781 23.3516 4.64844 23.6719 4.14062 23.6172C3.63281 23.5625 3.23437 23.2031 2.99219 22.6484Z" fill="url(#paint12_radial_18_31665)"></path><path d="M2.99219 22.6484C2.07068 20.538 1.78913 17.4452 2.21096 15.0703C2.63279 12.6953 3.20759 11.951 3.20759 11.951C3.31231 11.3264 3.83281 11.2818 4.40626 11.5703C6.73409 13.4144 13.3119 15.2264 14.2432 18.0781C14.5947 19.3034 14.6279 21.3125 14.1641 22.5156C14.0409 22.8657 13.5 23.3516 13.0625 23.4141C12.625 23.4765 9.47656 23.3516 8.61719 23.3516C7.75781 23.3516 4.64844 23.6719 4.14062 23.6172C3.63281 23.5625 3.23437 23.2031 2.99219 22.6484Z" fill="url(#paint13_linear_18_31665)"></path><path d="M2.99219 22.6484C2.07068 20.538 1.78913 17.4452 2.21096 15.0703C2.63279 12.6953 3.20759 11.951 3.20759 11.951C3.31231 11.3264 3.83281 11.2818 4.40626 11.5703C6.73409 13.4144 13.3119 15.2264 14.2432 18.0781C14.5947 19.3034 14.6279 21.3125 14.1641 22.5156C14.0409 22.8657 13.5 23.3516 13.0625 23.4141C12.625 23.4765 9.47656 23.3516 8.61719 23.3516C7.75781 23.3516 4.64844 23.6719 4.14062 23.6172C3.63281 23.5625 3.23437 23.2031 2.99219 22.6484Z" fill="url(#paint14_radial_18_31665)"></path><path d="M2.99219 22.6484C2.07068 20.538 1.78913 17.4452 2.21096 15.0703C2.63279 12.6953 3.20759 11.951 3.20759 11.951C3.31231 11.3264 3.83281 11.2818 4.40626 11.5703C6.73409 13.4144 13.3119 15.2264 14.2432 18.0781C14.5947 19.3034 14.6279 21.3125 14.1641 22.5156C14.0409 22.8657 13.5 23.3516 13.0625 23.4141C12.625 23.4765 9.47656 23.3516 8.61719 23.3516C7.75781 23.3516 4.64844 23.6719 4.14062 23.6172C3.63281 23.5625 3.23437 23.2031 2.99219 22.6484Z" fill="url(#paint15_radial_18_31665)"></path><path d="M2.99219 22.6484C2.07068 20.538 1.78913 17.4452 2.21096 15.0703C2.63279 12.6953 3.20759 11.951 3.20759 11.951C3.31231 11.3264 3.83281 11.2818 4.40626 11.5703C6.73409 13.4144 13.3119 15.2264 14.2432 18.0781C14.5947 19.3034 14.6279 21.3125 14.1641 22.5156C14.0409 22.8657 13.5 23.3516 13.0625 23.4141C12.625 23.4765 9.47656 23.3516 8.61719 23.3516C7.75781 23.3516 4.64844 23.6719 4.14062 23.6172C3.63281 23.5625 3.23437 23.2031 2.99219 22.6484Z" fill="url(#paint16_radial_18_31665)"></path><g filter="url(#filter3_f_18_31665)"><path d="M2.70313 13.6719C3.04135 12.4711 3.36224 12.0555 3.36224 12.0555C3.46697 11.4309 3.98746 11.3864 4.56092 11.6749C6.88874 13.5189 13.0809 15.1104 14.0121 17.9622C14.1731 18.5231 14.2766 19.0394 14.3287 19.5128L2.70313 13.6719Z" fill="url(#paint17_linear_18_31665)"></path><path d="M2.70313 13.6719C3.04135 12.4711 3.36224 12.0555 3.36224 12.0555C3.46697 11.4309 3.98746 11.3864 4.56092 11.6749C6.88874 13.5189 13.0809 15.1104 14.0121 17.9622C14.1731 18.5231 14.2766 19.0394 14.3287 19.5128L2.70313 13.6719Z" fill="url(#paint18_linear_18_31665)"></path></g><path d="M9.83184 2.82184C6.62184 4.07184 4.07184 6.62184 2.82184 9.83184C2.48184 10.7118 2.82184 11.7018 3.62184 12.1918L14.0418 18.5418C14.6618 18.9218 15.4418 18.9218 16.0618 18.5418C17.0718 17.9218 17.9318 17.0718 18.5418 16.0618C18.9218 15.4418 18.9218 14.6618 18.5418 14.0418L12.1918 3.62184C11.7018 2.82184 10.7118 2.48184 9.83184 2.82184Z" fill="#D79453"></path><path d="M9.83184 2.82184C6.62184 4.07184 4.07184 6.62184 2.82184 9.83184C2.48184 10.7118 2.82184 11.7018 3.62184 12.1918L14.0418 18.5418C14.6618 18.9218 15.4418 18.9218 16.0618 18.5418C17.0718 17.9218 17.9318 17.0718 18.5418 16.0618C18.9218 15.4418 18.9218 14.6618 18.5418 14.0418L12.1918 3.62184C11.7018 2.82184 10.7118 2.48184 9.83184 2.82184Z" fill="url(#paint19_radial_18_31665)"></path><path d="M9.83184 2.82184C6.62184 4.07184 4.07184 6.62184 2.82184 9.83184C2.48184 10.7118 2.82184 11.7018 3.62184 12.1918L14.0418 18.5418C14.6618 18.9218 15.4418 18.9218 16.0618 18.5418C17.0718 17.9218 17.9318 17.0718 18.5418 16.0618C18.9218 15.4418 18.9218 14.6618 18.5418 14.0418L12.1918 3.62184C11.7018 2.82184 10.7118 2.48184 9.83184 2.82184Z" fill="url(#paint20_radial_18_31665)"></path><path d="M9.83184 2.82184C6.62184 4.07184 4.07184 6.62184 2.82184 9.83184C2.48184 10.7118 2.82184 11.7018 3.62184 12.1918L14.0418 18.5418C14.6618 18.9218 15.4418 18.9218 16.0618 18.5418C17.0718 17.9218 17.9318 17.0718 18.5418 16.0618C18.9218 15.4418 18.9218 14.6618 18.5418 14.0418L12.1918 3.62184C11.7018 2.82184 10.7118 2.48184 9.83184 2.82184Z" fill="url(#paint21_radial_18_31665)"></path><path d="M9.83184 2.82184C6.62184 4.07184 4.07184 6.62184 2.82184 9.83184C2.48184 10.7118 2.82184 11.7018 3.62184 12.1918L14.0418 18.5418C14.6618 18.9218 15.4418 18.9218 16.0618 18.5418C17.0718 17.9218 17.9318 17.0718 18.5418 16.0618C18.9218 15.4418 18.9218 14.6618 18.5418 14.0418L12.1918 3.62184C11.7018 2.82184 10.7118 2.48184 9.83184 2.82184Z" fill="url(#paint22_linear_18_31665)"></path><path d="M9.83184 2.82184C6.62184 4.07184 4.07184 6.62184 2.82184 9.83184C2.48184 10.7118 2.82184 11.7018 3.62184 12.1918L14.0418 18.5418C14.6618 18.9218 15.4418 18.9218 16.0618 18.5418C17.0718 17.9218 17.9318 17.0718 18.5418 16.0618C18.9218 15.4418 18.9218 14.6618 18.5418 14.0418L12.1918 3.62184C11.7018 2.82184 10.7118 2.48184 9.83184 2.82184Z" fill="url(#paint23_radial_18_31665)"></path><path d="M9.83184 2.82184C6.62184 4.07184 4.07184 6.62184 2.82184 9.83184C2.48184 10.7118 2.82184 11.7018 3.62184 12.1918L14.0418 18.5418C14.6618 18.9218 15.4418 18.9218 16.0618 18.5418C17.0718 17.9218 17.9318 17.0718 18.5418 16.0618C18.9218 15.4418 18.9218 14.6618 18.5418 14.0418L12.1918 3.62184C11.7018 2.82184 10.7118 2.48184 9.83184 2.82184Z" fill="url(#paint24_radial_18_31665)"></path><defs><filter id="filter0_f_18_31665" x="22.0349" y="3.64062" width="2.65265" height="9.875" filterUnits="userSpaceOnUse" color-interpolation-filters="sRGB"><feFlood flood-opacity="0" result="BackgroundImageFix"></feFlood><feBlend mode="normal" in="SourceGraphic" in2="BackgroundImageFix" result="shape"></feBlend><feGaussianBlur stdDeviation="0.125" result="effect1_foregroundBlur_18_31665"></feGaussianBlur></filter><filter id="filter1_f_18_31665" x="10.7815" y="2.47656" width="8.64819" height="12.0078" filterUnits="userSpaceOnUse" color-interpolation-filters="sRGB"><feFlood flood-opacity="0" result="BackgroundImageFix"></feFlood><feBlend mode="normal" in="SourceGraphic" in2="BackgroundImageFix" result="shape"></feBlend><feGaussianBlur stdDeviation="0.125" result="effect1_foregroundBlur_18_31665"></feGaussianBlur></filter><filter id="filter2_f_18_31665" x="3.89062" y="22.5416" width="9.57812" height="2.2804" filterUnits="userSpaceOnUse" color-interpolation-filters="sRGB"><feFlood flood-opacity="0" result="BackgroundImageFix"></feFlood><feBlend mode="normal" in="SourceGraphic" in2="BackgroundImageFix" result="shape"></feBlend><feGaussianBlur stdDeviation="0.125" result="effect1_foregroundBlur_18_31665"></feGaussianBlur></filter><filter id="filter3_f_18_31665" x="2.45312" y="11.2538" width="12.1255" height="8.50903" filterUnits="userSpaceOnUse" color-interpolation-filters="sRGB"><feFlood flood-opacity="0" result="BackgroundImageFix"></feFlood><feBlend mode="normal" in="SourceGraphic" in2="BackgroundImageFix" result="shape"></feBlend><feGaussianBlur stdDeviation="0.125" result="effect1_foregroundBlur_18_31665"></feGaussianBlur></filter><radialGradient id="paint0_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(22.8125 12.9375) rotate(42.7741) scale(12.5164 7.08839)"><stop offset="0.0937591" stop-color="#C05159"></stop><stop offset="0.553697" stop-color="#F6AC6A"></stop><stop offset="0.832916" stop-color="#FFD186"></stop><stop offset="0.916927" stop-color="#FFDC87"></stop></radialGradient><linearGradient id="paint1_linear_18_31665" x1="24.7344" y1="4.67187" x2="20.8594" y2="12.8906" gradientUnits="userSpaceOnUse"><stop stop-color="#EBD67C"></stop><stop offset="0.0655686" stop-color="#FFFFA6"></stop><stop offset="0.530552" stop-color="#F8C281"></stop><stop offset="0.937338" stop-color="#E99E6B"></stop></linearGradient><radialGradient id="paint2_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(22.9009 13.1847) rotate(-127.648) scale(14.3438 11.7966)"><stop stop-color="#FFBE66"></stop><stop offset="1" stop-color="#E2AE5B"></stop></radialGradient><radialGradient id="paint3_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(18 11.4375) rotate(53.9726) scale(11.9013 4.84018)"><stop stop-color="#D67C63"></stop><stop offset="1" stop-color="#D97D67" stop-opacity="0"></stop></radialGradient><radialGradient id="paint4_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(23 4.1875) rotate(45.7639) scale(3.31486 5.75622)"><stop stop-color="#FFE4A6"></stop><stop offset="0.711285" stop-color="#F8B76F"></stop><stop offset="1" stop-color="#F9B870" stop-opacity="0"></stop></radialGradient><radialGradient id="paint5_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(22.875 12.4375) rotate(88.9391) scale(3.37558 1.29066)"><stop stop-color="#FFBC67"></stop><stop offset="1" stop-color="#FFBC67" stop-opacity="0"></stop></radialGradient><linearGradient id="paint6_linear_18_31665" x1="20.375" y1="15.6875" x2="20.125" y2="12.7813" gradientUnits="userSpaceOnUse"><stop offset="0.461609" stop-color="#B45077"></stop><stop offset="0.855389" stop-color="#B75077" stop-opacity="0"></stop></linearGradient><linearGradient id="paint7_linear_18_31665" x1="12.9375" y1="2.57056" x2="18.5625" y2="14.3891" gradientUnits="userSpaceOnUse"><stop stop-color="#DDC173"></stop><stop offset="0.485173" stop-color="#D59F65"></stop><stop offset="1" stop-color="#E49966"></stop></linearGradient><radialGradient id="paint8_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(13.5625 23.5) rotate(109.113) scale(6.68078 10.2578)"><stop offset="0.165756" stop-color="#FFBF7E"></stop><stop offset="0.827674" stop-color="#DF8C6D"></stop><stop offset="1" stop-color="#B05A66"></stop></radialGradient><radialGradient id="paint9_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(15.1875 26) rotate(41.0652) scale(8.37243 2.03649)"><stop stop-color="#FFD483"></stop><stop offset="1" stop-color="#FFD688" stop-opacity="0"></stop></radialGradient><linearGradient id="paint10_linear_18_31665" x1="3.96063" y1="23.794" x2="13.3748" y2="23.5143" gradientUnits="userSpaceOnUse"><stop stop-color="#A8716F"></stop><stop offset="0.103615" stop-color="#B37173"></stop><stop offset="0.225484" stop-color="#DB9F84"></stop><stop offset="0.799889" stop-color="#F1BB8A"></stop><stop offset="1" stop-color="#FFD780"></stop></linearGradient><radialGradient id="paint11_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(11.4219 23.1719) rotate(-178.616) scale(3.23532 0.569081)"><stop offset="0.621498" stop-color="#AF5A3E"></stop><stop offset="1" stop-color="#B35445" stop-opacity="0"></stop></radialGradient><radialGradient id="paint12_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(13.625 19.125) rotate(-171.737) scale(15.2205 15.0767)"><stop offset="0.138435" stop-color="#FFB974"></stop><stop offset="0.403618" stop-color="#F2A56D"></stop><stop offset="0.925938" stop-color="#A16948"></stop></radialGradient><linearGradient id="paint13_linear_18_31665" x1="8.22184" y1="13.125" x2="6.81191" y2="15.4996" gradientUnits="userSpaceOnUse"><stop offset="0.610751" stop-color="#984847"></stop><stop offset="0.850075" stop-color="#9A4947" stop-opacity="0"></stop></linearGradient><radialGradient id="paint14_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(7.25 23.7461) scale(11.25 5.68361)"><stop stop-color="#C66364"></stop><stop offset="1" stop-color="#D4766B" stop-opacity="0"></stop></radialGradient><radialGradient id="paint15_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(7.875 23.5313) scale(10.0937 1.29657)"><stop stop-color="#B64B4B"></stop><stop offset="1" stop-color="#C56158" stop-opacity="0"></stop></radialGradient><radialGradient id="paint16_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(11.4375 19.875) rotate(-46.8882) scale(4.02385 7.51767)"><stop stop-color="#FFC083"></stop><stop offset="0.620218" stop-color="#FFBD7D" stop-opacity="0"></stop></radialGradient><linearGradient id="paint17_linear_18_31665" x1="2.8125" y1="13.0312" x2="14.5582" y2="18.9404" gradientUnits="userSpaceOnUse"><stop stop-color="#B89367"></stop><stop offset="1" stop-color="#C5835E"></stop></linearGradient><linearGradient id="paint18_linear_18_31665" x1="8.21875" y1="14.6406" x2="7.59349" y2="15.6717" gradientUnits="userSpaceOnUse"><stop offset="0.351552" stop-color="#A74746"></stop><stop offset="0.845198" stop-color="#A04346" stop-opacity="0"></stop></linearGradient><radialGradient id="paint19_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(15.5625 14.5625) rotate(140.244) scale(18.3733 13.7403)"><stop stop-color="#FDAE69"></stop><stop offset="0.729021" stop-color="#CE8C4F"></stop><stop offset="0.921546" stop-color="#AD7B45"></stop><stop offset="1" stop-color="#8B6B4A"></stop></radialGradient><radialGradient id="paint20_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(15.0625 7) rotate(65.3152) scale(11.0745 3.16547)"><stop offset="0.233237" stop-color="#FFD47C"></stop><stop offset="0.853648" stop-color="#FFD98B" stop-opacity="0"></stop></radialGradient><radialGradient id="paint21_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(15.3125 8.875) rotate(100.886) scale(6.6191 5.57808)"><stop offset="0.128419" stop-color="#FFD88C"></stop><stop offset="0.924134" stop-color="#FFBE7B" stop-opacity="0"></stop></radialGradient><linearGradient id="paint22_linear_18_31665" x1="7.25" y1="15.1875" x2="10.7588" y2="10.3142" gradientUnits="userSpaceOnUse"><stop offset="0.142353" stop-color="#C15F4D"></stop><stop offset="1" stop-color="#D58366" stop-opacity="0"></stop></linearGradient><radialGradient id="paint23_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(8.15625 15.7813) rotate(28.5422) scale(12.5574 1.96589)"><stop offset="0.149989" stop-color="#E4745D"></stop><stop offset="0.453292" stop-color="#C8604C"></stop><stop offset="0.632597" stop-color="#C0605F"></stop><stop offset="1" stop-color="#C0605F" stop-opacity="0"></stop></radialGradient><radialGradient id="paint24_radial_18_31665" cx="0" cy="0" r="1" gradientUnits="userSpaceOnUse" gradientTransform="translate(1.40625 2.69067) rotate(46.0943) scale(22.3963)"><stop offset="0.935802" stop-color="#C17C61" stop-opacity="0"></stop><stop offset="0.982109" stop-color="#C17C61"></stop></radialGradient></defs></svg>

	

	<span>Croissant</span>
	

	<div class="border-br-gray-200 absolute bottom-0.5 right-0.5 h-1 w-1 border-[3px] border-l-transparent border-t-transparent border-b-gray-200 border-r-gray-200 dark:border-b-gray-700 dark:border-r-gray-700"></div></div>
		
		</button>
	
	
	</div>

	<button class="tag tag-ghost px-1! -ml-0.5 mb-1 md:mb-1.5" type="button">+ 1</button></div></div>

		<div class="flex flex-col-reverse lg:flex-row lg:items-center lg:justify-between"><div class="-mb-px flex h-12 items-center overflow-x-auto overflow-y-hidden ">
	<a class="tab-alternate active" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa"><svg class="mr-1.5 text-gray-400 flex-none" style="" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 24 24"><path class="uim-quaternary" d="M20.23 7.24L12 12L3.77 7.24a1.98 1.98 0 0 1 .7-.71L11 2.76c.62-.35 1.38-.35 2 0l6.53 3.77c.29.173.531.418.7.71z" opacity=".25" fill="currentColor"></path><path class="uim-tertiary" d="M12 12v9.5a2.09 2.09 0 0 1-.91-.21L4.5 17.48a2.003 2.003 0 0 1-1-1.73v-7.5a2.06 2.06 0 0 1 .27-1.01L12 12z" opacity=".5" fill="currentColor"></path><path class="uim-primary" d="M20.5 8.25v7.5a2.003 2.003 0 0 1-1 1.73l-6.62 3.82c-.275.13-.576.198-.88.2V12l8.23-4.76c.175.308.268.656.27 1.01z" fill="currentColor"></path></svg>
	Dataset card
	

	
		</a><a class="tab-alternate" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/viewer/"><svg class="mr-1.5 text-gray-400 flex-none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 12 12"><path fill="currentColor" d="M2.5 2h7a1 1 0 0 1 1 1v6a1 1 0 0 1-1 1h-7a1 1 0 0 1-1-1V3a1 1 0 0 1 1-1Zm0 2v2h3V4h-3Zm4 0v2h3V4h-3Zm-4 3v2h3V7h-3Zm4 0v2h3V7h-3Z"></path></svg>
	Data Studio
	

	
		</a><a class="tab-alternate" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/tree/main"><svg class="mr-1.5 text-gray-400 flex-none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 24 24"><path class="uim-tertiary" d="M21 19h-8a1 1 0 0 1 0-2h8a1 1 0 0 1 0 2zm0-4h-8a1 1 0 0 1 0-2h8a1 1 0 0 1 0 2zm0-8h-8a1 1 0 0 1 0-2h8a1 1 0 0 1 0 2zm0 4h-8a1 1 0 0 1 0-2h8a1 1 0 0 1 0 2z" opacity=".5" fill="currentColor"></path><path class="uim-primary" d="M9 19a1 1 0 0 1-1-1V6a1 1 0 0 1 2 0v12a1 1 0 0 1-1 1zm-6-4.333a1 1 0 0 1-.64-1.769L3.438 12l-1.078-.898a1 1 0 0 1 1.28-1.538l2 1.667a1 1 0 0 1 0 1.538l-2 1.667a.999.999 0 0 1-.64.231z" fill="currentColor"></path></svg>
	<span class="xl:hidden">Files</span>
		<span class="hidden xl:inline">Files and versions</span>
	

	
		</a><a class="tab-alternate" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/discussions"><svg class="mr-1.5 text-gray-400 flex-none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M20.6081 3C21.7684 3 22.8053 3.49196 23.5284 4.38415C23.9756 4.93678 24.4428 5.82749 24.4808 7.16133C24.9674 7.01707 25.4353 6.93643 25.8725 6.93643C26.9833 6.93643 27.9865 7.37587 28.696 8.17411C29.6075 9.19872 30.0124 10.4579 29.8361 11.7177C29.7523 12.3177 29.5581 12.8555 29.2678 13.3534C29.8798 13.8646 30.3306 14.5763 30.5485 15.4322C30.719 16.1032 30.8939 17.5006 29.9808 18.9403C30.0389 19.0342 30.0934 19.1319 30.1442 19.2318C30.6932 20.3074 30.7283 21.5229 30.2439 22.6548C29.5093 24.3704 27.6841 25.7219 24.1397 27.1727C21.9347 28.0753 19.9174 28.6523 19.8994 28.6575C16.9842 29.4379 14.3477 29.8345 12.0653 29.8345C7.87017 29.8345 4.8668 28.508 3.13831 25.8921C0.356375 21.6797 0.754104 17.8269 4.35369 14.1131C6.34591 12.058 7.67023 9.02782 7.94613 8.36275C8.50224 6.39343 9.97271 4.20438 12.4172 4.20438H12.4179C12.6236 4.20438 12.8314 4.2214 13.0364 4.25468C14.107 4.42854 15.0428 5.06476 15.7115 6.02205C16.4331 5.09583 17.134 4.359 17.7682 3.94323C18.7242 3.31737 19.6794 3 20.6081 3ZM20.6081 5.95917C20.2427 5.95917 19.7963 6.1197 19.3039 6.44225C17.7754 7.44319 14.8258 12.6772 13.7458 14.7131C13.3839 15.3952 12.7655 15.6837 12.2086 15.6837C11.1036 15.6837 10.2408 14.5497 12.1076 13.1085C14.9146 10.9402 13.9299 7.39584 12.5898 7.1776C12.5311 7.16799 12.4731 7.16355 12.4172 7.16355C11.1989 7.16355 10.6615 9.33114 10.6615 9.33114C10.6615 9.33114 9.0863 13.4148 6.38031 16.206C3.67434 18.998 3.5346 21.2388 5.50675 24.2246C6.85185 26.2606 9.42666 26.8753 12.0653 26.8753C14.8021 26.8753 17.6077 26.2139 19.1799 25.793C19.2574 25.7723 28.8193 22.984 27.6081 20.6107C27.4046 20.212 27.0693 20.0522 26.6471 20.0522C24.9416 20.0522 21.8393 22.6726 20.5057 22.6726C20.2076 22.6726 19.9976 22.5416 19.9116 22.222C19.3433 20.1173 28.552 19.2325 27.7758 16.1839C27.639 15.6445 27.2677 15.4256 26.746 15.4263C24.4923 15.4263 19.4358 19.5181 18.3759 19.5181C18.2949 19.5181 18.2368 19.4937 18.2053 19.4419C17.6743 18.557 17.9653 17.9394 21.7082 15.6009C25.4511 13.2617 28.0783 11.8545 26.5841 10.1752C26.4121 9.98141 26.1684 9.8956 25.8725 9.8956C23.6001 9.89634 18.2311 14.9403 18.2311 14.9403C18.2311 14.9403 16.7821 16.496 15.9057 16.496C15.7043 16.496 15.533 16.4139 15.4169 16.2112C14.7956 15.1296 21.1879 10.1286 21.5484 8.06535C21.7928 6.66715 21.3771 5.95917 20.6081 5.95917Z" fill="#FF9D00"></path><path d="M5.50686 24.2246C3.53472 21.2387 3.67446 18.9979 6.38043 16.206C9.08641 13.4147 10.6615 9.33111 10.6615 9.33111C10.6615 9.33111 11.2499 6.95933 12.59 7.17757C13.93 7.39581 14.9139 10.9401 12.1069 13.1084C9.29997 15.276 12.6659 16.7489 13.7459 14.713C14.8258 12.6772 17.7747 7.44316 19.304 6.44221C20.8326 5.44128 21.9089 6.00204 21.5484 8.06532C21.188 10.1286 14.795 15.1295 15.4171 16.2118C16.0391 17.2934 18.2312 14.9402 18.2312 14.9402C18.2312 14.9402 25.0907 8.49588 26.5842 10.1752C28.0776 11.8545 25.4512 13.2616 21.7082 15.6008C17.9646 17.9393 17.6744 18.557 18.2054 19.4418C18.7372 20.3266 26.9998 13.1351 27.7759 16.1838C28.5513 19.2324 19.3434 20.1173 19.9117 22.2219C20.48 24.3274 26.3979 18.2382 27.6082 20.6107C28.8193 22.9839 19.2574 25.7722 19.18 25.7929C16.0914 26.62 8.24723 28.3726 5.50686 24.2246Z" fill="#FFD21E"></path></svg>
	Community
	<div class="ml-1.5 flex h-4 min-w-[1rem] items-center justify-center rounded px-1 text-xs leading-none shadow-sm bg-black text-white dark:bg-gray-800 dark:text-gray-200">1</div>

	
		</a></div>
	
			</div></div></header>
</div>
	
<div class="container relative flex flex-col md:grid md:space-y-0 w-full md:grid-cols-12 md:flex-1 md:grid-rows-full space-y-4 md:gap-6 ">
		<section class="pt-6 border-gray-100 md:col-span-8 pb-24 relative break-words copiable-code-container">
				<div class="SVELTE_HYDRATER contents" data-target="UnsafeBanner" data-props="{&quot;classNames&quot;:&quot;mb-4&quot;,&quot;repoId&quot;:&quot;ChuGyouk/medical-o1-train-kormedmcqa&quot;,&quot;repoType&quot;:&quot;dataset&quot;,&quot;minLevel&quot;:&quot;unsafe&quot;}"></div>
					<div class="SVELTE_HYDRATER contents" data-target="DatasetViewer" data-props="{&quot;data&quot;:{&quot;kind&quot;:&quot;DatasetAndSampleData&quot;,&quot;datasetInfo&quot;:[{&quot;isValid&quot;:true,&quot;href&quot;:&quot;&quot;,&quot;label&quot;:&quot;Size of downloaded dataset files:&quot;,&quot;value&quot;:&quot;38.6 MB&quot;},{&quot;isValid&quot;:true,&quot;href&quot;:&quot;/datasets/ChuGyouk/medical-o1-train-kormedmcqa/tree/refs%2Fconvert%2Fparquet/&quot;,&quot;label&quot;:&quot;Size of the auto-converted Parquet files:&quot;,&quot;value&quot;:&quot;38.6 MB&quot;},{&quot;isValid&quot;:true,&quot;href&quot;:&quot;&quot;,&quot;label&quot;:&quot;Number of rows:&quot;,&quot;value&quot;:&quot;8,751&quot;}],&quot;partial&quot;:false,&quot;configsData&quot;:{&quot;configInfos&quot;:[{&quot;name&quot;:&quot;default&quot;,&quot;status&quot;:&quot;ok&quot;,&quot;numRows&quot;:8751}],&quot;selectedConfig&quot;:&quot;default&quot;,&quot;hasSelectedConfigParquet&quot;:true},&quot;splitsData&quot;:{&quot;splitInfos&quot;:[{&quot;name&quot;:&quot;train&quot;,&quot;numRows&quot;:8751}],&quot;selectedSplit&quot;:&quot;train&quot;},&quot;sampleData&quot;:{&quot;dataset&quot;:&quot;ChuGyouk/medical-o1-train-kormedmcqa&quot;,&quot;config&quot;:&quot;default&quot;,&quot;split&quot;:&quot;train&quot;,&quot;capabilities&quot;:{&quot;rows&quot;:true,&quot;search&quot;:true,&quot;filter&quot;:true,&quot;statistics&quot;:true},&quot;navigation&quot;:{&quot;p&quot;:0},&quot;jwt&quot;:&quot;eyJhbGciOiJFZERTQSJ9.eyJyZWFkIjp0cnVlLCJwZXJtaXNzaW9ucyI6eyJyZXBvLmNvbnRlbnQucmVhZCI6dHJ1ZX0sImlhdCI6MTc0MjkxODU5NSwic3ViIjoiL2RhdGFzZXRzL0NodUd5b3VrL21lZGljYWwtbzEtdHJhaW4ta29ybWVkbWNxYSIsImV4cCI6MTc0MjkyMjE5NSwiaXNzIjoiaHR0cHM6Ly9odWdnaW5nZmFjZS5jbyJ9.g808faITaKa-pthwVwEDvQiTnhFE-F3DXBvuwxgcS-G0noSf5EX_9TjNaEoxLe-Pnrn8vbE91HdDdvAeKzL-Dw&quot;,&quot;sampleData&quot;:{&quot;columns&quot;:[{&quot;name&quot;:&quot;subject&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;subject&quot;,&quot;column_type&quot;:&quot;string_label&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;no_label_count&quot;:0,&quot;no_label_proportion&quot;:0,&quot;n_unique&quot;:10,&quot;frequencies&quot;:{&quot;physical_therapist&quot;:867,&quot;pharm&quot;:888,&quot;doctor&quot;:1875,&quot;paramedic_1&quot;:681,&quot;medical_laboratory_technologist&quot;:977,&quot;dentist&quot;:514,&quot;dental_hygienist&quot;:817,&quot;dental_technician&quot;:844,&quot;nurse&quot;:820,&quot;nurse_assistant&quot;:468}}}},{&quot;name&quot;:&quot;year&quot;,&quot;align&quot;:&quot;right&quot;,&quot;type&quot;:&quot;int64&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;year&quot;,&quot;column_type&quot;:&quot;int&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:2012,&quot;max&quot;:2024,&quot;mean&quot;:2019.80368,&quot;median&quot;:2020,&quot;std&quot;:2.75757,&quot;histogram&quot;:{&quot;hist&quot;:[522,436,343,1574,3640,2142,94],&quot;bin_edges&quot;:[2012,2014,2016,2018,2020,2022,2024,2024]}}}},{&quot;name&quot;:&quot;period&quot;,&quot;align&quot;:&quot;right&quot;,&quot;type&quot;:&quot;int64&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;period&quot;,&quot;column_type&quot;:&quot;int&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:7,&quot;mean&quot;:2.03051,&quot;median&quot;:2,&quot;std&quot;:1.25004,&quot;histogram&quot;:{&quot;hist&quot;:[3761,2853,1017,596,314,173,37],&quot;bin_edges&quot;:[1,2,3,4,5,6,7,7]}}}},{&quot;name&quot;:&quot;q_number&quot;,&quot;align&quot;:&quot;right&quot;,&quot;type&quot;:&quot;int64&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;q_number&quot;,&quot;column_type&quot;:&quot;int&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:120,&quot;mean&quot;:48.02765,&quot;median&quot;:47,&quot;std&quot;:28.51835,&quot;histogram&quot;:{&quot;hist&quot;:[1143,1090,1117,1151,1194,1107,866,654,350,79],&quot;bin_edges&quot;:[1,13,25,37,49,61,73,85,97,109,120]}}}},{&quot;name&quot;:&quot;question&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;question&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:646,&quot;mean&quot;:90.32328,&quot;median&quot;:57,&quot;std&quot;:88.73939,&quot;histogram&quot;:{&quot;hist&quot;:[4949,2055,786,393,265,150,93,40,15,5],&quot;bin_edges&quot;:[1,66,131,196,261,326,391,456,521,586,646]}}}},{&quot;name&quot;:&quot;A&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;A&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:57,&quot;mean&quot;:9.08468,&quot;median&quot;:6,&quot;std&quot;:7.15048,&quot;histogram&quot;:{&quot;hist&quot;:[4557,1780,1414,693,198,73,25,8,2,1],&quot;bin_edges&quot;:[1,7,13,19,25,31,37,43,49,55,57]}}}},{&quot;name&quot;:&quot;B&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;B&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:71,&quot;mean&quot;:10.60336,&quot;median&quot;:7,&quot;std&quot;:8.06685,&quot;histogram&quot;:{&quot;hist&quot;:[4796,1914,1477,424,109,26,1,3,1],&quot;bin_edges&quot;:[1,9,17,25,33,41,49,57,65,71]}}}},{&quot;name&quot;:&quot;C&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;C&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:72,&quot;mean&quot;:12.06194,&quot;median&quot;:8,&quot;std&quot;:9.04837,&quot;histogram&quot;:{&quot;hist&quot;:[4378,1841,1587,693,186,49,11,5,1],&quot;bin_edges&quot;:[1,9,17,25,33,41,49,57,65,72]}}}},{&quot;name&quot;:&quot;D&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;D&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:77,&quot;mean&quot;:13.75431,&quot;median&quot;:10,&quot;std&quot;:10.19524,&quot;histogram&quot;:{&quot;hist&quot;:[3864,1914,1579,904,351,91,32,11,4,1],&quot;bin_edges&quot;:[1,9,17,25,33,41,49,57,65,73,77]}}}},{&quot;name&quot;:&quot;E&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;E&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:101,&quot;mean&quot;:16.23746,&quot;median&quot;:12,&quot;std&quot;:12.01406,&quot;histogram&quot;:{&quot;hist&quot;:[4189,2136,1569,639,161,39,12,4,1,1],&quot;bin_edges&quot;:[1,12,23,34,45,56,67,78,89,100,101]}}}},{&quot;name&quot;:&quot;answer&quot;,&quot;align&quot;:&quot;right&quot;,&quot;type&quot;:&quot;int64&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;answer&quot;,&quot;column_type&quot;:&quot;int&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:1,&quot;max&quot;:5,&quot;mean&quot;:3.10627,&quot;median&quot;:3,&quot;std&quot;:1.40534,&quot;histogram&quot;:{&quot;hist&quot;:[1540,1684,1754,1852,1921],&quot;bin_edges&quot;:[1,2,3,4,5,5]}}}},{&quot;name&quot;:&quot;thinking&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;thinking&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:646,&quot;max&quot;:27750,&quot;mean&quot;:5498.54657,&quot;median&quot;:5352,&quot;std&quot;:1773.52489,&quot;histogram&quot;:{&quot;hist&quot;:[655,5484,2280,240,67,14,4,2,3,2],&quot;bin_edges&quot;:[646,3357,6068,8779,11490,14201,16912,19623,22334,25045,27750]}}}},{&quot;name&quot;:&quot;response&quot;,&quot;align&quot;:&quot;depends on text direction&quot;,&quot;type&quot;:&quot;string&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;response&quot;,&quot;column_type&quot;:&quot;string_text&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:105,&quot;max&quot;:3328,&quot;mean&quot;:1227.67455,&quot;median&quot;:1174,&quot;std&quot;:370.18657,&quot;histogram&quot;:{&quot;hist&quot;:[50,472,2723,3196,1458,568,197,67,16,4],&quot;bin_edges&quot;:[105,428,751,1074,1397,1720,2043,2366,2689,3012,3328]}}}},{&quot;name&quot;:&quot;__index_level_0__&quot;,&quot;align&quot;:&quot;right&quot;,&quot;type&quot;:&quot;int64&quot;,&quot;statistics&quot;:{&quot;column_name&quot;:&quot;__index_level_0__&quot;,&quot;column_type&quot;:&quot;int&quot;,&quot;column_statistics&quot;:{&quot;nan_count&quot;:0,&quot;nan_proportion&quot;:0,&quot;min&quot;:0,&quot;max&quot;:8343,&quot;mean&quot;:3986.92915,&quot;median&quot;:3968,&quot;std&quot;:2496.3533,&quot;histogram&quot;:{&quot;hist&quot;:[1242,835,835,835,835,835,835,835,835,829],&quot;bin_edges&quot;:[0,835,1670,2505,3340,4175,5010,5845,6680,7515,8343]}}}}],&quot;rows&quot;:[{&quot;rowIdx&quot;:0,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;paramedic_1&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2023,&quot;string&quot;:&quot;2,023&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:90,&quot;string&quot;:&quot;90&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê³¼ëŸ‰íˆ¬ì—¬ ì‹œ í”¼ë¶€ ë° ì ë§‰ì˜ ê±´ì¡°, ë™ê³µí™•ëŒ€, ê³ ì²´ì˜¨ ë“±ì˜ ì¤‘ë… ì¦ìƒì´ ë‚˜íƒ€ë‚˜ë©° í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼(í”¼ì¡°ìŠ¤í‹°ê·¸ë¯¼)ì„ í•´ë…ì œë¡œ ì‚¬ìš©í•  ìˆ˜ ìžˆëŠ” ë¬¼ì§ˆì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë‹¤ì´ì•„ì œíŒœ&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì•„íŠ¸ë¡œí•€&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì‚´ì¶©ì œ&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëª¨ë¥´í•€&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì—íƒ„ì˜¬&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;\nThe question is asking for a substance that, when overdosed, causes symptoms like dry skin and mucous membranes, dilated pupils, and hyperthermia, and for which physostigmine is used as an antidote.  Let's analyze each option and see which one fits the description.\n\n* **Symptoms described:** Dry skin and mucous membranes, dilated pupils, hyperthermia. These are classic signs of **anticholinergic toxicity**.  Anticholinergic drugs block the action of acetylcholine, a neurotransmitter responsible for various functions, including muscle contraction, gland secretions, and heart rate regulation. Blocking acetylcholine leads to these symptoms.\n\n* **Physostigmine as an antidote:** Physostigmine is a cholinesterase inhibitor. It increases the level of acetylcholine in the synapse by preventing its breakdown.  It's used as an antidote for anticholinergic poisoning because it counteracts the effects of anticholinergic drugs by increasing acetylcholine levels, thus overcoming the blockade.\n\nNow let's examine each option:\n\n* **A. ë‹¤ì´ì•„ì œíŒœ (Diazepam):**  Diazepam is a benzodiazepine, primarily used as an anxiolytic, sedative, muscle relaxant, and anticonvulsant.  Overdose symptoms of diazepam include drowsiness, confusion, impaired coordination, and respiratory depression.  It's not typically associated with anticholinergic effects like dry skin, dilated pupils, and hyperthermia.  Flumazenil is the antidote for benzodiazepine overdose, not physostigmine.\n\n* **B. ì•„íŠ¸ë¡œí•€ (Atropine):** Atropine is a classic anticholinergic drug. It's a muscarinic antagonist, meaning it blocks the muscarinic acetylcholine receptors.  Overdose of atropine would directly cause the symptoms listed: dry skin (decreased sweating), dry mucous membranes (decreased saliva), dilated pupils (mydriasis), and hyperthermia (due to decreased sweating).  Physostigmine is indeed used as an antidote for atropine poisoning to reverse these anticholinergic effects.\n\n* **C. ì‚´ì¶©ì œ (Insecticide):**  This is a broad category.  Some insecticides, like organophosphates and carbamates, are cholinesterase inhibitors.  They *increase* acetylcholine levels, leading to cholinergic toxicity (opposite of anticholinergic). Symptoms of organophosphate/carbamate poisoning include SLUDGE (Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis) and muscle weakness, miosis (constricted pupils), bradycardia.  Other insecticides, like pyrethroids, primarily affect the nervous system through sodium channel modulation, and don't typically cause anticholinergic symptoms.  However, some older insecticides might have anticholinergic properties, but generally, insecticides are not the primary cause of anticholinergic poisoning for which physostigmine is a first-line antidote.  Organophosphate poisoning, which is more common with insecticides, is treated with atropine (ironically, to block the *excess* acetylcholine effects) and pralidoxime (to reactivate cholinesterase), not physostigmine.  This option is less likely than atropine.\n\n* **D. ëª¨ë¥´í•€ (Morphine):** Morphine is an opioid analgesic.  Overdose symptoms of morphine include respiratory depression, pinpoint pupils (miosis), constipation, and decreased level of consciousness.  It does not cause anticholinergic symptoms like dilated pupils and hyperthermia.  Naloxone is the antidote for opioid overdose.\n\n* **E. ì—íƒ„ì˜¬ (Ethanol):** Ethanol is alcohol.  Ethanol intoxication symptoms include impaired coordination, slurred speech, confusion, and respiratory depression in severe cases.  While it can cause vasodilation which might contribute to warmth, it doesn't typically cause hyperthermia in the same way anticholinergics do.  It also doesn't cause dilated pupils in the same way.  The primary concerns with ethanol overdose are CNS depression and respiratory depression.  There is no specific antidote in the same way as physostigmine for anticholinergics or naloxone for opioids. Treatment is supportive.\n\n**Conclusion:**\n\nBased on the symptoms and the antidote, **atropine (B)** is the most fitting answer.  Atropine is a known anticholinergic drug that causes the described symptoms upon overdose, and physostigmine is a well-established antidote for anticholinergic poisoning, including atropine poisoning.\n\nLet's double check the symptoms and antidote for atropine overdose:\n\n* **Symptoms of Atropine Overdose (Anticholinergic Toxidrome):**\n    * **Mad as a hatter:** Delirium, hallucinations, confusion\n    * **Blind as a bat:** Mydriasis (dilated pupils), blurred vision\n    * **Red as a beet:** Vasodilation, flushed skin\n    * **Hot as a hare:** Hyperthermia, anhidrosis (lack of sweating)\n    * **Dry as a bone:** Dry skin, dry mucous membranes\n    * **Other:** Tachycardia, urinary retention, decreased bowel sounds\n\nThe symptoms listed in the question (dry skin and mucous membranes, dilated pupils, hyperthermia) are all core components of anticholinergic toxidrome and are characteristic of atropine overdose.  And physostigmine is indeed used to treat anticholinergic poisoning, particularly in cases with severe delirium or other significant symptoms.\n\nTherefore, the most appropriate answer is **B. ì•„íŠ¸ë¡œí•€ (Atropine)**.\n\n\nLet's consider why other options are less likely:\n\n* **Diazepam:**  Wrong symptoms, wrong antidote.\n* **Insecticide:** Too broad, and while some might have anticholinergic properties, the more common insecticide poisonings (organophosphates, carbamates) cause cholinergic, not anticholinergic symptoms. Physostigmine might be contraindicated in organophosphate poisoning in some contexts (though it's complex and sometimes used with caution in specific situations), and atropine is the primary anticholinergic used as antidote for organophosphate poisoning.\n* **Morphine:** Wrong symptoms, wrong antidote.\n* **Ethanol:** Wrong symptoms, no specific antidote like physostigmine for this symptom profile.\n\n\nThus, Atropine is the clear best answer.\n&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **B. ì•„íŠ¸ë¡œí•€**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n**ì œì‹œëœ ì¦ìƒ:**\n\n* **í”¼ë¶€ ë° ì ë§‰ ê±´ì¡°:**  ë•€ ë¶„ë¹„ ê°ì†Œ ë° ì¹¨ ë¶„ë¹„ ê°ì†Œë¡œ ì¸í•´ ë‚˜íƒ€ë‚˜ëŠ” ì¦ìƒìœ¼ë¡œ, ë¶€êµê° ì‹ ê²½ ì–µì œ(í•­ì½œë¦° ìž‘ìš©)ì™€ ê´€ë ¨ì´ ìžˆìŠµë‹ˆë‹¤.\n* **ë™ê³µ í™•ëŒ€:**  ë™ê³µ ì¡°ì ˆ ê·¼ìœ¡ì˜ ë§ˆë¹„ë¡œ ì¸í•´ ë‚˜íƒ€ë‚˜ëŠ” ì¦ìƒìœ¼ë¡œ, ë¶€êµê° ì‹ ê²½ ì–µì œ(í•­ì½œë¦° ìž‘ìš©)ì˜ ëŒ€í‘œì ì¸ ì¦ìƒìž…ë‹ˆë‹¤.\n* **ê³ ì²´ì˜¨:**  ë•€ ë¶„ë¹„ ê°ì†Œë¡œ ì¸í•œ ì²´ì˜¨ ì¡°ì ˆ ìž¥ì• ë¡œ ë°œìƒí•  ìˆ˜ ìžˆìœ¼ë©°, í•­ì½œë¦° ìž‘ìš©ê³¼ ê´€ë ¨ì´ ìžˆìŠµë‹ˆë‹¤.\n\n**í•´ë…ì œ: í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ (í”¼ì¡°ìŠ¤í‹°ê·¸ë¯¼)**\n\n* í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì½œë¦°ì—ìŠ¤í„°ë¼ì œ ì–µì œì œìž…ë‹ˆë‹¤. ì½œë¦°ì—ìŠ¤í„°ë¼ì œëŠ” ì•„ì„¸í‹¸ì½œë¦°ì„ ë¶„í•´í•˜ëŠ” íš¨ì†Œì´ë¯€ë¡œ, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„ì„¸í‹¸ì½œë¦°ì˜ ë¶„í•´ë¥¼ ì–µì œí•˜ì—¬ ì•„ì„¸í‹¸ì½œë¦°ì˜ ë†ë„ë¥¼ ì¦ê°€ì‹œí‚µë‹ˆë‹¤.\n* ì´ëŠ” **í•­ì½œë¦° ìž‘ìš© ë¬¼ì§ˆì˜ ì¤‘ë…ì„ í•´ë…í•˜ëŠ” ë° ì‚¬ìš©**ë©ë‹ˆë‹¤. í•­ì½œë¦° ìž‘ìš© ë¬¼ì§ˆì€ ì•„ì„¸í‹¸ì½œë¦°ì˜ ìž‘ìš©ì„ ì–µì œí•˜ë¯€ë¡œ, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„ì„¸í‹¸ì½œë¦° ë†ë„ë¥¼ ë†’ì—¬ í•­ì½œë¦° ìž‘ìš©ì„ ìƒì‡„ì‹œí‚¤ëŠ” íš¨ê³¼ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.\n\n**ê° ì„ íƒì§€ ë¶„ì„:**\n\n* **A. ë‹¤ì´ì•„ì œíŒœ:**  ë²¤ì¡°ë””ì•„ì œí•€ ê³„ì—´ì˜ ì•½ë¬¼ë¡œ, ì£¼ë¡œ ì§„ì •, ìˆ˜ë©´, í•­ë¶ˆì•ˆ ìž‘ìš©ì„ í•©ë‹ˆë‹¤. ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ ì¡¸ìŒ, í˜¼ëž€, ìš´ë™ì‹¤ì¡°, í˜¸í¡ ì–µì œ ë“±ì˜ ì¦ìƒì´ ë‚˜íƒ€ë‚˜ì§€ë§Œ, í”¼ë¶€ ê±´ì¡°, ë™ê³µ í™•ëŒ€, ê³ ì²´ì˜¨ê³¼ ê°™ì€ í•­ì½œë¦° ì¦ìƒì€ ë‚˜íƒ€ë‚˜ì§€ ì•ŠìŠµë‹ˆë‹¤. í•´ë…ì œëŠ” í”Œë£¨ë§ˆì œë‹ìž…ë‹ˆë‹¤.\n\n* **B. ì•„íŠ¸ë¡œí•€:**  ëŒ€í‘œì ì¸ **í•­ì½œë¦° ìž‘ìš©ì œ**ìž…ë‹ˆë‹¤.  ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ ì œì‹œëœ ì¦ìƒì¸ í”¼ë¶€ ë° ì ë§‰ ê±´ì¡°, ë™ê³µ í™•ëŒ€, ê³ ì²´ì˜¨ ë“±ì´ ë‚˜íƒ€ë‚©ë‹ˆë‹¤. ë˜í•œ, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„íŠ¸ë¡œí•€ ì¤‘ë…ì˜ í•´ë…ì œë¡œ ì‚¬ìš©ë©ë‹ˆë‹¤.\n\n* **C. ì‚´ì¶©ì œ:**  ì‚´ì¶©ì œì˜ ì¢…ë¥˜ëŠ” ë§¤ìš° ë‹¤ì–‘í•©ë‹ˆë‹¤. ìœ ê¸°ì¸ê³„ ì‚´ì¶©ì œë‚˜ ì¹´ë°”ë©”ì´íŠ¸ê³„ ì‚´ì¶©ì œëŠ” ì½œë¦°ì—ìŠ¤í„°ë¼ì œ ì–µì œì œë¡œì„œ, ì˜¤ížˆë ¤ ì½œë¦°ì„± ì¦ìƒ(ê·¼ìœ¡ ê²½ë ¨, ì¹¨ í˜ë¦¼, ë™ê³µ ì¶•ì†Œ ë“±)ì„ ìœ ë°œí•˜ë©°, í•´ë…ì œë¡œëŠ” ì•„íŠ¸ë¡œí•€ (í•­ì½œë¦°ì œ)ê³¼ ì˜¥ì‹¬ ì œì œê°€ ì‚¬ìš©ë©ë‹ˆë‹¤. ì œì‹œëœ ì¦ìƒê³¼ëŠ” ë°˜ëŒ€ë˜ëŠ” ê²½ìš°ê°€ ë§ŽìŠµë‹ˆë‹¤.\n\n* **D. ëª¨ë¥´í•€:**  ë§ˆì•½ì„± ì§„í†µì œì¸ ì˜¤í”¼ì˜¤ì´ë“œ ê³„ì—´ ì•½ë¬¼ìž…ë‹ˆë‹¤. ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ í˜¸í¡ ì–µì œ, ë™ê³µ ì¶•ì†Œ, ë³€ë¹„ ë“±ì˜ ì¦ìƒì´ ë‚˜íƒ€ë‚˜ë©°, í•´ë…ì œëŠ” ë‚ ë¡ì†ìž…ë‹ˆë‹¤. ì œì‹œëœ ì¦ìƒê³¼ëŠ” ê±°ë¦¬ê°€ ë©‰ë‹ˆë‹¤.\n\n* **E. ì—íƒ„ì˜¬:**  ì•Œì½”ì˜¬ìž…ë‹ˆë‹¤. ê³¼ëŸ‰ ì„­ì·¨ ì‹œ ì¤‘ì¶”ì‹ ê²½ ì–µì œ, ìš´ë™ ì‹¤ì¡°, íŒë‹¨ë ¥ ì €í•˜ ë“±ì˜ ì¦ìƒì´ ë‚˜íƒ€ë‚˜ì§€ë§Œ, í”¼ë¶€ ê±´ì¡°, ë™ê³µ í™•ëŒ€, ê³ ì²´ì˜¨ê³¼ ê°™ì€ í•­ì½œë¦° ì¦ìƒì€ ë‚˜íƒ€ë‚˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n\n**ê²°ë¡ :**\n\nì œì‹œëœ ì¤‘ë… ì¦ìƒê³¼ í•´ë…ì œ(í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼)ë¥¼ ê³ ë ¤í–ˆì„ ë•Œ, ê°€ìž¥ ì í•©í•œ ë¬¼ì§ˆì€ **B. ì•„íŠ¸ë¡œí•€**ìž…ë‹ˆë‹¤. ì•„íŠ¸ë¡œí•€ì€ í•­ì½œë¦° ìž‘ìš©ì œë¡œì„œ ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ ì œì‹œëœ ì¦ìƒì„ ìœ ë°œí•˜ë©°, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„íŠ¸ë¡œí•€ ì¤‘ë…ì˜ í•´ë…ì œë¡œ ì‚¬ìš©ë©ë‹ˆë‹¤.\n\n**ë”°ë¼ì„œ ì •ë‹µì€ Bìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:7494,&quot;string&quot;:&quot;7,494&quot;}}},{&quot;rowIdx&quot;:1,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;paramedic_1&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2023,&quot;string&quot;:&quot;2,023&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:65,&quot;string&quot;:&quot;65&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì²™ì¶”ì†ìƒì´ ì˜ì‹¬ë˜ëŠ” í™˜ìžë¥¼ ì´ì†¡í•˜ê¸° ìœ„í•œ ì²™ì¶”ë³´í˜¸ì¡°ì¹˜ (ì²™ì¶”ì›€ì§ìž„ì œí•œ) ë°©ë²•ìœ¼ë¡œ ì˜³ì€ ê²ƒì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ê°€ ìœ ì§€ë˜ë„ë¡ ëª© ê³ ì •ìž¥ì¹˜ ì ìš©&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì¢Œìš°ë¡œ 45Â° ëŒë¦´ ìˆ˜ ìžˆë„ë¡ ëŠìŠ¨í•˜ê²Œ ê³ ì •&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëª©ë¼ˆì˜ êµ½íž˜ì´ë‚˜ ì••ë°•ì´ ë°œìƒí•˜ì§€ ì•Šë„ë¡ ê³¼ì‹ ì „ ìƒíƒœë¡œ ê³ ì •&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëª¸í†µì€ ìœ„ì•„ëž˜ë¡œëŠ” ì›€ì§ì´ê³  ì™¼ìª½ Â· ì˜¤ë¥¸ìª½ìœ¼ë¡œëŠ” ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì •&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;\nThe question is asking about the correct method of spinal motion restriction (spinal immobilization) for a patient suspected of having a spinal injury during transport.  Let's analyze each option in Korean and then translate to English for clarity.\n\n* **Understanding the Goal:** The primary goal of spinal motion restriction is to prevent further injury to the spinal cord by minimizing movement of the spine, especially in cases of suspected spinal injury. This is crucial during patient transport to avoid exacerbating potential damage.\n\n* **Analyzing each option:**\n\n    * **A. ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì • (Fix the torso completely to a long spine board first, then fix the head.)**\n        * **Thinking:** This sounds like a logical sequence.  Stabilizing the torso first provides a stable base before immobilizing the head. If you fix the head first and then try to move the torso onto the board, you risk moving the neck and spine. So, torso first, then head sounds correct.\n\n    * **B. ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ê°€ ìœ ì§€ë˜ë„ë¡ ëª© ê³ ì •ìž¥ì¹˜ ì ìš© (Apply a cervical collar so that the head-tilt and chin-lift position is maintained.)**\n        * **Thinking:** The head-tilt chin-lift maneuver is used to open the airway in unresponsive patients, *not* for spinal immobilization.  In spinal injury, we want to maintain a *neutral* position if possible, not necessarily head-tilt chin-lift.  Also, maintaining head-tilt chin-lift with a cervical collar sounds contradictory and potentially harmful for spinal injury.  This option seems incorrect.\n\n    * **C. ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì¢Œìš°ë¡œ 45Â° ëŒë¦´ ìˆ˜ ìžˆë„ë¡ ëŠìŠ¨í•˜ê²Œ ê³ ì • (Fix the cervical collar loosely so that it can be turned 45Â° left and right.)**\n        * **Thinking:**  The purpose of a cervical collar (ëª© ê³ ì •ìž¥ì¹˜) in spinal immobilization is to *restrict* movement, not allow it. Allowing 45Â° rotation defeats the purpose.  This is definitely incorrect.  Spinal immobilization needs to be *rigid*, not loose.\n\n    * **D. ëª©ë¼ˆì˜ êµ½íž˜ì´ë‚˜ ì••ë°•ì´ ë°œìƒí•˜ì§€ ì•Šë„ë¡ ê³¼ì‹ ì „ ìƒíƒœë¡œ ê³ ì • (Fix in a hyperextended position to prevent flexion or compression of the cervical vertebrae.)**\n        * **Thinking:** Hyperextension (ê³¼ì‹ ì „) of the neck is generally *contraindicated* in suspected spinal injury.  It can worsen the injury, especially if there's already a fracture or dislocation.  Neutral alignment is preferred.  Forcing hyperextension can cause more harm.  This is likely incorrect and dangerous.\n\n    * **E. ëª¸í†µì€ ìœ„ì•„ëž˜ë¡œëŠ” ì›€ì§ì´ê³  ì™¼ìª½ Â· ì˜¤ë¥¸ìª½ìœ¼ë¡œëŠ” ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì • (Fix the torso so that it moves up and down but not left and right.)**\n        * **Thinking:**  This option is confusing and nonsensical for spinal immobilization.  Spinal immobilization aims to restrict *all* movement of the torso and spine in all directions â€“ up/down, left/right, rotation, flexion, extension. Allowing up and down movement while restricting left/right is not a standard or recommended practice for spinal immobilization. This is incorrect and illogical.\n\n\n* **Re-evaluating and confirming the best answer:**\n\n    * Option A makes the most sense in terms of sequence and overall principle of immobilization.\n    * Options B, C, D, and E are all clearly wrong based on basic principles of spinal immobilization and first aid.\n\n* **Translating and confirming in English for clarity:**\n\n    * A. Fix the torso completely to a long spine board first, then fix the head. (Sounds correct)\n    * B. Apply a cervical collar so that the head-tilt and chin-lift position is maintained. (Incorrect - head-tilt chin-lift is for airway, not immobilization; and contraindicated for spinal injury in this context.)\n    * C. Fix the cervical collar loosely so that it can be turned 45Â° left and right. (Incorrect - collar must restrict, not allow movement.)\n    * D. Fix in a hyperextended position to prevent flexion or compression of the cervical vertebrae. (Incorrect and dangerous - hyperextension is generally contraindicated; neutral is preferred.)\n    * E. Fix the torso so that it moves up and down but not left and right. (Incorrect and illogical - immobilization needs to restrict all torso movement.)\n\n\n* **Conclusion:** Option A appears to be the only correct method for spinal motion restriction in the context of transporting a patient with suspected spinal injury.\n\n\nTherefore, the answer is A.\n\nLet's double-check typical spinal immobilization procedures:\n\n1. **Manual stabilization:**  Immediately stabilize the patient's head and neck manually, preventing any movement.\n2. **Cervical collar application:** Apply a properly sized cervical collar.\n3. **Log roll (if needed):** If the patient needs to be moved (e.g., onto a spine board), perform a log roll while maintaining manual stabilization of the head and neck.\n4. **Spine board application:** Center the patient onto a long spine board. Secure the torso to the board first (straps across chest, pelvis, thighs).\n5. **Head immobilization:**  Secure the head to the spine board using head blocks and tape or straps. Ensure the head is in a neutral, in-line position if possible (unless resistance is met or it causes pain).\n6. **Extremity immobilization (optional):**  Sometimes, straps are also used to secure the legs to the spine board.\n\nThis process aligns with option A:  torso to spine board first, then head.\n\n&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **A. ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nì²™ì¶” ì†ìƒì´ ì˜ì‹¬ë˜ëŠ” í™˜ìžì˜ ì²™ì¶” ë³´í˜¸ ì¡°ì¹˜ (ì²™ì¶” ì›€ì§ìž„ ì œí•œ)ì˜ í•µì‹¬ì€ ì²™ì¶”ì˜ ì¶”ê°€ì ì¸ ì›€ì§ìž„ì„ ìµœì†Œí™”í•˜ì—¬ 2ì°¨ ì†ìƒì„ ì˜ˆë°©í•˜ëŠ” ê²ƒìž…ë‹ˆë‹¤.  ê° ì„ íƒì§€ë¥¼ ë¶„ì„í•´ ë³´ê² ìŠµë‹ˆë‹¤.\n\n* **A. ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •:**  **ì˜³ì€ ë°©ë²•ìž…ë‹ˆë‹¤.**  ì²™ì¶” ê³ ì •íŒì„ ì‚¬ìš©í•˜ì—¬ ëª¸í†µì„ ë¨¼ì € ì•ˆì •ì ìœ¼ë¡œ ê³ ì •í•˜ëŠ” ê²ƒì€ ì²™ì¶” ì „ì²´ë¥¼ ì•ˆì •í™”í•˜ëŠ” ë° ì¤‘ìš”í•©ë‹ˆë‹¤. ëª¸í†µì´ ê³ ì •ëœ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •í•´ì•¼ ì²™ì¶”ì˜ ì¶• ë°©í–¥ ì›€ì§ìž„ì„ ìµœì†Œí™”í•˜ê³ , ë¨¸ë¦¬ ê³ ì • ì‹œ ë°œìƒí•  ìˆ˜ ìžˆëŠ” ëª¸í†µì˜ ì›€ì§ìž„ì„ ë°©ì§€í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n* **B. ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ê°€ ìœ ì§€ë˜ë„ë¡ ëª© ê³ ì •ìž¥ì¹˜ ì ìš©:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° (head-tilt chin-lift) ìžì„¸ëŠ” ê¸°ë„ í™•ë³´ë¥¼ ìœ„í•´ ì‚¬ìš©í•˜ëŠ” ë°©ë²•ìœ¼ë¡œ, ì²™ì¶” ì†ìƒ í™˜ìžì—ê²ŒëŠ” ê¸ˆê¸°ìž…ë‹ˆë‹¤. ì²™ì¶” ì†ìƒ í™˜ìžì—ê²ŒëŠ” ì²™ì¶”ë¥¼ ì¤‘ë¦½ ìžì„¸ë¡œ ìœ ì§€í•˜ê³  ì›€ì§ìž„ì„ ìµœì†Œí™”í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•˜ë©°, ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ëŠ” ì²™ì¶”ì— ë¶ˆí•„ìš”í•œ ì›€ì§ìž„ì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n* **C. ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì¢Œìš°ë¡œ 45Â° ëŒë¦´ ìˆ˜ ìžˆë„ë¡ ëŠìŠ¨í•˜ê²Œ ê³ ì •:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ëª© ê³ ì •ìž¥ì¹˜ (cervical collar)ëŠ” ëª©ë¼ˆì˜ ì›€ì§ìž„ì„ ìµœëŒ€í•œ ì œí•œí•˜ê¸° ìœ„í•´ ì‚¬ìš©í•˜ëŠ” ê²ƒìž…ë‹ˆë‹¤. ëŠìŠ¨í•˜ê²Œ ê³ ì •í•˜ë©´ ëª©ë¼ˆë¥¼ ì œëŒ€ë¡œ ê³ ì •í•  ìˆ˜ ì—†ê³ , ì˜¤ížˆë ¤ ì›€ì§ìž„ì´ ë°œìƒí•˜ì—¬ ì²™ì¶” ì†ìƒì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì ì ˆí•œ í¬ê¸°ë¡œ í™˜ìžì˜ ëª©ì— ë”± ë§žê²Œ, ì›€ì§ìž„ì´ ê±°ì˜ ì—†ë„ë¡ ë‹¨ë‹¨ížˆ ê³ ì •í•´ì•¼ í•©ë‹ˆë‹¤.\n\n* **D. ëª©ë¼ˆì˜ êµ½íž˜ì´ë‚˜ ì••ë°•ì´ ë°œìƒí•˜ì§€ ì•Šë„ë¡ ê³¼ì‹ ì „ ìƒíƒœë¡œ ê³ ì •:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ì²™ì¶”ë¥¼ ê³¼ì‹ ì „ (hyperextension) ìƒíƒœë¡œ ê³ ì •í•˜ëŠ” ê²ƒì€ ì˜¤ížˆë ¤ ì²™ì¶” ì†ìƒì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. íŠ¹ížˆ ì²™ì¶” ê³¨ì ˆì´ë‚˜ íƒˆêµ¬ê°€ ìžˆëŠ” ê²½ìš° ê³¼ì‹ ì „ì€ ì‹ ê²½ ì†ìƒì„ ìœ ë°œí•˜ê±°ë‚˜ ì•…í™”ì‹œí‚¬ ìœ„í—˜ì´ ìžˆìŠµë‹ˆë‹¤. ì²™ì¶”ëŠ” ê°€ëŠ¥í•œ í•œ ì¤‘ë¦½ ìžì„¸ (neutral position)ë¡œ ìœ ì§€í•˜ëŠ” ê²ƒì´ ì›ì¹™ìž…ë‹ˆë‹¤.\n\n* **E. ëª¸í†µì€ ìœ„ì•„ëž˜ë¡œëŠ” ì›€ì§ì´ê³  ì™¼ìª½ Â· ì˜¤ë¥¸ìª½ìœ¼ë¡œëŠ” ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì •:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ì²™ì¶” ë³´í˜¸ ì¡°ì¹˜ëŠ” ì²™ì¶”ì˜ ëª¨ë“  ë°©í–¥ìœ¼ë¡œì˜ ì›€ì§ìž„ì„ ì œí•œí•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤. ëª¸í†µì„ ìœ„ì•„ëž˜ë¡œ ì›€ì§ì´ê²Œ í—ˆìš©í•˜ëŠ” ê²ƒì€ ì²™ì¶”ì˜ ì›€ì§ìž„ì„ ì™„ì „ížˆ ì œí•œí•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë©°, ì²™ì¶” ì†ìƒ í™˜ìžì—ê²ŒëŠ” ìœ„í—˜í•œ ì²˜ì¹˜ìž…ë‹ˆë‹¤. ëª¸í†µì€ ëª¨ë“  ë°©í–¥ìœ¼ë¡œ ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì •í•´ì•¼ í•©ë‹ˆë‹¤.\n\n\n**ë”°ë¼ì„œ, ì²™ì¶”ì†ìƒ ì˜ì‹¬ í™˜ìž ì´ì†¡ ì‹œ ì²™ì¶” ë³´í˜¸ ì¡°ì¹˜ë¡œ ê°€ìž¥ ì ì ˆí•œ ë°©ë²•ì€ Aìž…ë‹ˆë‹¤.**\n\n**ì •ë‹µ: A**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:7472,&quot;string&quot;:&quot;7,472&quot;}}},{&quot;rowIdx&quot;:2,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;paramedic_1&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2021,&quot;string&quot;:&quot;2,021&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:82,&quot;string&quot;:&quot;82&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;65ì„¸ ë‚¨ìžê°€ 20ë¶„ ì „ì— ê°‘ìžê¸° 1,000cc ì •ë„ ë‘ì°¨ë¡€ í”¼ë¥¼ í† í•œ í›„ ë‚´ì›í•˜ì˜€ë‹¤. í™˜ìžëŠ” 5ë…„ ì „ë¶€í„° ì•Œì½”ì˜¬ì„± ê°„ê²½í™”ë¡œ ì¹˜ë£Œë°›ê³  ìžˆìœ¼ë©°, ì‘ê¸‰ì‹¤ ë‚´ì› í›„ì—ë„ ê³„ì†ì ì¸ ì„ í™ìƒ‰ í† í˜ˆì„ í•˜ì˜€ë‹¤. ì˜ì‹ì€ í˜¼ìˆ˜ìƒíƒœì´ë©°, í˜ˆì•• 60/40mmHg, ë§¥ë°• 115íšŒ/ë¶„, í˜¸í¡ 28íšŒ/ë¶„ì´ê³ , í”¼ë¶€ëŠ” ì°¨ê³  ì¶•ì¶•í•˜ë‹¤. ìš°ì„  í•´ì•¼ í•  ì²˜ì¹˜ëŠ”?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì•„ì´ê²” ì‚½ìž…&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê¸°ê´€ë‚´ ì‚½ê´€&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë¹„ìœ„ê´€íŠœë¸Œ ì‚½ìž…&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í›„ë‘íŠœë¸Œê¸°ë„ê¸° ì‚½ìž…&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ ì‚½ìž…&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down this medical case step-by-step, simulating a thought process to arrive at the correct answer.\n\n**1. Deconstructing the Patient Information:**\n\n* **Age and Gender:** 65-year-old male.  Age is relevant as older patients might have comorbidities or less physiological reserve.\n* **Chief Complaint:** Sudden onset of massive hematemesis (vomiting blood) - 1000cc twice in 20 minutes. This is a *huge* amount of blood loss in a short time.\n* **Medical History:** Alcoholic liver cirrhosis (5 years).  This is *critical*.  Cirrhosis is a major risk factor for esophageal varices, a common cause of upper GI bleeding and hematemesis in these patients.\n* **Current Status on Arrival:**\n    * **Ongoing hematemesis:** Still vomiting bright red blood. This indicates active, ongoing bleeding and emphasizes the urgency of the situation.\n    * **Consciousness:** Comatose.  This is extremely concerning and suggests significant blood loss and likely hypoperfusion of the brain. Airway compromise is a major concern.\n    * **Vitals:**\n        * **BP 60/40 mmHg:**  Severe hypotension.  This is shock.\n        * **HR 115 bpm:** Tachycardia.  Compensatory mechanism for hypovolemia.\n        * **RR 28 bpm:** Tachypnea.  Likely compensatory for metabolic acidosis and hypoxemia due to blood loss.\n        * **Skin:** Cold and clammy.  Signs of peripheral vasoconstriction and poor perfusion, further indicating shock.\n\n**2. Synthesizing the Information and Identifying the Problem:**\n\n* **Massive Hemorrhage:** The patient is experiencing a massive upper GI bleed, most likely due to esophageal varices secondary to liver cirrhosis.\n* **Hypovolemic Shock:**  The vital signs (hypotension, tachycardia, tachypnea, cold/clammy skin) and altered mental status (coma) definitively indicate hypovolemic shock due to blood loss.\n* **Airway Compromise:** Comatose state and ongoing hematemesis put the patient at extremely high risk for airway obstruction due to aspiration of blood.  The patient may also have reduced respiratory drive due to shock.\n\n**3. Prioritizing Immediate Actions - The ABCs:**\n\nIn any emergency, especially with a comatose and bleeding patient, the ABCs (Airway, Breathing, Circulation) are paramount.\n\n* **Airway (A):**  This is *the most critical* priority in this scenario. The patient is comatose and vomiting blood.  The immediate risk is airway obstruction from aspiration. We *must* secure the airway.\n* **Breathing (B):**  Tachypnea is present, but the quality of breathing is unknown and potentially compromised due to coma and shock.  Securing the airway will likely necessitate assisted ventilation.\n* **Circulation (C):**  The patient is in severe shock.  While addressing circulation is crucial (IV access, fluids, blood products), it is secondary to securing the airway in this *immediate* moment because without a patent airway and adequate oxygenation, circulatory interventions will be less effective, and the patient will quickly deteriorate further.\n\n**4. Evaluating the Answer Choices in Light of Priorities:**\n\n* **A. ì•„ì´ê²” ì‚½ìž… (i-gel insertion):**  An i-gel is a supraglottic airway device (SGAD).  It can provide a decent airway, is relatively easy to insert, and can protect against aspiration to some extent.  It's better than nothing, but not ideal in this situation.\n* **B. ê¸°ê´€ë‚´ ì‚½ê´€ (Endotracheal intubation):**  Endotracheal intubation (ETI) is the *gold standard* for airway management. It provides a definitive airway, protects against aspiration, allows for positive pressure ventilation and high FiO2 delivery.  It's more complex than SGADs, but in a comatose patient with massive hematemesis, it's the most secure and protective option.\n* **C. ë¹„ìœ„ê´€íŠœë¸Œ ì‚½ìž… (Nasogastric tube insertion):** An NG tube is used to decompress the stomach and can help remove blood and gastric contents.  While helpful *later* for managing the bleeding and assessing ongoing loss, it does *not* address the immediate airway crisis.  It could even *increase* the risk of aspiration during insertion in a comatose patient.\n* **D. í›„ë‘íŠœë¸Œê¸°ë„ê¸° ì‚½ìž… (Laryngeal tube insertion):** A laryngeal tube (like the King LT) is another type of SGAD.  Similar to the i-gel, it can provide an airway, but less secure than ETI, and may not be optimal for aspiration risk.\n* **E. í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ ì‚½ìž… (Laryngeal mask airway (LMA) insertion):** An LMA is also an SGAD.  Similar pros and cons to i-gel and laryngeal tube.  Less secure than ETI, especially in a patient with high aspiration risk and ongoing bleeding.\n\n**5. Choosing the Best Answer:**\n\nConsidering the patient's comatose state, massive hematemesis, and high risk of aspiration, the *most important* and *first* intervention is to secure the airway definitively.  Endotracheal intubation (B) is the best option because it provides the most secure airway, protects against aspiration, and allows for controlled ventilation and oxygenation, which are crucial in this critical situation.\n\nWhile SGADs (A, D, E) might be considered in less critical airway situations or if intubation is immediately impossible, in this scenario, the patient is clearly unstable and requires the most definitive airway management. NG tube (C) is not the *priority* initial intervention and doesn't address the airway.\n\n**Final Answer Selection and Justification:**\n\nThe best answer is **B. ê¸°ê´€ë‚´ ì‚½ê´€ (Endotracheal intubation)**.\n\n**Reasoning Summary:**\n\n* **Life-threatening situation:** Massive hematemesis, coma, and shock.\n* **Primary concern:** Airway protection and securing breathing due to coma and aspiration risk from vomiting blood.\n* **Endotracheal intubation (ETI):** Gold standard for airway management, provides definitive airway, aspiration protection, and ventilation control.\n* **Other options (SGADs):** Less secure airway, higher aspiration risk, less ideal in this critical patient.\n* **NG tube:** Not the priority for initial airway management and doesn't address immediate airway threats.\n\nTherefore, securing the airway with endotracheal intubation is the most appropriate first action in this emergency situation.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;## ì •ë‹µ í•´ì„¤\n\nì •ë‹µì€ **B. ê¸°ê´€ë‚´ ì‚½ê´€** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\ní™˜ìžëŠ” ë‹¤ìŒê³¼ ê°™ì€ ì‹¬ê°í•œ ìƒíƒœìž…ë‹ˆë‹¤.\n\n* **ëŒ€ëŸ‰ í† í˜ˆ:** 1,000cc ë‘ ì°¨ë¡€ í† í˜ˆì€ ë§¤ìš° ë§Žì€ ì–‘ì´ë©°, í™œë ¥ ì§•í›„ë¥¼ ë¶ˆì•ˆì •í•˜ê²Œ ë§Œë“¤ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n* **ì§€ì†ì ì¸ í† í˜ˆ:** ì‘ê¸‰ì‹¤ ë‚´ì› í›„ì—ë„ ê³„ì† í† í˜ˆì„ í•œë‹¤ëŠ” ê²ƒì€ ì¶œí˜ˆì´ ë©ˆì¶”ì§€ ì•Šê³  ìžˆë‹¤ëŠ” ê²ƒì„ ì˜ë¯¸í•˜ë©°, ë”ìš± ìœ„í—˜í•œ ìƒí™©ìž…ë‹ˆë‹¤.\n* **í˜¼ìˆ˜ìƒíƒœ:** ì˜ì‹ ì €í•˜ëŠ” ë‡Œ í˜ˆë¥˜ ê°ì†Œ ë˜ëŠ” ì‹¬ê°í•œ ì „ì‹  ìƒíƒœ ì•…í™”ë¥¼ ì˜ë¯¸í•˜ë©°, ê¸°ë„ ìœ ì§€ ë° í˜¸í¡ ê´€ë¦¬ê°€ ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.\n* **ì‡¼í¬ ìƒíƒœ:** í˜ˆì•• 60/40mmHgëŠ” ì‹¬ê°í•œ ì €í˜ˆì••ìœ¼ë¡œ ì‡¼í¬ ìƒíƒœë¥¼ ì˜ë¯¸í•˜ë©°, ì¦‰ê°ì ì¸ í˜ˆì•¡ëŸ‰ ë³´ì¶© ë° ì›ì¸ ì¹˜ë£Œê°€ í•„ìš”í•©ë‹ˆë‹¤.\n* **ë¹ˆë§¥ ë° ë¹ˆí˜¸í¡:** ì‹¬ë°•ìˆ˜ 115íšŒ/ë¶„, í˜¸í¡ìˆ˜ 28íšŒ/ë¶„ì€ ì‡¼í¬ì— ëŒ€í•œ ë³´ìƒ ê¸°ì „ìœ¼ë¡œ ë‚˜íƒ€ë‚˜ëŠ” ë°˜ì‘ìž…ë‹ˆë‹¤.\n* **ì°¨ê°€ìš´ í”¼ë¶€:** ë§ì´ˆ í˜ˆê´€ ìˆ˜ì¶•ìœ¼ë¡œ ì¸í•œ ì‡¼í¬ì˜ ì§•í›„ìž…ë‹ˆë‹¤.\n* **ì•Œì½”ì˜¬ì„± ê°„ê²½í™”:** ê¸°ì € ì§ˆí™˜ìœ¼ë¡œ ì‹ë„ ì •ë§¥ë¥˜ ì¶œí˜ˆì˜ ê°€ëŠ¥ì„±ì´ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. ì‹ë„ ì •ë§¥ë¥˜ ì¶œí˜ˆì€ ê°„ê²½ë³€ í™˜ìžì—ì„œ í”í•˜ê²Œ ë°œìƒí•˜ëŠ” ëŒ€ëŸ‰ í† í˜ˆì˜ ì›ì¸ìž…ë‹ˆë‹¤.\n\n**ìš°ì„ ì ìœ¼ë¡œ í•´ì•¼ í•  ì²˜ì¹˜:**\n\nê°€ìž¥ ê¸‰í•˜ê³  ì¤‘ìš”í•œ ì²˜ì¹˜ëŠ” **ê¸°ë„ í™•ë³´ ë° ìœ ì§€** ìž…ë‹ˆë‹¤. í™˜ìžëŠ” í˜¼ìˆ˜ìƒíƒœì´ê³  ì§€ì†ì ì¸ í† í˜ˆì„ í•˜ê³  ìžˆì–´ ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. ë˜í•œ ì‡¼í¬ ìƒíƒœë¡œ ìžë°œ í˜¸í¡ì´ ì¶©ë¶„í•˜ì§€ ì•Šì„ ê°€ëŠ¥ì„±ì´ ë†’ìŠµë‹ˆë‹¤.\n\në”°ë¼ì„œ, **ê¸°ê´€ë‚´ ì‚½ê´€**ì„ í†µí•´ ê¸°ë„ë¥¼ í™•ë³´í•˜ê³  ì¸ê³µí˜¸í¡ì„ ì‹œìž‘í•˜ì—¬ ì‚°ì†Œ ê³µê¸‰ ë° ê¸°ë„ í¡ì¸ì„ ì˜ˆë°©í•˜ëŠ” ê²ƒì´ ìµœìš°ì„ ì ìœ¼ë¡œ í•´ì•¼ í•  ì²˜ì¹˜ìž…ë‹ˆë‹¤.\n\n**ê° ì„ íƒì§€ë³„ ì„¤ëª…:**\n\n* **A. ì•„ì´ê²” ì‚½ìž…:** ì•„ì´ê²”ì€ í›„ë‘ë§ˆìŠ¤í¬ê¸°ë„ê¸°(LMA)ì˜ ì¼ì¢…ìœ¼ë¡œ, ê¸°ê´€ë‚´ ì‚½ê´€ë³´ë‹¤ëŠ” ê°„ë‹¨í•˜ê²Œ ê¸°ë„ í™•ë³´ê°€ ê°€ëŠ¥í•˜ì§€ë§Œ, ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžë‚˜ í˜¼ìˆ˜ìƒíƒœ í™˜ìžì—ì„œëŠ” ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë†’ê³ , ê¸°ê´€ë‚´ ì‚½ê´€ë§Œí¼ í™•ì‹¤í•œ ê¸°ë„ ë³´í˜¸ê°€ ì–´ë µìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ë¡œëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n* **B. ê¸°ê´€ë‚´ ì‚½ê´€:** ìœ„ì—ì„œ ì„¤ëª…í•œ ê²ƒì²˜ëŸ¼, í˜¼ìˆ˜ìƒíƒœ ë° ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžì—ê²Œ ê°€ìž¥ í™•ì‹¤í•˜ê³  ì•ˆì „í•œ ê¸°ë„ í™•ë³´ ë°©ë²•ìž…ë‹ˆë‹¤. ì¸ê³µí˜¸í¡ê¸°ë¥¼ ì—°ê²°í•˜ì—¬ ì ì ˆí•œ í™˜ê¸°ë¥¼ ì œê³µí•˜ê³ , ê¸°ë„ í¡ì¸ì„ ì˜ˆë°©í•˜ë©°, í–¥í›„ ì²˜ì¹˜ë¥¼ ìœ„í•œ ì•ˆì •ì ì¸ í™˜ê²½ì„ ì œê³µí•©ë‹ˆë‹¤. **ì •ë‹µ**ìž…ë‹ˆë‹¤.\n* **C. ë¹„ìœ„ê´€íŠœë¸Œ ì‚½ìž…:** ë¹„ìœ„ê´€ íŠœë¸Œ ì‚½ìž…ì€ ìœ„ìž¥ê´€ ë‚´ ì¶œí˜ˆëŸ‰ì„ í™•ì¸í•˜ê³  ìœ„ ë‚´ìš©ë¬¼ì„ ì œê±°í•˜ì—¬ í¡ì¸ì„ ì˜ˆë°©í•˜ëŠ” ë° ë„ì›€ì´ ë  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ê¸°ë„ í™•ë³´ê°€ ìš°ì„ ì´ë©°, ë¹„ìœ„ê´€ ì‚½ìž…ì€ ê¸°ê´€ë‚´ ì‚½ê´€ í›„ ê³ ë ¤í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ëŠ” ì•„ë‹™ë‹ˆë‹¤.\n* **D. í›„ë‘íŠœë¸Œê¸°ë„ê¸° ì‚½ìž…:** í›„ë‘íŠœë¸Œê¸°ë„ê¸°ëŠ” LMAì™€ ë§ˆì°¬ê°€ì§€ë¡œ ê¸°ê´€ë‚´ ì‚½ê´€ë³´ë‹¤ëŠ” ê°„ë‹¨í•˜ê²Œ ê¸°ë„ í™•ë³´ê°€ ê°€ëŠ¥í•˜ì§€ë§Œ, ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžë‚˜ í˜¼ìˆ˜ìƒíƒœ í™˜ìžì—ì„œëŠ” ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë†’ê³ , ê¸°ê´€ë‚´ ì‚½ê´€ë§Œí¼ í™•ì‹¤í•œ ê¸°ë„ ë³´í˜¸ê°€ ì–´ë µìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ë¡œëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n* **E. í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ ì‚½ìž…:** í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ (LMA)ëŠ” ì•„ì´ê²”ê³¼ ë§ˆì°¬ê°€ì§€ë¡œ ê¸°ê´€ë‚´ ì‚½ê´€ë³´ë‹¤ëŠ” ê°„ë‹¨í•˜ê²Œ ê¸°ë„ í™•ë³´ê°€ ê°€ëŠ¥í•˜ì§€ë§Œ, ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžë‚˜ í˜¼ìˆ˜ìƒíƒœ í™˜ìžì—ì„œëŠ” ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë†’ê³ , ê¸°ê´€ë‚´ ì‚½ê´€ë§Œí¼ í™•ì‹¤í•œ ê¸°ë„ ë³´í˜¸ê°€ ì–´ë µìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ë¡œëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ,**  í˜¼ìˆ˜ìƒíƒœ ë° ëŒ€ëŸ‰ í† í˜ˆ, ì‡¼í¬ ìƒíƒœì¸ í™˜ìžì—ê²Œ ê°€ìž¥ ìš°ì„ ì ìœ¼ë¡œ í•´ì•¼ í•  ì²˜ì¹˜ëŠ” **ê¸°ê´€ë‚´ ì‚½ê´€ì„ í†µí•œ ê¸°ë„ í™•ë³´ ë° ìœ ì§€** ìž…ë‹ˆë‹¤. ì´í›„ ìˆ˜ì•¡ ë° í˜ˆì•¡ ì œì œ íˆ¬ì—¬ë¥¼ í†µí•œ í˜ˆì•• ì•ˆì •í™”, ì¶œí˜ˆ ì›ì¸ íŒŒì•… ë° ì§€í˜ˆ ë“±ì˜ ì¶”ê°€ì ì¸ ì²˜ì¹˜ë¥¼ ì§„í–‰í•´ì•¼ í•©ë‹ˆë‹¤.&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:7146,&quot;string&quot;:&quot;7,146&quot;}}},{&quot;rowIdx&quot;:3,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;doctor&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2014,&quot;string&quot;:&quot;2,014&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3,&quot;string&quot;:&quot;3&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:14,&quot;string&quot;:&quot;14&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìš”ì–‘ë³‘ì›ì„ ê°œì„¤ ìš´ì˜í•˜ê³  ìžˆëŠ” ì˜ì‚¬ 'ê°‘'ì€ ì˜ë£Œê¸°ê´€ ì¸ì¦í‰ê°€ë¥¼ ë°›ì€ í›„ ì˜ë£Œê¸°ê´€ ì¸ì¦ì„œë¥¼ êµë¶€ë°›ì•˜ë‹¤. ì˜ì‚¬ 'ê°‘'ì´ ìš”ì–‘ë³‘ì› ì§„ë£Œë‚´ìš©ê³¼ ì¸ì¦ ê²°ê³¼ë¥¼ ì‹œë‚´ë²„ìŠ¤ ì°¨ëŸ‰ì˜ ì™¸ë¶€ ì˜†ë©´ì— ê´‘ê³ í•˜ê¸° ìœ„í•´ ë¯¸ë¦¬ ì‹¬ì˜ë¥¼ ë°›ìœ¼ë ¤ í•  ë•Œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì‹ ì²­ì„œë¥¼ ì œì¶œí•´ì•¼ í•˜ëŠ” ê¸°ê´€ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëŒ€í•œì˜ì‚¬í˜‘íšŒ&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì›&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì›&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì›&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down this Korean medical law question step-by-step to arrive at the correct answer.\n\n**1. Understanding the Question (Analyze the Korean Text)**\n\n* **ìš”ì–‘ë³‘ì› (yoyangbyeongwon):**  Nursing hospital or long-term care hospital. This is the type of medical institution we are dealing with.\n* **ê°œì„¤ ìš´ì˜í•˜ê³  ìžˆëŠ” ì˜ì‚¬ 'ê°‘' (gaeseol unyeonghago inneun uisa 'gap'):** Doctor 'Gap' who establishes and operates. This tells us the subject is a doctor who runs a nursing hospital.\n* **ì˜ë£Œê¸°ê´€ ì¸ì¦í‰ê°€ë¥¼ ë°›ì€ í›„ ì˜ë£Œê¸°ê´€ ì¸ì¦ì„œë¥¼ êµë¶€ë°›ì•˜ë‹¤ (uiryogigwan ì¸ì¦pyeonggareul badeun hu uiryogigwan ì¸ì¦seoreul gyobubadeatda):**  Received medical institution certification after undergoing medical institution accreditation assessment and receiving a medical institution certification certificate. This is important â€“ the hospital is certified.\n* **ìš”ì–‘ë³‘ì› ì§„ë£Œë‚´ìš©ê³¼ ì¸ì¦ ê²°ê³¼ë¥¼ ì‹œë‚´ë²„ìŠ¤ ì°¨ëŸ‰ì˜ ì™¸ë¶€ ì˜†ë©´ì— ê´‘ê³ í•˜ê¸° ìœ„í•´ (yoyangbyeongwon jinryonaeyonggwa ì¸ì¦ gyeolgwaleul sinaebeoseu charyang-ui oebu yeopmyeone gwang-gohagi wihae):** In order to advertise the nursing hospital's treatment details and certification results on the external side of a city bus. This is the core action: advertising.\n* **ë¯¸ë¦¬ ì‹¬ì˜ë¥¼ ë°›ìœ¼ë ¤ í•  ë•Œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì‹ ì²­ì„œë¥¼ ì œì¶œí•´ì•¼ í•˜ëŠ” ê¸°ê´€ì€? (miri simuireul badeuryeo hal ttae uiryogwanggo simuisincheongseoreul jechulhaeya haneun gigwan-eun?):**  Which institution should the medical advertisement review application be submitted to when intending to receive prior review? This is the question itself - where to apply for pre-approval for the advertisement.\n\n**In simpler English:**  A doctor operating a certified nursing hospital wants to advertise their hospital's services and certification on the side of a city bus.  Where should they submit their application for pre-approval of this medical advertisement?\n\n**2. Identifying the Key Issue: Medical Advertisement Review**\n\nThe core of the question is *ì˜ë£Œê´‘ê³  ì‹¬ì˜ (uiryogwanggo simui)* - medical advertisement review or pre-approval.  This is the central concept to focus on. We need to know which organization is responsible for reviewing medical advertisements in Korea.\n\n**3. Recalling Knowledge of Korean Medical Law/Regulations (or Quick Research if Unfamiliar)**\n\n* **Medical Advertising Regulations in Korea:**  Korean medical law is quite strict about advertising medical institutions and services.  Pre-approval is generally required for many types of medical advertisements to protect patients and prevent misleading information.\n* **Who Reviews Medical Ads?**  This is the crucial piece of information. In Korea, the **ì˜ë£Œê´‘ê³ ì‹¬ì˜ìœ„ì›íšŒ (uiryogwanggo simui wiwonhoe)** â€“ Medical Advertisement Review Committee â€“ is responsible for this. This committee is usually associated with or delegated to specific medical professional associations.\n\n**4. Evaluating the Answer Choices (Analyze each option in Korean and English):**\n\n* **A. ëŒ€í•œì˜ì‚¬í˜‘íšŒ (Daehan Uisa Hyeophoe): Korean Medical Association (KMA)** -  The KMA is the main professional organization for doctors in Korea.  They *do* play a role in medical advertisement review.  In fact, the Medical Advertisement Review Committee is often under the KMA's umbrella or delegated to them. This is a strong candidate.\n\n* **B. êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨ (Gungmin Geongang Boheom Gongdan): National Health Insurance Service (NHIS)** - The NHIS is responsible for managing the national health insurance system. Their primary focus is on insurance, payments, and healthcare policy *financing*.  They are *not* primarily involved in advertisement review.  Less likely.\n\n* **C. í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì› (Hanguk Bogeon Uiryo Yeonguwon): Korea Institute for Health and Social Affairs (KIHASA)** - KIHASA is a research institute focused on health and social welfare policy. They conduct research and advise the government. They are not involved in *advertisement review*. Unlikely.\n\n* **D. ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì› (Uryogigwan Injeungpyeonggawon): Korea Institute for Healthcare Accreditation (KOIHA)** - KOIHA is the organization that conducts medical institution accreditation assessments (as mentioned in the question itself).  They *certify* hospitals. While related to hospital quality, their main role isn't *advertisement review*. Less likely.\n\n* **E. í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì› (Hanguk Uiryo Bunjaeng Jojeong Jungjaewon): Korea Medical Dispute Mediation and Arbitration Agency (KMDMA)** - KMDMA handles medical disputes and mediation.  They are about *resolving* issues after they occur, not *preventing* misleading advertising.  Unlikely.\n\n**5. Selecting the Most Likely Answer:**\n\nBased on the analysis, the **Korean Medical Association (ëŒ€í•œì˜ì‚¬í˜‘íšŒ)** is the most likely organization to handle medical advertisement review applications.  They are the central professional body for doctors and are often delegated this responsibility by the Ministry of Health and Welfare.\n\n**6. Confirmation (If Possible):**\n\nA quick search for \&quot;ì˜ë£Œê´‘ê³  ì‹¬ì˜ ëŒ€í•œì˜ì‚¬í˜‘íšŒ\&quot; (medical advertisement review Korean Medical Association) in Korean would likely confirm that the KMA is indeed the relevant body for medical advertisement pre-approval in many cases, particularly for doctors and clinics.\n\n**Conclusion:**\n\nTherefore, the answer is **A. ëŒ€í•œì˜ì‚¬í˜‘íšŒ (Korean Medical Association)**.  The reasoning is based on understanding the core issue of medical advertisement review and knowing or deducing the relevant organization responsible for this in Korea.  The other options are related to healthcare but have different primary functions and are not the correct body for advertisement pre-approval.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **A. ëŒ€í•œì˜ì‚¬í˜‘íšŒ**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n* **ì˜ë£Œë²•** ì œ56ì¡° ë° ë™ë²• ì‹œí–‰ë ¹ ì œ23ì¡°ì— ë”°ë¥´ë©´, ì˜ë£Œê¸°ê´€ì˜ ê¸°ëŠ¥, ì§„ë£Œê³¼ëª©, ì§„ë£Œ ë‚´ìš© ë“±ì— ëŒ€í•œ ê´‘ê³ ëŠ” **ì‚¬ì „ì‹¬ì˜**ë¥¼ ë°›ì•„ì•¼ í•©ë‹ˆë‹¤.\n* ì˜ë£Œê´‘ê³  ì‹¬ì˜ ì—…ë¬´ëŠ” ì˜ë£Œë²•ì— ë”°ë¼ **ê° ì˜ë£Œì¸ ë‹¨ì²´(ì˜ì‚¬í˜‘íšŒ, ì¹˜ê³¼ì˜ì‚¬í˜‘íšŒ, í•œì˜ì‚¬í˜‘íšŒ ë“±)**ì— ìœ„íƒë˜ì–´ ìžˆìŠµë‹ˆë‹¤.\n* ë”°ë¼ì„œ ì˜ì‚¬ 'ê°‘'ì€ ì˜ì‚¬ì´ê¸° ë•Œë¬¸ì—, **ëŒ€í•œì˜ì‚¬í˜‘íšŒ**ì— ì˜ë£Œê´‘ê³  ì‹¬ì˜ì‹ ì²­ì„œë¥¼ ì œì¶œí•´ì•¼ í•©ë‹ˆë‹¤.\n\n**ì˜¤ë‹µ ì´ìœ :**\n\n* **B. êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨:** êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨ì€ ê±´ê°•ë³´í—˜ ë° ìž¥ê¸°ìš”ì–‘ë³´í—˜ ìš´ì˜ì„ ë‹´ë‹¹í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì™€ëŠ” ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n* **C. í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì›:** í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì›ì€ ë³´ê±´ì˜ë£Œ ê¸°ìˆ  í‰ê°€ ë° ì—°êµ¬ë¥¼ ìˆ˜í–‰í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì™€ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n* **D. ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì›:** ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì›ì€ ì˜ë£Œê¸°ê´€ ì¸ì¦í‰ê°€ë¥¼ ë‹´ë‹¹í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ, ì¸ì¦ ìžì²´ëŠ” ê´‘ê³ ì— í™œìš©ë  ìˆ˜ ìžˆì§€ë§Œ ê´‘ê³  ì‹¬ì˜ë¥¼ ë‹´ë‹¹í•˜ì§€ëŠ” ì•ŠìŠµë‹ˆë‹¤.\n* **E. í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì›:** í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì›ì€ ì˜ë£Œë¶„ìŸ ì¡°ì • ë° ì¤‘ìž¬ë¥¼ ë‹´ë‹¹í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì™€ëŠ” ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n\n**í•µì‹¬ ìš”ì•½:**\n\nì˜ë£Œê´‘ê³  ì‚¬ì „ì‹¬ì˜ëŠ” **í•´ë‹¹ ì˜ë£Œì¸ì˜ ì§ì—­ë³„ ì¤‘ì•™íšŒ (ì˜ì‚¬í˜‘íšŒ, ì¹˜ê³¼ì˜ì‚¬í˜‘íšŒ ë“±)**ì—ì„œ ë‹´ë‹¹í•©ë‹ˆë‹¤. ë”°ë¼ì„œ ì˜ì‚¬ì¸ 'ê°‘'ì€ **ëŒ€í•œì˜ì‚¬í˜‘íšŒ**ì— ì‹¬ì˜ì‹ ì²­ì„ í•´ì•¼ í•©ë‹ˆë‹¤.&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:61,&quot;string&quot;:&quot;61&quot;}}},{&quot;rowIdx&quot;:4,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;nurse_assistant&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2023,&quot;string&quot;:&quot;2,023&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê°„í˜¸ì¡°ë¬´ì‚¬ê°€ ì§ì—…ìœ¤ë¦¬ë¥¼ ì‹¤ì²œí•˜ëŠ” ëª©ì ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë²•ì ì¸ ì±…ìž„ ë©´ì œ&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì—…ë¬´ ìˆ˜í–‰ ì‹œê°„ ë‹¨ì¶•&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í™˜ìžì˜ ë¹„ë°€ì„ ì¹œêµ¬ì™€ ê³µìœ &quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì§ë©´í•œ ìœ¤ë¦¬ì  ë”œë ˆë§ˆ íšŒí”¼&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;\nThe question is asking about the purpose of a nursing assistant practicing professional ethics. I need to analyze each option and choose the one that best represents the core reason for ethical practice in nursing assistance.\n\n* **Analyze each option:**\n    * **A. ë²•ì ì¸ ì±…ìž„ ë©´ì œ (Exemption from legal responsibility):** While ethical practice *can* help prevent legal issues, it's not the primary *purpose*. Ethics goes beyond just avoiding legal trouble. Legal compliance is a consequence, not the main goal.\n    * **B. ì—…ë¬´ ìˆ˜í–‰ ì‹œê°„ ë‹¨ì¶• (Shortening work performance time):** Ethical practice might *sometimes* involve efficiency, but it's definitely not about shortening work time as the main purpose.  Ethical considerations can sometimes *increase* the time spent on a task (e.g., ensuring informed consent, providing emotional support).\n    * **C. í™˜ìžì˜ ë¹„ë°€ì„ ì¹œêµ¬ì™€ ê³µìœ  (Sharing patient's secrets with friends):** This is the *opposite* of ethical practice.  Patient confidentiality is a core ethical principle. This option is clearly wrong.\n    * **D. ì§ë©´í•œ ìœ¤ë¦¬ì  ë”œë ˆë§ˆ íšŒí”¼ (Avoiding ethical dilemmas faced):** Ethical practice isn't about avoiding dilemmas, but about *resolving* them in a principled way.  Dilemmas are inherent in healthcare, and ethics provides a framework for navigating them. This option is also incorrect.\n    * **E. ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘ (Respect for human dignity and personality):** This aligns perfectly with the core principles of healthcare ethics.  Ethical practice in nursing, and nursing assistance, is fundamentally about respecting patients as individuals with inherent dignity and worth.\n\n* **Identify the best answer:** Option E directly addresses the fundamental purpose of healthcare ethics â€“ respecting patients' dignity and personhood.  The other options are either irrelevant, incorrect, or represent side effects rather than the primary purpose.\n\n* **Confirm the answer:**  Thinking about the core values of nursing and healthcare, patient-centered care, respect, dignity, and autonomy are central. Ethical practice is the means to uphold these values. Option E encapsulates this perfectly.\n\nTherefore, the answer should be E.\n&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **E. ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nê°„í˜¸ì¡°ë¬´ì‚¬ê°€ ì§ì—…ìœ¤ë¦¬ë¥¼ ì‹¤ì²œí•˜ëŠ” ê°€ìž¥ ì¤‘ìš”í•œ ëª©ì ì€ í™˜ìžë¥¼ ì¸ê°„ìœ¼ë¡œì„œ ì¡´ì¤‘í•˜ê³ , ê·¸ë“¤ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²©ì„ ë³´í˜¸í•˜ëŠ” ë° ìžˆìŠµë‹ˆë‹¤.  ë‹¤ë¥¸ ì„ íƒì§€ë“¤ì€ ìœ¤ë¦¬ ì‹¤ì²œì˜ ëª©ì ê³¼ëŠ” ê±°ë¦¬ê°€ ë©‰ë‹ˆë‹¤.\n\n* **A. ë²•ì ì¸ ì±…ìž„ ë©´ì œ:** ìœ¤ë¦¬ì  ì‹¤ì²œì€ ë²•ì  ë¬¸ì œë¥¼ ì˜ˆë°©í•˜ëŠ” ë° ë„ì›€ì´ ë  ìˆ˜ ìžˆì§€ë§Œ, ë²•ì  ì±…ìž„ì„ íšŒí”¼í•˜ëŠ” ê²ƒì´ ìœ¤ë¦¬ ì‹¤ì²œì˜ ì£¼ëœ ëª©ì ì€ ì•„ë‹™ë‹ˆë‹¤. ìœ¤ë¦¬ëŠ” ë²•ë¥ ë³´ë‹¤ ë” ë†’ì€ ë„ë•ì  ê¸°ì¤€ì„ í¬í•¨í•©ë‹ˆë‹¤.\n* **B. ì—…ë¬´ ìˆ˜í–‰ ì‹œê°„ ë‹¨ì¶•:** ìœ¤ë¦¬ì  ì‹¤ì²œì€ ë•Œë¡œëŠ” ì—…ë¬´ ì‹œê°„ì„ ëŠ˜ë¦´ ìˆ˜ë„ ìžˆìŠµë‹ˆë‹¤. í™˜ìžì˜ ê¶Œë¦¬ë¥¼ ì¡´ì¤‘í•˜ê³  ìœ¤ë¦¬ì  ë¬¸ì œë¥¼ í•´ê²°í•˜ëŠ” ë° ì¶©ë¶„í•œ ì‹œê°„ì„ í• ì• í•´ì•¼ í•˜ê¸° ë•Œë¬¸ìž…ë‹ˆë‹¤.\n* **C. í™˜ìžì˜ ë¹„ë°€ì„ ì¹œêµ¬ì™€ ê³µìœ :** ì´ëŠ” ëª…ë°±ížˆ ìœ¤ë¦¬ ìœ„ë°˜ìž…ë‹ˆë‹¤. í™˜ìžì˜ ë¹„ë°€ ìœ ì§€ëŠ” ê°„í˜¸ ì§ì—… ìœ¤ë¦¬ì˜ í•µì‹¬ìž…ë‹ˆë‹¤.\n* **D. ì§ë©´í•œ ìœ¤ë¦¬ì  ë”œë ˆë§ˆ íšŒí”¼:** ìœ¤ë¦¬ì  ë”œë ˆë§ˆë¥¼ íšŒí”¼í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ìœ¤ë¦¬ì  ì›ì¹™ì— ë”°ë¼ ë”œë ˆë§ˆë¥¼ í•´ê²°í•˜ê³  ìµœì„ ì˜ ê²°ì •ì„ ë‚´ë¦¬ëŠ” ê²ƒì´ ìœ¤ë¦¬ ì‹¤ì²œì˜ ëª©í‘œìž…ë‹ˆë‹¤.\n* **E. ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘:**  í™˜ìžë¥¼ ë‹¨ìˆœížˆ ì¹˜ë£Œì˜ ëŒ€ìƒìœ¼ë¡œ ë³´ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì¡´ì—„í•œ ì¸ê°„ìœ¼ë¡œì„œ ì¡´ì¤‘í•˜ê³  ê·¸ë“¤ì˜ ê°€ì¹˜ì™€ ê¶Œë¦¬ë¥¼ ë³´í˜¸í•˜ëŠ” ê²ƒì´ ìœ¤ë¦¬ì  ì‹¤ì²œì˜ í•µì‹¬ìž…ë‹ˆë‹¤. ì´ëŠ” ê°„í˜¸ ë° ì˜ë£Œ ìœ¤ë¦¬ì˜ ê°€ìž¥ ê¸°ë³¸ì ì¸ ì›ì¹™ìž…ë‹ˆë‹¤.\n\n**ë”°ë¼ì„œ ì •ë‹µì€ Eìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:6586,&quot;string&quot;:&quot;6,586&quot;}}},{&quot;rowIdx&quot;:5,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;pharm&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2019,&quot;string&quot;:&quot;2,019&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:86,&quot;string&quot;:&quot;86&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë§¥ë¥˜ê°€ ì§€ì†ë  ë•Œ ë°œìƒí•˜ëŠ” í•©ë³‘ì¦ì¸ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼(stasis dermatitis) ì˜ ë°œìƒ ê¸°ì „ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì•Œë¶€ë¯¼ì˜ í˜ˆê´€ ì™¸ ì¹¨ì°©&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë§¥ë¥˜ ë¶€ìœ„ì˜ ì„¸ê·  ê°ì—¼&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ëŒ€ì‹ì„¸í¬ì˜ ì‹ìž‘ìš©&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ë¦¼í”„êµ¬ì˜ ë©´ì—­ë°˜ì‘&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3,&quot;string&quot;:&quot;3&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer and explanation for the question about stasis dermatitis and its mechanism.\n\n**1. Deconstructing the Question:**\n\n* **Keywords:** ì •ë§¥ë¥˜ (varicose veins), ì§€ì†ë  ë•Œ (persistent), í•©ë³‘ì¦ (complication), ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ (stasis dermatitis), ë°œìƒ ê¸°ì „ (pathogenesis/mechanism).\n* **Core Question:** What is the underlying process that leads to stasis dermatitis when varicose veins persist?\n* **Target Condition:** Stasis dermatitis (also known as venous stasis dermatitis or gravitational dermatitis).  This immediately signals a connection to venous insufficiency or poor venous return.\n* **Answer Choices:**  The choices focus on different cellular/molecular events: albumin deposition, bacterial infection, red blood cell lysis, macrophage phagocytosis, lymphocyte immune response.  These are all plausible elements in various inflammatory or tissue damage scenarios, so we need to connect them specifically to venous insufficiency and stasis dermatitis.\n\n**2.  Recalling Knowledge about Stasis Dermatitis:**\n\n* **Etiology (Cause):** Primarily caused by chronic venous insufficiency. Varicose veins are a common manifestation of this.  The key is impaired venous return from the legs.\n* **Pathophysiology (Mechanism):**  Venous hypertension (high pressure in veins) is the central issue. This leads to:\n    * **Fluid leakage:** Increased pressure pushes fluid out of capillaries and venules into the surrounding tissues.\n    * **Red blood cell extravasation:**  RBCs also leak out, along with other blood components.\n    * **Inflammation:** The presence of leaked fluid and blood components triggers an inflammatory response.\n    * **Skin changes:**  Chronic inflammation leads to the characteristic skin changes: edema, hyperpigmentation (brown discoloration), induration (hardening), and potentially ulceration.\n\n**3.  Analyzing Each Answer Choice in Light of Stasis Dermatitis Pathophysiology:**\n\n* **A. ì•Œë¶€ë¯¼ì˜ í˜ˆê´€ ì™¸ ì¹¨ì°© (Albumin extravascular deposition):** Albumin is a major plasma protein.  Increased vascular permeability *does* lead to albumin leakage. Albumin in the interstitial space can contribute to edema and inflammation.  This sounds *plausible*.\n\n* **B. ì •ë§¥ë¥˜ ë¶€ìœ„ì˜ ì„¸ê·  ê°ì—¼ (Bacterial infection in varicose vein area):** While secondary bacterial infections can occur in stasis dermatitis (especially if ulcers develop), infection is *not* the primary mechanism of *developing* stasis dermatitis.  It's a complication *of* stasis dermatitis or ulcers, not the cause of the initial skin changes. This is *less likely* to be the primary mechanism.\n\n* **C. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´ (Lysis of extravasated red blood cells):** This is a *key* point in stasis dermatitis.  Extravasated RBCs release hemoglobin.  Hemoglobin breaks down into hemosiderin, an iron-containing pigment. Hemosiderin deposition in the skin is responsible for the characteristic *brown* discoloration (hyperpigmentation) of stasis dermatitis. This sounds *very likely*.\n\n* **D. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ëŒ€ì‹ì„¸í¬ì˜ ì‹ìž‘ìš© (Phagocytosis by extravasated macrophages):** Macrophages are involved in inflammation and tissue repair. They *will* be present in the area and *will* phagocytose debris, including RBCs and hemosiderin. However, their phagocytosis is a *response* to the underlying issue (RBC extravasation and lysis), not the primary *mechanism causing* the dermatitis. This is *less likely* to be the *primary* mechanism, although macrophages are involved in the overall process.\n\n* **E. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ë¦¼í”„êµ¬ì˜ ë©´ì—­ë°˜ì‘ (Immune response by extravasated lymphocytes):** Lymphocytes are also involved in inflammation and immune responses. In chronic inflammation like stasis dermatitis, lymphocytes are present.  However, the *primary driver* of the skin changes isn't primarily a lymphocyte-mediated immune reaction like in allergic contact dermatitis.  While lymphocytes contribute to the inflammatory milieu, they aren't the *initiating mechanism* responsible for the characteristic skin changes. This is *less likely* to be the primary mechanism.\n\n**4.  Comparing and Contrasting, Focusing on \&quot;Mechanism\&quot;:**\n\nWe need to identify the *most direct and primary* mechanism for the *characteristic features* of stasis dermatitis, especially the brown discoloration.\n\n* **Choice C (RBC lysis and hemosiderin deposition)** directly explains the brown discoloration, a hallmark of stasis dermatitis.  It's a direct consequence of venous hypertension and RBC extravasation.\n* **Choice A (Albumin leakage)** contributes to edema but doesn't directly explain the *brown* discoloration.\n* **Choices B, D, and E** are either secondary events (infection) or components of the inflammatory response but don't directly explain the *brown* pigmentation characteristic of stasis dermatitis.\n\n**5.  Conclusion and Explanation:**\n\nChoice C (í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´ - Lysis of extravasated red blood cells) is the most accurate and direct answer.\n\n* **Explanation in Korean (similar to the provided example):** ì •ë§¥ë¥˜ê°€ ì§€ì†ë˜ë©´ ì •ë§¥ì•• ìƒìŠ¹ìœ¼ë¡œ ì¸í•´ í˜ˆê´€ì—ì„œ ì í˜ˆêµ¬ê°€ í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œë©ë‹ˆë‹¤. ìœ ì¶œëœ ì í˜ˆêµ¬ëŠ” ìš©í•´ë˜ì–´ í—¤ëª¨ê¸€ë¡œë¹ˆì„ ë°©ì¶œí•˜ê³ , í—¤ëª¨ê¸€ë¡œë¹ˆì€ í—¤ëª¨ì‹œë°ë¦°ìœ¼ë¡œ ì „í™˜ë©ë‹ˆë‹¤. í—¤ëª¨ì‹œë°ë¦°ì€ ê°ˆìƒ‰ ìƒ‰ì†Œì´ë¯€ë¡œ, í”¼ë¶€ì— ì¹¨ì°©ë˜ì–´ ê°ˆìƒ‰ì˜ ìƒ‰ì†Œ ì¹¨ì°©ì„ ìœ ë°œí•©ë‹ˆë‹¤. ë˜í•œ, ì í˜ˆêµ¬ ìš©í•´ ê³¼ì •ì—ì„œ ë°©ì¶œë˜ëŠ” ë¬¼ì§ˆë“¤ì€ ì—¼ì¦ ë°˜ì‘ì„ ìœ ë°œí•˜ì—¬ í”¼ë¶€ì—¼ì„ ì•…í™”ì‹œí‚µë‹ˆë‹¤. ë”°ë¼ì„œ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ ë°œìƒ ê¸°ì „ì€ í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´ìž…ë‹ˆë‹¤.\n\n* **Explanation in English (for further clarity):**  Persistent varicose veins lead to venous hypertension, causing red blood cells to leak out of blood vessels into the surrounding tissues. These extravasated red blood cells are then lysed (broken down), releasing hemoglobin. Hemoglobin is further degraded into hemosiderin, an iron-containing pigment that is brown in color.  Hemosiderin deposition in the skin causes the characteristic brown pigmentation of stasis dermatitis.  Furthermore, the breakdown products of red blood cells contribute to inflammation, exacerbating the dermatitis. Therefore, the mechanism of stasis dermatitis is primarily the lysis of extravasated red blood cells.\n\nThis detailed thought process systematically eliminates incorrect options and reinforces why choice C is the correct answer, linking it directly to the key pathological feature of stasis dermatitis â€“ the brown discoloration and the underlying venous insufficiency mechanism.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **C. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼(stasis dermatitis)ì€ ë§Œì„± ì •ë§¥ ê¸°ëŠ¥ ë¶€ì „ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” í”¼ë¶€ ì§ˆí™˜ìž…ë‹ˆë‹¤.  ì •ë§¥ë¥˜ê°€ ì§€ì†ë˜ë©´ ë‹¤ìŒê³¼ ê°™ì€ ê¸°ì „ìœ¼ë¡œ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì´ ë°œìƒí•©ë‹ˆë‹¤.\n\n1. **ì •ë§¥ì•• ìƒìŠ¹:** ì •ë§¥ë¥˜ëŠ” ì •ë§¥ì˜ íŒë§‰ ê¸°ëŠ¥ ë¶€ì „ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ë©°, ì´ëŠ” ë‹¤ë¦¬ ì •ë§¥ì˜ í˜ˆì•¡ ìˆœí™˜ ìž¥ì• ë¥¼ ì¼ìœ¼í‚¤ê³  ì •ë§¥ì••ì„ ìƒìŠ¹ì‹œí‚µë‹ˆë‹¤.\n2. **í˜ˆê´€ íˆ¬ê³¼ì„± ì¦ê°€:** ì§€ì†ì ì¸ ì •ë§¥ì•• ìƒìŠ¹ì€ ëª¨ì„¸í˜ˆê´€ê³¼ ì†Œì •ë§¥ì˜ íˆ¬ê³¼ì„±ì„ ì¦ê°€ì‹œí‚µë‹ˆë‹¤.\n3. **ì í˜ˆêµ¬ ë° í˜ˆìž¥ ì„±ë¶„ ìœ ì¶œ:** ì¦ê°€ëœ í˜ˆê´€ íˆ¬ê³¼ì„±ìœ¼ë¡œ ì¸í•´ ì í˜ˆêµ¬, ì•Œë¶€ë¯¼, ì„¬ìœ ì†Œì› ë“± í˜ˆìž¥ ì„±ë¶„ë“¤ì´ í˜ˆê´€ ë°– ì¡°ì§ìœ¼ë¡œ ìœ ì¶œë©ë‹ˆë‹¤.\n4. **ì í˜ˆêµ¬ ìš©í•´ ë° í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©:** í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ëŠ” íŒŒê´´(ìš©í•´)ë˜ê³ , ì í˜ˆêµ¬ ë‚´ì˜ í—¤ëª¨ê¸€ë¡œë¹ˆì€ í—¤ëª¨ì‹œë°ë¦°ì´ë¼ëŠ” ê°ˆìƒ‰ ìƒ‰ì†Œë¡œ ë³€í™˜ë©ë‹ˆë‹¤. ì´ í—¤ëª¨ì‹œë°ë¦°ì´ í”¼ë¶€ì— ì¹¨ì°©ë˜ì–´ ê°ˆìƒ‰ì˜ ìƒ‰ì†Œ ì¹¨ì°©ì„ ìœ ë°œí•©ë‹ˆë‹¤. ì´ê²ƒì´ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ íŠ¹ì§•ì ì¸ ê°ˆìƒ‰ ë³€ìƒ‰ì˜ ì›ì¸ìž…ë‹ˆë‹¤.\n5. **ì—¼ì¦ ë°˜ì‘ ë° ì„¬ìœ í™”:** ìœ ì¶œëœ í˜ˆìž¥ ì„±ë¶„ê³¼ ì í˜ˆêµ¬ ìš©í•´ ì‚°ë¬¼ì€ í”¼ë¶€ì— ì—¼ì¦ ë°˜ì‘ì„ ìœ ë°œí•˜ê³ , ë§Œì„±ì ì¸ ì—¼ì¦ì€ í”¼ë¶€ì˜ ì„¬ìœ í™”ë¥¼ ì´‰ì§„í•˜ì—¬ í”¼ë¶€ë¥¼ ë‘ê»ê³  ë‹¨ë‹¨í•˜ê²Œ ë§Œë“¤ë©° (ê²½í™”), ê°€ë ¤ì›€ì¦, í†µì¦, ê¶¤ì–‘ ë“±ì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n**ì˜¤ë‹µ ì„ íƒì§€ í•´ì„¤:**\n\n* **A. ì•Œë¶€ë¯¼ì˜ í˜ˆê´€ ì™¸ ì¹¨ì°©:** ì•Œë¶€ë¯¼ì€ í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œë  ìˆ˜ ìžˆì§€ë§Œ, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ ì£¼ëœ ë°œìƒ ê¸°ì „ì´ë¼ê¸°ë³´ë‹¤ëŠ” ë¶€ì¢…ê³¼ ê´€ë ¨ì´ ê¹ŠìŠµë‹ˆë‹¤. ì•Œë¶€ë¯¼ ìžì²´ëŠ” ê°ˆìƒ‰ ìƒ‰ì†Œ ì¹¨ì°©ì„ ìœ ë°œí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n* **B. ì •ë§¥ë¥˜ ë¶€ìœ„ì˜ ì„¸ê·  ê°ì—¼:** ì„¸ê·  ê°ì—¼ì€ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ í•©ë³‘ì¦ìœ¼ë¡œ ë°œìƒí•  ìˆ˜ ìžˆì§€ë§Œ, ì¼ì°¨ì ì¸ ë°œìƒ ê¸°ì „ì€ ì•„ë‹™ë‹ˆë‹¤. ê°ì—¼ì€ í”¼ë¶€ì—¼ì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆì§€ë§Œ, í”¼ë¶€ì—¼ ìžì²´ì˜ ì‹œìž‘ ì›ì¸ì€ ì•„ë‹™ë‹ˆë‹¤.\n* **D. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ëŒ€ì‹ì„¸í¬ì˜ ì‹ìž‘ìš©:** ëŒ€ì‹ì„¸í¬ëŠ” í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œë˜ì–´ ì‹ìž‘ìš©ì„ í•  ìˆ˜ ìžˆì§€ë§Œ, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ ê°ˆìƒ‰ ìƒ‰ì†Œ ì¹¨ì°©ì˜ ì§ì ‘ì ì¸ ì›ì¸ì€ ì•„ë‹™ë‹ˆë‹¤. ëŒ€ì‹ì„¸í¬ëŠ” ì—¼ì¦ ë°˜ì‘ì— ê´€ì—¬í•˜ì§€ë§Œ, ì£¼ëœ ê¸°ì „ì€ ì í˜ˆêµ¬ ìš©í•´ì™€ í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©ìž…ë‹ˆë‹¤.\n* **E. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ë¦¼í”„êµ¬ì˜ ë©´ì—­ë°˜ì‘:** ë¦¼í”„êµ¬ëŠ” ë©´ì—­ ë°˜ì‘ì— ê´€ì—¬í•˜ë©°, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì—ë„ ì—¼ì¦ ë°˜ì‘ì˜ ì¼ë¶€ë¡œ ë¦¼í”„êµ¬ê°€ ê´€ì—¬í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ì£¼ëœ ë°œìƒ ê¸°ì „ì€ ë¦¼í”„êµ¬ì˜ ë©´ì—­ ë°˜ì‘ë³´ë‹¤ëŠ” ì í˜ˆêµ¬ ìš©í•´ì™€ í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©ìž…ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ í•µì‹¬ ë°œìƒ ê¸°ì „ì€ ì •ë§¥ì•• ìƒìŠ¹ìœ¼ë¡œ ì¸í•œ ì í˜ˆêµ¬ì˜ í˜ˆê´€ ì™¸ ìœ ì¶œ ë° ìš©í•´, ê·¸ë¦¬ê³  ê·¸ ê²°ê³¼ë¡œ ë°œìƒí•˜ëŠ” í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©ìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3145,&quot;string&quot;:&quot;3,145&quot;}}},{&quot;rowIdx&quot;:6,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;nurse&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2019,&quot;string&quot;:&quot;2,019&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:45,&quot;string&quot;:&quot;45&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì§€ì—­ì‚¬íšŒê°„í˜¸ì‚¬ê°€ ì˜ì•„ë¥¼ ë‘” ë‹¤ë¬¸í™” ì—¬ì„±ì„ ëŒ€ìƒìœ¼ë¡œ ê³ í˜•ì‹ì— ëŒ€í•´ êµìœ¡í•˜ë ¤ê³  í•  ë•Œ ë¬¸í™”ì  ì°¨ì´ì ì„ í™•ì¸í•˜ê¸° ìœ„í•´ ì‚¬ì •í•´ì•¼ í•  ì‚¬í•­ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìœ ì¹˜ì˜ ê°œìˆ˜&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì•„ê¸°ì˜ ì›”ë ¹&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;\nThe question is asking about what a community health nurse should assess to understand cultural differences when educating a multicultural woman with an infant about solid foods.  Let's break down each option and think about its relevance to cultural differences and solid food education.\n\n* **A. ìœ ì¹˜ì˜ ê°œìˆ˜ (Number of baby teeth):**  While the number of teeth *can* be an indicator of readiness for certain textures of food (and sometimes related to developmental stage), it's not directly tied to cultural differences in solid food introduction.  Different cultures might introduce solids at different stages regardless of teeth, and the types of solids offered could vary culturally.  Teeth are more of a biological factor than a cultural one in this context.\n\n* **B. ì•„ê¸°ì˜ ì›”ë ¹ (Infant's age in months):**  Age is a crucial factor in determining when to start solids in general.  However, cultural practices can significantly influence *when* and *how* solids are introduced.  For example, some cultures might start earlier or later than the generally recommended age, and the types of first foods might differ based on cultural norms.  Age provides a baseline, but cultural context is essential for tailoring education.\n\n* **C. ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€ (Whether solid foods are being given):**  Knowing if the mother is *already* introducing solids is important.  If she is, the nurse needs to understand *what* she's giving and *why*.  This can reveal cultural practices and potential misunderstandings or needs for guidance.  If she isn't, the nurse needs to understand her knowledge and beliefs about when to start, which can also be culturally influenced.  This option seems quite relevant to understanding current practices and potential cultural influences.\n\n* **D. ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ (Infant's height and weight):**  Growth parameters are important for assessing the infant's overall health and nutritional status.  While nutrition is related to solid food introduction, height and weight themselves don't directly reveal cultural differences in *approaches* to solid foods.  They are more about the *outcome* of feeding practices, not the cultural practices themselves.  Growth monitoring is important in general, but not the primary factor for assessing cultural differences in solid food education.\n\n* **E. ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™” (Country of origin and Korean food culture):**  This option directly addresses cultural differences.  Understanding the mother's country of origin and its food culture is crucial to understand her background beliefs and practices regarding infant feeding.  Comparing her culture's food practices with Korean food culture (the context of the nurse's practice and potentially the dominant culture the mother is navigating) is essential for culturally sensitive education.  This option appears highly relevant to assessing cultural differences.\n\n**Comparing C and E:** Both C and E are strong contenders.\n\n* **C (ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€):**  Focuses on current practice.  It's important to know what's happening *now*.  However, it doesn't directly address the *cultural background* driving those practices.\n\n* **E (ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”):** Directly addresses the cultural background.  Knowing her origin and comparing it to the local culture provides the context for understanding *why* certain practices might be in place or preferred.\n\n**The question is specifically about identifying cultural differences.**  While knowing if solids are being given (C) is useful information, understanding the cultural *context* (E) is more directly relevant to identifying and addressing cultural differences in solid food education.  Knowing the cultural background helps the nurse understand the *reasons* behind current practices and tailor education accordingly.\n\n**Consider a scenario:** A nurse is educating a woman from a Southeast Asian country about solid foods.\n\n* Knowing the number of teeth (A) or height/weight (D) is generally useful but not culturally specific.\n* Knowing the infant's age (B) is important for general guidance but doesn't capture cultural nuances.\n* Knowing if she's giving solids (C) is helpful to know current practice, but not *why* she's doing it that way.\n* Knowing her country of origin and understanding its food culture (E) is *crucial*.  For example, in some cultures, rice porridge might be a very early and culturally preferred first food, while in others, pureed fruits or vegetables might be more common.  Understanding these cultural norms is essential for respectful and effective education.  Comparing it to Korean food culture can also highlight potential differences or areas where she might need support navigating the new cultural context.\n\n\n**Conclusion:** Option E, \&quot;ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™” (Country of origin and Korean food culture),\&quot; is the most direct and relevant factor to assess to understand cultural differences when educating a multicultural woman about solid foods.  It provides the cultural context needed to tailor education effectively.  While C is also relevant, E is more fundamental for understanding cultural differences.\n\n\nTherefore, the answer is likely **E**.\n\nLet's re-examine the options in Korean to double-check the nuances:\n\n* A. ìœ ì¹˜ì˜ ê°œìˆ˜: Number of deciduous teeth (baby teeth)\n* B. ì•„ê¸°ì˜ ì›”ë ¹: Baby's age in months\n* C. ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€: Whether solid food is being implemented/given\n* D. ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ: Baby's height and weight\n* E. ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”: Country of origin and Korean food culture\n\nThe question specifically asks about assessing \&quot;ë¬¸í™”ì  ì°¨ì´ì  (cultural differences).\&quot;  Option E directly addresses this.  The other options are less directly related to cultural differences in solid food education specifically.\n\n**Final Answer: E.**\n\nLet's confirm the logic again.  To provide culturally competent education on solid foods, a community health nurse needs to understand the mother's cultural background and how it might differ from the dominant culture (Korean in this case).  This understanding is best achieved by assessing her country of origin and the food culture of both her origin and the host country. This allows for tailoring the education to respect her cultural practices while ensuring the infant's nutritional needs are met within a safe and healthy framework.\n&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;**ì •ë‹µì€ E. ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nì§€ì—­ì‚¬íšŒê°„í˜¸ì‚¬ê°€ ë‹¤ë¬¸í™” ì—¬ì„±ì—ê²Œ ì˜ì•„ ê³ í˜•ì‹ êµìœ¡ì„ í•  ë•Œ ë¬¸í™”ì  ì°¨ì´ë¥¼ í™•ì¸í•˜ê¸° ìœ„í•´ ê°€ìž¥ ë¨¼ì € ì‚¬ì •í•´ì•¼ í•  ê²ƒì€ **ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”**ìž…ë‹ˆë‹¤. ê·¸ ì´ìœ ëŠ” ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.\n\n* **ë¬¸í™”ì  ë°°ê²½ì˜ ì¤‘ìš”ì„±:**  ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°, ì¢…ë¥˜, ë°©ë²• ë“±ì€ ë¬¸í™”ì  ë°°ê²½ì— ë”°ë¼ í¬ê²Œ ë‹¤ë¥¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ê° ë¬¸í™”ê¶Œë§ˆë‹¤ ì „í†µì ìœ¼ë¡œ ì˜ì•„ì—ê²Œ ë¨¹ì´ëŠ” ìŒì‹, ì„ í˜¸í•˜ëŠ” ì§ˆê°, ì‹ìž¬ë£Œ ë“±ì´ ë‹¤ë¥´ë©°, ì´ëŸ¬í•œ ë¬¸í™”ì  ì°¨ì´ë¥¼ ì´í•´í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n* **íš¨ê³¼ì ì¸ êµìœ¡:**  ë‹¤ë¬¸í™” ì—¬ì„±ì˜ ì¶œì‹ êµ­ ìŒì‹ ë¬¸í™”ë¥¼ ì´í•´í•˜ë©´, í•œêµ­ ë¬¸í™”ì™€ì˜ ì°¨ì´ì ì„ íŒŒì•…í•˜ê³ , ê·¸ë…€ì˜ ë¬¸í™”ì  ë°°ê²½ì„ ì¡´ì¤‘í•˜ë©´ì„œ í•œêµ­ ë¬¸í™”ì— ì ì‘í•  ìˆ˜ ìžˆë„ë¡ ë§žì¶¤í˜• êµìœ¡ì„ ì œê³µí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì˜ˆë¥¼ ë“¤ì–´, íŠ¹ì • ë¬¸í™”ê¶Œì—ì„œëŠ” ìŒ€ë¯¸ìŒì„ ë¨¼ì € ì‹œìž‘í•˜ëŠ” ë°˜ë©´, ë‹¤ë¥¸ ë¬¸í™”ê¶Œì—ì„œëŠ” ê³¼ì¼ì´ë‚˜ ì±„ì†Œë¥¼ ë¨¼ì € ì‹œìž‘í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ì°¨ì´ë¥¼ ì•Œê³  êµìœ¡í•´ì•¼ êµìœ¡ì˜ íš¨ê³¼ë¥¼ ë†’ì¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n* **ì‹ ë¢° ê´€ê³„ í˜•ì„±:**  ê°„í˜¸ì‚¬ê°€ ëŒ€ìƒìžì˜ ë¬¸í™”ì  ë°°ê²½ì— ê´€ì‹¬ì„ ê°€ì§€ê³  ì´í•´í•˜ë ¤ëŠ” ë…¸ë ¥ì„ ë³´ì´ë©´, ëŒ€ìƒìžì™€ì˜ ì‹ ë¢° ê´€ê³„ë¥¼ í˜•ì„±í•˜ëŠ” ë° ë„ì›€ì´ ë©ë‹ˆë‹¤. ì‹ ë¢° ê´€ê³„ëŠ” íš¨ê³¼ì ì¸ ê°„í˜¸ ì¤‘ìž¬ì˜ ê¸°ë³¸ìž…ë‹ˆë‹¤.\n\n**ë‹¤ë¥¸ ì„ íƒì§€ ì˜¤ë‹µ ì´ìœ :**\n\n* **A. ìœ ì¹˜ì˜ ê°œìˆ˜:** ìœ ì¹˜ì˜ ê°œìˆ˜ëŠ” ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°ë¥¼ ê²°ì •í•˜ëŠ” ì¼ë°˜ì ì¸ ì§€í‘œê°€ ë  ìˆ˜ ìžˆì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ë¥¼ íŒŒì•…í•˜ëŠ” ë° ì§ì ‘ì ì¸ ì •ë³´ëŠ” ì•„ë‹™ë‹ˆë‹¤. ìœ ì¹˜ ë°œë‹¬ì€ ê°œì¸ì°¨ê°€ í¬ê³  ë¬¸í™”ì  ë°°ê²½ê³¼ ì§ì ‘ì ì¸ ê´€ë ¨ì€ ì ìŠµë‹ˆë‹¤.\n* **B. ì•„ê¸°ì˜ ì›”ë ¹:** ì•„ê¸°ì˜ ì›”ë ¹ì€ ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°ë¥¼ ê²°ì •í•˜ëŠ” ì¤‘ìš”í•œ ìš”ì†Œì´ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ë¥¼ ì„¤ëª…í•´ì£¼ì§€ëŠ” ì•ŠìŠµë‹ˆë‹¤. ì›”ë ¹ì€ ì¼ë°˜ì ì¸ ê°€ì´ë“œë¼ì¸ì¼ ë¿, ë¬¸í™”ì— ë”°ë¼ ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°ì— ëŒ€í•œ ê´€ì ì´ ë‹¤ë¥¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n* **C. ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€:** ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€ë¥¼ í™•ì¸í•˜ëŠ” ê²ƒì€ í˜„ìž¬ ìƒí™©ì„ íŒŒì•…í•˜ëŠ” ë° ë„ì›€ì´ ë˜ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ì˜ ê·¼ë³¸ì ì¸ ì›ì¸ì„ ì•Œ ìˆ˜ëŠ” ì—†ìŠµë‹ˆë‹¤. ì´ë¯¸ ê³ í˜•ì‹ì„ í•˜ê³  ìžˆë‹¤ë©´ ì–´ë–¤ ì¢…ë¥˜ì˜ ìŒì‹ì„ ì£¼ê³  ìžˆëŠ”ì§€, ê·¸ ì´ìœ ëŠ” ë¬´ì—‡ì¸ì§€ ë¬¸í™”ì  ë°°ê²½ê³¼ í•¨ê»˜ íŒŒì•…í•´ì•¼ í•©ë‹ˆë‹¤.\n* **D. ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ:** ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²ŒëŠ” ì„±ìž¥ ë°œë‹¬ ìƒíƒœë¥¼ í‰ê°€í•˜ëŠ” ì¤‘ìš”í•œ ì§€í‘œì´ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ë¥¼ ì§ì ‘ì ìœ¼ë¡œ ë°˜ì˜í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ì˜ì–‘ ìƒíƒœ í‰ê°€ì— í•„ìš”í•˜ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ ì‚¬ì •ì˜ ìš°ì„ ìˆœìœ„ëŠ” ì•„ë‹™ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ë‹¤ë¬¸í™” ì—¬ì„±ì—ê²Œ íš¨ê³¼ì ì¸ ê³ í˜•ì‹ êµìœ¡ì„ ì œê³µí•˜ê¸° ìœ„í•´ì„œëŠ” ê·¸ë…€ì˜ ë¬¸í™”ì  ë°°ê²½ì„ ì´í•´í•˜ëŠ” ê²ƒì´ ê°€ìž¥ ì¤‘ìš”í•˜ë©°, ì´ë¥¼ ìœ„í•´ ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”ì— ëŒ€í•œ ì‚¬ì •ì´ í•„ìˆ˜ì ìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2411,&quot;string&quot;:&quot;2,411&quot;}}},{&quot;rowIdx&quot;:7,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;dental_technician&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2019,&quot;string&quot;:&quot;2,019&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì•ˆê¶(face bow)ì— ê´€í•œ ì„¤ëª…ìœ¼ë¡œ ì˜³ì€ ê²ƒì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;êµí•©ê´€ê³„ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê¸°êµ¬ì´ë‹¤.&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ” ê¸°êµ¬ì´ë‹¤.&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë³´ì² ë¬¼ì„ ì œìž‘í•˜ëŠ” ë°ì— ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ ì´ë‹¤.&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4,&quot;string&quot;:&quot;4&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer (D) for the question about face bows.\n\n**1. Understanding the Question:**\n\nThe question is asking for the *correct* description of a face bow.  This immediately tells me I need to know what a face bow is and what it does.  The Korean term \&quot;ì•ˆê¶\&quot; is given, and it's translated as \&quot;face bow\&quot; in English.  The answer choices are all in Korean and relate to different aspects of dental procedures.  I need to translate and understand each choice in the context of a face bow.\n\n**2.  Initial Brainstorm and Recall about Face Bows:**\n\nMy immediate thoughts about face bows are:\n\n* **Dentistry:** It's a dental instrument.\n* **Relating jaws to skull:**  It's used to transfer the relationship of the upper jaw (maxilla) to the skull.  This is the key function I recall.\n* **Articulator:** It's used in conjunction with an articulator (êµí•©ê¸° in Korean), a device that simulates jaw movements for dental lab work.\n* **Mounting maxillary cast:** The face bow helps mount the maxillary cast (upper jaw model) onto the articulator in a way that mimics the patient's actual jaw position relative to their skull.\n* **Not about guides for movements:** It's *not* primarily about guiding jaw movements like protrusion (forward) or lateral (sideways).  Those are related to condylar guidance and incisal guidance, which are *set on the articulator* *after* mounting the casts, often *using* face bow information, but the face bow itself isn't the guide.\n* **Not directly for prosthesis fabrication guide:** While the face bow information *is* crucial for accurate prosthesis fabrication, it's not *directly* a \&quot;guide\&quot; in the sense of shaping the prosthesis itself. It sets up the *articulation* which *then* guides prosthesis fabrication.\n\n**3. Analyzing Each Answer Choice (and Translating):**\n\nLet's translate and analyze each option:\n\n* **A. êµí•©ê´€ê³„ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê¸°êµ¬ì´ë‹¤. (It is an instrument to reproduce occlusal relationships.)**\n    * *Analysis:*  While face bows contribute to reproducing occlusal relationships on the articulator, this is a *very* broad statement and could apply to many dental instruments.  It's not *specific* to the primary function of a face bow. It's *partially* true but not the best answer.\n\n* **B. ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤. (It is an instrument that acts as a guide for protrusive movement.)**\n    * *Analysis:* Face bows do *not* directly guide protrusive movement.  Protrusive movement is guided by the condylar guidance on the articulator, set *after* face bow transfer.  This is *incorrect*.\n\n* **C. ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤. (It is an instrument that acts as a guide for lateral movement.)**\n    * *Analysis:* Similar to B, face bows do *not* directly guide lateral movement. Lateral movement is also guided by condylar guidance on the articulator. This is *incorrect*.\n\n* **D. ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ” ê¸°êµ¬ì´ë‹¤. (It is an instrument that transfers the positional relationship of the maxilla from the skull.)**\n    * *Analysis:* This is the *most accurate and specific* description of a face bow's primary function.  \&quot;ë‘ê°œê³¨\&quot; (skull), \&quot;ìƒì•…\&quot; (maxilla), \&quot;ìœ„ì¹˜ ê´€ê³„\&quot; (positional relationship), and \&quot;ì˜®ê¸°ëŠ” ê¸°êµ¬\&quot; (instrument to transfer) perfectly describe what a face bow does. This looks like the correct answer.\n\n* **E. ë³´ì² ë¬¼ì„ ì œìž‘í•˜ëŠ” ë°ì— ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ ì´ë‹¤. (It is an instrument that acts as a guide in fabricating prostheses.)**\n    * *Analysis:* Again, while face bow information is *essential* for accurate prosthesis fabrication, the face bow itself isn't a *direct guide* in the *fabrication process*. It provides the *foundation* (accurate articulation) upon which a prosthesis can be fabricated correctly.  It's too broad and not the *primary* function.  It's *indirectly* related, but not the best answer.\n\n**4.  Confirming the Best Answer:**\n\nComparing the analyses, option D stands out as the most precise and accurate description of the core function of a face bow. Options A and E are too general, while B and C are factually incorrect.\n\n**5. Final Answer Selection:**\n\nTherefore, the best and most correct answer is **D**.\n\n**Self-Correction/Refinement during the Process:**\n\n* Initially, I might have considered A as *partially* correct because face bows *do* contribute to occlusal relationships.  However, realizing it's too broad and doesn't capture the *specific* function helped me refine my thinking.\n* I double-checked my understanding of \&quot;guide\&quot; in the context of B, C, and E. I clarified that \&quot;guide\&quot; in these options is meant in the sense of *directly controlling movement* or *shaping the prosthesis*, which is not what a face bow does directly. It's more about establishing the *correct starting point* for articulation.\n* I focused on the keyword \&quot;ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ”\&quot; (transferring the positional relationship of the maxilla from the skull) in option D and recognized this as the defining purpose of a face bow.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **D. ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ” ê¸°êµ¬ì´ë‹¤.** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n* **ì•ˆê¶ (Face Bow) ì˜ ì£¼ìš” ê¸°ëŠ¥:** ì•ˆê¶ì€ í™˜ìžì˜ **ë‘ê°œê³¨**ì„ ê¸°ì¤€ìœ¼ë¡œ **ìƒì•…** ì¹˜ì•„ê¶ì˜ **3ì°¨ì›ì ì¸ ìœ„ì¹˜ ê´€ê³„**ë¥¼ ì±„ë“í•˜ì—¬ êµí•©ê¸°ë¼ëŠ” ê¸°ê³„ë¡œ ì˜®ê¸°ëŠ” ê¸°êµ¬ìž…ë‹ˆë‹¤.  ì‰½ê²Œ ë§í•´, í™˜ìžì˜ ì–¼êµ´ì—ì„œ ìœ—í„±ì˜ ìœ„ì¹˜ë¥¼ ì •í™•í•˜ê²Œ ë³¸ë– ì„œ êµí•©ê¸°ì— ìž¬í˜„í•˜ëŠ” ì—­í• ì„ í•©ë‹ˆë‹¤.\n\n* **ê° ì„ íƒì§€ë³„ ì˜¤ë‹µ ì´ìœ :**\n\n    * **A. êµí•©ê´€ê³„ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê¸°êµ¬ì´ë‹¤.**  (X) : êµí•©ê´€ê³„ ìž¬í˜„ì— *ì¼ì • ë¶€ë¶„* ê¸°ì—¬í•˜ì§€ë§Œ, ì•ˆê¶ì˜ *ì£¼ìš” ê¸°ëŠ¥*ì€ êµí•©ê´€ê³„ ìžì²´ë¥¼ ìž¬í˜„í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼ **ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„**ë¥¼ ì˜®ê¸°ëŠ” ê²ƒìž…ë‹ˆë‹¤. êµí•©ê´€ê³„ëŠ” êµí•©ê¸° ìƒì—ì„œ í•˜ì•… ëª¨í˜•ê³¼ í•¨ê»˜ ìž¬í˜„ë©ë‹ˆë‹¤.  ë”°ë¼ì„œ ë„ˆë¬´ í¬ê´„ì ì¸ ì„¤ëª…ìž…ë‹ˆë‹¤.\n\n    * **B. ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.** (X) : ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ (protrusive guide) ëŠ” ì£¼ë¡œ êµí•©ê¸° ìƒì—ì„œ **ê³¼ë¡œ (condylar path)** ì„¤ì •ì„ í†µí•´ ìž¬í˜„ë©ë‹ˆë‹¤. ì•ˆê¶ì€ ì „ë°©ìš´ë™ ê°€ì´ë“œì™€ ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n\n    * **C. ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.** (X) : ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ (lateral guide) ì—­ì‹œ ì£¼ë¡œ êµí•©ê¸° ìƒì—ì„œ **ê³¼ë¡œ (condylar path)** ë° **Bennet angle** ì„¤ì •ì„ í†µí•´ ìž¬í˜„ë©ë‹ˆë‹¤. ì•ˆê¶ì€ ì¸¡ë°©ìš´ë™ ê°€ì´ë“œì™€ ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n\n    * **E. ë³´ì² ë¬¼ì„ ì œìž‘í•˜ëŠ” ë°ì— ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ ì´ë‹¤.** (X) : ì•ˆê¶ì€ ë³´ì² ë¬¼ ì œìž‘ ê³¼ì •ì—ì„œ **ì •í™•í•œ êµí•©**ì„ êµ¬í˜„í•˜ëŠ” ë° *í•„ìˆ˜ì ì¸ ì •ë³´*ë¥¼ ì œê³µí•˜ì§€ë§Œ, ì§ì ‘ì ìœ¼ë¡œ ë³´ì² ë¬¼ ì œìž‘ì„ *ê°€ì´ë“œ* í•˜ëŠ” ê¸°êµ¬ëŠ” ì•„ë‹™ë‹ˆë‹¤. ë³´ì² ë¬¼ ì œìž‘ ê°€ì´ë“œëŠ” ì£¼ë¡œ ì¸ìƒìž¬, ì™ìŠ¤ì—…, ë ˆì§„ ë“± ë‹¤ë¥¸ ìž¬ë£Œì™€ ê¸°êµ¬ë¥¼ í†µí•´ ì´ë£¨ì–´ì§‘ë‹ˆë‹¤.  ì•ˆê¶ì€ ê·¸ **ê¸°ì´ˆì ì¸ ìœ„ì¹˜ ì •ë³´**ë¥¼ ì œê³µí•˜ëŠ” ì—­í• ìž…ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ì•ˆê¶ì˜ ê°€ìž¥ í•µì‹¬ì ì¸ ê¸°ëŠ¥ì€ ë‘ê°œê³¨ì„ ê¸°ì¤€ìœ¼ë¡œ í•œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì •í™•í•˜ê²Œ ì˜®ê²¨ êµí•©ê¸°ì—ì„œ ìž¬í˜„í•˜ì—¬, í™˜ìžì˜ ì‹¤ì œ êµ¬ê°• ë‚´ ìƒí™©ê³¼ ìœ ì‚¬í•œ í™˜ê²½ì—ì„œ ë³´ì² ë¬¼ì„ ì œìž‘í•  ìˆ˜ ìžˆë„ë¡ ë•ëŠ” ê²ƒìž…ë‹ˆë‹¤. ë”°ë¼ì„œ Dê°€ ê°€ìž¥ ì •í™•í•œ ì„¤ëª…ìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4750,&quot;string&quot;:&quot;4,750&quot;}}},{&quot;rowIdx&quot;:8,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;pharm&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2020,&quot;string&quot;:&quot;2,020&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3,&quot;string&quot;:&quot;3&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:64,&quot;string&quot;:&quot;64&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í˜„ìž¬ ìœ ë°©ì•” ì¹˜ë£Œ ì¤‘ì¸ 52ì„¸ í™˜ìžì—ê²Œ íê²½ê¸° í˜ˆê´€ìš´ë™ì¦ìƒ(vasomotor symptom) ê³¼ ìš°ìš¸ì¦ìƒì´ ë‚˜íƒ€ë‚˜ ì¹˜ë£Œë¥¼ ì‹œìž‘í•˜ë ¤ê³  í•œë‹¤. ì ì ˆí•œ ì•½ë¬¼ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë¼ë¡ì‹œíŽœ(raloxifene)&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë²¤ë¼íŒì‹ (venlafaxine)&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (medroxyprogesterone)&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë°”ì œë…ì‹œíŽœ/ì—ìŠ¤íŠ¸ë¡œê²(bazedoxifene/conjugated equine estrogen)&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì—ìŠ¤íŠ¸ë¼ë””ì˜¬/ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (estradiol/medroxyprogesterone)&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer for this clinical scenario.\n\n**1. Deconstructing the Question:**\n\n* **Patient Profile:** 52-year-old woman, currently undergoing breast cancer treatment.  This is *critical*. Breast cancer treatment immediately raises red flags regarding hormone-sensitive therapies.\n* **Symptoms:** Vasomotor symptoms (hot flashes, night sweats) and depressive symptoms. These are common menopausal symptoms, but also could be side effects of breast cancer treatment itself (like chemotherapy or endocrine therapy).\n* **Goal:**  Treat vasomotor and depressive symptoms *in the context of ongoing breast cancer treatment*. This means we need to prioritize safety and avoid exacerbating the cancer or interfering with its treatment.\n* **Question Type:**  \&quot;Appropriate medication.\&quot; This is a medication selection question, requiring knowledge of drug classes and their contraindications/indications, particularly in the context of breast cancer.\n\n**2. Analyzing Each Answer Option:**\n\n* **A. Raloxifene (ë¼ë¡ì‹œíŽœ):**\n    * Class: Selective Estrogen Receptor Modulator (SERM).\n    * Mechanism: Estrogen agonist in bone, antagonist in breast and uterus.\n    * Breast Cancer: Used for breast cancer risk reduction and treatment of osteoporosis in postmenopausal women.  However, it's *not* for vasomotor symptoms and *could* potentially have complex interactions in a patient currently *undergoing* breast cancer treatment.  While it's not directly contraindicated, it's not a primary choice for vasomotor symptoms, and we need to be cautious in a patient actively being treated.  *Initial thought: Maybe, but unlikely best option for symptoms.*\n\n* **B. Venlafaxine (ë²¤ë¼íŒì‹ ):**\n    * Class: Serotonin-Norepinephrine Reuptake Inhibitor (SNRI).\n    * Mechanism: Antidepressant, also effective for vasomotor symptoms in menopausal women, especially those who cannot or should not take hormone therapy.\n    * Breast Cancer: Generally considered safe in breast cancer patients.  Non-hormonal approach.  Addresses both depression and vasomotor symptoms. *Initial thought: Strong candidate.*\n\n* **C. Medroxyprogesterone (ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ ):**\n    * Class: Progestin (synthetic progesterone).\n    * Mechanism: Can sometimes help with vasomotor symptoms, but less effective than estrogen. Historically used, but not preferred.\n    * Breast Cancer:  Progestins *can* stimulate breast cancer growth in some cases.  Generally contraindicated or used with extreme caution in breast cancer patients.  Definitely not a first-line choice. *Initial thought:  Likely contraindicated, very risky.*\n\n* **D. Bazedoxifene/Conjugated Equine Estrogen (ë°”ì œë…ì‹œíŽœ/ì—ìŠ¤íŠ¸ë¡œê²):**\n    * Class:  Estrogen with a SERM (bazedoxifene).  \&quot;Tissue-selective estrogen complex (TSEC)\&quot;.\n    * Mechanism:  Estrogen component for vasomotor symptoms; bazedoxifene to protect the uterus from estrogen's proliferative effects.\n    * Breast Cancer: *Estrogen is generally contraindicated in breast cancer patients*, especially those currently being treated.  Adding bazedoxifene doesn't negate the estrogen risk in breast tissue.  This combination is for menopausal symptoms, but absolutely contraindicated due to the estrogen component. *Initial thought:  Strong contraindication, definitely wrong.*\n\n* **E. Estradiol/Medroxyprogesterone (ì—ìŠ¤íŠ¸ë¼ë””ì˜¬/ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ ):**\n    * Class:  Estrogen and Progestin (Hormone Therapy - HT).\n    * Mechanism: Estrogen for vasomotor symptoms; progestin to protect the uterus from estrogen.\n    * Breast Cancer: *Absolutely contraindicated* in breast cancer patients, especially during active treatment.  Estrogen and progestin can fuel breast cancer growth.  This is the classic hormone therapy regimen and is the *opposite* of what's safe in this context. *Initial thought:  Strongest contraindication, definitively wrong.*\n\n**3. Prioritization and Selection:**\n\n* **Rule out contraindicated options:** D and E are estrogen-containing therapies, absolutely contraindicated in breast cancer. C (medroxyprogesterone alone) is also risky and less effective, not a good choice.\n* **Compare remaining options:** A (raloxifene) and B (venlafaxine).\n    * Raloxifene is a SERM, and while not directly contraindicated, it's not the best choice for vasomotor symptoms, and its complex estrogen agonist/antagonist profile raises concerns during active breast cancer treatment. It's more for osteoporosis prevention and breast cancer risk reduction in *high-risk* women, not symptom management in *active* breast cancer.\n    * Venlafaxine is a non-hormonal SNRI, effective for both vasomotor symptoms and depression. It's considered safe and often used in breast cancer patients experiencing menopausal symptoms.\n\n**4. Final Answer and Justification:**\n\nVenlafaxine (ë²¤ë¼íŒì‹ ) is the most appropriate choice because:\n\n* It effectively treats both vasomotor symptoms and depressive symptoms.\n* It is a non-hormonal option, avoiding the risks associated with estrogen or progestin in a breast cancer patient.\n* It is generally considered safe and well-tolerated in breast cancer patients.\n\nTherefore, the answer is **B**.\n\n**Self-Correction/Refinement during the process:**\n\nInitially, I might have briefly considered raloxifene because it has some \&quot;breast-related\&quot; actions. However, upon closer examination, realizing it's not primarily for symptom relief and the context of *active* breast cancer treatment, venlafaxine emerges as the clearly superior and safer choice.  The key is always to prioritize patient safety and contraindications, especially in complex cases like this.  Thinking about *why* each option is right or wrong, and explicitly considering the patient's specific situation, leads to the correct answer.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **B. ë²¤ë¼íŒì‹ (venlafaxine)** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n**í™˜ìž ìƒíƒœ:**\n\n* 52ì„¸ ì—¬ì„±\n* í˜„ìž¬ ìœ ë°©ì•” ì¹˜ë£Œ ì¤‘\n* íê²½ê¸° í˜ˆê´€ìš´ë™ì¦ìƒ (vasomotor symptom, ì•ˆë©´í™ì¡°, ì•¼ê°„ ë°œí•œ ë“±)\n* ìš°ìš¸ ì¦ìƒ\n\n**ê° ì„ íƒì§€ ë¶„ì„:**\n\n* **A. ë¼ë¡ì‹œíŽœ(raloxifene):**  ì„ íƒì  ì—ìŠ¤íŠ¸ë¡œê² ìˆ˜ìš©ì²´ ì¡°ì ˆì œ(SERM)ë¡œ, íê²½ í›„ ì—¬ì„±ì˜ ê³¨ë‹¤ê³µì¦ ì¹˜ë£Œ ë° ìœ ë°©ì•” ì˜ˆë°©ì— ì‚¬ìš©ë©ë‹ˆë‹¤.  í•˜ì§€ë§Œ í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™” íš¨ê³¼ëŠ” ì œí•œì ì´ë©°, ìœ ë°©ì•” í™˜ìžì—ê²ŒëŠ” ì£¼ëœ ì¹˜ë£Œ ì˜µì…˜ì´ ì•„ë‹™ë‹ˆë‹¤. ì˜¤ížˆë ¤ ìœ ë°©ì•” ì¹˜ë£Œ ì¤‘ì¸ í™˜ìžì—ê²ŒëŠ” ì‹ ì¤‘í•˜ê²Œ ì‚¬ìš©í•´ì•¼ í•©ë‹ˆë‹¤.\n\n* **B. ë²¤ë¼íŒì‹ (venlafaxine):**  ì„¸ë¡œí† ë‹Œ-ë…¸ë¥´ì—í”¼ë„¤í”„ë¦° ìž¬í¡ìˆ˜ ì–µì œì œ(SNRI) ê³„ì—´ì˜ í•­ìš°ìš¸ì œë¡œ, í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™” íš¨ê³¼ê°€ ìž…ì¦ë˜ì—ˆìŠµë‹ˆë‹¤.  íŠ¹ížˆ ìœ ë°©ì•” í™˜ìžë‚˜ í˜¸ë¥´ëª¬ ì¹˜ë£Œê°€ ê¸ˆê¸°ì¸ ì—¬ì„±ì—ê²Œ í˜ˆê´€ìš´ë™ì¦ìƒ ì¹˜ë£Œì˜ 1ì°¨ ì„ íƒ ì•½ë¬¼ë¡œ ê¶Œìž¥ë©ë‹ˆë‹¤. ìš°ìš¸ ì¦ìƒ ê°œì„ ì—ë„ íš¨ê³¼ì ì´ë¯€ë¡œ ì´ í™˜ìžì—ê²Œ ì ì ˆí•œ ì„ íƒìž…ë‹ˆë‹¤.\n\n* **C. ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (medroxyprogesterone):**  í”„ë¡œê²ŒìŠ¤í‹´ ì œì œë¡œ, ê³¼ê±° í˜ˆê´€ìš´ë™ì¦ìƒ ì¹˜ë£Œì— ì‚¬ìš©ë˜ê¸°ë„ í–ˆì§€ë§Œ, ì—ìŠ¤íŠ¸ë¡œê²ì— ë¹„í•´ íš¨ê³¼ê°€ ë–¨ì–´ì§€ê³  ë¶€ìž‘ìš© ìœ„í—˜ì´ ìžˆìŠµë‹ˆë‹¤. íŠ¹ížˆ ìœ ë°©ì•” í™˜ìžì—ê²ŒëŠ” í”„ë¡œê²ŒìŠ¤í…Œë¡ ì´ ìœ ë°©ì•” ì„¸í¬ ì„±ìž¥ì„ ì´‰ì§„í•  ìˆ˜ ìžˆë‹¤ëŠ” ìš°ë ¤ ë•Œë¬¸ì— ì¼ë°˜ì ìœ¼ë¡œ ê¶Œìž¥ë˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n\n* **D. ë°”ì œë…ì‹œíŽœ/ì—ìŠ¤íŠ¸ë¡œê²(bazedoxifene/conjugated equine estrogen):**  ì—ìŠ¤íŠ¸ë¡œê²ê³¼ ì„ íƒì  ì—ìŠ¤íŠ¸ë¡œê² ìˆ˜ìš©ì²´ ì¡°ì ˆì œ(SERM) ë³µí•©ì œìž…ë‹ˆë‹¤. ì—ìŠ¤íŠ¸ë¡œê²ì€ í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™”ì— íš¨ê³¼ì ì´ì§€ë§Œ, ìœ ë°©ì•” ë³‘ë ¥ì´ ìžˆê±°ë‚˜ í˜„ìž¬ ì¹˜ë£Œ ì¤‘ì¸ í™˜ìžì—ê²ŒëŠ” ê¸ˆê¸°ìž…ë‹ˆë‹¤. ì—ìŠ¤íŠ¸ë¡œê²ì€ ìœ ë°©ì•” ìž¬ë°œ ìœ„í—˜ì„ ë†’ì¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n* **E. ì—ìŠ¤íŠ¸ë¼ë””ì˜¬/ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (estradiol/medroxyprogesterone):**  ì—ìŠ¤íŠ¸ë¡œê²ê³¼ í”„ë¡œê²ŒìŠ¤í…Œë¡  ë³µí•© í˜¸ë¥´ëª¬ ì¹˜ë£Œì œìž…ë‹ˆë‹¤.  Dì™€ ë§ˆì°¬ê°€ì§€ë¡œ ì—ìŠ¤íŠ¸ë¡œê² ì„±ë¶„ ë•Œë¬¸ì— ìœ ë°©ì•” í™˜ìžì—ê²ŒëŠ” ê¸ˆê¸°ìž…ë‹ˆë‹¤.\n\n**ê²°ë¡ :**\n\nìœ ë°©ì•” ì¹˜ë£Œ ì¤‘ì¸ í™˜ìžì—ê²Œ í˜ˆê´€ìš´ë™ì¦ìƒê³¼ ìš°ìš¸ ì¦ìƒ ì¹˜ë£Œë¥¼ ìœ„í•´ ê°€ìž¥ ì ì ˆí•œ ì•½ë¬¼ì€ **B. ë²¤ë¼íŒì‹ (venlafaxine)** ìž…ë‹ˆë‹¤. ë²¤ë¼íŒì‹ ì€ ë¹„í˜¸ë¥´ëª¬ ì œì œë¡œ ìœ ë°©ì•”ì— ëŒ€í•œ ìœ„í—˜ ì—†ì´ í˜ˆê´€ìš´ë™ì¦ìƒê³¼ ìš°ìš¸ ì¦ìƒì„ ë™ì‹œì— íš¨ê³¼ì ìœ¼ë¡œ ê´€ë¦¬í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n**ì°¸ê³ :**\n\n* ìœ ë°©ì•” í™˜ìžì˜ íê²½ê¸° ì¦ìƒ ê´€ë¦¬ëŠ” í˜¸ë¥´ëª¬ ì¹˜ë£Œë³´ë‹¤ëŠ” ë¹„í˜¸ë¥´ëª¬ ì¹˜ë£Œë¥¼ ìš°ì„ ì ìœ¼ë¡œ ê³ ë ¤í•©ë‹ˆë‹¤.\n* ë²¤ë¼íŒì‹  ì™¸ì—ë„ ì„ íƒì  ì„¸ë¡œí† ë‹Œ ìž¬í¡ìˆ˜ ì–µì œì œ(SSRI) ê³„ì—´ì˜ í•­ìš°ìš¸ì œ (ì˜ˆ: íŒŒë¡ì„¸í‹´, ì‹œíƒˆë¡œí”„ëžŒ, ì—ìŠ¤ì‹œíƒˆë¡œí”„ëžŒ) ë˜í•œ í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™”ì— íš¨ê³¼ì ì´ë©° ìœ ë°©ì•” í™˜ìžì—ê²Œ ì‚¬ìš© ê°€ëŠ¥í•©ë‹ˆë‹¤.\n* í™˜ìžì˜ ìƒíƒœì™€ ì„ í˜¸ë„, ì•½ë¬¼ ë¶€ìž‘ìš© ë“±ì„ ê³ ë ¤í•˜ì—¬ ê°œë³„ì ìœ¼ë¡œ ì¹˜ë£Œ ê³„íšì„ ìˆ˜ë¦½í•´ì•¼ í•©ë‹ˆë‹¤.&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3579,&quot;string&quot;:&quot;3,579&quot;}}},{&quot;rowIdx&quot;:9,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;dentist&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2020,&quot;string&quot;:&quot;2,020&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:28,&quot;string&quot;:&quot;28&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì´ì˜ì¹˜ ì•…ê°„ê´€ê³„ ê¸°ë¡ê³¼ì •ì—ì„œ ë‹¤ìŒ ìˆ ì‹ìœ¼ë¡œ ì±„ë“í•˜ëŠ” ê²ƒì€?\nÂ· ìˆ ìžì˜ ì™¼ì†ìœ¼ë¡œ í™˜ìžì˜ êµ¬ê°•ë‚´ ìƒí•˜ì•… ê¸°ë¡ìƒì„ ì¹˜ì¡°ì œì— ì •í™•í•˜ê²Œ ìœ„ì¹˜ì‹œí‚¨ë‹¤. Â· ìˆ ìžì˜ ì˜¤ë¥¸ì† ì—„ì§€ë¥¼ í™˜ìžì˜ ì´ë¶€ì— ìœ„ì¹˜ì‹œí‚¤ê³  í„±ì„ ê°€ë³ê²Œ ìž¡ëŠ”ë‹¤. Â· í™˜ìžì˜ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ ì ‘ë²ˆìš´ë™ì„ í™•ì¸ í›„ íêµ¬ì‹œí‚¨ë‹¤.&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¤‘ì‹¬ìœ„&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì „ë°©í™œì£¼ë¡œ&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìµœëŒ€ê°œêµ¬ìœ„&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìµœì „ë°©ì ‘ì´‰ìœ„&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í›„ë°©í•œê³„ê°œêµ¬ë¡œ&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer for the given question about interocclusal record taking in complete dentures.\n\n**1. Deconstructing the Question:**\n\nThe question is asking about a specific technique for obtaining an interocclusal record in complete denture prosthodontics.  It provides a step-by-step procedure and asks what position this procedure is intended to record.  The key is to carefully analyze the described steps.\n\n**2. Analyzing the Provided Steps:**\n\nLet's go through each step and interpret its significance:\n\n* **\&quot;ìˆ ìžì˜ ì™¼ì†ìœ¼ë¡œ í™˜ìžì˜ êµ¬ê°•ë‚´ ìƒí•˜ì•… ê¸°ë¡ìƒì„ ì¹˜ì¡°ì œì— ì •í™•í•˜ê²Œ ìœ„ì¹˜ì‹œí‚¨ë‹¤.\&quot;** (The operator's left hand accurately positions the maxillary and mandibular record bases onto the alveolar ridges within the patient's mouth.)\n    * *Interpretation:* This step sets the stage for recording a jaw relationship. Record bases are used in complete denture fabrication to simulate denture bases and provide a stable platform for recording jaw positions.  \&quot;ì¹˜ì¡°ì œ\&quot; (alveolar ridge) is crucial â€“ it indicates we're dealing with edentulous patients.\n\n* **\&quot;ìˆ ìžì˜ ì˜¤ë¥¸ì† ì—„ì§€ë¥¼ í™˜ìžì˜ ì´ë¶€ì— ìœ„ì¹˜ì‹œí‚¤ê³  í„±ì„ ê°€ë³ê²Œ ìž¡ëŠ”ë‹¤.\&quot;** (The operator's right thumb is positioned on the patient's chin and gently holds the jaw.)\n    * *Interpretation:* This step describes how the operator is manipulating the patient's mandible.  Placing the thumb on the chin and gently holding the jaw implies controlled mandibular manipulation.\n\n* **\&quot;í™˜ìžì˜ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ ì ‘ë²ˆìš´ë™ì„ í™•ì¸ í›„ íêµ¬ì‹œí‚¨ë‹¤.\&quot;** (Gently push the patient's mandible posteriorly and superiorly, check for hinge movement, and then close the mouth.)\n    * *Interpretation:* This is the *most* critical step. \&quot;í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ\&quot; (gently push posteriorly and superiorly) is the key maneuver. \&quot;ì ‘ë²ˆìš´ë™\&quot; (hinge movement) is also extremely important. This procedure is designed to guide the mandible into a specific, repeatable position.  Pushing posteriorly and superiorly, along with checking for hinge movement, strongly suggests an attempt to locate the **centric relation**.\n\n**3. Connecting Steps to Dental Concepts:**\n\nNow, let's link these interpreted steps to known dental concepts, especially related to interocclusal records:\n\n* **Centric Relation (CR):**  CR is a maxillomandibular relationship where the condyles are in their most superior-anterior position in the glenoid fossae, resting against the posterior slopes of the articular eminences, with the discs interposed.  It's a hinge position, and it's considered a reproducible and physiologically acceptable starting point for denture construction.  The described technique of pushing posteriorly and superiorly *strongly* aligns with attempts to achieve CR.\n\n* **Protrusive Record (ì „ë°©í™œì£¼ë¡œ):** This record captures the mandible in a protruded position, used for setting condylar guidance on articulators. The described technique doesn't involve protrusion; it's about posterior and superior movement.\n\n* **Maximum Intercuspation (MI) or Maximum Opening (ìµœëŒ€ê°œêµ¬ìœ„):** MI is the position of maximum tooth contact. Maximum opening is the widest mouth opening.  The described technique isn't about either of these.  It's about a specific jaw *relationship*, not maximum opening or tooth intercuspation (which isn't relevant in edentulous patients with record bases).\n\n* **Retruded Contact Position (RCP) or Centric Occlusion (CO) (ìµœì „ë°©ì ‘ì´‰ìœ„):** RCP/CO refers to the first tooth contact in centric relation.  While related to CR, the description emphasizes achieving the condylar position (hinge movement) rather than just the first contact.  The focus is on the *position* of the condyles, which is the definition of CR.  \&quot;ìµœì „ë°©ì ‘ì´‰ìœ„\&quot; (most anterior contact position) could be misinterpreted as CO, but in the context of the procedure described (posterior-superior guidance), it's not the best fit.  Also, \&quot;ìµœì „ë°©ì ‘ì´‰ìœ„\&quot; is a less common term, and while it might sometimes be used synonymously with CO, it doesn't capture the essence of the CR-seeking maneuver.\n\n* **Maximum Retrusion (í›„ë°©í•œê³„ê°œêµ¬ë¡œ):** This refers to the most retruded position the mandible can achieve.  While the technique involves posterior movement, the description doesn't aim for the *extreme* retrusion.  It's about a controlled, reproducible hinge position, not just pushing the mandible as far back as possible.  Also, \&quot;í›„ë°©í•œê³„ê°œêµ¬ë¡œ\&quot; is a less direct translation and might be confusing in this context. \&quot;í›„ë°©í•œê³„ê°œêµ¬ë¡œ\&quot; might refer to the posterior limit of opening movement, which is not what the procedure is describing.\n\n**4. Selecting the Best Answer:**\n\nBased on the analysis, the procedure described is clearly aimed at recording **Centric Relation (ì¤‘ì‹¬ìœ„)**. The key phrases \&quot;í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ\&quot; (gently push posteriorly and superiorly) and \&quot;ì ‘ë²ˆìš´ë™\&quot; (hinge movement) are strong indicators of a centric relation recording technique.\n\n**5. Confirming and Refining (Self-Correction):**\n\nLet's re-read the question and the steps to ensure no misinterpretations. The steps are consistent with a common technique for guiding the mandible into centric relation in edentulous patients. The options are:\n\n* A. ì¤‘ì‹¬ìœ„ (Centric Relation) - **Strong candidate**\n* B. ì „ë°©í™œì£¼ë¡œ (Protrusive Record) - Incorrect, procedure is posterior, not anterior.\n* C. ìµœëŒ€ê°œêµ¬ìœ„ (Maximum Opening Position) - Incorrect, procedure is about jaw relation, not opening.\n* D. ìµœì „ë°©ì ‘ì´‰ìœ„ (Most Anterior Contact Position) - Less precise, and the technique is focused on condylar position, not first contact.  Also, \&quot;ìµœì „ë°©ì ‘ì´‰ìœ„\&quot; is a slightly unusual term; \&quot;ì¤‘ì‹¬êµí•©ìœ„\&quot; (Centric Occlusion) would be more common and still not the best fit.\n* E. í›„ë°©í•œê³„ê°œêµ¬ë¡œ (Maximum Retrusion Opening) -  Incorrect, procedure is not about maximum retrusion or opening limit.\n\n**Conclusion:**  The most accurate answer is **A. ì¤‘ì‹¬ìœ„ (Centric Relation)**. The described technique is a classic method for guiding the mandible into centric relation for recording in complete denture prosthodontics.  The other options are not supported by the described steps.  The Korean terms also reinforce this conclusion, with \&quot;ì¤‘ì‹¬ìœ„\&quot; being the standard term for Centric Relation in Korean dentistry.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **A. ì¤‘ì‹¬ìœ„**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ì—¬ ì ‘ë²ˆìš´ë™ì„ í™•ì¸í•˜ëŠ” ê³¼ì •ìœ¼ë¡œ, ì´ëŠ” **ì¤‘ì‹¬ìœ„(Centric Relation)**ë¥¼ ì±„ë“í•˜ê¸° ìœ„í•œ ëŒ€í‘œì ì¸ ë°©ë²•ìž…ë‹ˆë‹¤.\n\nê° ì„ íƒì§€ë³„ ì„¤ëª…ì€ ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.\n\n* **A. ì¤‘ì‹¬ìœ„ (Centric Relation):**  í•˜ì•… ê³¼ë‘ê°€ ê´€ì ˆì™€ì˜ ê°€ìž¥ ìƒë°©-í›„ë°© ìœ„ì¹˜ì— ë†“ì´ëŠ” ì•…ìœ„ ê´€ê³„ìž…ë‹ˆë‹¤. ì´ì˜ì¹˜ ì œìž‘ ì‹œ ê¸°ì¤€ ì•…ìœ„ë¡œ ì‚¬ìš©ë˜ë©°, ìž¬í˜„ì„±ì´ ë†’ì€ ìœ„ì¹˜ìž…ë‹ˆë‹¤. ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ì—¬ ì¤‘ì‹¬ìœ„ë¥¼ ì±„ë“í•˜ëŠ” ì „í˜•ì ì¸ ë°©ë²•ê³¼ ì¼ì¹˜í•©ë‹ˆë‹¤.\n\n* **B. ì „ë°©í™œì£¼ë¡œ (Protrusive Record):** í•˜ì•…ì„ ì „ë°©ìœ¼ë¡œ ë‚´ë°€ì—ˆì„ ë•Œì˜ ì•…ìœ„ ê´€ê³„ë¥¼ ê¸°ë¡í•˜ëŠ” ê²ƒìž…ë‹ˆë‹¤.  ì£¼ë¡œ êµí•©ê¸° ìƒì—ì„œ ì „ë°©ìœ ë„ê°ì„ ì„¤ì •í•˜ê¸° ìœ„í•´ ì‚¬ìš©ë©ë‹ˆë‹¤. ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ ì „ë°©ìœ¼ë¡œ ë‚´ë¯¸ëŠ” ê²ƒì´ ì•„ë‹ˆë¼ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ë¯€ë¡œ ì „ë°©í™œì£¼ë¡œì™€ëŠ” ê±°ë¦¬ê°€ ë©‰ë‹ˆë‹¤.\n\n* **C. ìµœëŒ€ê°œêµ¬ìœ„ (Maximum Opening Position):** ìž…ì„ ìµœëŒ€í•œ í¬ê²Œ ë²Œë ¸ì„ ë•Œì˜ ìœ„ì¹˜ìž…ë‹ˆë‹¤. ì•…ê´€ì ˆ ì§ˆí™˜ í‰ê°€ ë“±ì— ì‚¬ìš©ë  ìˆ˜ ìžˆì§€ë§Œ, ì•…ê°„ê´€ê³„ ê¸°ë¡ê³¼ëŠ” ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤. ì œì‹œëœ ìˆ ì‹ì€ ìž…ì„ ë²Œë¦¬ëŠ” ë™ìž‘ê³¼ëŠ” ê´€ë ¨ì´ ì—†ê³ , í•˜ì•…ì˜ íŠ¹ì • ìœ„ì¹˜ë¥¼ ìœ ë„í•˜ëŠ” ê²ƒì— ì´ˆì ì„ ë§žì¶”ê³  ìžˆìŠµë‹ˆë‹¤.\n\n* **D. ìµœì „ë°©ì ‘ì´‰ìœ„ (Most Anterior Contact Position):** í•˜ì•…ì„ ìµœëŒ€í•œ ì „ë°©ìœ¼ë¡œ ë‚´ë°€ì–´ ì¹˜ì•„ê°€ ì²˜ìŒ ë‹¿ëŠ” ìœ„ì¹˜ë¥¼ ì˜ë¯¸í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ì¼ë°˜ì ìœ¼ë¡œ \&quot;ìµœì „ë°©ì ‘ì´‰ìœ„\&quot;ë¼ëŠ” ìš©ì–´ëŠ” ì¤‘ì‹¬ìœ„ë‚˜ ì¤‘ì‹¬êµí•©ìœ„ì™€ ê°™ì€ íŠ¹ì • ì•…ìœ„ ê´€ê³„ë¥¼ ì§€ì¹­í•˜ëŠ” í‘œì¤€ì ì¸ ìš©ì–´ëŠ” ì•„ë‹™ë‹ˆë‹¤.  ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ë¯€ë¡œ ìµœì „ë°©ì ‘ì´‰ìœ„ì™€ëŠ” ë°˜ëŒ€ ë°©í–¥ìž…ë‹ˆë‹¤.\n\n* **E. í›„ë°©í•œê³„ê°œêµ¬ë¡œ (Maximum Retrusion Opening):** í•˜ì•…ì„ ìµœëŒ€í•œ í›„ë°©ìœ¼ë¡œ ë°€ë©´ì„œ ìž…ì„ ë²Œë¦´ ë•Œì˜ ê²½ë¡œë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.  ì•…ê´€ì ˆ í‰ê°€ ë“±ì— ì‚¬ìš©ë  ìˆ˜ ìžˆì§€ë§Œ, ì•…ê°„ê´€ê³„ ê¸°ë¡ê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.  ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ë°©ìœ¼ë¡œ ìœ ë„í•˜ì§€ë§Œ, ê°œêµ¬ ìš´ë™ë³´ë‹¤ëŠ” íêµ¬ ìƒíƒœì—ì„œ ì¤‘ì‹¬ìœ„ë¥¼ ê¸°ë¡í•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ì—¬ ì ‘ë²ˆìš´ë™ì„ í™•ì¸í•˜ëŠ” ì¤‘ì‹¬ìœ„ ì±„ë“ ë°©ë²•ê³¼ ì •í™•ížˆ ì¼ì¹˜í•˜ë¯€ë¡œ, ì •ë‹µì€ A. ì¤‘ì‹¬ìœ„ìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:16,&quot;string&quot;:&quot;16&quot;}}},{&quot;rowIdx&quot;:10,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;doctor&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2013,&quot;string&quot;:&quot;2,013&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:26,&quot;string&quot;:&quot;26&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;6ê°œì›” ë‚¨ì•„ê°€ ì¶œìƒ í›„ë¶€í„° í•˜ì§€ì˜ ì›€ì§ìž„ì´ ì—†ì–´ ë³‘ì›ì— ì™”ë‹¤. ê°œêµ¬ë¦¬ ë‹¤ë¦¬ ëª¨ì–‘ì„ í•˜ê³  ëˆ„ì›Œ ìžˆì—ˆë‹¤.í˜€ì— ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•(fasciculation) ì´ ë³´ì˜€ë‹¤. ë‹¤ë¦¬ì— ìžê·¹ì„ ì£¼ì–´ë„ ì›€ì§ìž„ì´ ì—†ì—ˆê³ , ê¹Šì€íž˜ì¤„ë°˜ì‚¬ëŠ”ì—†ì—ˆë‹¤. í˜ˆì•¡ê²€ì‚¬ ê²°ê³¼ëŠ” ë‹¤ìŒê³¼ ê°™ì•˜ë‹¤. ì§„ë‹¨ì€?ì•„ìŠ¤íŒŒë¥´í…Œì´íŠ¸ì•„ë¯¸ë…¸ì „ë‹¬íš¨ì†Œ 30 U/L, ì•Œë¼ë‹Œì•„ë¯¸ë…¸ì „ë‹¬íš¨ì†Œ 20 U/L,í¬ë ˆì•„í‹´í‚¤ë‚˜ì•„ì œ 100 U/L (ì°¸ê³ ì¹˜, 5ï½ž130), ì –ì‚°íƒˆìˆ˜ì†Œíš¨ì†Œ 170 U/L (ì°¸ê³ ì¹˜, 170ï½ž580) &quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë‡Œì„±ë§ˆë¹„&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¤‘ì¦ê·¼ë¬´ë ¥ì¦&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê¸¸ëž­- ë°”ë ˆì¦í›„êµ°&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down this medical case step-by-step to arrive at the most likely diagnosis.\n\n**1. Understanding the Patient Presentation:**\n\n* **Age:** 6 months old infant. This is crucial, as certain conditions are more common or present differently at this age.\n* **Chief Complaint:** Lack of leg movement since birth. This is a significant neurological symptom.\n* **Posture:** \&quot;Frog-leg position.\&quot;  This posture in infants often suggests hypotonia (low muscle tone) and weakness, particularly in the hips and legs.\n* **Physical Exam Findings:**\n    * **Tongue fasciculations:** Involuntary muscle twitches of the tongue. This is a key finding indicating *lower motor neuron* involvement.\n    * **No leg movement to stimulation:**  Strongly suggests paralysis or severe weakness in the legs.\n    * **Absent deep tendon reflexes:**  This is another crucial finding pointing towards *lower motor neuron* pathology.\n\n**2. Interpreting the Lab Results:**\n\n* **Aspartate aminotransferase (AST) 30 U/L, Alanine aminotransferase (ALT) 20 U/L:** These are liver enzymes.  The values are within normal limits.  This is not particularly helpful for differentiating the given diagnoses.  It rules out significant liver damage, which is not directly relevant to the neurological symptoms.\n* **Creatine kinase (CK) 100 U/L (Reference: 5-130 U/L):** CK is an enzyme released from muscle tissue when it's damaged. The value is *within the normal range*.  While some muscle diseases elevate CK, a normal CK level doesn't exclude all muscle disorders.  It makes rapidly progressing muscle degeneration *less likely*, but doesn't rule out slower or congenital myopathies entirely.  However, in the context of other findings, it weakens the possibility of something like Duchenne muscular dystrophy (which usually has *very* high CK levels).\n* **Lactate dehydrogenase (LDH) 170 U/L (Reference: 170-580 U/L):** LDH is another enzyme found in many tissues, including muscle.  The value is at the *lower end of the normal range*. This is also not particularly helpful in differentiating the diagnoses and does not point strongly to muscle damage.\n\n**3.  Analyzing the Differential Diagnoses and Matching with Findings:**\n\nLet's evaluate each option based on the clinical picture:\n\n* **A. Cerebral Palsy (ë‡Œì„±ë§ˆë¹„):**\n    * **Pros:** Can present with limb weakness and abnormal posture.\n    * **Cons:**  *Usually* presents with *upper motor neuron* signs (increased reflexes, spasticity).  Tongue fasciculations and absent deep tendon reflexes are *not* typical of cerebral palsy.  Cerebral palsy is caused by brain damage, not primarily lower motor neuron issues.  While hypotonia can occur in some forms of CP, the combination of hypotonia, absent reflexes, and fasciculations makes CP less likely as the *primary* diagnosis.\n\n* **B. Myasthenia Gravis (ì¤‘ì¦ê·¼ë¬´ë ¥ì¦):**\n    * **Pros:** Can cause muscle weakness, and in infants, it can present with generalized weakness (\&quot;floppy baby\&quot;).\n    * **Cons:**  *No fasciculations*.  Myasthenia gravis is a *neuromuscular junction* disorder, not a motor neuron disease. Deep tendon reflexes are typically *normal* or only mildly reduced.  Tongue fasciculations are not a feature.\n\n* **C. Guillain-BarrÃ© Syndrome (ê¸¸ëž­-ë°”ë ˆì¦í›„êµ°):**\n    * **Pros:** Can cause rapidly progressive weakness, areflexia (absent reflexes), and hypotonia.\n    * **Cons:**  *Rare* in infants, especially at birth.  GBS is usually an *acquired* condition, often post-infectious.  Presenting *at birth* is extremely atypical.  While GBS affects peripheral nerves, tongue fasciculations are less commonly described.  However, in severe cases with bulbar involvement, cranial nerve issues could manifest. Still, less typical than the other findings.\n\n* **D. Progressive Muscular Dystrophy (ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼):**\n    * **Pros:** Can cause muscle weakness and hypotonia. Some types can present early in infancy.\n    * **Cons:**  CK is usually *significantly elevated* in muscular dystrophies, especially Duchenne and Becker.  The *normal CK* makes this less likely.  Fasciculations are *not* a typical feature of muscular dystrophies. Deep tendon reflexes might be reduced later in the disease, but are not the primary early finding.\n\n* **E. Spinal Muscular Atrophy (SMA) (ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦):**\n    * **Pros:** Fits *perfectly* with the clinical picture.\n        * **Onset at birth/early infancy:**  SMA Type 1 (Werdnig-Hoffmann disease) is a severe form presenting at birth or within the first few months of life.\n        * **Generalized weakness, especially legs:**  \&quot;Frog-leg position\&quot; is classic for SMA Type 1.\n        * **Tongue fasciculations:**  A *hallmark* of SMA due to lower motor neuron involvement.\n        * **Absent deep tendon reflexes:**  Another *hallmark* of lower motor neuron disease like SMA.\n        * **Normal CK (or only slightly elevated):**  Consistent with SMA.  CK might be slightly elevated due to chronic muscle atrophy, but not dramatically so in early stages.\n        * **Normal liver enzymes and LDH:** Consistent with SMA.\n\n**4. Conclusion:**\n\nConsidering all the clinical and lab findings, **Spinal Muscular Atrophy (SMA)** is the most consistent diagnosis.  The key findings of *tongue fasciculations*, *absent deep tendon reflexes*, *generalized weakness (especially legs)*, and the *infantile onset* strongly point towards SMA.  The normal CK level does not rule out SMA and is indeed typical in early SMA.\n\nTherefore, the answer is **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Spinal Muscular Atrophy)**.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nì œì‹œëœ ì¦ìƒê³¼ ê²€ì‚¬ ê²°ê³¼ëŠ” ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Spinal Muscular Atrophy, SMA)ì˜ ì „í˜•ì ì¸ íŠ¹ì§•ì„ ë³´ìž…ë‹ˆë‹¤. ê° ì„ íƒì§€ë¥¼ í•˜ë‚˜ì”© ì‚´íŽ´ë³´ê² ìŠµë‹ˆë‹¤.\n\n* **A. ë‡Œì„±ë§ˆë¹„ (Cerebral Palsy):** ë‡Œì„±ë§ˆë¹„ëŠ” ì¶œìƒ ì „í›„ì˜ ë‡Œ ì†ìƒìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ë©°, ìš´ë™ ë° ìžì„¸ ìž¥ì• ë¥¼ ì¼ìœ¼í‚µë‹ˆë‹¤. í•˜ì§€ë§Œ ë‡Œì„±ë§ˆë¹„ëŠ” ì¼ë°˜ì ìœ¼ë¡œ *ìƒìœ„ ìš´ë™ ì‹ ê²½ì›* ì§ˆí™˜ìœ¼ë¡œ, ì‹¬ë¶€ê±´ë°˜ì‚¬í•­ì§„, ê²½ì§ê³¼ ê°™ì€ ì¦ìƒì„ ë³´ìž…ë‹ˆë‹¤. í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ í”í•˜ì§€ ì•Šìœ¼ë©°, ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤ì€ ë‡Œì„±ë§ˆë¹„ì˜ ì£¼ìš” íŠ¹ì§•ì´ ì•„ë‹™ë‹ˆë‹¤.\n\n* **B. ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ (Myasthenia Gravis):** ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ì€ ì‹ ê²½-ê·¼ ì ‘í•©ë¶€ì˜ ì´ìƒìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ì§ˆí™˜ìœ¼ë¡œ, ê·¼ìœ¡ì˜ í”¼ë¡œì™€ ì‡ ì•½ì´ íŠ¹ì§•ìž…ë‹ˆë‹¤. í•˜ì§€ë§Œ ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ì€ *ë³€ë™ì„±* ê·¼ë ¥ ì•½í™”ë¥¼ ë³´ì´ë©°, í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ í”í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ì‹¬ë¶€ê±´ë°˜ì‚¬ëŠ” ì¼ë°˜ì ìœ¼ë¡œ ì •ìƒìž…ë‹ˆë‹¤.\n\n* **C. ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ° (Guillain-BarrÃ© Syndrome):** ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ°ì€ ê¸‰ì„± ì—¼ì¦ì„± íƒˆìˆ˜ì´ˆì„± ë‹¤ë°œì‹ ê²½ë³‘ì¦ìœ¼ë¡œ, ê¸‰ì„±ìœ¼ë¡œ ì§„í–‰í•˜ëŠ” ê·¼ë ¥ ì•½í™”ì™€ ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤ì„ íŠ¹ì§•ìœ¼ë¡œ í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ°ì€ ì¼ë°˜ì ìœ¼ë¡œ *ê°ê° ì´ìƒ*ì„ ë™ë°˜í•˜ë©°, í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ í”í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ë˜í•œ, ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ°ì€ ì¶œìƒ ì‹œë¶€í„° ì¦ìƒì´ ë‚˜íƒ€ë‚˜ëŠ” ê²½ìš°ëŠ” ë“œë¬¼ê³ , ì£¼ë¡œ ê°ì—¼ í›„ ìˆ˜ì¼ì—ì„œ ìˆ˜ì£¼ í›„ì— ë°œìƒí•©ë‹ˆë‹¤.\n\n* **D. ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ (Progressive Muscular Dystrophy):** ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ëŠ” ìœ ì „ì ì¸ ê·¼ìœ¡ ì§ˆí™˜ìœ¼ë¡œ, ê·¼ìœ¡ ì„¬ìœ ì˜ í‡´í–‰ê³¼ ì‡ ì•½ì„ ì¼ìœ¼í‚µë‹ˆë‹¤. ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ ì¤‘ ì¼ë¶€ëŠ” ì˜ì•„ê¸°ì— ë°œë³‘í•  ìˆ˜ ìžˆì§€ë§Œ, ì¼ë°˜ì ìœ¼ë¡œ *í¬ë ˆì•„í‹´í‚¤ë‚˜ì•„ì œ (CK) ìˆ˜ì¹˜ê°€ ë§¤ìš° ë†’ê²Œ ìƒìŠ¹*í•©ë‹ˆë‹¤. ì œì‹œëœ ê²€ì‚¬ ê²°ê³¼ì—ì„œ CK ìˆ˜ì¹˜ëŠ” ì •ìƒ ë²”ìœ„ ë‚´ì— ìžˆìœ¼ë¯€ë¡œ ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ì˜ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤. ë˜í•œ, í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ì˜ íŠ¹ì§•ì ì¸ ì¦ìƒì€ ì•„ë‹™ë‹ˆë‹¤.\n\n* **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Spinal Muscular Atrophy, SMA):** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ ìš´ë™ ì‹ ê²½ ì„¸í¬ì˜ í‡´í–‰ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ìœ ì „ ì§ˆí™˜ìœ¼ë¡œ, ê·¼ìœ¡ì˜ ì‡ ì•½ê³¼ ìœ„ì¶•ì„ íŠ¹ì§•ìœ¼ë¡œ í•©ë‹ˆë‹¤. íŠ¹ížˆ *ì œ1í˜• ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Werdnig-Hoffmann disease)*ì€ ì˜ì•„ê¸°ì— ë°œë³‘í•˜ë©°, ì¶œìƒ ì‹œë¶€í„° ë˜ëŠ” ìƒí›„ 6ê°œì›” ì´ë‚´ì— ì‹¬ê°í•œ ê·¼ë ¥ ì•½í™”ê°€ ë‚˜íƒ€ë‚©ë‹ˆë‹¤.\n\n**ì œì‹œëœ ì¦ìƒê³¼ ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì˜ íŠ¹ì§•:**\n\n* **6ê°œì›” ë‚¨ì•„, ì¶œìƒ í›„ë¶€í„° í•˜ì§€ ì›€ì§ìž„ ì—†ìŒ:** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ íŠ¹ížˆ í•˜ì§€ ê·¼ë ¥ ì•½í™”ë¥¼ ë‘ë“œëŸ¬ì§€ê²Œ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.\n* **ê°œêµ¬ë¦¬ ë‹¤ë¦¬ ëª¨ì–‘:** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ í™˜ì•„ëŠ” íŠ¹ì§•ì ìœ¼ë¡œ ê°œêµ¬ë¦¬ ë‹¤ë¦¬ ìžì„¸ë¥¼ ì·¨í•©ë‹ˆë‹¤. ì´ëŠ” ê³ ê´€ì ˆ ì™¸ì „ ë° ë¬´ë¦Ž êµ´ê³¡ìœ¼ë¡œ ì¸í•œ ìžì„¸ìž…ë‹ˆë‹¤.\n* **í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶• (fasciculation):** í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì˜ ë§¤ìš° íŠ¹ì§•ì ì¸ ì†Œê²¬ìž…ë‹ˆë‹¤. ì´ëŠ” ìš´ë™ ì‹ ê²½ ì„¸í¬ì˜ í‡´í–‰ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” í˜„ìƒìž…ë‹ˆë‹¤.\n* **ë‹¤ë¦¬ì— ìžê·¹ì„ ì£¼ì–´ë„ ì›€ì§ìž„ ì—†ìŒ, ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤:** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ í•˜ìœ„ ìš´ë™ ì‹ ê²½ì› ì§ˆí™˜ìœ¼ë¡œ, ê·¼ë ¥ ì•½í™” ë° ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤ì„ ìœ ë°œí•©ë‹ˆë‹¤.\n* **ì •ìƒ ë²”ìœ„ì˜ í˜ˆì•¡ ê²€ì‚¬ ê²°ê³¼ (CK, LDH):** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ ê·¼ìœ¡ ìžì²´ì˜ ì§ˆí™˜ì´ ì•„ë‹ˆë¯€ë¡œ, CK ìˆ˜ì¹˜ëŠ” ì¼ë°˜ì ìœ¼ë¡œ ì •ìƒì´ê±°ë‚˜ ê²½ë¯¸í•˜ê²Œ ìƒìŠ¹í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì œì‹œëœ CK ìˆ˜ì¹˜ëŠ” ì •ìƒ ë²”ìœ„ ë‚´ì— ìžˆìŠµë‹ˆë‹¤. LDH ë˜í•œ ì •ìƒ ë²”ìœ„ ë‚´ì— ìžˆìŠµë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ì œì‹œëœ ìž„ìƒ ì–‘ìƒê³¼ ê²€ì‚¬ ê²°ê³¼ëŠ” ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (íŠ¹ížˆ ì œ1í˜•)ì— ê°€ìž¥ ë¶€í•©í•©ë‹ˆë‹¤.** ë”°ë¼ì„œ ì •ë‹µì€ **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦** ìž…ë‹ˆë‹¤.&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:910,&quot;string&quot;:&quot;910&quot;}}},{&quot;rowIdx&quot;:11,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;doctor&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2014,&quot;string&quot;:&quot;2,014&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:6,&quot;string&quot;:&quot;6&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¸ê°„ì˜ í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬(circadian rhythm) ì„ ì£¼ê´€í•˜ëŠ” ìƒë¬¼í•™ì  ì‹œê³„ì¸ í•˜ë£¨ì£¼ê¸°ì¡°ì •ìž(circadian pacemaker) ê°€ ìœ„ì¹˜í•˜ê³  ìžˆëŠ” ë¶€ìœ„ëŠ”?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì†”ê¸°í•µ(raphe nucleus)&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì²­ìƒ‰ë°˜ì (locus ceruleus)&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê¼¬ë¦¬í•µ(caudate nucleus)&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë Œì¦ˆí•µ(lentiform nucleus)&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus)&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;The question is asking about the location of the circadian pacemaker in the human brain.\n- I need to identify the brain region that is responsible for regulating the circadian rhythm.\n- I know that the circadian rhythm is the body's internal clock that regulates sleep-wake cycles and other physiological processes over a 24-hour period.\n- I need to recall the specific brain structure known to be the master circadian pacemaker.\n\nLet's consider each option:\nA. ì†”ê¸°í•µ (raphe nucleus):  The raphe nucleus is primarily associated with serotonin production and regulation of mood, sleep, and pain. While it plays a role in sleep, it is not the primary circadian pacemaker.\n\nB. ì²­ìƒ‰ë°˜ì  (locus ceruleus): The locus ceruleus is the main site for norepinephrine production in the brain. It is involved in arousal, attention, and stress response.  While it is related to wakefulness, it's not the master circadian pacemaker.\n\nC. ê¼¬ë¦¬í•µ (caudate nucleus): The caudate nucleus is part of the basal ganglia and is involved in motor control, procedural learning, and habit formation. It is not directly related to circadian rhythm regulation.\n\nD. ë Œì¦ˆí•µ (lentiform nucleus): The lentiform nucleus is also part of the basal ganglia and includes the putamen and globus pallidus. It is involved in motor control and is not the primary circadian pacemaker.\n\nE. ì‹œì‹ ê²½êµì°¨ìƒí•µ (suprachiasmatic nucleus - SCN): The suprachiasmatic nucleus is a small nucleus in the hypothalamus, located just above the optic chiasm. It is well-established as the primary circadian pacemaker in mammals, including humans.  It receives direct input from the retina about light levels, which helps synchronize the body's internal clock with the external environment (day-night cycle).\n\nBased on my knowledge, the suprachiasmatic nucleus (SCN) is the correct answer.  It is the master clock that regulates circadian rhythms.\n\nTherefore, the answer is E. ì‹œì‹ ê²½êµì°¨ìƒí•µ (suprachiasmatic nucleus).&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **E. ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus)** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n* **í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬(circadian rhythm)** ì€ ì•½ 24ì‹œê°„ ì£¼ê¸°ë¡œ ë°˜ë³µë˜ëŠ” ìƒì²´ ë¦¬ë“¬ìœ¼ë¡œ, ìˆ˜ë©´-ê°ì„± ì£¼ê¸°, í˜¸ë¥´ëª¬ ë¶„ë¹„, ì²´ì˜¨ ë³€í™” ë“± ë‹¤ì–‘í•œ ìƒë¦¬ì  ê³¼ì •ì— ì˜í–¥ì„ ë¯¸ì¹©ë‹ˆë‹¤.\n* **í•˜ë£¨ì£¼ê¸°ì¡°ì •ìž(circadian pacemaker)** ëŠ” ì´ëŸ¬í•œ í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì„ ì£¼ê´€í•˜ëŠ” ìƒë¬¼í•™ì  ì‹œê³„ ì—­í• ì„ í•˜ëŠ” ë‡Œ ë¶€ìœ„ìž…ë‹ˆë‹¤.\n\nê° ì„ íƒì§€ë¥¼ ì‚´íŽ´ë³´ë©´ ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤:\n\n* **A. ì†”ê¸°í•µ(raphe nucleus):** ì†”ê¸°í•µì€ ì£¼ë¡œ ì„¸ë¡œí† ë‹Œì„ ìƒì„±í•˜ë©°, ê¸°ë¶„, ìˆ˜ë©´, í†µì¦ ì¡°ì ˆì— ê´€ì—¬í•©ë‹ˆë‹¤. ìˆ˜ë©´ì— ì˜í–¥ì„ ë¯¸ì¹˜ì§€ë§Œ, í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì˜ ì£¼ê´€ìžëŠ” ì•„ë‹™ë‹ˆë‹¤.\n* **B. ì²­ìƒ‰ë°˜ì (locus ceruleus):** ì²­ìƒ‰ë°˜ì ì€ ë…¸ë¥´ì—í”¼ë„¤í”„ë¦°ì„ ìƒì„±í•˜ë©°, ê°ì„±, ì£¼ì˜ ì§‘ì¤‘, ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘ì— ê´€ì—¬í•©ë‹ˆë‹¤. ê°ì„±ì— ì˜í–¥ì„ ë¯¸ì¹˜ì§€ë§Œ, í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì˜ ì£¼ê´€ìžëŠ” ì•„ë‹™ë‹ˆë‹¤.\n* **C. ê¼¬ë¦¬í•µ(caudate nucleus):** ê¼¬ë¦¬í•µì€ ê¸°ì €í•µì˜ ì¼ë¶€ë¡œ, ìš´ë™ ì¡°ì ˆ, ì ˆì°¨ ê¸°ì–µ, ìŠµê´€ í˜•ì„±ì— ê´€ì—¬í•©ë‹ˆë‹¤. í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.\n* **D. ë Œì¦ˆí•µ(lentiform nucleus):** ë Œì¦ˆí•µ ì—­ì‹œ ê¸°ì €í•µì˜ ì¼ë¶€ë¡œ, ìš´ë™ ì¡°ì ˆì— ê´€ì—¬í•©ë‹ˆë‹¤. í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.\n* **E. ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus - SCN):** ì‹œì‹ ê²½êµì°¨ìƒí•µì€ ì‹œìƒí•˜ë¶€ì— ìœ„ì¹˜í•œ ìž‘ì€ í•µìœ¼ë¡œ, **í¬ìœ ë¥˜ì˜ ì£¼ìš” í•˜ë£¨ì£¼ê¸°ì¡°ì •ìž** ë¡œ ì•Œë ¤ì ¸ ìžˆìŠµë‹ˆë‹¤. ì‹œì‹ ê²½ìœ¼ë¡œë¶€í„° ë¹› ì •ë³´ë¥¼ ì§ì ‘ ë°›ì•„ë“¤ì—¬ ì™¸ë¶€ í™˜ê²½(ë‚®ê³¼ ë°¤)ì— ìƒì²´ ì‹œê³„ë¥¼ ë™ê¸°í™”ì‹œí‚¤ëŠ” ì—­í• ì„ í•©ë‹ˆë‹¤.\n\në”°ë¼ì„œ, ì¸ê°„ì˜ í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì„ ì£¼ê´€í•˜ëŠ” ìƒë¬¼í•™ì  ì‹œê³„, ì¦‰ í•˜ë£¨ì£¼ê¸°ì¡°ì •ìžëŠ” **ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus)** ìž…ë‹ˆë‹¤.\n\n**ì •ë‹µ:** **E**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:982,&quot;string&quot;:&quot;982&quot;}}},{&quot;rowIdx&quot;:12,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;doctor&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2014,&quot;string&quot;:&quot;2,014&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3,&quot;string&quot;:&quot;3&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:64,&quot;string&quot;:&quot;64&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;42ì„¸ ì‚°ê³¼ë ¥ 2-0-1-2ì¸ ì—¬ìžê°€ 2ì£¼ ì „ ì‹œìž‘ëœ ì§ˆì¶œí˜ˆë¡œ ë³‘ì›ì— ì™”ë‹¤. í‰ì†Œ ì›”ê²½ì€ 30ì¼ ê°„ê²©ìœ¼ë¡œ ê·œì¹™ì ì´ì—ˆìœ¼ë©°, ìµœì¢…ì›”ê²½ì‹œìž‘ì¼ì€ 4ì£¼ ì „ì´ì—ˆë‹¤. í˜ˆì•• 110/70 mmHg, ë§¥ë°• 72íšŒ/ë¶„, ì²´ì˜¨ 36.7â„ƒì˜€ë‹¤. ì´ˆìŒíŒŒê²€ì‚¬ì—ì„œ ìžê¶ ë° ìžê¶ë¶€ì†ê¸°ëŠ” ì •ìƒì´ì—ˆë‹¤. í˜ˆì•¡ ë° ì†Œë³€ê²€ì‚¬ì™€ ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ëŠ” ë‹¤ìŒê³¼ ê°™ì•˜ë‹¤. ì§„ë‹¨ì€? í˜ˆì•¡: í˜ˆìƒ‰ì†Œ 11.6 g/dL, ë°±í˜ˆêµ¬ 8,000/mm^3, í˜ˆì†ŒíŒ 250,000/mm^3 ì†Œë³€ìž„ì‹ ë°˜ì‘: ìŒì„± ìžê¶ë‚´ë§‰: ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰(disordered proliferative endometrium) &quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìžê¶ë‚´ë§‰ì•”&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìžê¶ë‚´ë§‰ì—¼&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìžê¶ë‚´ë§‰ìœ ì°©ì¦&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìžê¶ë‚´ë§‰ì¦ì‹ì¦&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the diagnosis of dysfunctional uterine bleeding (DUB) in this case.\n\n**1.  Understanding the Patient's Presentation:**\n\n* **Age:** 42 years old -  This is important.  Women in their 40s are in perimenopause, where hormonal fluctuations are common and can lead to irregular bleeding.\n* **Parity (2-0-1-2):**  Two full-term pregnancies, one abortion, two living children.  This obstetrical history doesn't directly point to a diagnosis, but it's relevant patient history.\n* **Chief Complaint:** Vaginal bleeding for 2 weeks.  This is the primary symptom and needs to be explained.\n* **Menstrual History:** Regular 30-day cycles, LMP 4 weeks ago.  Initially seems normal, but the current bleeding is *outside* of her expected menstrual cycle.\n* **Vitals:** Normal blood pressure, pulse, and temperature.  This rules out acute infection or significant hypovolemia for now.\n* **Pelvic Ultrasound:** Normal uterus and adnexa. This is crucial. It rules out structural abnormalities like fibroids, polyps, ovarian cysts, or ectopic pregnancy as the *primary* cause of bleeding.\n* **Lab Results:**\n    * **Hemoglobin 11.6 g/dL:** Slightly low, indicating some blood loss, but not severely anemic.\n    * **WBC 8,000/mm^3:** Normal, rules out significant infection.\n    * **Platelets 250,000/mm^3:** Normal, rules out bleeding disorders related to platelets.\n    * **Urine Pregnancy Test: Negative:**  Rules out pregnancy as the cause of bleeding.\n    * **Endometrial Biopsy: Disordered Proliferative Endometrium:** This is the key finding.  \&quot;Proliferative\&quot; means the endometrium is growing (estrogen-driven). \&quot;Disordered\&quot; or \&quot;Dyssynchronous\&quot; implies that the growth is not happening in a coordinated, cyclical way, which is typical in a normal menstrual cycle.\n\n**2.  Systematic Differential Diagnosis (Thinking through the options and ruling them out):**\n\n* **A. Endometrial Cancer (ìžê¶ë‚´ë§‰ì•”):**\n    * **Why consider it?**  Abnormal bleeding is a key symptom of endometrial cancer, especially in perimenopausal and postmenopausal women.\n    * **Why rule it out (or at least make it less likely)?**\n        * **Age:** While possible at 42, endometrial cancer is more common in older women.\n        * **Endometrial Biopsy Result:** \&quot;Disordered proliferative endometrium\&quot; is *not* typical of endometrial cancer. Cancerous endometrium would show atypical cells, hyperplasia with atypia, or adenocarcinoma.  \&quot;Disordered proliferative\&quot; is a *benign* finding, albeit abnormal in its dyssynchrony.\n        * **Normal Ultrasound:** While not definitive, a normal ultrasound makes structural cancer less likely (though not impossible).\n    * **Conclusion:**  Less likely given the biopsy and ultrasound, but endometrial cancer *cannot* be completely ruled out without further investigation if the bleeding persists or worsens.\n\n* **B. Endometritis (ìžê¶ë‚´ë§‰ì—¼):**\n    * **Why consider it?**  Infection can cause abnormal bleeding.\n    * **Why rule it out?**\n        * **Normal Vitals:** No fever (36.7â„ƒ) or tachycardia (pulse 72 bpm) which are often seen in acute infection.\n        * **Normal WBC:**  WBC count is within the normal range, not elevated, which would be expected in infection.\n        * **\&quot;Proliferative\&quot; Endometrium:** Endometritis would typically cause inflammation and potentially a more mixed or necrotic picture on biopsy, not primarily \&quot;proliferative.\&quot;\n    * **Conclusion:**  Unlikely given the normal vitals, WBC, and biopsy result.\n\n* **C. Asherman's Syndrome (ìžê¶ë‚´ë§‰ìœ ì°©ì¦):**\n    * **Why consider it?** Asherman's can cause abnormal bleeding (often *reduced* or absent menstruation, but sometimes irregular bleeding).  It's associated with prior uterine procedures (D&amp;C, etc.).\n    * **Why rule it out?**\n        * **Patient History:** No mention of prior D&amp;C or uterine surgery.\n        * **Bleeding:**  Patient has *excessive* bleeding, not reduced. Asherman's more typically presents with amenorrhea or hypomenorrhea.\n        * **\&quot;Proliferative\&quot; Endometrium:**  Asherman's is characterized by *scarring* and *thinning* of the endometrium, not disordered proliferation.\n    * **Conclusion:**  Unlikely given the history, bleeding pattern, and biopsy result.\n\n* **D. Endometrial Hyperplasia (ìžê¶ë‚´ë§‰ì¦ì‹ì¦):**\n    * **Why consider it?**  Endometrial hyperplasia is a precursor to endometrial cancer, and it *can* present with abnormal bleeding.\n    * **Why rule it out (partially)?**\n        * **Biopsy Result:**  The biopsy says \&quot;disordered proliferative endometrium,\&quot; *not* \&quot;endometrial hyperplasia.\&quot;  While disordered proliferation can be *a form* of simple hyperplasia *without atypia*, the term \&quot;disordered proliferative\&quot; is more often used to describe the benign hormonal imbalance of DUB, rather than a pre-cancerous lesion.  If the biopsy had mentioned \&quot;hyperplasia,\&quot; especially with atypia, this would be much higher on the differential.  The absence of \&quot;hyperplasia\&quot; in the biopsy report is important.\n    * **Conclusion:** Less likely given the specific biopsy term.  If the report had said \&quot;simple hyperplasia without atypia,\&quot; it would be closer to DUB, but the term \&quot;disordered proliferative\&quot; is more directly associated with hormonal imbalance.\n\n* **E. Dysfunctional Uterine Bleeding (ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ):**\n    * **Why consider it?**\n        * **Age:** Perimenopausal age is the classic demographic.\n        * **Irregular Bleeding:**  Presents with bleeding outside normal menstruation.\n        * **Normal Ultrasound:** Rules out structural causes.\n        * **Negative Pregnancy Test:** Rules out pregnancy.\n        * **\&quot;Disordered Proliferative Endometrium\&quot;:** This is the *hallmark* biopsy finding for DUB.  It reflects anovulation or inconsistent ovulation, leading to unopposed estrogen stimulation and irregular endometrial shedding.\n    * **Conclusion:**  Highly likely.  All pieces of the puzzle fit.\n\n**3.  Final Diagnosis and Justification:**\n\nDysfunctional Uterine Bleeding (DUB) (ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ) is the most likely diagnosis.\n\n* **Reasoning:**\n    * The patient is perimenopausal, a typical age group for DUB.\n    * She presents with abnormal vaginal bleeding.\n    * Ultrasound is normal, ruling out structural lesions.\n    * Pregnancy is ruled out.\n    * Endometrial biopsy shows \&quot;disordered proliferative endometrium,\&quot; which is the characteristic histological finding in DUB due to hormonal imbalances (often anovulation or oligo-ovulation).\n\n**4.  Further Management (Although not asked in the question, it's good to consider):**\n\n* **Confirm Diagnosis:**  Rule out other less likely possibilities if bleeding persists or worsens.  Repeat biopsy if needed.\n* **Treatment:** Depends on severity of bleeding and patient's desire for future fertility.  Options include:\n    * **Observation:** If bleeding is mild and patient is not anemic.\n    * **Hormonal therapy:** Progestins (oral or IUD) to regulate cycles and reduce bleeding.  Combined oral contraceptives if contraception is also desired.\n    * **NSAIDs:** To reduce bleeding during periods.\n    * **Iron supplementation:** If anemic.\n    * **Endometrial ablation or hysterectomy:**  For severe, refractory cases, especially if fertility is no longer desired.\n\n\nBy systematically going through the patient's presentation, considering the differential diagnoses, and carefully evaluating the lab results, especially the biopsy, we arrive at the most appropriate diagnosis: Dysfunctional Uterine Bleeding.  The key is to recognize that \&quot;disordered proliferative endometrium\&quot; in the context of abnormal bleeding and normal pelvic exam is highly suggestive of DUB.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **E. ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n**í™˜ìžì˜ ì¦ìƒ ë° ê²€ì‚¬ ê²°ê³¼ ë¶„ì„:**\n\n* **42ì„¸ ì—¬ì„±, 2ì£¼ ì „ë¶€í„° ì‹œìž‘ëœ ì§ˆì¶œí˜ˆ:**  ê°€ìž¥ ì¤‘ìš”í•œ ì¦ìƒìž…ë‹ˆë‹¤.\n* **ê·œì¹™ì ì¸ ì›”ê²½ë ¥, ìµœì¢…ì›”ê²½ì‹œìž‘ì¼ 4ì£¼ ì „:** í‰ì†Œ ì›”ê²½ ì£¼ê¸°ëŠ” ê·œì¹™ì ì´ì—ˆìœ¼ë‚˜, í˜„ìž¬ ì¶œí˜ˆì€ ì›”ê²½ ì£¼ê¸°ì— ë§žì§€ ì•ŠëŠ” ë¹„ì •ìƒ ì¶œí˜ˆìž…ë‹ˆë‹¤.\n* **ì •ìƒ í™œë ¥ ì§•í›„ (í˜ˆì••, ë§¥ë°•, ì²´ì˜¨):** ê¸‰ì„± ê°ì—¼ì´ë‚˜ ì‹¬ê°í•œ ì „ì‹  ì§ˆí™˜ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.\n* **ì •ìƒ ìžê¶ ë° ìžê¶ë¶€ì†ê¸° ì´ˆìŒíŒŒ:**  ìžê¶ê·¼ì¢…, ìžê¶ë‚´ë§‰ í´ë¦½, ë‚œì†Œ ë‚­ì¢… ë“± êµ¬ì¡°ì ì¸ ì´ìƒìœ¼ë¡œ ì¸í•œ ì¶œí˜ˆ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.\n* **í˜ˆì•¡ ê²€ì‚¬:** ê²½ë¯¸í•œ ë¹ˆí˜ˆ (í˜ˆìƒ‰ì†Œ 11.6 g/dL) ì™¸ì—ëŠ” ì •ìƒìž…ë‹ˆë‹¤. ì—¼ì¦ ì†Œê²¬ (ë°±í˜ˆêµ¬ ì •ìƒ) ë„ ì—†ìŠµë‹ˆë‹¤.\n* **ì†Œë³€ìž„ì‹ ë°˜ì‘ ìŒì„±:** ìž„ì‹  ê´€ë ¨ ì¶œí˜ˆì€ ì•„ë‹™ë‹ˆë‹¤.\n* **ìžê¶ë‚´ë§‰ìƒê²€: ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰ (disordered proliferative endometrium):**  **í•µì‹¬ì ì¸ ì§„ë‹¨ ë‹¨ì„œìž…ë‹ˆë‹¤.**\n\n**ê° ì„ íƒì§€ë³„ ê°€ëŠ¥ì„± í‰ê°€:**\n\n* **A. ìžê¶ë‚´ë§‰ì•”:**\n    * ìžê¶ë‚´ë§‰ì•”ì€ ë¹„ì •ìƒ ì§ˆì¶œí˜ˆì˜ ì¤‘ìš”í•œ ì›ì¸ì´ì§€ë§Œ, **ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ê°€ \&quot;ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰\&quot;ìœ¼ë¡œ ì•”ì„¸í¬ë‚˜ ë¹„ì •í˜• ì„¸í¬ê°€ ë°œê²¬ë˜ì§€ ì•Šì•˜ìœ¼ë¯€ë¡œ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.**  ìžê¶ë‚´ë§‰ì•”ì€ ë³´í†µ ì¦ì‹ì¦, ë¹„ì •í˜• ì¦ì‹ì¦, ë˜ëŠ” ì•”ì„¸í¬ ìžì²´ë¡œ ì§„ë‹¨ë©ë‹ˆë‹¤.\n* **B. ìžê¶ë‚´ë§‰ì—¼:**\n    * ìžê¶ë‚´ë§‰ì—¼ì€ ì—¼ì¦ìœ¼ë¡œ ì¸í•œ ì¶œí˜ˆì„ ìœ ë°œí•  ìˆ˜ ìžˆì§€ë§Œ, **ì •ìƒ ë°±í˜ˆêµ¬ ìˆ˜ì¹˜ì™€ ì •ìƒ ì²´ì˜¨**ìœ¼ë¡œ ê°ì—¼ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤. ë˜í•œ, ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ê°€ ì—¼ì¦ì„± ë³€í™”ë³´ë‹¤ëŠ” \&quot;ì¦ì‹ê¸°\&quot; ë³€í™”ë¥¼ ë³´ì´ê³  ìžˆìŠµë‹ˆë‹¤.\n* **C. ìžê¶ë‚´ë§‰ìœ ì°©ì¦ (Asherman's syndrome):**\n    * ìžê¶ë‚´ë§‰ìœ ì°©ì¦ì€ ìžê¶ë‚´ë§‰ ì†ìƒ í›„ ìœ ì°©ì´ ë°œìƒí•˜ì—¬ ì›”ê²½ëŸ‰ ê°ì†Œë‚˜ ë¬´ì›”ê²½ì„ ìœ ë°œí•˜ëŠ” ì§ˆí™˜ìž…ë‹ˆë‹¤. **ì§ˆì¶œí˜ˆì´ ì£¼ ì¦ìƒì¸ ì´ í™˜ìžì—ê²ŒëŠ” ì í•©í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.**\n* **D. ìžê¶ë‚´ë§‰ì¦ì‹ì¦:**\n    * ìžê¶ë‚´ë§‰ì¦ì‹ì¦ì€ ìžê¶ë‚´ë§‰ì´ ê³¼ë„í•˜ê²Œ ì¦ì‹í•˜ëŠ” ì§ˆí™˜ìœ¼ë¡œ, ë¹„ì •ìƒ ì¶œí˜ˆì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ, ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ê°€ \&quot;ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰\&quot;ìœ¼ë¡œ, **ì¦ì‹ì¦ìœ¼ë¡œ ëª…í™•í•˜ê²Œ ì§„ë‹¨í•˜ê¸°ì—ëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤.** \&quot;ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰\&quot;ì€ ìžê¶ë‚´ë§‰ì¦ì‹ì¦ì˜ ì´ˆê¸° ë‹¨ê³„ í˜¹ì€ ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì—ì„œ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆëŠ” ë¹„íŠ¹ì´ì ì¸ ì†Œê²¬ìž…ë‹ˆë‹¤.\n* **E. ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ (Dysfunctional Uterine Bleeding, DUB):**\n    * **ê°€ìž¥ ê°€ëŠ¥ì„±ì´ ë†’ì€ ì§„ë‹¨ìž…ë‹ˆë‹¤.** ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì€ ê¸°ì§ˆì ì¸ ì§ˆí™˜ ì—†ì´ í˜¸ë¥´ëª¬ ë¶ˆê· í˜•ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ë¹„ì •ìƒ ìžê¶ ì¶œí˜ˆì„ ì˜ë¯¸í•©ë‹ˆë‹¤.\n    * **í™˜ìžì˜ ë‚˜ì´ (42ì„¸, ê°€ìž„ê¸° í›„ë°˜), ê·œì¹™ì ì¸ ì›”ê²½ë ¥ ë³€í™”, ì •ìƒ ì´ˆìŒíŒŒ, \&quot;ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰\&quot; ì†Œê²¬ì€ ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì— í•©ë‹¹í•©ë‹ˆë‹¤.**  íŠ¹ížˆ \&quot;ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰\&quot;ì€ ë°°ëž€ ìž¥ì•  ë“±ìœ¼ë¡œ ì¸í•´ í”„ë¡œê²ŒìŠ¤í…Œë¡ ì˜ ìž‘ìš© ì—†ì´ ì—ìŠ¤íŠ¸ë¡œê²ì—ë§Œ ì§€ì†ì ìœ¼ë¡œ ë…¸ì¶œëœ ìžê¶ë‚´ë§‰ì—ì„œ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆìœ¼ë©°, ì´ëŠ” ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì˜ í”í•œ ì›ì¸ìž…ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ,** í™˜ìžì˜ ì¦ìƒ, ê²€ì‚¬ ê²°ê³¼, íŠ¹ížˆ ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ë¥¼ ì¢…í•©ì ìœ¼ë¡œ ê³ ë ¤í–ˆì„ ë•Œ, **ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ (E)** ì´ ê°€ìž¥ ê°€ëŠ¥ì„± ë†’ì€ ì§„ë‹¨ìž…ë‹ˆë‹¤.  ë‹¤ë¥¸ ì‹¬ê°í•œ ì§ˆí™˜ì˜ ê°€ëŠ¥ì„±ì€ ë‚®ì§€ë§Œ, ì§€ì†ì ì¸ ì¶œí˜ˆ ì‹œ ìžê¶ë‚´ë§‰ì•” ë“±ì˜ ê°€ëŠ¥ì„±ì„ ë°°ì œí•˜ê¸° ìœ„í•´ ì¶”ì  ê´€ì°°ì´ í•„ìš”í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1083,&quot;string&quot;:&quot;1,083&quot;}}},{&quot;rowIdx&quot;:13,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;doctor&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2016,&quot;string&quot;:&quot;2,016&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:13,&quot;string&quot;:&quot;13&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;64ì„¸ ë‚¨ìžê°€ ì˜ì‹ì´ íë ¤ì§„ ì±„ë¡œ ë°œê²¬ë˜ì–´ ì‘ê¸‰ì‹¤ì— ì‹¤ë ¤ì™”ë‹¤. ì§‘ì•ˆì¼ë¡œ ì†ì´ ìƒí•´ ì‹ì‚¬ë¥¼ í•˜ì§€ ì•Šê³  3ì¼ ë™ì•ˆ ë§¤ì¼ ì†Œì£¼ 4ë³‘ì„ ë§ˆì…¨ë‹¤ê³  í•˜ì˜€ë‹¤. ë‹¹ë‡¨ë³‘ì´ë‚˜ ê³ í˜ˆì••ì„ ì•“ì€ ì ì€ ì—†ì—ˆê³  í‰ì†Œ ë³µìš©í•˜ëŠ” ì•½ë„ ì—†ë‹¤ê³  í•˜ì˜€ë‹¤. ì˜ì‹ì€ í˜¼ë¯¸í•˜ì˜€ê³  í˜ˆì•• 110/70 mmHg, ë§¥ë°• 86íšŒ/ë¶„, í˜¸í¡ 20íšŒ/ë¶„, ì²´ì˜¨ 36.3â„ƒì˜€ë‹¤. í˜ˆì•¡ê²€ì‚¬ ê²°ê³¼ëŠ” ë‹¤ìŒê³¼ ê°™ì•˜ë‹¤. ì›ì¸ì€?í¬ë„ë‹¹ 46 mg/dL,  ì¸ìŠë¦° 1.5 Î¼U/mL (ì°¸ê³ ì¹˜, 2 ~ 20) &quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œ&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë§ì´ˆ í¬ë„ë‹¹ ì´ìš© ì¦ê°€&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž ë¶„ë¹„ ì¦ê°€&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3,&quot;string&quot;:&quot;3&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down this medical case step-by-step, mimicking a thought process for solving this clinical reasoning question.\n\n**1. Initial Information Gathering and Problem Identification:**\n\n* **Patient Profile:** 64-year-old male, altered consciousness, Korean (contextual for drinking habits).\n* **Key History:** 3 days of heavy alcohol intake (4 bottles of Soju/day), no food intake, emotional distress related to housework. No prior diabetes, hypertension, or medications.\n* **Vitals:**  Stable blood pressure (110/70 mmHg), normal heart rate (86 bpm), normal respiratory rate (20 bpm), normal temperature (36.3Â°C).  Vitals are not immediately alarming, suggesting no acute shock or infection.  However, altered consciousness *is* alarming.\n* **Blood Glucose:**  **Extremely low glucose (46 mg/dL).** This is the most critical finding.\n* **Insulin:** Low insulin (1.5 Î¼U/mL, normal 2-20).  This is also significant and needs to be interpreted in the context of the low glucose.\n\n**Problem Identification:** Hypoglycemia.  The altered consciousness is highly likely due to the low blood sugar.\n\n**2.  Considering the History and Pathophysiology of Hypoglycemia:**\n\n* **Alcohol and Hypoglycemia:** Alcohol is a known cause of hypoglycemia, especially in the context of fasting.  Alcohol metabolism in the liver has a significant impact on glucose homeostasis.\n* **Fasting:**  No food intake for 3 days depletes liver glycogen stores.  The body relies more heavily on gluconeogenesis (making glucose from non-carbohydrate sources).\n* **Soju:** Soju is an alcoholic beverage.  Ethanol is the key ingredient.\n\n**3.  Mechanism of Alcohol-Induced Hypoglycemia:**\n\n* **Ethanol Metabolism:** Ethanol is metabolized in the liver primarily by alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH).\n* **NAD+/NADH Ratio Shift:**  This metabolic pathway consumes NAD+ and produces NADH. This increases the NADH/NAD+ ratio in the liver.\n* **Impact on Gluconeogenesis:**  Several key steps in gluconeogenesis are NAD+-dependent (e.g., lactate to pyruvate, malate to oxaloacetate).  The increased NADH/NAD+ ratio *inhibits* these steps.\n* **Impact on Glycolysis:**  Conversely, some steps in glycolysis are NADH-producing.  The increased NADH/NAD+ ratio *favors* glycolysis, but this is less relevant in a fasted state where the goal is to *produce* glucose, not consume it.\n* **Impact on Glycogenolysis:**  While alcohol can initially stimulate glycogenolysis, prolonged alcohol intake and depleted glycogen stores will make glycogenolysis less effective.\n\n**4.  Analyzing the Answer Choices in light of the Pathophysiology:**\n\n* **A. Glucagon ë¶„ë¹„ ì–µì œ (Glucagon secretion inhibition):** Glucagon is a counter-regulatory hormone that *raises* blood glucose. It stimulates glycogenolysis and gluconeogenesis.  If glucagon secretion is inhibited, this would worsen hypoglycemia.  Alcohol *can* suppress glucagon secretion to some extent, contributing to hypoglycemia.  This is a *possible* mechanism.\n\n* **B. ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ (Liver glycogenolysis inhibition):** Glycogenolysis is the breakdown of glycogen into glucose.  While alcohol doesn't directly *inhibit* glycogenolysis, in a state of depleted glycogen stores (due to fasting and alcohol metabolism), glycogenolysis would be less effective anyway.  And as mentioned before, alcohol *can* initially stimulate glycogenolysis, but not for long periods especially with fasting. Indirectly, the liver's energy being focused on alcohol metabolism might reduce its capacity for glycogenolysis.  Less direct than other options, but possibly contributing.\n\n* **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ (Liver gluconeogenesis inhibition):** Gluconeogenesis is the process of making new glucose from non-carbohydrate sources.  As discussed earlier, alcohol metabolism *directly inhibits* gluconeogenesis due to the NADH/NAD+ ratio shift. This is a *strong* mechanism.\n\n* **D. ë§ì´ˆ í¬ë„ë‹¹ ì´ìš© ì¦ê°€ (Increased peripheral glucose utilization):**  While insulin stimulates peripheral glucose uptake, insulin is *low* in this case (1.5 Î¼U/mL).  Alcohol itself *doesn't* directly increase peripheral glucose uptake in a way that would explain this profound hypoglycemia.  This is less likely.  Furthermore, low insulin suggests decreased, not increased, peripheral glucose utilization.\n\n* **E. ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž ë¶„ë¹„ ì¦ê°€ (Increased insulin-like growth factor secretion):** Insulin-like growth factors (IGFs) have some insulin-like effects, but they are not the primary regulator of acute glucose homeostasis.  IGF-1, for example, is more involved in long-term growth and development.  And IGFs are unlikely to be acutely increased by alcohol in a way that causes significant hypoglycemia.  This is very unlikely.\n\n**5.  Selecting the Best Answer:**\n\n* **Option C (ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ - Liver gluconeogenesis inhibition)** is the most direct and well-established mechanism for alcohol-induced hypoglycemia, especially in the context of fasting.  The NADH/NAD+ shift from alcohol metabolism directly impairs gluconeogenesis.\n\n* **Option A (ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œ - Glucagon secretion inhibition)** is also a contributing factor, but perhaps less direct and less dominant than gluconeogenesis inhibition.\n\n* **Option B (ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ - Liver glycogenolysis inhibition)** is less direct and less likely to be the primary mechanism.\n\n* **Options D and E** are very unlikely.\n\n**6. Final Answer and Justification:**\n\nThe most likely primary cause of hypoglycemia in this patient is **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ (Liver gluconeogenesis inhibition)**.  The combination of heavy alcohol consumption and fasting leads to a metabolic state where the liver's ability to produce glucose through gluconeogenesis is impaired due to the altered NADH/NAD+ ratio caused by ethanol metabolism.  This, coupled with depleted glycogen stores from fasting, leads to a rapid drop in blood glucose and altered consciousness.\n\nTherefore, the answer is **C**.\n\n**(Self-Correction/Refinement):**  Initially, I might have considered A and C both strongly. However, focusing on the *primary* mechanism in the context of the question wording (\&quot;ì›ì¸ì€?\&quot;) and the pathophysiology, gluconeogenesis inhibition is the more direct and dominant effect of alcohol in this scenario. Glucagon suppression is more of a secondary/contributory factor.  Therefore, C is the most accurate and best answer.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;## ì •ë‹µ: C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ\n\n**í•´ì„¤:**\n\n**í™˜ìžì˜ ìƒíƒœ:**\n\n* **64ì„¸ ë‚¨ì„±, ì˜ì‹ í˜¼ë¯¸:**  ì¤‘ì¶”ì‹ ê²½ê³„ ê¸°ëŠ¥ ì €í•˜ë¥¼ ì‹œì‚¬í•©ë‹ˆë‹¤.\n* **3ì¼ê°„ ì‹ì‚¬ ì•ˆ í•˜ê³  ì†Œì£¼ 4ë³‘/ì¼:** ì‹¬í•œ ì•Œì½”ì˜¬ ì„­ì·¨ì™€ ê¸ˆì‹ ìƒíƒœìž…ë‹ˆë‹¤.\n* **ë‹¹ë‡¨, ê³ í˜ˆì•• ë³‘ë ¥ ì—†ìŒ, ì•½ë¬¼ ë³µìš©ë ¥ ì—†ìŒ:** ê¸°ì¡´ ì§ˆí™˜ì´ë‚˜ ì•½ë¬¼ë¡œ ì¸í•œ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.\n* **ì •ìƒ í˜ˆì••, ë§¥ë°•, í˜¸í¡, ì²´ì˜¨:**  ê¸‰ì„± ì‡¼í¬ë‚˜ ì‹¬ê°í•œ ê°ì—¼ì˜ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.\n* **í˜ˆì•¡ ê²€ì‚¬:**\n    * **í¬ë„ë‹¹ 46 mg/dL (ì €í˜ˆë‹¹):**  ì˜ì‹ í˜¼ë¯¸ì˜ ê°€ìž¥ ìœ ë ¥í•œ ì›ì¸ìž…ë‹ˆë‹¤.\n    * **ì¸ìŠë¦° 1.5 Î¼U/mL (ë‚®ì€ ì¸ìŠë¦°):**  ì €í˜ˆë‹¹ ìƒí™©ì—ì„œ ì¸ìŠë¦° ë¶„ë¹„ê°€ ì–µì œëœ ê²ƒì€ ì •ìƒì ì¸ ë°˜ì‘ìž…ë‹ˆë‹¤.\n\n**ê° ì„ íƒì§€ ë¶„ì„:**\n\n* **A. ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œ:** ê¸€ë£¨ì¹´ê³¤ì€ í˜ˆë‹¹ì„ ìƒìŠ¹ì‹œí‚¤ëŠ” í˜¸ë¥´ëª¬ìž…ë‹ˆë‹¤. ì €í˜ˆë‹¹ ìƒí™©ì—ì„œëŠ” ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ê°€ **ì´‰ì§„**ë˜ì–´ì•¼ í˜ˆë‹¹ì„ ì˜¬ë¦¬ë ¤ê³  í•©ë‹ˆë‹¤. ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œëŠ” ì €í˜ˆë‹¹ì„ ì•…í™”ì‹œí‚¤ë¯€ë¡œ, ì›ì¸ì´ ë  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.\n\n* **B. ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ:** ê¸€ë¦¬ì½”ê²ë¶„í•´ëŠ” ê°„ì— ì €ìž¥ëœ ê¸€ë¦¬ì½”ê²ì„ í¬ë„ë‹¹ìœ¼ë¡œ ë¶„í•´í•˜ì—¬ í˜ˆë‹¹ì„ ì˜¬ë¦¬ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤.  ì•Œì½”ì˜¬ì€ ê°„ì—ì„œ ëŒ€ì‚¬ë˜ë©´ì„œ NADH/NAD+ ë¹„ìœ¨ì„ ì¦ê°€ì‹œì¼œ ê¸€ë¦¬ì½”ê²ë¶„í•´ë¥¼ **ì¼ì‹œì ìœ¼ë¡œ ì´‰ì§„**í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ìž¥ê¸°ê°„ ê¸ˆì‹ ìƒíƒœì—ì„œëŠ” ê°„ ê¸€ë¦¬ì½”ê² ì €ìž¥ëŸ‰ì´ ì´ë¯¸ ê³ ê°ˆë˜ì—ˆì„ ê°€ëŠ¥ì„±ì´ ë†’ê³ , ì•Œì½”ì˜¬ ëŒ€ì‚¬ë¡œ ì¸í•´ ê°„ ê¸°ëŠ¥ì´ ì €í•˜ë˜ì–´ ê¸€ë¦¬ì½”ê²ë¶„í•´ê°€ ì œëŒ€ë¡œ ì´ë£¨ì–´ì§€ì§€ ì•Šì„ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  í•˜ì§€ë§Œ **ì£¼ëœ ì›ì¸**ì´ë¼ê³  ë³´ê¸° ì–´ë µìŠµë‹ˆë‹¤.\n\n* **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ:** í¬ë„ë‹¹ì‹ í•©ì„±ì€ ê°„ì—ì„œ ì•„ë¯¸ë…¸ì‚°, ì –ì‚°, ê¸€ë¦¬ì„¸ë¡¤ ë“± ë¹„íƒ„ìˆ˜í™”ë¬¼ ë¬¼ì§ˆë¡œë¶€í„° í¬ë„ë‹¹ì„ ìƒˆë¡œ í•©ì„±í•˜ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤.  **ì•Œì½”ì˜¬ì€ ê°„ì—ì„œ ëŒ€ì‚¬ë˜ë©´ì„œ NADH/NAD+ ë¹„ìœ¨ì„ ì¦ê°€ì‹œí‚¤ê³ , ì´ëŠ” í¬ë„ë‹¹ì‹ í•©ì„± ê³¼ì •ì˜ ì¤‘ìš”í•œ íš¨ì†Œ ë°˜ì‘ì„ ì–µì œí•©ë‹ˆë‹¤.** íŠ¹ížˆ ê¸ˆì‹ ìƒíƒœì—ì„œëŠ” í˜ˆë‹¹ ìœ ì§€ë¥¼ í¬ë„ë‹¹ì‹ í•©ì„±ì— í¬ê²Œ ì˜ì¡´í•˜ê²Œ ë˜ëŠ”ë°, ì•Œì½”ì˜¬ ì„­ì·¨ë¡œ ì¸í•´ í¬ë„ë‹¹ì‹ í•©ì„±ì´ ì–µì œë˜ë©´ ì‹¬ê°í•œ ì €í˜ˆë‹¹ì´ ë°œìƒí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. **ì´ê²ƒì´ ê°€ìž¥ ìœ ë ¥í•œ ì›ì¸ìž…ë‹ˆë‹¤.**\n\n* **D. ë§ì´ˆ í¬ë„ë‹¹ ì´ìš© ì¦ê°€:** ì¸ìŠë¦°ì€ ë§ì´ˆ ì¡°ì§ì—ì„œ í¬ë„ë‹¹ ì´ìš©ì„ ì´‰ì§„í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ í™˜ìžì˜ ì¸ìŠë¦° ìˆ˜ì¹˜ëŠ” ë‚®ìœ¼ë¯€ë¡œ, ë§ì´ˆ í¬ë„ë‹¹ ì´ìš©ì´ ì¦ê°€í–ˆì„ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤. ì˜¤ížˆë ¤ ì €í˜ˆë‹¹ ìƒí™©ì—ì„œëŠ” ì¸ìŠë¦° ë¶„ë¹„ê°€ ì–µì œë˜ì–´ ë§ì´ˆ í¬ë„ë‹¹ ì´ìš©ì´ ê°ì†Œí•˜ëŠ” ê²ƒì´ ì •ìƒì ì¸ ë°˜ì‘ìž…ë‹ˆë‹¤.\n\n* **E. ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž ë¶„ë¹„ ì¦ê°€:** ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž (IGF)ëŠ” ì¸ìŠë¦°ê³¼ ìœ ì‚¬í•œ ìž‘ìš©ì„ í•˜ì§€ë§Œ, ê¸‰ì„± ì €í˜ˆë‹¹ì˜ ì›ì¸ìœ¼ë¡œ ë³´ê¸° ì–´ë µìŠµë‹ˆë‹¤. IGFëŠ” ì£¼ë¡œ ì„±ìž¥ê³¼ ë°œë‹¬ì— ê´€ì—¬í•˜ë©°, í˜ˆë‹¹ ì¡°ì ˆì— ë¯¸ì¹˜ëŠ” ì˜í–¥ì€ ì¸ìŠë¦°ì— ë¹„í•´ ë¯¸ë¯¸í•©ë‹ˆë‹¤.\n\n**ê²°ë¡ :**\n\ní™˜ìžì˜ ê²½ìš°, 3ì¼ê°„ì˜ ê¸ˆì‹ê³¼ ê³¼ë„í•œ ì•Œì½”ì˜¬ ì„­ì·¨ë¡œ ì¸í•´ ê°„ì˜ í¬ë„ë‹¹ì‹ í•©ì„±ì´ ì–µì œë˜ì–´ ì‹¬ê°í•œ ì €í˜ˆë‹¹ì´ ë°œìƒí•œ ê²ƒìœ¼ë¡œ íŒë‹¨ë©ë‹ˆë‹¤. ë”°ë¼ì„œ ê°€ìž¥ ì ì ˆí•œ ì›ì¸ì€ **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ** ìž…ë‹ˆë‹¤.\n\n**ì¶”ê°€ ì„¤ëª…:**\n\n* ì•Œì½”ì˜¬ì€ ê°„ì—ì„œ ì•Œì½”ì˜¬ íƒˆìˆ˜ì†Œíš¨ì†Œ (ADH)ì™€ ì•Œë°ížˆë“œ íƒˆìˆ˜ì†Œíš¨ì†Œ (ALDH)ì— ì˜í•´ ëŒ€ì‚¬ë©ë‹ˆë‹¤. ì´ ê³¼ì •ì—ì„œ NAD+ê°€ NADHë¡œ í™˜ì›ë˜ì–´ ê°„ì„¸í¬ ë‚´ NADH/NAD+ ë¹„ìœ¨ì´ ì¦ê°€í•©ë‹ˆë‹¤.\n* ë†’ì€ NADH/NAD+ ë¹„ìœ¨ì€ ê°„ì„¸í¬ ë‚´ ëŒ€ì‚¬ ê²½ë¡œì— ì˜í–¥ì„ ë¯¸ì³, íŠ¹ížˆ í¬ë„ë‹¹ì‹ í•©ì„± ê²½ë¡œë¥¼ ì–µì œí•©ë‹ˆë‹¤.\n* ê¸ˆì‹ ìƒíƒœì—ì„œëŠ” ê°„ ê¸€ë¦¬ì½”ê² ì €ìž¥ëŸ‰ì´ ê°ì†Œí•˜ê³ , í¬ë„ë‹¹ì‹ í•©ì„±ì´ í˜ˆë‹¹ ìœ ì§€ì— ë”ìš± ì¤‘ìš”í•´ì§‘ë‹ˆë‹¤.\n* ì•Œì½”ì˜¬ ì„­ì·¨ë¡œ ì¸í•´ í¬ë„ë‹¹ì‹ í•©ì„±ì´ ì–µì œë˜ë©´, í˜ˆë‹¹ì´ ê¸‰ê²©ížˆ ë–¨ì–´ì ¸ ì €í˜ˆë‹¹ì„± í˜¼ìˆ˜ê°€ ë°œìƒí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n**ë”°ë¼ì„œ ì •ë‹µì€ C ìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1401,&quot;string&quot;:&quot;1,401&quot;}}},{&quot;rowIdx&quot;:14,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;nurse_assistant&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2022,&quot;string&quot;:&quot;2,022&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:94,&quot;string&quot;:&quot;94&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìš”ì¶”ì²œìž ì§í›„ 9ì„¸ ë‚¨ì•„ê°€ ì†Œë³€ì„ ë³´ê³  ì‹¶ë‹¤ê³  í•  ë•Œ ê°„í˜¸ ë³´ì¡°í™œë™ìœ¼ë¡œ ì˜³ì€ ê²ƒì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì´ë™ì‹ ë³€ê¸°ì— ì•‰ížŒë‹¤.&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í™”ìž¥ì‹¤ì„ ë‹¤ë…€ì˜¤ê²Œ í•œë‹¤.&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìœ ì¹˜ë„ë‡¨ì„¸íŠ¸ë¥¼ ì¤€ë¹„í•œë‹¤.&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¹¨ëŒ€ ìœ„ì— ì„œì„œ ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;\nThe question is asking about the appropriate nursing assistant activity when a 9-year-old boy wants to urinate immediately after a lumbar puncture. We need to consider the potential complications and restrictions after a lumbar puncture, especially in children.\n\nLet's analyze each option:\n\n* **A. ì´ë™ì‹ ë³€ê¸°ì— ì•‰ížŒë‹¤. (Sit him on a portable commode.)**: This is a possibility. A portable commode is convenient for patients who have difficulty moving to the bathroom, but it still requires the patient to sit upright.\n\n* **B. í™”ìž¥ì‹¤ì„ ë‹¤ë…€ì˜¤ê²Œ í•œë‹¤. (Let him go to the bathroom.)**:  Lumbar puncture is a procedure that involves inserting a needle into the spinal canal. One of the major concerns after a lumbar puncture is post-lumbar puncture headache (PLPH), which is often aggravated by standing or sitting upright.  Encouraging the child to walk to the bathroom might worsen potential headache and is generally not recommended immediately after the procedure.\n\n* **C. ìœ ì¹˜ë„ë‡¨ì„¸íŠ¸ë¥¼ ì¤€ë¹„í•œë‹¤. (Prepare a Foley catheter set.)**:  A Foley catheter is an invasive procedure, and it is not a routine intervention just because a patient needs to urinate after a lumbar puncture. Catheterization is only considered if the patient is unable to void naturally and urinary retention is suspected. This is too invasive and not a first-line approach.\n\n* **D. ì¹¨ëŒ€ ìœ„ì— ì„œì„œ ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤. (Let him stand on the bed to urinate.)**:  Standing upright after a lumbar puncture can increase the risk and severity of a post-lumbar puncture headache. Also, having a child stand on the bed to urinate is unsafe and impractical. This option is highly inappropriate.\n\n* **E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤. (Let him urinate into a bedpan while lying down.)**:  After a lumbar puncture, patients are often advised to lie flat for a period of time to minimize the risk of post-lumbar puncture headache. Urinating in a bedpan while lying down is a common and safe practice for patients who need to void but should remain lying down. This seems like the most appropriate option given the circumstances.\n\nConsidering the need to minimize movement and maintain a lying position to prevent or reduce post-lumbar puncture headache, options B and D are clearly not suitable. Option C is too invasive and not necessary as a first step. Option A is better than B and D, but still requires sitting up, which might be less desirable than remaining lying down. Option E allows the child to urinate while remaining in a lying position, which is the recommended position after a lumbar puncture.\n\nTherefore, option E seems to be the most appropriate nursing assistant activity.\n\nLet's double-check the typical post-lumbar puncture care.  Post-procedure care often includes:\n    * Monitoring vital signs and neurological status.\n    * Encouraging fluid intake to help with CSF production and hydration.\n    * Pain management, if needed.\n    * **Maintaining a flat or prone position for a period of time (often 1-2 hours or more) to minimize CSF leakage and prevent headache.**\n\nBased on this typical care, minimizing upright posture immediately after lumbar puncture is important.  Option E, using a bedpan while lying down, aligns best with this principle.\n\n\n**Final Answer Selection:** E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤. (Let him urinate into a bedpan while lying down.)\n\n**Reasoning:**\nAfter a lumbar puncture, especially in children, minimizing movement and maintaining a lying position is crucial to prevent or reduce post-lumbar puncture headache.  Among the options, using a bedpan while lying down (option E) is the only option that allows the child to urinate without getting up or sitting upright.  The other options either involve sitting up (A), walking to the bathroom (B), standing (D), or are unnecessarily invasive (C).  Using a bedpan while lying down is a standard nursing intervention to facilitate urination for patients who need to remain in a recumbent position.\n\n&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nìš”ì¶”ì²œìž(Lumbar puncture, spinal tap)ëŠ” ë‡Œì²™ìˆ˜ì•¡ ê²€ì‚¬ë¥¼ ìœ„í•´ ì²™ì¶”ë¼ˆ ì‚¬ì´ë¡œ ë°”ëŠ˜ì„ ì‚½ìž…í•˜ëŠ” ì‹œìˆ ìž…ë‹ˆë‹¤. ì‹œìˆ  í›„ ê°€ìž¥ í”í•œ ë¶€ìž‘ìš© ì¤‘ í•˜ë‚˜ëŠ” ë‘í†µì¸ë°, ì´ëŠ” ë‡Œì²™ìˆ˜ì•¡ì´ ëˆ„ì¶œë˜ì–´ ë°œìƒí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ë‘í†µì„ ì˜ˆë°©í•˜ê±°ë‚˜ ì™„í™”í•˜ê¸° ìœ„í•´ ìš”ì¶”ì²œìž í›„ì—ëŠ” ì¼ì • ì‹œê°„ ë™ì•ˆ **ë¨¸ë¦¬ë¥¼ ë‚®ì¶”ê³  ëˆ„ì›ŒìžˆëŠ” ìžì„¸**ë¥¼ ìœ ì§€í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n\nê° ì„ íƒì§€ë¥¼ ë¶„ì„í•´ ë³´ê² ìŠµë‹ˆë‹¤.\n\n* **A. ì´ë™ì‹ ë³€ê¸°ì— ì•‰ížŒë‹¤.** : ì´ë™ì‹ ë³€ê¸°ëŠ” ì¹¨ìƒ ì˜†ì—ì„œ ì‚¬ìš©í•  ìˆ˜ ìžˆì–´ íŽ¸ë¦¬í•˜ì§€ë§Œ, ì•‰ëŠ” ìžì„¸ëŠ” ë¨¸ë¦¬ë¥¼ ë†’ì´ê²Œ ë˜ì–´ ë‡Œì²™ìˆ˜ì•¡ ëˆ„ì¶œë¡œ ì¸í•œ ë‘í†µì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ë”°ë¼ì„œ ìš”ì¶”ì²œìž ì§í›„ì—ëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n\n* **B. í™”ìž¥ì‹¤ì„ ë‹¤ë…€ì˜¤ê²Œ í•œë‹¤.** : í™”ìž¥ì‹¤ê¹Œì§€ ê±¸ì–´ê°€ê³  ì•‰ì•˜ë‹¤ ì¼ì–´ë‚˜ëŠ” ë™ìž‘ì€ ë¨¸ë¦¬ë¥¼ ë†’ì´ëŠ” ê²ƒì€ ë¬¼ë¡ ì´ê³  ì›€ì§ìž„ ìžì²´ë„ ë‘í†µì„ ìœ ë°œí•˜ê±°ë‚˜ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ìš”ì¶”ì²œìž ì§í›„ì—ëŠ” ì›€ì§ìž„ì„ ìµœì†Œí™”í•´ì•¼ í•©ë‹ˆë‹¤.\n\n* **C. ìœ ì¹˜ë„ë‡¨ì„¸íŠ¸ë¥¼ ì¤€ë¹„í•œë‹¤.** : ìœ ì¹˜ë„ë‡¨ëŠ” ì†Œë³€ì„ ìŠ¤ìŠ¤ë¡œ ë³¼ ìˆ˜ ì—†ëŠ” ê²½ìš°ë‚˜ ìˆ˜ìˆ  í›„ ìž¥ì‹œê°„ ì¹¨ìƒ ì•ˆì •ì´ í•„ìš”í•œ ê²½ìš° ë“±ì— ê³ ë ¤ë©ë‹ˆë‹¤. ë‹¨ìˆœ ë°°ë‡¨ë¥¼ ìœ„í•´ ìš”ì¶”ì²œìž ì§í›„ì— ìœ ì¹˜ë„ë‡¨ë¥¼ ì‹œí–‰í•˜ëŠ” ê²ƒì€ ê³¼ë„í•œ ì²˜ì¹˜ì´ë©°, ê°ì—¼ ë“±ì˜ ìœ„í—˜ë„ ìžˆìŠµë‹ˆë‹¤.\n\n* **D. ì¹¨ëŒ€ ìœ„ì— ì„œì„œ ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.** : ì¹¨ëŒ€ ìœ„ì— ì„œëŠ” ê²ƒì€ ë§¤ìš° ìœ„í—˜í•˜ë©°, ë¨¸ë¦¬ë¥¼ ë†’ì´ëŠ” ìžì„¸ëŠ” ë‘í†µì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì•ˆì „ ë¬¸ì œì™€ ì˜í•™ì  ì¸¡ë©´ ëª¨ë‘ì—ì„œ ë¶€ì ì ˆí•œ ë°©ë²•ìž…ë‹ˆë‹¤.\n\n* **E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.** : ëˆ„ìš´ ìžì„¸ëŠ” ë¨¸ë¦¬ë¥¼ ë‚®ê²Œ ìœ ì§€í•˜ì—¬ ë‡Œì²™ìˆ˜ì•¡ ëˆ„ì¶œì„ ìµœì†Œí™”í•˜ê³  ë‘í†µì„ ì˜ˆë°©í•˜ëŠ” ë° ë„ì›€ì´ ë©ë‹ˆë‹¤. ì†Œë³€ê¸°ëŠ” ì¹¨ìƒì— ëˆ„ìš´ ìƒíƒœë¡œ ë°°ë‡¨í•  ìˆ˜ ìžˆë„ë¡ ë•ëŠ” ë„êµ¬ì´ë¯€ë¡œ, ìš”ì¶”ì²œìž ì§í›„ ì†Œë³€ì„ ë³´ê³  ì‹¶ì–´í•˜ëŠ” í™˜ìžì—ê²Œ ê°€ìž¥ ì ì ˆí•œ ê°„í˜¸ ë³´ì¡° í™œë™ìž…ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ìš”ì¶”ì²œìž ì§í›„ 9ì„¸ ë‚¨ì•„ì˜ ë°°ë‡¨ ìš”êµ¬ ì‹œ ê°€ìž¥ ì•ˆì „í•˜ê³  ì ì ˆí•œ ê°„í˜¸ ë³´ì¡°ëŠ” ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ë„ë¡ ë•ëŠ” ê²ƒìž…ë‹ˆë‹¤.**\n\n**ë”°ë¼ì„œ ì •ë‹µì€ Eìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:6580,&quot;string&quot;:&quot;6,580&quot;}}},{&quot;rowIdx&quot;:15,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;dental_technician&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2020,&quot;string&quot;:&quot;2,020&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:78,&quot;string&quot;:&quot;78&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ã€Œì˜ë£Œë²•ã€ìƒ ì§„ë‹¨ì„œë¥¼ êµë¶€í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì•½ì‚¬&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê°„í˜¸ì‚¬&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¡°ì‚°ì‚¬&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¹˜ê³¼ì˜ì‚¬&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë°©ì‚¬ì„ ì‚¬&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4,&quot;string&quot;:&quot;4&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;\nThe question is asking about who is authorized to issue a medical certificate according to the Medical Service Act in Korea.  I need to determine which of the listed professions is legally authorized to issue a diagnosis certificate (ì§„ë‹¨ì„œ).\n\nLet's analyze each option based on my knowledge of healthcare professions and general understanding of who can make diagnoses and issue medical certificates:\n\n* **A. ì•½ì‚¬ (Pharmacist):** Pharmacists are experts in medications. They dispense drugs, counsel patients on drug use, and manage medication therapy.  However, they do not diagnose illnesses or issue medical certificates (ì§„ë‹¨ì„œ).  Their role is primarily related to medication management, not diagnosis.\n\n* **B. ê°„í˜¸ì‚¬ (Nurse):** Nurses provide direct patient care, administer medications, monitor vital signs, and assist doctors.  While nurses play a crucial role in patient care and assessment,  they are generally not authorized to independently diagnose illnesses or issue medical certificates.  Their role is to assist and implement the care plans prescribed by physicians.  There might be advanced practice nurses with expanded roles in some specific contexts, but generally, in a standard medical setting, nurses don't issue ì§„ë‹¨ì„œ.\n\n* **C. ì¡°ì‚°ì‚¬ (Midwife):** Midwives specialize in pregnancy, childbirth, and postpartum care. In Korea (and many other countries), midwives are legally recognized healthcare professionals. They can manage normal deliveries, provide prenatal and postnatal care.  Crucially, midwives, within their scope of practice (pregnancy and childbirth), are authorized to make diagnoses related to their specialty and issue certain types of medical certificates related to childbirth.  This is a potential candidate.\n\n* **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist):** Dentists are medical professionals specialized in oral health. They diagnose and treat diseases of the teeth, gums, and related structures.  Dentists are definitely authorized to make diagnoses and issue medical certificates (ì§„ë‹¨ì„œ) related to dental conditions.  This is another strong candidate.\n\n* **E. ë°©ì‚¬ì„ ì‚¬ (Radiologic Technologist/Radiographer):** Radiologic technologists operate medical imaging equipment like X-ray, CT, and MRI machines. They are skilled in capturing medical images, but they do not interpret these images or make diagnoses.  Diagnosis based on images is the responsibility of radiologists or other physicians. Radiographers are not authorized to issue medical certificates.\n\n\nBased on this analysis:\n\n* **Pharmacists (ì•½ì‚¬)** are not authorized.\n* **Nurses (ê°„í˜¸ì‚¬)** are generally not authorized.\n* **Midwives (ì¡°ì‚°ì‚¬)** might be authorized within their specialty (pregnancy and childbirth).\n* **Dentists (ì¹˜ê³¼ì˜ì‚¬)** are definitely authorized, specifically for dental conditions.\n* **Radiologic Technologists (ë°©ì‚¬ì„ ì‚¬)** are not authorized.\n\n\nThe question is about who can issue a \&quot;ì§„ë‹¨ì„œ\&quot; in general under the \&quot;ì˜ë£Œë²•\&quot; (Medical Service Act).  \&quot;ì§„ë‹¨ì„œ\&quot; usually implies a medical certificate issued by a physician for a medical condition.  Considering the options and the general understanding of medical practice, both dentists and potentially midwives could issue certain types of ì§„ë‹¨ì„œ within their respective scopes.\n\nHowever, \&quot;ì§„ë‹¨ì„œ\&quot; (diagnosis certificate) is most commonly associated with physicians (ì˜ì‚¬).  Looking at the options, \&quot;ì¹˜ê³¼ì˜ì‚¬\&quot; (Dentist) is a type of physician, specifically a doctor of dental medicine.  \&quot;ì¡°ì‚°ì‚¬\&quot; (Midwife), while a recognized healthcare professional who can make diagnoses and issue certificates related to childbirth, their scope is more limited compared to a general physician or dentist.\n\nIn the context of the Medical Service Act and the general understanding of \&quot;ì§„ë‹¨ì„œ,\&quot;  the most straightforward and broadly applicable answer would be a medical doctor or a dentist.  Between Dentists and Midwives,  Dentists are more generally and commonly associated with issuing \&quot;ì§„ë‹¨ì„œ\&quot; in various medical contexts beyond just childbirth.  While midwives can issue certificates related to childbirth,  dentists' authority to issue certificates is within their domain of dental health, and \&quot;ì§„ë‹¨ì„œ\&quot; in common parlance and legal context often refers to a certificate from a doctor.\n\nLet's consider the term \&quot;ì˜ë£Œì¸\&quot; (medical personnel/healthcare provider) in the context of the Medical Service Act.  Generally, \&quot;ì˜ë£Œì¸\&quot; under Korean law includes doctors (ì˜ì‚¬), dentists (ì¹˜ê³¼ì˜ì‚¬), oriental medicine doctors (í•œì˜ì‚¬), midwives (ì¡°ì‚°ì‚¬), and nurses (ê°„í˜¸ì‚¬).  However, the authority to issue a \&quot;ì§„ë‹¨ì„œ\&quot; is usually more restricted to doctors, dentists, and oriental medicine doctors, and potentially midwives within their specific domain.\n\nConsidering the options provided and the most common understanding of who issues \&quot;ì§„ë‹¨ì„œ\&quot; under the Medical Service Act,  **Dentists (ì¹˜ê³¼ì˜ì‚¬)** are definitely authorized to issue diagnosis certificates within their scope of practice (dental and oral health).  Midwives are likely authorized to issue certificates related to childbirth.  Between these two, dentists have a broader scope of issuing \&quot;ì§„ë‹¨ì„œ\&quot; beyond just pregnancy/childbirth.\n\nIf I have to choose the *most* appropriate and generally correct answer from the given options, considering \&quot;ì§„ë‹¨ì„œ\&quot; in a broader medical context,  **Dentist (ì¹˜ê³¼ì˜ì‚¬)** seems like the most fitting choice.  While midwives can issue certificates within their specialty, dentists' authority is more broadly recognized for issuing \&quot;ì§„ë‹¨ì„œ\&quot; related to health conditions within their domain.\n\nTherefore, based on common medical practice, legal context, and the nature of \&quot;ì§„ë‹¨ì„œ,\&quot;  the most appropriate answer is likely **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist)**.\n\nLet's double-check if there's any specific nuance in Korean law that might lean towards midwives more strongly than dentists for issuing \&quot;ì§„ë‹¨ì„œ.\&quot;  However, generally, dentists are unequivocally authorized to issue diagnosis certificates related to dental health.  And \&quot;ì§„ë‹¨ì„œ\&quot; in a general medical context is often associated with doctors and dentists.\n\nGiven the options and the most reasonable interpretation of \&quot;ì˜ë£Œë²•\&quot; and \&quot;ì§„ë‹¨ì„œ,\&quot;  **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist)** is the most likely and correct answer.  While midwives have a role in issuing certificates related to childbirth, dentists have a more general and broader scope of issuing \&quot;ì§„ë‹¨ì„œ\&quot; within their field of expertise.  Pharmacists, nurses, and radiographers are clearly not authorized to issue \&quot;ì§„ë‹¨ì„œ.\&quot;\n\nFinal Answer Selection:  **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist)** appears to be the most appropriate and correct answer.\n&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;**ì •ë‹µì€ D. ì¹˜ê³¼ì˜ì‚¬ìž…ë‹ˆë‹¤.**\n\n**í•´ì„¤:**\n\nã€Œì˜ë£Œë²•ã€ìƒ ì§„ë‹¨ì„œë¥¼ êµë¶€í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì€ ì˜ì‚¬, ì¹˜ê³¼ì˜ì‚¬, í•œì˜ì‚¬ìž…ë‹ˆë‹¤.  ì¡°ì‚°ì‚¬ëŠ” ì œí•œì ìœ¼ë¡œ ì¶œìƒ, ì‚¬ì‚°, ì‚¬ë§ ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆì§€ë§Œ, ì¼ë°˜ì ì¸ ì§ˆë³‘ì— ëŒ€í•œ ì§„ë‹¨ì„œëŠ” ë°œê¸‰í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤. ì•½ì‚¬, ê°„í˜¸ì‚¬, ë°©ì‚¬ì„ ì‚¬ëŠ” ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì´ ì•„ë‹™ë‹ˆë‹¤.\n\n**ê° ì„ íƒì§€ë³„ ì„¤ëª…:**\n\n* **A. ì•½ì‚¬ (è—¥å¸«):** ì•½ì‚¬ëŠ” ì˜ì•½í’ˆ ì¡°ì œ ë° ë³µì•½ ì§€ë„ ë“±ì„ ë‹´ë‹¹í•˜ëŠ” ì˜ë£Œì¸ì´ì§€ë§Œ, ì§„ë‹¨ ë° ì§„ë‹¨ì„œ ë°œê¸‰ ê¶Œí•œì€ ì—†ìŠµë‹ˆë‹¤.\n* **B. ê°„í˜¸ì‚¬ (çœ‹è­·å¸«):** ê°„í˜¸ì‚¬ëŠ” í™˜ìž ê°„í˜¸ ë° ì§„ë£Œ ë³´ì¡° ì—…ë¬´ë¥¼ ìˆ˜í–‰í•˜ì§€ë§Œ, ë…ë¦½ì ìœ¼ë¡œ ì§„ë‹¨ì„ ë‚´ë¦¬ê³  ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ê¶Œí•œì€ ì—†ìŠµë‹ˆë‹¤.\n* **C. ì¡°ì‚°ì‚¬ (åŠ©ç”£å¸«):** ì¡°ì‚°ì‚¬ëŠ” ìž„ì‚°ë¶€, í•´ì‚°ë¶€ ë° ì‹ ìƒì•„ì— ëŒ€í•œ ë³´ê±´ê³¼ ì–‘í˜¸ì§€ë„ë¥¼ í•˜ë©°, ë¶„ë§Œ ì‹œ ì§„ì°°, ë¶„ë§Œ ë³´ì¡° ë° ë¶„ë§Œ í›„ ì²˜ì¹˜ ë“±ì„ ë‹´ë‹¹í•©ë‹ˆë‹¤. ã€Œì˜ë£Œë²•ã€ ì œ28ì¡°ì— ë”°ë¼ ì¡°ì‚°ì‚¬ëŠ” ìžì‹ ì´ ë¶„ë§Œí•œ ì¶œìƒ, ì‚¬ì‚°, ë˜ëŠ” ì‚¬ë§ì˜ ì¦ëª…ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ê·¸ëŸ¬ë‚˜ ì¼ë°˜ì ì¸ ì§ˆë³‘ì— ëŒ€í•œ ì§„ë‹¨ì„œëŠ” ë°œê¸‰í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.\n* **D. ì¹˜ê³¼ì˜ì‚¬ (é½’ç§‘é†«å¸«):** ì¹˜ê³¼ì˜ì‚¬ëŠ” ì¹˜ê³¼ ì˜ë£Œë¥¼ ë‹´ë‹¹í•˜ëŠ” ì˜ë£Œì¸ìœ¼ë¡œ, ã€Œì˜ë£Œë²•ã€ìƒ ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì— í•´ë‹¹ë©ë‹ˆë‹¤. ì¹˜ê³¼ ì§ˆí™˜ì— ëŒ€í•œ ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n* **E. ë°©ì‚¬ì„ ì‚¬ (æ”¾å°„ç·šå¸«):** ë°©ì‚¬ì„ ì‚¬ëŠ” ë°©ì‚¬ì„  ì´¬ì˜ ë° ê´€ë ¨ ê¸°ìˆ  ì—…ë¬´ë¥¼ ìˆ˜í–‰í•˜ëŠ” ì˜ë£Œê¸°ì‚¬ì´ë©°, ì§„ë‹¨ ë° ì§„ë‹¨ì„œ ë°œê¸‰ ê¶Œí•œì€ ì—†ìŠµë‹ˆë‹¤.\n\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ã€Œì˜ë£Œë²•ã€ìƒ ì¼ë°˜ì ì¸ ì§„ë‹¨ì„œë¥¼ êµë¶€í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì€ ì˜ì‚¬, ì¹˜ê³¼ì˜ì‚¬, í•œì˜ì‚¬ì´ë©°, ì œì‹œëœ ì„ íƒì§€ ì¤‘ì—ì„œëŠ” ì¹˜ê³¼ì˜ì‚¬ë§Œì´ ì´ì— í•´ë‹¹ë©ë‹ˆë‹¤.**\n\n**ë”°ë¼ì„œ ì •ë‹µì€ Dìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4887,&quot;string&quot;:&quot;4,887&quot;}}},{&quot;rowIdx&quot;:16,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;paramedic_1&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2021,&quot;string&quot;:&quot;2,021&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:98,&quot;string&quot;:&quot;98&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì†Œì•„ í™˜ìží‰ê°€ ì‹œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•  ìˆ˜ ìžˆëŠ” ê²½ìš°ëŠ”?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë¶€ëª¨ê°€ ì „ê³¼ìžì¸ ê²½ìš°&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í•™ì—… ì„±ì ì´ ë‚®ì€ ê²½ìš°&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í”¼ë¶€ê°ì—¼ì´ ë°œìƒí•œ ê²½ìš°&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì†ìƒê²½ìœ„ì™€ ìž„ìƒì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì€ ê²½ìš°&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì—‰ë©ì´ë‚˜ íŒ”, ë‹¤ë¦¬ì— ëª½ê³ ë°˜ì ì´ ìžˆëŠ” ê²½ìš°&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4,&quot;string&quot;:&quot;4&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer and explanation for the Korean question about child abuse suspicion.\n\n**1. Understanding the Question:**\n\nThe question is asking about situations where child abuse should be *suspected* during a pediatric patient evaluation.  The key word here is \&quot;suspected.\&quot; It doesn't mean definitive proof, but rather indicators that should raise a red flag and warrant further investigation.\n\n**2. Analyzing Each Option (and initial thoughts):**\n\n* **A. ë¶€ëª¨ê°€ ì „ê³¼ìžì¸ ê²½ìš° (Parents with a criminal record):**\n    * **Initial thought:**  This feels discriminatory and not directly indicative of child abuse.  Having a criminal record doesn't automatically make someone an abuser.  It's a *risk factor*, but not a direct sign.\n    * **Refinement:** While statistically, individuals with certain criminal histories *might* have a higher risk, it's not a reliable indicator *in itself* to suspect abuse in a clinical setting.  We need more direct signs related to the child.  This option seems weak and possibly biased.\n\n* **B. í•™ì—… ì„±ì ì´ ë‚®ì€ ê²½ìš° (Low academic performance):**\n    * **Initial thought:**  Many factors can cause low academic performance â€“ learning disabilities, socioeconomic issues, lack of parental support, etc. Child abuse *could* be a contributing factor, but it's very non-specific.\n    * **Refinement:**  Low academic performance alone is not a strong indicator of abuse.  It's a symptom of *potential* problems, but too broad.  Abuse is a *possible* cause, but many other more likely causes exist.  This is also weak.\n\n* **C. í”¼ë¶€ê°ì—¼ì´ ë°œìƒí•œ ê²½ìš° (Skin infection):**\n    * **Initial thought:**  Skin infections are common in children.  Poor hygiene *could* be linked to neglect, which is a form of abuse. However, many skin infections are just infections, especially in young children in daycare, etc.\n    * **Refinement:**  While neglect *can* lead to skin infections, it's not a direct or reliable indicator of abuse *in general*.  Good hygiene practices vary across families and cultures.  This is also a weak indicator and too broad.\n\n* **D. ì†ìƒê²½ìœ„ì™€ ìž„ìƒì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì€ ê²½ìš° (Discrepancy between the injury explanation and clinical findings):**\n    * **Initial thought:**  This immediately stands out.  If a parent says \&quot;the child fell off the bed,\&quot; but the injuries are inconsistent with a fall from bed height (e.g., spiral fractures, multiple bruises in various stages of healing, injuries in protected areas), that's a huge red flag.  This points to a potential attempt to conceal the true cause of injury.\n    * **Refinement:**  This is a *strong* indicator.  Inconsistent stories are a classic sign of potential abuse.  It suggests someone is trying to hide what happened.  This option is very relevant to suspecting abuse.\n\n* **E. ì—‰ë©ì´ë‚˜ íŒ”, ë‹¤ë¦¬ì— ëª½ê³ ë°˜ì ì´ ìžˆëŠ” ê²½ìš° (Mongolian spots on buttocks, arms, or legs):**\n    * **Initial thought:**  Mongolian spots are common birthmarks, especially in Asian populations. They are *not* bruises and are benign.  Confusing them with bruises is a common misconception.  This option is a *distraction* and tests knowledge of normal infant skin markings vs. abuse.\n    * **Refinement:**  Mongolian spots are *normal* and *not* a sign of abuse. In fact, *mistaking* them for bruises can lead to *false* accusations of abuse.  This option is definitively *wrong* as an indicator of *suspecting* abuse. It's about *differentiating* normal findings from suspicious ones.\n\n**3. Comparing the Options and Selecting the Best Answer:**\n\n* Options A, B, and C are weak and non-specific. They are not reliable indicators for *suspecting* child abuse in a clinical setting. They might be *correlating factors* in some studies, but not direct clinical signs.\n* Option E is the opposite of an indicator of abuse; it's a normal finding that should *not* be mistaken for abuse.\n* Option D is the *strongest* and most *direct* clinical indicator of *suspecting* child abuse.  Discrepancies in the story and the physical findings are a major red flag for clinicians.\n\n**4. Formulating the Explanation:**\n\nThe explanation needs to:\n\n* Clearly state that **D is the correct answer**.\n* Explain *why* D is correct (inconsistency = suspicious).\n* Briefly explain *why* the other options are incorrect, focusing on why they are not *direct* or *reliable* indicators of *suspecting* abuse.  For E, it's important to explain what Mongolian spots are and why they are *not* bruises.\n* Use clear and concise language, suitable for someone learning about child abuse indicators.\n\n**5.  Korean Language Considerations (for the target audience):**\n\n* Ensure the explanation is in clear and grammatically correct Korean.\n* Use appropriate medical terminology in Korean (ì†ìƒê²½ìœ„, ìž„ìƒì¦ìƒ, ëª½ê³ ë°˜ì , í”¼ë¶€ê°ì—¼, í•™ì—… ì„±ì , ì „ê³¼ìž).\n* Maintain a respectful and informative tone.\n\n\nBy following these steps of analyzing each option, comparing their relevance to the question, and then constructing a clear explanation in Korean, we arrive at the correct answer (D) and the detailed explanation provided in the initial example.  The key is to focus on the *directness* and *reliability* of each option as a clinical indicator for *suspecting* child abuse.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **D. ì†ìƒê²½ìœ„ì™€ ìž„ìƒì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì€ ê²½ìš°**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nì†Œì•„ í™˜ìž í‰ê°€ ì‹œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•´ì•¼ í•˜ëŠ” ê°€ìž¥ ì¤‘ìš”í•œ ê²½ìš°ëŠ” **ì†ìƒ ê²½ìœ„ì™€ ìž„ìƒ ì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì„ ë•Œ** ìž…ë‹ˆë‹¤. ì´ëŠ” ë³´í˜¸ìžê°€ ì„¤ëª…í•˜ëŠ” ì‚¬ê³ ë‚˜ ì†ìƒì˜ ì›ì¸ê³¼ ì‹¤ì œ í™˜ìžì˜ ìƒíƒœ, ì†ìƒ ë¶€ìœ„, ì†ìƒ ì •ë„ ë“±ì´ ë§žì§€ ì•ŠëŠ” ê²½ìš°ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.  ì˜ˆë¥¼ ë“¤ì–´, \&quot;ì¹¨ëŒ€ì—ì„œ ë–¨ì–´ì¡Œë‹¤\&quot;ê³  ì„¤ëª…í•˜ì§€ë§Œ, ì•„ì´ì—ê²ŒëŠ” ë†’ì€ ê³³ì—ì„œ ì¶”ë½í•´ì•¼ ìƒê¸¸ ìˆ˜ ìžˆëŠ” ì‹¬ê°í•œ ê³¨ì ˆì´ë‚˜ ë‘ë¶€ ì†ìƒì´ ìžˆê±°ë‚˜, ì—¬ëŸ¬ ë¶€ìœ„ì— ë‹¤ì–‘í•œ ì‹œê¸°ì˜ ë©ì´ ë°œê²¬ë˜ëŠ” ê²½ìš° í•™ëŒ€ë¥¼ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n\n**ë‹¤ë¥¸ ì„ íƒì§€ ì„¤ëª…:**\n\n* **A. ë¶€ëª¨ê°€ ì „ê³¼ìžì¸ ê²½ìš°:** ë¶€ëª¨ì˜ ì „ê³¼ ê¸°ë¡ì€ ì•„ë™ í•™ëŒ€ì˜ ìœ„í—˜ ìš”ì¸ì´ ë  ìˆ˜ ìžˆì§€ë§Œ, **ì „ê³¼ ê¸°ë¡ë§Œìœ¼ë¡œ í•™ëŒ€ë¥¼ ë‹¨ì • ì§€ì„ ìˆ˜ëŠ” ì—†ìŠµë‹ˆë‹¤.**  ëª¨ë“  ì „ê³¼ìžê°€ ì•„ë™ í•™ëŒ€ìžì¸ ê²ƒì€ ì•„ë‹ˆë©°, ì „ê³¼ ê¸°ë¡ì´ ì—†ëŠ” ë¶€ëª¨ë„ í•™ëŒ€ë¥¼ ì €ì§€ë¥¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ì „ê³¼ ê¸°ë¡ì€ í•™ëŒ€ ì˜ì‹¬ì˜ **ì¶”ê°€ì ì¸ ê³ ë ¤ ì‚¬í•­**ì´ ë  ìˆ˜ ìžˆì§€ë§Œ, í•µì‹¬ì ì¸ ì˜ì‹¬ ì‚¬ìœ ëŠ” ì•„ë‹™ë‹ˆë‹¤.\n\n* **B. í•™ì—… ì„±ì ì´ ë‚®ì€ ê²½ìš°:** í•™ì—… ì„±ì  ì €í•˜ëŠ” ì•„ë™ í•™ëŒ€ì˜ ê°„ì ‘ì ì¸ ì˜í–¥ì¼ ìˆ˜ ìžˆì§€ë§Œ, **í•™ì—… ì„±ì ë§Œìœ¼ë¡œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ê¸°ëŠ” ì–´ë µìŠµë‹ˆë‹¤.**  í•™ì—… ë¶€ì§„ì˜ ì›ì¸ì€ ë‹¤ì–‘í•˜ë©° (í•™ìŠµ ìž¥ì• , ê°€ì • í™˜ê²½ ë¬¸ì œ, ë°œë‹¬ ë¬¸ì œ ë“±), í•™ëŒ€ê°€ ì•„ë‹Œ ë‹¤ë¥¸ ìš”ì¸ì¼ ê°€ëŠ¥ì„±ì´ ë” ë†’ìŠµë‹ˆë‹¤.\n\n* **C. í”¼ë¶€ê°ì—¼ì´ ë°œìƒí•œ ê²½ìš°:** í”¼ë¶€ ê°ì—¼ì€ ìœ„ìƒ ìƒíƒœ ë¶ˆëŸ‰ì´ë‚˜ ë‹¤ë¥¸ ì§ˆí™˜ìœ¼ë¡œ ì¸í•´ ë°œìƒí•  ìˆ˜ ìžˆìœ¼ë©°, **í”¼ë¶€ ê°ì—¼ë§Œìœ¼ë¡œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ê¸°ëŠ” ì–´ë µìŠµë‹ˆë‹¤.**  ë¬¼ë¡  ì‹¬ê°í•œ ë°©ìž„ì€ í”¼ë¶€ ê°ì—¼ì„ ìœ ë°œí•  ìˆ˜ ìžˆì§€ë§Œ, í”¼ë¶€ ê°ì—¼ ìžì²´ëŠ” í”í•œ ì†Œì•„ ì§ˆí™˜ìž…ë‹ˆë‹¤. ë°©ìž„ìœ¼ë¡œ ì¸í•œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ë ¤ë©´ ë‹¤ë¥¸ ì¦ìƒë“¤ê³¼ í•¨ê»˜ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤.\n\n* **E. ì—‰ë©ì´ë‚˜ íŒ”, ë‹¤ë¦¬ì— ëª½ê³ ë°˜ì ì´ ìžˆëŠ” ê²½ìš°:** ëª½ê³ ë°˜ì ì€ ë™ì–‘ì¸ì—ê²Œ í”í•˜ê²Œ ë‚˜íƒ€ë‚˜ëŠ” **ì •ìƒì ì¸ í”¼ë¶€ ë³€í™”**ì´ë©°, **í•™ëŒ€ì™€ ì „í˜€ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.**  ì˜¤ížˆë ¤ ëª½ê³ ë°˜ì ì„ ë©ìœ¼ë¡œ ì˜¤ì¸í•˜ì—¬ í•™ëŒ€ë¡œ ìž˜ëª» ì‹ ê³ ë˜ëŠ” ê²½ìš°ê°€ ìžˆìŠµë‹ˆë‹¤. ëª½ê³ ë°˜ì ì€ ì¶œìƒ ì‹œë¶€í„° ë‚˜íƒ€ë‚˜ë©°, ì‹œê°„ì´ ì§€ë‚˜ë©´ì„œ ìžì—°ì ìœ¼ë¡œ ì‚¬ë¼ì§‘ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ,** ì•„ë™ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ëŠ” ê°€ìž¥ ì¤‘ìš”í•œ ë‹¨ì„œëŠ” **ì†ìƒ ê²½ìœ„ì™€ ìž„ìƒ ì¦ìƒì˜ ë¶ˆì¼ì¹˜**ìž…ë‹ˆë‹¤.  ë‹¤ë¥¸ ì„ íƒì§€ë“¤ì€ í•™ëŒ€ì™€ ê´€ë ¨ë  ìˆ˜ ìžˆì§€ë§Œ, ì§ì ‘ì ì¸ ì˜ì‹¬ ì‚¬ìœ ëŠ” ì•„ë‹ˆë©°, ì˜¤ížˆë ¤ ì˜¤í•´ë¥¼ ë¶ˆëŸ¬ì¼ìœ¼í‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ì˜ë£Œì§„ì€ ì†ìƒ ê²½ìœ„ì™€ ìž„ìƒ ì¦ìƒì„ ë©´ë°€ížˆ ë¹„êµí•˜ê³ , ì•„ë™ì˜ ì•ˆì „ì„ ìµœìš°ì„ ìœ¼ë¡œ ê³ ë ¤í•˜ì—¬ ì‹ ì¤‘í•˜ê²Œ íŒë‹¨í•´ì•¼ í•©ë‹ˆë‹¤.&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:7159,&quot;string&quot;:&quot;7,159&quot;}}},{&quot;rowIdx&quot;:17,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;nurse&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2021,&quot;string&quot;:&quot;2,021&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:51,&quot;string&quot;:&quot;51&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í‰ë¶€ì™¸ìƒìœ¼ë¡œ í‰ë§‰ê°• ë‚´ í˜ˆì•¡ì´ ì¶•ì ë˜ì—ˆì„ ë•Œ ìš°ì„ ì ì¸ ì‚¬ì •ê²°ê³¼ëŠ”?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë§ì´ˆë¶€ì¢…&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë§ì´ˆê°ê° ì €í•˜&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê°•í•˜ê³  ëŠë¦° ë§¥ë°•&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í™˜ì¸¡ ë¶€ìœ„ íƒ€ì§„ ì‹œ ê³¼ê³µëª…ìŒ&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4,&quot;string&quot;:&quot;4&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;\nThe question is asking about the priority assessment finding when blood accumulates in the pleural space due to chest trauma. This condition is called hemothorax.  Let's analyze each option and see which one is the most relevant and indicative of hemothorax.\n\n* **Hemothorax:** Blood in the pleural space. Pleural space is the space between the visceral and parietal pleura, normally containing a small amount of lubricating fluid. Blood accumulation in this space is usually due to trauma, surgery, or sometimes spontaneously.\n\n* **Consequences of Hemothorax:**\n    * **Reduced Lung Expansion:** Blood in the pleural space takes up space, compressing the lung and preventing full expansion. This leads to impaired gas exchange and respiratory distress.\n    * **Hypovolemia (if significant blood loss):** Depending on the amount of blood lost, it can lead to hypovolemia and shock.\n\nLet's evaluate each option:\n\n* **A. ë§ì´ˆë¶€ì¢… (Peripheral edema):** Peripheral edema is usually caused by fluid overload, heart failure, kidney problems, or venous insufficiency.  It's not a primary or direct consequence of hemothorax.  While severe hypovolemic shock *could* eventually lead to kidney issues and potentially edema, it's not a *priority* finding or the most direct result.  This is unlikely to be the *primary* or *priority* finding.\n\n* **B. ë§ì´ˆê°ê° ì €í•˜ (Decreased peripheral sensation):**  Decreased peripheral sensation can be caused by various conditions, including nerve damage, circulatory problems, or certain neurological conditions.  While severe hypovolemic shock *could* lead to decreased peripheral perfusion and potentially sensory changes, it's not the *most direct* and *priority* finding related to hemothorax itself.  It's a less direct consequence compared to respiratory findings.\n\n* **C. ê°•í•˜ê³  ëŠë¦° ë§¥ë°• (Strong and slow pulse):**  A strong and slow pulse (bradycardia) is not typically associated with hemothorax.  In fact, in response to blood loss and hypovolemia (if significant), the body usually tries to compensate with an *increased* heart rate (tachycardia) to maintain cardiac output.  Bradycardia might be seen in certain situations like increased intracranial pressure, but not typically in hemothorax. This option is unlikely.\n\n* **D. ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ (Decreased breath sounds on auscultation):**  Hemothorax directly affects the lungs. Blood in the pleural space compresses the lung, preventing it from expanding properly.  When auscultating the lungs, the breath sounds over the affected area will be diminished or absent due to the reduced air movement into that part of the lung. This is a *direct* and *primary* physical finding expected in hemothorax.\n\n* **E. í™˜ì¸¡ ë¶€ìœ„ íƒ€ì§„ ì‹œ ê³¼ê³µëª…ìŒ (Hyperresonance on percussion of the affected side):**  Hyperresonance on percussion indicates increased air in the pleural space, such as in pneumothorax (air in the pleural space).  In hemothorax, the pleural space is filled with blood, which is a fluid. Fluid in the pleural space would generally lead to *dullness* or *flatness* on percussion, not hyperresonance. Hyperresonance is the opposite of what you'd expect in hemothorax.\n\n**Comparing D and others:**\n\nOption D (decreased breath sounds) is the most direct and immediate physical finding expected in hemothorax.  The other options are either less directly related, less likely, or even contradictory to the pathophysiology of hemothorax.\n\nTherefore, the most appropriate answer is D.\n\n**Final Answer Selection Process:**\n\n1. **Understand the condition:** Hemothorax = blood in the pleural space.\n2. **Consider the direct effects:** Blood occupies space, compressing the lung.\n3. **Evaluate each option based on direct effects and typical findings:**\n    * A. Peripheral edema - Indirect, less likely, not priority.\n    * B. Decreased peripheral sensation - Indirect, less likely, not priority.\n    * C. Strong and slow pulse - Contradictory to typical response to blood loss.\n    * D. Decreased breath sounds - Direct result of lung compression, primary finding.\n    * E. Hyperresonance on percussion - Opposite of what's expected in fluid accumulation.\n\n4. **Select the best fit:** Option D (decreased breath sounds) is the most direct, relevant, and priority assessment finding in hemothorax.\n\nTherefore, the answer is D.\n\nLet's translate the options and the question to English for clarity:\n\n**Question:** What is the priority assessment finding when blood accumulates in the pleural space due to chest trauma (hemothorax)?\n\nA. Peripheral edema\nB. Decreased peripheral sensation\nC. Strong and slow pulse\nD. Decreased breath sounds on auscultation\nE. Hyperresonance on percussion of the affected side\n\n**Conclusion:** The most appropriate answer is D.\n&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **D. ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\ní‰ë¶€ì™¸ìƒìœ¼ë¡œ ì¸í•´ í‰ë§‰ê°• ë‚´ì— í˜ˆì•¡ì´ ì¶•ì ë˜ëŠ” í˜ˆí‰(hemothorax)ì€ íë¥¼ ì••ë°•í•˜ì—¬ íí™œëŸ‰ì„ ê°ì†Œì‹œí‚¤ê³  ê°€ìŠ¤ êµí™˜ì„ ë°©í•´í•©ë‹ˆë‹¤.  ë”°ë¼ì„œ ê°€ìž¥ ìš°ì„ ì ìœ¼ë¡œ ë‚˜íƒ€ë‚˜ëŠ” ì‚¬ì • ê²°ê³¼ëŠ” í˜¸í¡ê¸°ê³„ ë³€í™”ì™€ ê´€ë ¨ëœ ì¦ìƒìž…ë‹ˆë‹¤.\n\nê° ì„ íƒì§€ë¥¼ ë¶„ì„í•´ ë³´ê² ìŠµë‹ˆë‹¤.\n\n* **A. ë§ì´ˆë¶€ì¢…:** ë§ì´ˆë¶€ì¢…ì€ ì£¼ë¡œ ì‹¬ë¶€ì „, ì‹ ìž¥ ì§ˆí™˜, ì •ë§¥ ë¶€ì „ ë“± ìˆœí™˜ê¸°ê³„ ë¬¸ì œì™€ ê´€ë ¨ì´ ìžˆìœ¼ë©°, í˜ˆí‰ì˜ ì§ì ‘ì ì¸ ìš°ì„  ì‚¬ì • ê²°ê³¼ëŠ” ì•„ë‹™ë‹ˆë‹¤. í˜ˆì•¡ëŸ‰ ê°ì†Œë¡œ ì¸í•´ ë°œìƒí•  ìˆ˜ ìžˆì§€ë§Œ, ìš°ì„ ì ì¸ ì¦ìƒì€ ì•„ë‹™ë‹ˆë‹¤.\n\n* **B. ë§ì´ˆê°ê° ì €í•˜:** ë§ì´ˆê°ê° ì €í•˜ëŠ” ì‹ ê²½ ì†ìƒ, ë§ì´ˆí˜ˆê´€ ì§ˆí™˜ ë“± ì‹ ê²½ê³„ ë˜ëŠ” í˜ˆê´€ ë¬¸ì œì™€ ê´€ë ¨ì´ ê¹ŠìŠµë‹ˆë‹¤. í˜ˆí‰ìœ¼ë¡œ ì¸í•œ í˜ˆì•¡ëŸ‰ ê°ì†Œë¡œ ë§ì´ˆ ìˆœí™˜ì´ ê°ì†Œí•˜ì—¬ ê°ê° ì €í•˜ê°€ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆì§€ë§Œ, í˜¸í¡ê¸°ê³„ ì¦ìƒë³´ë‹¤ ìš°ì„ ì ì¸ ì‚¬ì • ê²°ê³¼ëŠ” ì•„ë‹™ë‹ˆë‹¤.\n\n* **C. ê°•í•˜ê³  ëŠë¦° ë§¥ë°•:** ê°•í•˜ê³  ëŠë¦° ë§¥ë°• (ì„œë§¥)ì€ ì¼ë°˜ì ìœ¼ë¡œ í˜ˆí‰ê³¼ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤. ì˜¤ížˆë ¤ í˜ˆì•¡ëŸ‰ ê°ì†Œ ì‹œ ì‹¬ë°•ìˆ˜ê°€ ì¦ê°€í•˜ëŠ” ë¹ˆë§¥ì´ ë‚˜íƒ€ë‚  ê°€ëŠ¥ì„±ì´ ë†’ìŠµë‹ˆë‹¤. ì„œë§¥ì€ ë‘ê°œë‚´ì•• ìƒìŠ¹, ë¯¸ì£¼ì‹ ê²½ ìžê·¹ ë“± ë‹¤ë¥¸ ìƒí™©ì—ì„œ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n* **D. ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ:** í˜ˆí‰ìœ¼ë¡œ ì¸í•´ í‰ë§‰ê°• ë‚´ í˜ˆì•¡ì´ ì°¨ë©´ íê°€ ì••ë°•ë˜ì–´ íí¬ë¡œì˜ ê³µê¸° ì´ë™ì´ ê°ì†Œí•©ë‹ˆë‹¤.  ë”°ë¼ì„œ ì²­ì§„ ì‹œ í™˜ì¸¡ í‰ë¶€ì—ì„œ í˜¸í¡ìŒì´ ê°ì†Œí•˜ê±°ë‚˜ ì†Œì‹¤ë˜ëŠ” ê²ƒì€ í˜ˆí‰ì˜ ê°€ìž¥ ì§ì ‘ì ì´ê³  ìš°ì„ ì ì¸ ì‚¬ì • ê²°ê³¼ìž…ë‹ˆë‹¤.\n\n* **E. í™˜ì¸¡ ë¶€ìœ„ íƒ€ì§„ ì‹œ ê³¼ê³µëª…ìŒ:** ê³¼ê³µëª…ìŒì€ í‰ê°• ë‚´ ê³µê¸°ê°€ ì¦ê°€í–ˆì„ ë•Œ ë‚˜íƒ€ë‚˜ëŠ” íƒ€ì§„ìŒìœ¼ë¡œ, ê¸°í‰(pneumothorax)ì˜ íŠ¹ì§•ì ì¸ ì†Œê²¬ìž…ë‹ˆë‹¤. í˜ˆí‰ì€ í‰ê°• ë‚´ í˜ˆì•¡ì´ ì°¨ëŠ” ê²ƒì´ë¯€ë¡œ, íƒ€ì§„ ì‹œ ë‘”íƒìŒ(dullness)ì´ë‚˜ íŽ¸í‰ìŒ(flatness)ì´ ë‚˜íƒ€ë‚˜ëŠ” ê²ƒì´ ì¼ë°˜ì ìž…ë‹ˆë‹¤. ê³¼ê³µëª…ìŒì€ í˜ˆí‰ê³¼ëŠ” ë°˜ëŒ€ë˜ëŠ” ì†Œê²¬ìž…ë‹ˆë‹¤.\n\n\n**ê²°ë¡ ì ìœ¼ë¡œ, í‰ë¶€ì™¸ìƒìœ¼ë¡œ ì¸í•œ í˜ˆí‰ ì‹œ ê°€ìž¥ ìš°ì„ ì ìœ¼ë¡œ ì‚¬ì •í•´ì•¼ í•  ê²°ê³¼ëŠ” íì˜ ì••ë°•ìœ¼ë¡œ ì¸í•œ í˜¸í¡ìŒ ê°ì†Œìž…ë‹ˆë‹¤.**\n\n**ë”°ë¼ì„œ ì •ë‹µì€ Dìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2845,&quot;string&quot;:&quot;2,845&quot;}}},{&quot;rowIdx&quot;:18,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;dental_technician&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2020,&quot;string&quot;:&quot;2,020&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:73,&quot;string&quot;:&quot;73&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì˜ ì–¸ë”ì»·(undercut)ì„ ë©”ì›Œì£¼ëŠ” ê³¼ì •ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë¦´ë¦¬í”„(relief)&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë“±ê³ ì (tripoding)&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í˜•ì„± ë¸”ë¡ì•„ì›ƒ(shaped block out)&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìž„ì˜ ë¸”ë¡ì•„ì›ƒ(arbitrary block out)&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;í‰í–‰ ë¸”ë¡ì•„ì›ƒ(paralleled block out)&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down this Korean question and arrive at the correct answer.\n\n**1. Deconstructing the Question:**\n\n* **ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ (sujik bu-yeon-gyeol-jang-chi):**  This translates to \&quot;vertical minor connector.\&quot;  In dentistry, this refers to a part of a removable partial denture that connects the major connector (like a palatal bar or lingual bar) to other components like clasps or rests.  Think of it as a supporting arm extending vertically.\n\n* **ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ (jinaganeun buwi):**  \&quot;Area it passes through\&quot; or \&quot;area it crosses.\&quot;  This implies the minor connector is traversing a certain area in the mouth.\n\n* **ì–¸ë”ì»· (undercut):**  This is a crucial dental term. An undercut is a recessed area of a tooth or alveolar ridge that is *below* the height of contour. In simpler terms, it's a \&quot;cave\&quot; or \&quot;indentation\&quot; that can prevent the insertion and removal of a denture if not properly addressed.  Imagine a tooth with a bulge near the gumline; the area *below* that bulge toward the root is an undercut.\n\n* **ë©”ì›Œì£¼ëŠ” ê³¼ì • (mewo-juneun gwajeong):**  \&quot;Process of filling in\&quot; or \&quot;process of blocking out.\&quot; This indicates we need to eliminate or reduce the undercut.\n\n* **Question summary:** The question is asking for the process of filling in or eliminating undercuts in the area where a vertical minor connector of a removable partial denture will pass.  This is necessary to ensure the denture can be inserted and removed without interference or damage to the tissues.\n\n**2. Analyzing the Answer Choices:**\n\n* **A. ë¦´ë¦¬í”„ (relief):** Relief in dentistry refers to creating space *under* a denture base or connector to prevent pressure on soft tissues.  It's about *reducing* pressure, not necessarily filling undercuts.  While relief is important in denture fabrication, it's not directly related to *filling* undercuts specifically for minor connector placement. Itâ€™s more about preventing tissue impingement and ensuring proper seating.\n\n* **B. ë“±ê³ ì  (tripoding):** Tripoding is a technique used in surveying and dentistry to establish a stable and repeatable reference plane.  In dentistry, it's used on casts to orient them consistently on an articulator.  It has nothing to do with filling undercuts for minor connectors.\n\n* **C. í˜•ì„± ë¸”ë¡ì•„ì›ƒ (hyeongseong beulloka-ut):**  \&quot;Shaped block out.\&quot; Block out, in general, means to eliminate undercuts on a cast to facilitate the fabrication of a removable partial denture. \&quot;Shaped\&quot; implies a specific, contoured block out.  This sounds highly relevant to the question.  We are dealing with a specific structure (minor connector) and need a specific block out shape to accommodate it.\n\n* **D. ìž„ì˜ ë¸”ë¡ì•„ì›ƒ (imui beulloka-ut):** \&quot;Arbitrary block out.\&quot; \&quot;Arbitrary\&quot; means random or not specifically defined. While block out in general is about removing undercuts, \&quot;arbitrary\&quot; suggests a less precise or uncontrolled method.  For a vertical minor connector, which needs to be accurately positioned and have proper tissue contact, an arbitrary block out is unlikely to be the correct approach.  It might be used in simpler situations or initial blocking out before more refined steps.\n\n* **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ (pyeonghaeng beulloka-ut):** \&quot;Paralleled block out.\&quot;  Paralleled block out is done using a dental surveyor with the cast oriented on a specific path of insertion.  It aims to create parallel surfaces to guide the denture insertion and removal.  This is a more precise and controlled form of block out.  It sounds very relevant to the placement of a vertical minor connector, which needs to be properly aligned with the path of insertion and avoid interference.\n\n**3. Comparing and Contrasting C and E:**\n\nBoth \&quot;Shaped block out\&quot; and \&quot;Paralleled block out\&quot; seem related to blocking out undercuts for a minor connector. Let's refine the distinction.\n\n* **Shaped block out (C):**  Focuses on the *shape* of the block out needed to accommodate the minor connector.  This could involve creating a specific contour or form to ensure the minor connector fits smoothly and functions correctly.\n\n* **Paralleled block out (E):**  Emphasizes the *parallelism* of the block out to the path of insertion. This ensures the minor connector is aligned with the overall denture insertion path and avoids creating new undercuts or interferences during insertion/removal.\n\n**4.  Connecting to Minor Connector Function:**\n\nVertical minor connectors need to be accurately placed and have appropriate tissue contact for support, stability, and retention of the denture.  They also need to be non-interfering during insertion and removal.  Therefore, a precise and controlled block out is necessary.\n\n**5.  Choosing the Best Answer:**\n\nWhile \&quot;shaped block out\&quot; (C) is generally relevant, \&quot;paralleled block out\&quot; (E) is more specific and accurate in the context of vertical minor connectors.  Paralleled block out is performed using a surveyor and takes into account the path of insertion, which is crucial for the function and comfort of a removable partial denture.  It's a more refined and standard procedure for creating space for components like minor connectors.\n\n**6. Conclusion:**\n\nThe most appropriate answer is **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ (paralleled block out)** because it's the most precise and relevant technique for eliminating undercuts in the path of insertion for a vertical minor connector, ensuring proper denture fit and function.  While shaped block out is a broader term, paralleled block out is the more specific and technically correct method in this scenario.\n\n**Final Answer: E**&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ(paralleled block out)** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n* **ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜:** ê°€ì² ì„± êµ­ì†Œ ì˜ì¹˜(í‹€ë‹ˆ)ì˜ ì£¼ìš” ì—°ê²° ìž¥ì¹˜(ì˜ˆ: êµ¬ê°œë¶€ ì—°ê²°ìž¥ì¹˜, ì„¤ì¸¡ ì—°ê²°ìž¥ì¹˜)ì™€ ë‹¤ë¥¸ êµ¬ì„± ìš”ì†Œ(ì˜ˆ: ìœ ì§€ ìž¥ì¹˜, ì§€ì§€ ìž¥ì¹˜)ë¥¼ ì—°ê²°í•˜ëŠ” ìˆ˜ì§ìœ¼ë¡œ ë»—ì€ ìž‘ì€ ì—°ê²° ìž¥ì¹˜ìž…ë‹ˆë‹¤.\n\n* **ì–¸ë”ì»·(Undercut):** ì¹˜ì•„ë‚˜ ì¹˜ì¡°ê³¨ì˜ íŠ¹ì • ë¶€ìœ„ê°€ ê°€ìž¥ ë³¼ë¡í•œ ë¶€ë¶„(height of contour) ì•„ëž˜ë¡œ ì›€í‘¹ ë“¤ì–´ê°„ ë¶€ë¶„ìž…ë‹ˆë‹¤. ì–¸ë”ì»·ì€ ê°€ì² ì„± ì˜ì¹˜ì˜ ì‚½ìž… ë° ì œê±° ê²½ë¡œë¥¼ ë°©í•´í•˜ì—¬ ì˜ì¹˜ê°€ ì œëŒ€ë¡œ ìž¥ì°©ë˜ì§€ ëª»í•˜ê²Œ í•˜ê±°ë‚˜, ë¬´ë¦¬í•˜ê²Œ ì‚½ìž…/ì œê±° ì‹œ êµ¬ê°• ì¡°ì§ì— ì†ìƒì„ ì¤„ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n* **ë¸”ë¡ì•„ì›ƒ(Block out):**  ìž‘ì—… ëª¨í˜• ìƒì—ì„œ ì–¸ë”ì»·ì„ ì œê±°í•˜ê±°ë‚˜ ë©”ì›Œì£¼ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤. ì´ëŠ” ì˜ì¹˜ì˜ ì‚½ìž… ë° ì œê±° ê²½ë¡œë¥¼ ìš©ì´í•˜ê²Œ í•˜ê³ , ì˜ì¹˜ ì œìž‘ ê³¼ì •ì—ì„œ ë¶ˆí•„ìš”í•œ ë³€í˜•ì´ë‚˜ ì†ìƒì„ ë°©ì§€í•˜ê¸° ìœ„í•´ í•„ìˆ˜ì ìž…ë‹ˆë‹¤.\n\nì´ì œ ê° ì„ íƒì§€ë¥¼ ì‚´íŽ´ë³´ê² ìŠµë‹ˆë‹¤.\n\n* **A. ë¦´ë¦¬í”„(Relief):** ë¦´ë¦¬í”„ëŠ” ì˜ì¹˜ìƒ ë˜ëŠ” ì—°ê²° ìž¥ì¹˜ ì•„ëž˜ì— ê³µê°„ì„ ë‘ì–´ íŠ¹ì • ë¶€ìœ„ì— ì••ë ¥ì´ ì§‘ì¤‘ë˜ëŠ” ê²ƒì„ ë°©ì§€í•˜ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤. ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ê²ƒê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.\n\n* **B. ë“±ê³ ì (Tripoding):** ë“±ê³ ì ì€ ìž‘ì—… ëª¨í˜•ì„ íŠ¹ì •í•œ ìœ„ì¹˜ì— ì•ˆì •ì ìœ¼ë¡œ ê³ ì •í•˜ê³ , ëª¨í˜•ì˜ ìœ„ì¹˜ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê³¼ì •ìž…ë‹ˆë‹¤. ì–¸ë”ì»· ì œê±°ì™€ëŠ” ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n\n* **C. í˜•ì„± ë¸”ë¡ì•„ì›ƒ(Shaped block out):** í˜•ì„± ë¸”ë¡ì•„ì›ƒì€ íŠ¹ì • í˜•íƒœë¥¼ ë¶€ì—¬í•˜ì—¬ ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ë¸”ë¡ì•„ì›ƒ ë°©ë²•ìž…ë‹ˆë‹¤.  ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì— ì í•©í•  ìˆ˜ ìžˆì§€ë§Œ, ì¢€ ë” í¬ê´„ì ì¸ ê°œë…ìž…ë‹ˆë‹¤.\n\n* **D. ìž„ì˜ ë¸”ë¡ì•„ì›ƒ(Arbitrary block out):** ìž„ì˜ ë¸”ë¡ì•„ì›ƒì€ íŠ¹ë³„í•œ ê¸°ì¤€ ì—†ì´ ìž„ì˜ë¡œ ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ë°©ë²•ìž…ë‹ˆë‹¤. ì •ë°€í•œ ì˜ì¹˜ ì œìž‘ì—ëŠ” ì í•©í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n\n* **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ(Paralleled block out):** í‰í–‰ ë¸”ë¡ì•„ì›ƒì€ ì˜ì¹˜ì˜ ì‚½ìž… ë° ì œê±° ê²½ë¡œì™€ í‰í–‰í•˜ê²Œ ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ë°©ë²•ìž…ë‹ˆë‹¤.  ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ëŠ” ì˜ì¹˜ì˜ ì‚½ìž… ê²½ë¡œì™€ í‰í–‰í•˜ê²Œ ì„¤ê³„ë˜ëŠ” ê²½ìš°ê°€ ë§Žìœ¼ë¯€ë¡œ, **í‰í–‰ ë¸”ë¡ì•„ì›ƒì´ ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì˜ ì–¸ë”ì»·ì„ ë©”ì›Œì£¼ëŠ” ê°€ìž¥ ì ì ˆí•œ ê³¼ì •**ìž…ë‹ˆë‹¤.  í‰í–‰ ë¸”ë¡ì•„ì›ƒì„ í†µí•´ ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì–¸ë”ì»·ì— ê±¸ë¦¬ì§€ ì•Šê³  ì›í™œí•˜ê²Œ ì‚½ìž… ë° ì œê±°ë  ìˆ˜ ìžˆë„ë¡ ê³µê°„ì„ í™•ë³´í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì˜ ì–¸ë”ì»·ì„ ë©”ì›Œì£¼ëŠ” ê³¼ì •ì€ ì˜ì¹˜ì˜ ì‚½ìž… ê²½ë¡œë¥¼ ê³ ë ¤í•˜ì—¬ í‰í–‰í•˜ê²Œ ì–¸ë”ì»·ì„ ì œê±°í•˜ëŠ” \&quot;í‰í–‰ ë¸”ë¡ì•„ì›ƒ\&quot;ì´ ê°€ìž¥ ì í•©í•©ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4949,&quot;string&quot;:&quot;4,949&quot;}}},{&quot;rowIdx&quot;:19,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;nurse_assistant&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2022,&quot;string&quot;:&quot;2,022&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:47,&quot;string&quot;:&quot;47&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¸ì²´ì—ì„œ ë¹„íƒ€ë¯¼Dê°€ í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³ , ë„ë¥´ë…¸ì„ (ê±´ê°•ì„ )ì´ ìžˆëŠ” ê´‘ì„ ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Î±ì„ &quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Xì„ &quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì ì™¸ì„ &quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìžì™¸ì„ &quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê°€ì‹œê´‘ì„ &quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4,&quot;string&quot;:&quot;4&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to answer the question about vitamin D synthesis and the Dorno ray (health ray).\n\n**1. Understanding the Question (Korean to English and Key Terms):**\n\nThe question is in Korean and asks: \&quot;ì¸ì²´ì—ì„œ ë¹„íƒ€ë¯¼Dê°€ í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³ , ë„ë¥´ë…¸ì„ (ê±´ê°•ì„ )ì´ ìžˆëŠ” ê´‘ì„ ì€?\&quot;\n\nLet's translate and break down the key terms:\n\n* **ì¸ì²´ì—ì„œ (inche-eseo):** in the human body\n* **ë¹„íƒ€ë¯¼D (bitamin-D):** Vitamin D\n* **í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³  (hyeongseongdoerok jagyonghago):** works to form/synthesize/enable formation\n* **ë„ë¥´ë…¸ì„  (doreuno-seon):** Dorno ray (also known as *ê±´ê°•ì„ * - geon-gang-seon)\n* **(ê±´ê°•ì„ ) ((geon-gang-seon)):** (health ray) - clarification of Dorno ray\n* **ìžˆëŠ” ê´‘ì„ ì€? (inneun gwangseon-eun?):** which light ray is it?  (The \&quot;-eun\&quot; is a topic marker, and \&quot;-eun?\&quot; is a question marker)\n\nSo, the question is essentially asking:  \&quot;Which light ray acts in the human body to form Vitamin D and is also known as the Dorno ray (health ray)?\&quot;\n\n**2. Recalling Knowledge about Vitamin D and Sunlight:**\n\nMy knowledge base immediately connects vitamin D synthesis with sunlight.  I recall learning that exposure to sunlight is crucial for the body to produce vitamin D.  More specifically, I know it's a certain *type* of sunlight.\n\n**3. Considering the Options and Eliminating Incorrect Choices:**\n\nNow let's go through each option and analyze if it fits the criteria (Vitamin D synthesis and Dorno ray):\n\n* **A. Î±ì„  (alpha-seon): Î±-rays:**  Alpha rays are a type of particle radiation, not electromagnetic radiation (light). They are associated with radioactive decay.  They are *not* involved in vitamin D synthesis and are not the Dorno ray.  **Eliminate A.**\n\n* **B. Xì„  (X-seon): X-rays:** X-rays are high-energy electromagnetic radiation. They are used for medical imaging because they can penetrate soft tissues. While they are part of the electromagnetic spectrum, they are *not* the primary type of sunlight responsible for vitamin D synthesis.  X-rays are also generally considered harmful in excessive amounts and not associated with \&quot;health rays.\&quot;  **Eliminate B.**\n\n* **C. ì ì™¸ì„  (jeok-oe-seon): Infrared rays:** Infrared rays are associated with heat.  While sunlight contains infrared, it's primarily responsible for warming us.  Infrared is not directly involved in vitamin D synthesis. It is also not known as the Dorno ray. **Eliminate C.**\n\n* **D. ìžì™¸ì„  (ja-oe-seon): Ultraviolet rays:** Ultraviolet (UV) rays *are* the part of sunlight strongly linked to vitamin D synthesis. I recall learning that UVB rays, specifically, are crucial for the photochemical reaction in the skin that produces vitamin D.  The term \&quot;Dorno ray\&quot; or \&quot;health ray\&quot; is less common in modern scientific language but historically, and sometimes still, refers to UV rays, specifically the beneficial aspects. **This is a strong candidate.**\n\n* **E. ê°€ì‹œê´‘ì„  (gasi-gwangseon): Visible light:** Visible light is what we can see â€“ the colors of the rainbow.  While sunlight *contains* visible light, it's not the primary driver of vitamin D synthesis. Visible light is essential for vision and photosynthesis in plants, but not directly for vitamin D in humans in the same way UV is.  It's not the Dorno ray in the context of vitamin D and health. **Eliminate E.**\n\n**4. Confirming the Dorno Ray (ê±´ê°•ì„ ) Connection:**\n\nTo be absolutely certain, I can mentally (or actually if needed) search for \&quot;Dorno ray\&quot; or \&quot;ê±´ê°•ì„ \&quot; and \&quot;vitamin D.\&quot;  A quick search confirms that the Dorno ray, or *ê±´ê°•ì„ * (health ray), is indeed an older term referring to the beneficial UV rays, specifically those responsible for vitamin D production.  It's sometimes used in more holistic or alternative health contexts.  While not a strictly scientific term in mainstream modern science, it's historically and colloquially linked to the beneficial effects of UV.\n\n**5. Selecting the Best Answer:**\n\nBased on the above reasoning, **D. ìžì™¸ì„  (Ultraviolet rays)** is the correct answer. It is the light ray responsible for vitamin D synthesis in the human body, and it is also historically associated with the term \&quot;Dorno ray\&quot; or \&quot;health ray.\&quot;\n\n**Final Answer Selection and Confidence:**\n\nI am confident that **D. ìžì™¸ì„ ** is the correct answer.  The question is clearly designed to test knowledge of vitamin D synthesis and the historical/alternative health term \&quot;Dorno ray,\&quot; both of which point directly to ultraviolet radiation.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **D. ìžì™¸ì„ **ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n* **ë¹„íƒ€ë¯¼ D í˜•ì„±:** ìžì™¸ì„ , íŠ¹ížˆ UVBëŠ” í”¼ë¶€ì—ì„œ ë¹„íƒ€ë¯¼ Dë¥¼ í•©ì„±í•˜ëŠ” ë° í•„ìˆ˜ì ì¸ ì—­í• ì„ í•©ë‹ˆë‹¤. ìžì™¸ì„ ì´ í”¼ë¶€ì— ë‹¿ìœ¼ë©´ í”¼ë¶€ ì† 7-ë””í•˜ì´ë“œë¡œì½œë ˆìŠ¤í…Œë¡¤ì´ë¼ëŠ” ë¬¼ì§ˆì´ ë¹„íƒ€ë¯¼ D3ë¡œ ë³€í™˜ë©ë‹ˆë‹¤.\n* **ë„ë¥´ë…¸ì„  (ê±´ê°•ì„ ):** ë„ë¥´ë…¸ì„ ì€ ìžì™¸ì„ ì„ ê°€ë¦¬í‚¤ëŠ” ë‹¤ë¥¸ ì´ë¦„ìž…ë‹ˆë‹¤. ê³¼ê±°ì—ëŠ” ìžì™¸ì„ ì˜ ê±´ê°• ì¦ì§„ íš¨ê³¼ (ë¹„íƒ€ë¯¼ D í•©ì„±, ì‚´ê·  ìž‘ìš© ë“±)ë¥¼ ê°•ì¡°í•˜ë©° ë„ë¥´ë…¸ì„  ë˜ëŠ” ê±´ê°•ì„ ì´ë¼ê³  ë¶ˆë €ìŠµë‹ˆë‹¤.\n\n**ê° ì„ íƒì§€ë³„ ì„¤ëª…:**\n\n* **A. Î±ì„  (ì•ŒíŒŒì„ ):** ë°©ì‚¬ì„ ì˜ ì¼ì¢…ìœ¼ë¡œ, ì¸ì²´ íˆ¬ê³¼ë ¥ì´ ë§¤ìš° ì•½í•˜ë©° ë¹„íƒ€ë¯¼ D í•©ì„±ê³¼ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n* **B. Xì„  (ì—‘ìŠ¤ì„ ):** ë†’ì€ ì—ë„ˆì§€ë¥¼ ê°€ì§„ ì „ìžê¸°íŒŒë¡œ, ì˜ë£Œ ì˜ìƒ ì´¬ì˜ ë“±ì— ì‚¬ìš©ë˜ì§€ë§Œ ë¹„íƒ€ë¯¼ D í•©ì„±ê³¼ ê´€ë ¨ì´ ì—†ìœ¼ë©°, ê³¼ë‹¤ ë…¸ì¶œ ì‹œ ì¸ì²´ì— í•´ë¡­ìŠµë‹ˆë‹¤.\n* **C. ì ì™¸ì„  (ì €ì™¸ì„ ):** ì—´ ìž‘ìš©ì„ í•˜ëŠ” ì „ìžê¸°íŒŒë¡œ, ì˜¨ì—´ ì¹˜ë£Œ ë“±ì— ì‚¬ìš©ë˜ì§€ë§Œ ë¹„íƒ€ë¯¼ D í•©ì„±ê³¼ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.\n* **D. ìžì™¸ì„  (ìžì™¸ì„ ):** ë¹„íƒ€ë¯¼ D í•©ì„±ì— í•„ìˆ˜ì ì´ë©°, ë„ë¥´ë…¸ì„  (ê±´ê°•ì„ )ìœ¼ë¡œ ë¶ˆë¦¬ê¸°ë„ í•©ë‹ˆë‹¤. ê³¼ë‹¤ ë…¸ì¶œ ì‹œ í”¼ë¶€ì•”, í™”ìƒ ë“±ì˜ ìœ„í—˜ì´ ìžˆì§€ë§Œ ì ì ˆí•œ ì–‘ì˜ ë…¸ì¶œì€ ê±´ê°•ì— ìœ ìµí•©ë‹ˆë‹¤.\n* **E. ê°€ì‹œê´‘ì„  (ê°€ì‹œê´‘ì„ ):** ìš°ë¦¬ê°€ ëˆˆìœ¼ë¡œ ë³¼ ìˆ˜ ìžˆëŠ” ë¹›ìœ¼ë¡œ, ë¹„íƒ€ë¯¼ D í•©ì„±ì— ì§ì ‘ì ì¸ ì—­í• ì„ í•˜ì§€ëŠ” ì•ŠìŠµë‹ˆë‹¤.\n\n**ë”°ë¼ì„œ, ì¸ì²´ì—ì„œ ë¹„íƒ€ë¯¼Dê°€ í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³ , ë„ë¥´ë…¸ì„ (ê±´ê°•ì„ )ì´ ìžˆëŠ” ê´‘ì„ ì€ ìžì™¸ì„ ìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:6543,&quot;string&quot;:&quot;6,543&quot;}}},{&quot;rowIdx&quot;:20,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;dental_technician&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2019,&quot;string&quot;:&quot;2,019&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:7,&quot;string&quot;:&quot;7&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë‚©í˜•(wax pattern)ì„ ì œìž‘í•  ë•Œ ì¹˜ì•„ì˜ ìµœëŒ€ í’ìœµë¶€ê°€ ê³¼í’ìœµ (over contouring)ë  ê²½ìš°ì— ë‚˜íƒ€ë‚˜ëŠ” í˜„ìƒì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìžì •ìž‘ìš©ì´ ìž˜ëœë‹¤.&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¹˜ì£¼ì¡°ì§ì„ ê°•í™”í•œë‹¤.&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì´ ë°œìƒí•œë‹¤.&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ìƒë¦¬ì  ë§ˆì‚¬ì§€ì˜ íš¨ê³¼ê°€ ìžˆë‹¤.&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¹˜ê²½ë¶€ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì €ë¥˜ë˜ëŠ” ê²ƒì„ ë§‰ëŠ”ë‹¤.&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3,&quot;string&quot;:&quot;3&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer and explanation for the question about over-contoured wax patterns in dentistry.\n\n**1. Understanding the Question:**\n\nThe question is asking about the *consequences* of *over-contouring* the maximum convexity (greatest bulge or widest point) of a tooth when creating a wax pattern.  This is in the context of dental restorations (like crowns, bridges, etc.) where wax patterns are used to create the final prosthetic.\n\n**2. Defining Key Terms:**\n\n* **Wax Pattern (ë‚©í˜•):**  A wax replica of the tooth or teeth being restored. It's used as a mold to create the final restoration in metal, ceramic, or other materials.\n* **Maximum Convexity (ìµœëŒ€ í’ìœµë¶€):** The widest part of the tooth's crown, both buccolingually (cheek-to-tongue) and mesiodistally (front-to-back). This is crucial for proper function, esthetics, and periodontal health.\n* **Over-Contouring (ê³¼í’ìœµ):** Making the maximum convexity *too* prominent or bulging.  This means the restoration (if based on this wax pattern) will be wider than the natural tooth should be at that point.\n* **Self-Cleansing Action (ìžì •ìž‘ìš©):** The natural cleaning of the teeth by saliva, tongue, cheeks, and chewing forces.  Proper contours are essential for this.\n* **Periodontal Tissue (ì¹˜ì£¼ì¡°ì§):** The tissues surrounding and supporting the teeth: gums (gingiva), periodontal ligament, cementum, and alveolar bone.\n* **Free Gingiva (ìœ ë¦¬ì¹˜ì€):** The unattached portion of the gingiva, forming a collar around the tooth. It's the most susceptible part of the gingiva to inflammation.\n* **Physiological Massage (ìƒë¦¬ì  ë§ˆì‚¬ì§€):** The gentle stimulation of the gingiva during chewing, which promotes healthy blood circulation and keratinization of the gingiva.  Proper contours contribute to this.\n* **Food Impaction (ìŒì‹ë¬¼ ìž”ì‚¬ ì €ë¥˜):** Food getting trapped between teeth and the gingiva, often due to improper contours.\n* **Cervical Area (ì¹˜ê²½ë¶€):** The neck of the tooth, where the crown meets the root, and where the gingiva attaches.\n\n**3. Analyzing Each Answer Choice in Relation to Over-Contouring:**\n\n* **A. ìžì •ìž‘ìš©ì´ ìž˜ëœë‹¤. (Self-cleansing is good.):**  *Incorrect.* Over-contouring creates areas where saliva and the tongue can't easily reach to clean.  Food debris and plaque will accumulate more easily.  Therefore, self-cleansing will be *impaired*, not improved.\n\n* **B. ì¹˜ì£¼ì¡°ì§ì„ ê°•í™”í•œë‹¤. (Strengthens periodontal tissue.):** *Incorrect.* Over-contouring is detrimental to periodontal tissue.  It can lead to food impaction, plaque accumulation, and gingival inflammation.  It *weakens*, not strengthens, periodontal tissues.\n\n* **C. ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì´ ë°œìƒí•œë‹¤. (Inflammation occurs in the free gingiva.):** *Correct.* This is the most direct and common consequence of over-contouring. The excess contour presses on the free gingiva, creating a sheltered area for plaque and bacteria to accumulate. This leads to gingivitis (inflammation of the gingiva).\n\n* **D. ìƒë¦¬ì  ë§ˆì‚¬ì§€ì˜ íš¨ê³¼ê°€ ìžˆë‹¤. (Has the effect of physiological massage.):** *Incorrect.*  Proper contours, not over-contours, contribute to physiological massage. Over-contouring can actually hinder this natural massaging action as the tongue and cheeks may not properly stimulate the gingiva during function. Instead, it can lead to trauma from food impaction and improper forces.\n\n* **E. ì¹˜ê²½ë¶€ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì €ë¥˜ë˜ëŠ” ê²ƒì„ ë§‰ëŠ”ë‹¤. (Prevents food debris from accumulating at the cervical area.):** *Incorrect.*  Over-contouring, especially at the cervical area, actually *promotes* food impaction.  It creates ledges and areas where food can get trapped and compressed against the gingiva.  Proper contours, on the other hand, are designed to direct food away from the gingival margin.\n\n**4.  Connecting Over-Contouring to Periodontal Health (The Core Concept):**\n\nThe central theme here is the relationship between tooth contours and periodontal health.  Proper tooth contours are crucial for:\n\n* **Gingival Health:**  Allowing for proper gingival adaptation and preventing irritation.\n* **Self-Cleansing:** Facilitating natural cleaning by saliva, tongue, and cheeks.\n* **Food Deflection:** Directing food away from the gingival sulcus (the space between the tooth and gingiva).\n* **Occlusal Harmony:**  Ensuring proper bite forces and distribution.\n\nOver-contouring disrupts all of these. It leads to:\n\n* **Gingival Irritation/Inflammation:**  Direct pressure and plaque accumulation.\n* **Impaired Self-Cleansing:**  Areas difficult to clean.\n* **Food Impaction:**  Trapping food against the gingiva.\n* **Potential Occlusal Problems:**  Interference with proper bite.\n\n**5.  Formulating the Explanation:**\n\nBased on the above analysis, the correct answer is C.  The explanation should clearly articulate *why* over-contouring leads to gingival inflammation.  This involves:\n\n* **Direct Pressure:** The over-contoured area pushes against the free gingiva.\n* **Plaque Accumulation:**  The over-contour creates a protected area where plaque and bacteria thrive because self-cleansing is reduced.\n* **Gingivitis:** This plaque accumulation and irritation cause inflammation of the gingiva (gingivitis).\n\n**6.  Review and Refine:**\n\nReread the question, answer choices, and explanation to ensure everything is clear, concise, and accurate.  Confirm that the explanation directly addresses why C is correct and why the other options are incorrect.  Make sure the terminology is appropriate for a dental context.\n\nThis systematic approach, starting from understanding the question and key terms, analyzing each option, and focusing on the core concept of periodontal health and tooth contours, leads to the correct answer and a comprehensive explanation.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **C. ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì´ ë°œìƒí•œë‹¤.** ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\në‚©í˜• ì œìž‘ ì‹œ ì¹˜ì•„ì˜ ìµœëŒ€ í’ìœµë¶€ë¥¼ ê³¼í’ìœµ(over contouring)í•˜ê²Œ ë˜ë©´ ë‹¤ìŒê³¼ ê°™ì€ í˜„ìƒì´ ë‚˜íƒ€ë‚©ë‹ˆë‹¤.\n\n* **ìœ ë¦¬ì¹˜ì€ ì—¼ì¦ ë°œìƒ:** ê³¼ë„í•˜ê²Œ ë³¼ë¡í•˜ê²Œ í˜•ì„±ëœ ìµœëŒ€ í’ìœµë¶€ëŠ” ìž‡ëª¸(ìœ ë¦¬ì¹˜ì€)ì— ì••ë°•ì„ ê°€í•˜ê²Œ ë©ë‹ˆë‹¤. ì´ëŠ” ì¹˜íƒœì™€ ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì‰½ê²Œ ì¶•ì ë˜ëŠ” í™˜ê²½ì„ ì¡°ì„±í•˜ê³ , ìž‡ëª¸ì„ ìžê·¹í•˜ì—¬ ì—¼ì¦ì„ ìœ ë°œí•©ë‹ˆë‹¤. íŠ¹ížˆ ìœ ë¦¬ì¹˜ì€ì€ ì¹˜ì•„ì™€ ì§ì ‘ ë§žë‹¿ì•„ ìžˆì–´ ë”ìš± ë¯¼ê°í•˜ê²Œ ë°˜ì‘í•©ë‹ˆë‹¤.\n\n**ì˜¤ë‹µ í•´ì„¤:**\n\n* **A. ìžì •ìž‘ìš©ì´ ìž˜ëœë‹¤:** ê³¼í’ìœµì€ ì˜¤ížˆë ¤ ìžì •ìž‘ìš©ì„ ë°©í•´í•©ë‹ˆë‹¤.  ì •ìƒì ì¸ ì¹˜ì•„ í˜•íƒœëŠ” í˜€ì™€ ë³¼, ìž…ìˆ ì˜ ì›€ì§ìž„, ê·¸ë¦¬ê³  íƒ€ì•¡ì˜ íë¦„ì„ í†µí•´ ìžì—°ìŠ¤ëŸ½ê²Œ ì¹˜ì•„ê°€ ì„¸ì²™ë˜ëŠ” ìžì •ìž‘ìš©ì„ ë•ìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ê³¼í’ìœµì€ ì´ëŸ¬í•œ ìžì—°ì ì¸ ì„¸ì²™ ìž‘ìš©ì„ ì–´ë µê²Œ ë§Œë“¤ì–´ ì¹˜íƒœì™€ ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì‰½ê²Œ ì¶•ì ë©ë‹ˆë‹¤.\n\n* **B. ì¹˜ì£¼ì¡°ì§ì„ ê°•í™”í•œë‹¤:** ê³¼í’ìœµì€ ì¹˜ì£¼ì¡°ì§ì— ì˜¤ížˆë ¤ í•´ë¡œìš´ ì˜í–¥ì„ ë¯¸ì¹©ë‹ˆë‹¤. ì§€ì†ì ì¸ ì••ë°•ê³¼ ì—¼ì¦ì€ ì¹˜ì£¼ì¡°ì§ì„ ì•½í™”ì‹œí‚¤ê³ , ì¹˜ì£¼ ì§ˆí™˜ì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.\n\n* **D. ìƒë¦¬ì  ë§ˆì‚¬ì§€ì˜ íš¨ê³¼ê°€ ìžˆë‹¤:**  ì •ìƒì ì¸ ì¹˜ì•„ í˜•íƒœëŠ” ì €ìž‘ ìš´ë™ ì‹œ ìž‡ëª¸ì— ì ì ˆí•œ ìƒë¦¬ì  ë§ˆì‚¬ì§€ íš¨ê³¼ë¥¼ ì œê³µí•˜ì—¬ í˜ˆì•¡ ìˆœí™˜ì„ ì´‰ì§„í•˜ê³  ìž‡ëª¸ ê±´ê°•ì„ ìœ ì§€í•˜ëŠ” ë° ë„ì›€ì„ ì¤ë‹ˆë‹¤. í•˜ì§€ë§Œ ê³¼í’ìœµì€ ì˜¤ížˆë ¤ ìž‡ëª¸ì— ê³¼ë„í•œ ì••ë°•ì„ ê°€í•˜ê±°ë‚˜, ì •ìƒì ì¸ ìžê·¹ì„ ë°©í•´í•˜ì—¬ ìƒë¦¬ì  ë§ˆì‚¬ì§€ íš¨ê³¼ë¥¼ ì €í•´í•©ë‹ˆë‹¤.\n\n* **E. ì¹˜ê²½ë¶€ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì €ë¥˜ë˜ëŠ” ê²ƒì„ ë§‰ëŠ”ë‹¤:** ê³¼í’ìœµì€ ì˜¤ížˆë ¤ ì¹˜ê²½ë¶€(ì¹˜ì•„ì™€ ìž‡ëª¸ ê²½ê³„ ë¶€ìœ„)ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ë” ì‰½ê²Œ ì €ë¥˜ë˜ë„ë¡ ë§Œë“­ë‹ˆë‹¤. ê³¼ë„í•˜ê²Œ ëŒì¶œëœ ë¶€ìœ„ëŠ” ìŒì‹ë¬¼ì´ ê±¸ë¦¬ê¸° ì‰½ê³ , ì¹«ì†”ì§ˆë¡œë„ ê¹¨ë—í•˜ê²Œ ì œê±°í•˜ê¸° ì–´ë ¤ì›Œ ì¶©ì¹˜ë‚˜ ì¹˜ì£¼ ì§ˆí™˜ì˜ ìœ„í—˜ì„ ë†’ìž…ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ, ë‚©í˜• ì œìž‘ ì‹œ ìµœëŒ€ í’ìœµë¶€ì˜ ê³¼í’ìœµì€ ì¹˜ì£¼ ê±´ê°•ì— ë¶€ì •ì ì¸ ì˜í–¥ì„ ë¯¸ì¹˜ë©°, íŠ¹ížˆ ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì„ ìœ ë°œí•˜ëŠ” ì£¼ìš” ì›ì¸ì´ ë©ë‹ˆë‹¤.** ë”°ë¼ì„œ ë‚©í˜• ì œìž‘ ì‹œì—ëŠ” ì ì ˆí•œ ì¹˜ì•„ í˜•íƒœì™€ í’ìœµë„ë¥¼ ìž¬í˜„í•˜ëŠ” ê²ƒì´ ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:4752,&quot;string&quot;:&quot;4,752&quot;}}},{&quot;rowIdx&quot;:21,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;dental_technician&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2021,&quot;string&quot;:&quot;2,021&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:45,&quot;string&quot;:&quot;45&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¹˜ê³¼ìš© ì„ê³ ì œí’ˆ ì¤‘ ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë‚®ì€ ê²ƒì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê²½ì„ê³ &quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë³´í†µì„ê³ &quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¸ìƒìš©ì„ê³ &quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³ &quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³ &quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:3,&quot;string&quot;:&quot;3&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer to the question \&quot;ì¹˜ê³¼ìš© ì„ê³ ì œí’ˆ ì¤‘ ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë‚®ì€ ê²ƒì€?\&quot; (Among dental gypsum products, which has the lowest compressive strength?).\n\n1. **Understanding the Question:** The question is asking about the compressive strength of different types of dental gypsum.  \&quot;ê°€ìž¥ ë‚®ì€\&quot; (lowest) is the key phrase.  We need to identify the gypsum product with the *weakest* compressive strength.\n\n2. **Translating and Identifying Key Terms:**  Let's translate and understand the options:\n    * ì¹˜ê³¼ìš© ì„ê³ ì œí’ˆ (chigwa-yong seokgo-jepum): Dental gypsum products\n    * ì••ì¶•ê°•ë„ (apchuk-gangdo): Compressive strength\n    * ê°€ìž¥ ë‚®ì€ (gajang najeun): Lowest, weakest\n    * A. ê²½ì„ê³  (gyeong-seokgo):  Dental Stone (Type III) - often translated as \&quot;hard stone\&quot; or \&quot;dental stone, hard\&quot; in English.\n    * B. ë³´í†µì„ê³  (botong-seokgo): Plaster (Type II) - often translated as \&quot;model plaster\&quot; or \&quot;dental plaster\&quot;.\n    * C. ì¸ìƒìš©ì„ê³  (insang-yong seokgo): Impression Plaster (Type I) - specifically for dental impressions.\n    * D. ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (jeo-paengchang-yong cho-gyeong-seokgo): Low-expansion die stone (Type IV).  \&quot;ì´ˆê²½ì„ê³ \&quot; (cho-gyeong-seokgo) means \&quot;super hard stone\&quot; or \&quot;die stone.\&quot; \&quot;ì €íŒ½ì°½ìš©\&quot; (jeo-paengchang-yong) means \&quot;low expansion.\&quot;\n    * E. ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (go-paengchang-yong cho-gyeong-seokgo): High-expansion die stone (Type V). \&quot;ê³ íŒ½ì°½ìš©\&quot; (go-paengchang-yong) means \&quot;high expansion.\&quot;\n\n3. **Recalling Knowledge about Dental Gypsum Types:**  My knowledge base about dental materials immediately brings to mind the classification of dental gypsum products based on ADA (American Dental Association) specifications (or similar international standards).  These are categorized by type, roughly related to their strength and application:\n\n    * **Type I: Impression Plaster:**  Weakest.  Designed for taking impressions, where detail reproduction is more important than high strength.  Easy to separate from the impression.\n    * **Type II: Model Plaster:**  Slightly stronger than impression plaster. Used for study models, mounting casts on articulators, etc. Still relatively weak.\n    * **Type III: Dental Stone (or Hard Stone):** Stronger than plaster. Used for working casts, diagnostic casts, and denture bases.  More durable and resistant to abrasion than plaster.\n    * **Type IV: Die Stone (Low Expansion):**  Significantly stronger than dental stone.  High compressive strength and abrasion resistance. Low setting expansion for accurate dies used in crown and bridge fabrication.\n    * **Type V: Die Stone (High Expansion):**  Similar to Type IV in strength but with controlled, higher setting expansion to compensate for the shrinkage of certain casting alloys.\n\n4. **Relating Knowledge to the Options:** Now, let's match the options to the types and their relative strengths:\n\n    * A. ê²½ì„ê³  (Dental Stone) - Type III -  Moderate strength.\n    * B. ë³´í†µì„ê³  (Plaster) - Type II -  Weaker strength than stone.\n    * C. ì¸ìƒìš©ì„ê³  (Impression Plaster) - Type I -  Weakest strength.\n    * D. ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (Low-expansion die stone) - Type IV -  Highest strength (among these options).\n    * E. ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (High-expansion die stone) - Type V -  Highest strength (similar to Type IV, among these options).\n\n5. **Determining the Weakest:**  Based on the classification and understanding of the properties, Impression Plaster (Type I) is clearly the weakest among the given options.\n\n6. **Selecting the Answer:**  Therefore, the answer is **C. ì¸ìƒìš©ì„ê³  (Impression Plaster)**.\n\n7. **Verification (Self-Correction/Confirmation):**  To double-check, I quickly review the characteristics of each gypsum type again.  Impression plaster is indeed formulated to be weak and easily broken, facilitating removal from the mouth and model separation.  Plaster is stronger, stone stronger still, and die stones are the strongest.  The question specifically asks for the *lowest* compressive strength, so Impression Plaster fits perfectly.  The other options are all stronger gypsum products.\n\nThis systematic process of translation, recall, comparison, and verification leads confidently to the correct answer, C.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **C. ì¸ìƒìš© ì„ê³ **ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\nì¹˜ê³¼ìš© ì„ê³  ì œí’ˆì€ ìš©ë„ì— ë”°ë¼ ë‹¤ì–‘í•œ ì¢…ë¥˜ê°€ ìžˆìœ¼ë©°, ì••ì¶•ê°•ë„ëŠ” ê° ì œí’ˆì˜ ì£¼ìš” íŠ¹ì„± ì¤‘ í•˜ë‚˜ìž…ë‹ˆë‹¤. ì••ì¶•ê°•ë„ëŠ” ì„ê³ ê°€ ì••ë ¥ì— ì–¼ë§ˆë‚˜ ìž˜ ê²¬ë””ëŠ”ì§€ë¥¼ ë‚˜íƒ€ë‚´ëŠ” ì§€í‘œë¡œ, ë†’ì„ìˆ˜ë¡ ë‹¨ë‹¨í•˜ê³  ê°•í•œ ì„ê³ ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.\n\nê° ì„ê³  ì œí’ˆë³„ ì••ì¶•ê°•ë„ë¥¼ ë¹„êµí•˜ë©´ ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.\n\n* **ì¸ìƒìš© ì„ê³  (Impression Plaster):**  **ê°€ìž¥ ë‚®ì€ ì••ì¶•ê°•ë„**ë¥¼ ê°€ì§‘ë‹ˆë‹¤.  ì¸ìƒ ì±„ë“ ì‹œ êµ¬ê°• ë‚´ì—ì„œ ì‰½ê²Œ ì œê±°ë  ìˆ˜ ìžˆë„ë¡ ì•½í•˜ê²Œ ë§Œë“¤ì–´ì¡Œìœ¼ë©°, ì •ë°€í•œ ìž¬í˜„ì„±ë³´ë‹¤ëŠ” ìš©ì´í•œ ì œê±°ì— ì´ˆì ì„ ë§žì¶¥ë‹ˆë‹¤.\n\n* **ë³´í†µ ì„ê³  (Model Plaster):** ì¸ìƒìš© ì„ê³ ë³´ë‹¤ëŠ” ê°•í•˜ì§€ë§Œ, ê²½ì„ê³ ë‚˜ ì´ˆê²½ì„ê³ ë³´ë‹¤ëŠ” **ì••ì¶•ê°•ë„ê°€ ë‚®ìŠµë‹ˆë‹¤**. ì£¼ë¡œ ì§„ë‹¨ ëª¨í˜• ì œìž‘ì´ë‚˜ êµì • ëª¨í˜• ì œìž‘ ë“± ë¹„êµì  ê°•ë„ê°€ ëœ ìš”êµ¬ë˜ëŠ” ìš©ë„ì— ì‚¬ìš©ë©ë‹ˆë‹¤.\n\n* **ê²½ì„ê³  (Dental Stone):** ë³´í†µ ì„ê³ ë³´ë‹¤ **ì••ì¶•ê°•ë„ê°€ ë†’ìŠµë‹ˆë‹¤**. ìž‘ì—… ëª¨í˜•, ì™ìŠ¤ì—…, ì˜ì¹˜ìƒ ì œìž‘ ë“± ì–´ëŠ ì •ë„ ê°•ë„ê°€ í•„ìš”í•œ ìš©ë„ì— ì‚¬ìš©ë©ë‹ˆë‹¤.\n\n* **ì´ˆê²½ì„ê³  (Die Stone):**  **ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë†’ìŠµë‹ˆë‹¤**.  ì •ë°€í•œ ë³´ì² ë¬¼ ì œìž‘ì„ ìœ„í•œ ë‹¤ì´ ëª¨í˜• ì œìž‘ì— ì‚¬ìš©ë˜ë©°, ë†’ì€ ê°•ë„ì™€ ë‚´ë§ˆëª¨ì„±ì´ ìš”êµ¬ë©ë‹ˆë‹¤. ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³ ì™€ ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³  ëª¨ë‘ ê²½ì„ê³ ë³´ë‹¤ í›¨ì”¬ ë†’ì€ ì••ì¶•ê°•ë„ë¥¼ ê°€ì§‘ë‹ˆë‹¤.\n\n**ë”°ë¼ì„œ, ì¹˜ê³¼ìš© ì„ê³  ì œí’ˆ ì¤‘ ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë‚®ì€ ê²ƒì€ ì¸ìƒìš© ì„ê³ ìž…ë‹ˆë‹¤.**\n\n**ì¶”ê°€ ì„¤ëª…:**\n\n* **ì••ì¶•ê°•ë„ ìˆœì„œ (ë‚®ì€ ìˆœ -> ë†’ì€ ìˆœ):**  ì¸ìƒìš© ì„ê³  < ë³´í†µ ì„ê³  < ê²½ì„ê³  < ì´ˆê²½ì„ê³  (ì €íŒ½ì°½ìš©, ê³ íŒ½ì°½ìš©)\n\nì´ëŸ¬í•œ ì••ì¶•ê°•ë„ì˜ ì°¨ì´ëŠ” ì„ê³  ì œì¡° ê³¼ì •ì—ì„œ ì‚¬ìš©ë˜ëŠ” ì„ê³  ìž…ìžì˜ í˜•íƒœ, í¬ê¸°, ë¬¼-ì„ê³  ë¹„ìœ¨ ë“±ì— ì˜í•´ ê²°ì •ë©ë‹ˆë‹¤.\n\n**ê²°ë¡ ì ìœ¼ë¡œ ì •ë‹µì€ C ìž…ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5013,&quot;string&quot;:&quot;5,013&quot;}}},{&quot;rowIdx&quot;:22,&quot;cells&quot;:{&quot;subject&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;dental_technician&quot;},&quot;year&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2022,&quot;string&quot;:&quot;2,022&quot;},&quot;period&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:1,&quot;string&quot;:&quot;1&quot;},&quot;q_number&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5,&quot;string&quot;:&quot;5&quot;},&quot;question&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ëŠ” ì‹ ê²½ì€?&quot;},&quot;A&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ëŒ€êµ¬ê°œì‹ ê²½&quot;},&quot;B&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ë¹„êµ¬ê°œì‹ ê²½&quot;},&quot;C&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì†Œêµ¬ê°œì‹ ê²½&quot;},&quot;D&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì „ìƒì¹˜ì¡°ì‹ ê²½&quot;},&quot;E&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì¤‘ìƒì¹˜ì¡°ì‹ ê²½&quot;},&quot;answer&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:2,&quot;string&quot;:&quot;2&quot;},&quot;thinking&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;Let's break down the thought process to arrive at the correct answer for the Korean question about nerves innervating the anterior hard palate via the incisive canal.\n\n**1. Deconstructing the Question (Korean to English Translation and Key Terms)**\n\n* **ì ˆì¹˜ê³µ (jeolchi-gong):**  This translates to \&quot;incisive foramen\&quot; or \&quot;incisive canal.\&quot;  This is a crucial anatomical landmark.\n* **í†µê³¼í•˜ì—¬ (tong-gwaha-yeo):**  \&quot;Passing through\&quot; or \&quot;going through.\&quot; This indicates the nerve passes through the incisive canal.\n* **ê²½êµ¬ê°œ (gyeong-gu-gae):** \&quot;Hard palate.\&quot;  This is the area of innervation.\n* **ì „ë°© ë¶€ìœ„ (jeon-bang bu-wi):** \&quot;Anterior portion\&quot; or \&quot;front part.\&quot; This specifies the region of the hard palate.\n* **ì§€ë°°í•˜ëŠ” ì‹ ê²½ (ji-bae-ha-neun sin-gyeong):** \&quot;Nerve that innervates\&quot; or \&quot;nerve controlling.\&quot; This is asking for the nerve's name.\n* **ì‹ ê²½ (sin-gyeong):** \&quot;Nerve.\&quot;\n\n**Putting it together in English:**  \&quot;Which nerve passes through the incisive canal to innervate the anterior portion of the hard palate?\&quot;\n\n**Key Anatomical Concepts:**\n\n* **Incisive Canal/Foramen:**  A passageway in the anterior midline of the hard palate, located just behind the central incisors.  It connects the nasal cavity and the oral cavity.\n* **Hard Palate Innervation:** The hard palate is primarily innervated by branches of the maxillary nerve (V2), a branch of the trigeminal nerve (V).\n\n**2. Analyzing the Answer Choices and Eliminating Incorrect Options**\n\nLet's go through each option and consider its anatomical relevance:\n\n* **A. ëŒ€êµ¬ê°œì‹ ê²½ (dae-gu-gae sin-gyeong): Greater palatine nerve**\n    * \&quot;ëŒ€\&quot; (dae) means \&quot;large\&quot; or \&quot;greater.\&quot;\n    * \&quot;êµ¬ê°œ\&quot; (gu-gae) means \&quot;palate.\&quot;\n    * The greater palatine nerve emerges from the greater palatine foramen, located in the posterior hard palate (near the molars).  It innervates the *posterior* hard palate and gingiva.  Therefore, this is *unlikely* to be the answer as the question specifies the *anterior* hard palate.\n\n* **B. ë¹„êµ¬ê°œì‹ ê²½ (bi-gu-gae sin-gyeong): Nasopalatine nerve**\n    * \&quot;ë¹„\&quot; (bi) relates to \&quot;nose\&quot; or \&quot;nasal.\&quot;\n    * \&quot;êµ¬ê°œ\&quot; (gu-gae) means \&quot;palate.\&quot;\n    * The nasopalatine nerve is known to pass through the incisive canal/foramen. It originates from the sphenopalatine ganglion and travels along the nasal septum before entering the incisive canal to reach the anterior hard palate. This is a *strong candidate*.\n\n* **C. ì†Œêµ¬ê°œì‹ ê²½ (so-gu-gae sin-gyeong): Lesser palatine nerve**\n    * \&quot;ì†Œ\&quot; (so) means \&quot;small\&quot; or \&quot;lesser.\&quot;\n    * \&quot;êµ¬ê°œ\&quot; (gu-gae) means \&quot;palate.\&quot;\n    * The lesser palatine nerve emerges from the lesser palatine foramen, located *posterior* to the greater palatine foramen. It primarily innervates the *soft palate* and tonsillar area.  It does *not* innervate the anterior hard palate and does not pass through the incisive canal.  This is *unlikely*.\n\n* **D. ì „ìƒì¹˜ì¡°ì‹ ê²½ (jeon-sang-chi-jo sin-gyeong): Anterior superior alveolar nerve (ASA)**\n    * \&quot;ì „ìƒ\&quot; (jeon-sang) means \&quot;anterior superior.\&quot;\n    * \&quot;ì¹˜ì¡°\&quot; (chi-jo) refers to the \&quot;alveolar process\&quot; (the bone supporting the teeth).\n    * The ASA nerve innervates the anterior maxillary teeth (incisors, canines) and the *buccal* gingiva (cheek side) in the anterior maxilla. It runs within the maxillary bone and emerges onto the face. It does *not* pass through the incisive canal and primarily innervates teeth and buccal gingiva, not the palatal mucosa directly.  This is *unlikely*.\n\n* **E. ì¤‘ìƒì¹˜ì¡°ì‹ ê²½ (jung-sang-chi-jo sin-gyeong): Middle superior alveolar nerve (MSA)**\n    * \&quot;ì¤‘ìƒ\&quot; (jung-sang) means \&quot;middle superior.\&quot;\n    * \&quot;ì¹˜ì¡°\&quot; (chi-jo) refers to the \&quot;alveolar process.\&quot;\n    * The MSA nerve innervates the premolars, and sometimes the mesiobuccal root of the maxillary first molar, along with the buccal gingiva in the premolar region.  Like the ASA, it runs within the maxillary bone and doesn't pass through the incisive canal to innervate the hard palate.  This is *unlikely*.\n\n**3. Confirmation and Conclusion**\n\nBased on the anatomical knowledge and elimination process:\n\n* **Nasopalatine nerve (ë¹„êµ¬ê°œì‹ ê²½)** is the only nerve that correctly matches the description of passing through the incisive canal and innervating the anterior hard palate.\n\nTherefore, the answer is **B. ë¹„êµ¬ê°œì‹ ê²½**.\n\n**Final Answer Justification (in Korean, as requested):**\n\nì ˆì¹˜ê³µì€ ê²½êµ¬ê°œì˜ ì „ë°© ì¤‘ì•™ë¶€ì— ìœ„ì¹˜í•˜ë©°, ë¹„êµ¬ê°œì‹ ê²½ì´ ì´ êµ¬ë©ì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„, íŠ¹ížˆ ì•žë‹ˆ ë¶€ìœ„ì˜ ì ë§‰ê³¼ ê³¨ë§‰ì„ ì§€ë°°í•©ë‹ˆë‹¤.  ëŒ€êµ¬ê°œì‹ ê²½ì€ í›„ë°© ê²½êµ¬ê°œë¥¼, ì†Œêµ¬ê°œì‹ ê²½ì€ ì—°êµ¬ê°œë¥¼ ì§€ë°°í•˜ë©°, ìƒì¹˜ì¡°ì‹ ê²½ë“¤ì€ ì¹˜ì•„ì™€ ì¹˜ì¡°ê³¨, ê·¸ë¦¬ê³  ëº¨ìª½ ìž‡ëª¸ì„ ì§€ë°°í•©ë‹ˆë‹¤. ë”°ë¼ì„œ ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ëŠ” ì‹ ê²½ì€ ë¹„êµ¬ê°œì‹ ê²½ì´ ê°€ìž¥ ì ì ˆí•©ë‹ˆë‹¤.&quot;},&quot;response&quot;:{&quot;kind&quot;:&quot;string&quot;,&quot;value&quot;:&quot;ì •ë‹µì€ **B. ë¹„êµ¬ê°œì‹ ê²½**ìž…ë‹ˆë‹¤.\n\n**í•´ì„¤:**\n\n* **ì ˆì¹˜ê³µ (Incisive foramen):**  ê²½êµ¬ê°œì˜ ì •ì¤‘ì„ , ì•žë‹ˆ ë°”ë¡œ ë’¤ì— ìœ„ì¹˜í•œ êµ¬ë©ìž…ë‹ˆë‹¤.\n* **ë¹„êµ¬ê°œì‹ ê²½ (Nasopalatine nerve):**  ì ‘í˜•êµ¬ê°œì‹ ê²½ì ˆì—ì„œ ê¸°ì›í•˜ì—¬ ë¹„ê°•ì„ í†µí•´ ë‚´ë ¤ì™€ ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„, íŠ¹ížˆ ì•žë‹ˆ ë¶€ìœ„ì˜ ì ë§‰ê³¼ ê³¨ë§‰ì„ ì§€ë°°í•˜ëŠ” ê°ê° ì‹ ê²½ìž…ë‹ˆë‹¤.\n\n**ë‹¤ë¥¸ ì„ íƒì§€ ì„¤ëª…:**\n\n* **A. ëŒ€êµ¬ê°œì‹ ê²½ (Greater palatine nerve):**  ëŒ€êµ¬ê°œê³µì„ í†µí•´ ê²½êµ¬ê°œë¡œ ë‚˜ì™€ êµ¬ì¹˜ ë¶€ìœ„ì˜ ê²½êµ¬ê°œ ì ë§‰ê³¼ ìž‡ëª¸ì„ ì§€ë°°í•©ë‹ˆë‹¤. ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì§€ ì•Šìœ¼ë©° ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n* **C. ì†Œêµ¬ê°œì‹ ê²½ (Lesser palatine nerve):**  ì†Œêµ¬ê°œê³µì„ í†µí•´ ë‚˜ì™€ ì—°êµ¬ê°œì™€ íŽ¸ë„ ë¶€ìœ„ë¥¼ ì§€ë°°í•©ë‹ˆë‹¤. ê²½êµ¬ê°œë¥¼ ì§€ë°°í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n* **D. ì „ìƒì¹˜ì¡°ì‹ ê²½ (Anterior superior alveolar nerve):**  ìƒì•…ë™ ì „ë²½ ë‚´ì—ì„œ ì£¼í–‰í•˜ë©° ìƒì•… ì „ì¹˜ì™€ ê²¬ì¹˜, ê·¸ë¦¬ê³  í•´ë‹¹ ë¶€ìœ„ì˜ ëº¨ìª½ ìž‡ëª¸ê³¼ ìƒì•…ë™ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•©ë‹ˆë‹¤. ê²½êµ¬ê°œë¥¼ ì§ì ‘ ì§€ë°°í•˜ì§€ ì•Šìœ¼ë©° ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n* **E. ì¤‘ìƒì¹˜ì¡°ì‹ ê²½ (Middle superior alveolar nerve):**  ìƒì•…ë™ ì™¸ë²½ ë‚´ì—ì„œ ì£¼í–‰í•˜ë©° ìƒì•… ì†Œêµ¬ì¹˜ì™€ ì œ1ëŒ€êµ¬ì¹˜ì˜ ê·¼ì‹¬í˜‘ì¸¡ì¹˜ê·¼, ê·¸ë¦¬ê³  í•´ë‹¹ ë¶€ìœ„ì˜ ëº¨ìª½ ìž‡ëª¸ê³¼ ìƒì•…ë™ ì¸¡ë²½ ë¶€ìœ„ë¥¼ ì§€ë°°í•©ë‹ˆë‹¤. ê²½êµ¬ê°œë¥¼ ì§ì ‘ ì§€ë°°í•˜ì§€ ì•Šìœ¼ë©° ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n\n**ë”°ë¼ì„œ ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ëŠ” ì‹ ê²½ì€ ë¹„êµ¬ê°œì‹ ê²½ì´ ê°€ìž¥ ì •í™•í•©ë‹ˆë‹¤.**&quot;},&quot;__index_level_0__&quot;:{&quot;kind&quot;:&quot;number&quot;,&quot;value&quot;:5135,&quot;string&quot;:&quot;5,135&quot;}}}],&quot;truncated&quot;:true},&quot;paginationData&quot;:{&quot;pageIndex&quot;:0,&quot;numItemsPerPage&quot;:100,&quot;numTotalItems&quot;:8751,&quot;offset&quot;:0,&quot;length&quot;:100}},&quot;jwt&quot;:&quot;eyJhbGciOiJFZERTQSJ9.eyJyZWFkIjp0cnVlLCJwZXJtaXNzaW9ucyI6eyJyZXBvLmNvbnRlbnQucmVhZCI6dHJ1ZX0sImlhdCI6MTc0MjkxODU5NSwic3ViIjoiL2RhdGFzZXRzL0NodUd5b3VrL21lZGljYWwtbzEtdHJhaW4ta29ybWVkbWNxYSIsImV4cCI6MTc0MjkyMjE5NSwiaXNzIjoiaHR0cHM6Ly9odWdnaW5nZmFjZS5jbyJ9.g808faITaKa-pthwVwEDvQiTnhFE-F3DXBvuwxgcS-G0noSf5EX_9TjNaEoxLe-Pnrn8vbE91HdDdvAeKzL-Dw&quot;,&quot;displayUrls&quot;:true},&quot;dataset&quot;:&quot;ChuGyouk/medical-o1-train-kormedmcqa&quot;,&quot;isGated&quot;:false,&quot;isPrivate&quot;:false,&quot;hasParquetFormat&quot;:true,&quot;author&quot;:{&quot;_id&quot;:&quot;64ad53921db46d71a5c576e5&quot;,&quot;avatarUrl&quot;:&quot;https://cdn-avatars.huggingface.co/v1/production/uploads/64ad53921db46d71a5c576e5/fH08R-GANVBhZdYCDQjeG.png&quot;,&quot;fullname&quot;:&quot;ChuGyouk&quot;,&quot;name&quot;:&quot;ChuGyouk&quot;,&quot;type&quot;:&quot;user&quot;,&quot;isPro&quot;:true,&quot;isHf&quot;:false,&quot;isHfAdmin&quot;:false,&quot;isMod&quot;:false,&quot;followerCount&quot;:21},&quot;compact&quot;:true}"><div class="flex flex-col overflow-hidden shadow-xs mx-auto mb-10 rounded-lg border pt-2  px-2.5"><div class="mb-2 flex flex-wrap items-center gap-2"><div class="mr-auto flex items-center"><svg class="mr-1 flex-none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 12 12"><path fill="currentColor" d="M2.5 2h7a1 1 0 0 1 1 1v6a1 1 0 0 1-1 1h-7a1 1 0 0 1-1-1V3a1 1 0 0 1 1-1Zm0 2v2h3V4h-3Zm4 0v2h3V4h-3Zm-4 3v2h3V7h-3Zm4 0v2h3V7h-3Z"></path></svg>
	<div class="whitespace-nowrap font-semibold">Dataset Viewer</div>
	</div>
				<a href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/tree/refs%2Fconvert%2Fparquet/default" class="group mr-1 text-xs text-gray-400 max-sm:hidden"><svg class="text-[.6rem] mr-1 inline -translate-y-px" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path fill="currentColor" d="M12 10H6.78A11 11 0 0 1 27 16h2A13 13 0 0 0 6 7.68V4H4v8h8zm8 12h5.22A11 11 0 0 1 5 16H3a13 13 0 0 0 23 8.32V28h2v-8h-8z"></path></svg>
						<span class="underline decoration-gray-300 group-hover:decoration-gray-400 dark:decoration-gray-500 dark:group-hover:decoration-gray-300">Auto-converted</span> to Parquet
					</a>
				<button class="btn shadow-xs flex cursor-pointer items-center rounded-sm border px-1 py-0.5 text-xs font-normal text-gray-700 hover:text-gray-800 hover:shadow-inner dark:hover:text-gray-200"><svg class="mr-1.5" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32" style="transform: rotate(360deg);"><path d="M31 16l-7 7l-1.41-1.41L28.17 16l-5.58-5.59L24 9l7 7z" fill="currentColor"></path><path d="M1 16l7-7l1.41 1.41L3.83 16l5.58 5.59L8 23l-7-7z" fill="currentColor"></path><path d="M12.419 25.484L17.639 6l1.932.518L14.35 26z" fill="currentColor"></path></svg>API</button>
					<button class="btn shadow-xs flex cursor-pointer items-center rounded-sm border px-1 py-0.5 text-xs font-normal text-gray-700 hover:text-gray-800 hover:shadow-inner dark:hover:text-gray-200"><svg class="mr-1.5" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" fill="currentColor" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 12 12"><path d="M9.80603 2.86737H3.56107C3.37704 2.86737 3.20055 2.94048 3.07042 3.0706C2.94029 3.20073 2.86719 3.37723 2.86719 3.56126V9.80622C2.86719 9.99025 2.94029 10.1667 3.07042 10.2969C3.20055 10.427 3.37704 10.5001 3.56107 10.5001H9.80603C9.99006 10.5001 10.1666 10.427 10.2967 10.2969C10.4268 10.1667 10.4999 9.99025 10.4999 9.80622V3.56126C10.4999 3.37723 10.4268 3.20073 10.2967 3.0706C10.1666 2.94048 9.99006 2.86737 9.80603 2.86737Z" fill="currentColor" fill-opacity="0.3"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M2.40942 1.66191C2.05175 1.66191 1.7618 1.95186 1.7618 2.30953V6.76191H1.43799V2.30953C1.43799 1.77303 1.87291 1.3381 2.40942 1.3381H6.45704V1.66191H2.40942Z" fill="currentColor"></path></svg>Embed</button>

					<button class="bg-linear-to-b shadow-xs flex items-center gap-1.5 rounded-full border from-white to-red-100/90 px-2 py-0.5 text-xs font-medium text-[#2D3648] transition-shadow hover:shadow-inner dark:from-gray-900 dark:to-red-800/30 dark:text-gray-100 dark:hover:shadow-inner dark:hover:shadow-red-800/30" ><svg class="h-3.5 w-3.5 text-red-500" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 12 12"><path fill="currentColor" d="M2.5 2h7a1 1 0 0 1 1 1v6a1 1 0 0 1-1 1h-7a1 1 0 0 1-1-1V3a1 1 0 0 1 1-1Zm0 2v2h3V4h-3Zm4 0v2h3V4h-3Zm-4 3v2h3V7h-3Zm4 0v2h3V7h-3Z"></path></svg>
						<span>Data Studio</span></button></div>
		<div class="flex flex-1 flex-col overflow-hidden -mx-2.5"><div class="flex flex-1 flex-col overflow-hidden"><div class="flex min-h-0 flex-1"><div class="flex flex-1 flex-col overflow-hidden"><div class="md:-mx-2.5 flex min-w-0 flex-wrap border-t"><div class="flex min-w-0 flex-1 flex-wrap"><div class="grid flex-1 grid-cols-1 overflow-hidden text-sm md:grid-cols-2 md:place-content-center sm:mx-2.5"><label class="relative block flex-1 px-3 py-2 hover:bg-gray-50 dark:border-gray-850 dark:hover:bg-gray-950 md:border-r md:border-r-0 hidden" title="default"><span class="text-gray-500">Subset (1)</span>
			<div class="flex items-center whitespace-nowrap"><span class="truncate">default</span>
				<span class="mx-2 text-gray-500">Â·</span>
					<span class="text-gray-500">8.75k rows</span>
				<svg class="ml-auto min-w-6 pl-2" width="1em" height="1em" viewBox="0 0 12 7" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M1 1L6 6L11 1" stroke="currentColor"></path></svg></div>
			<select class="absolute inset-0 z-10 w-full cursor-pointer border-0 bg-white text-base opacity-0"><optgroup label="Subset (1)"><option value="default" selected>default (8.75k rows)</option></optgroup></select></label>
		<label class="relative block flex-1 px-3 py-2 hover:bg-gray-50 dark:border-gray-850 dark:hover:bg-gray-900 md:border-r md:border-r" title="train"><div class="text-gray-500">Split (1)</div>
				<div class="flex items-center overflow-hidden whitespace-nowrap"><span class="truncate">train</span>
					<span class="mx-2 text-gray-500">Â·</span>
						<span class="text-gray-500">8.75k rows</span>
					<svg class="ml-auto min-w-6 pl-2" width="1em" height="1em" viewBox="0 0 12 7" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M1 1L6 6L11 1" stroke="currentColor"></path></svg></div>
				<select class="absolute inset-0 z-10 w-full cursor-pointer border-0 bg-white text-base opacity-0"><optgroup label="Split (1)"><option value="train" selected>train (8.75k rows)</option></optgroup></select></label></div></div>
								</div>

							<div class="flex min-h-0 flex-1 flex-col ">
	<div class="bg-linear-to-r text-smd relative flex items-center dark:border-gray-900 dark:bg-gray-950 false border-t [&amp;:has(:focus)]:from-gray-50 [&amp;:has(:focus)]:to-transparent [&amp;:has(:focus)]:to-20% dark:[&amp;:has(:focus)]:from-gray-900"><form class="flex-1"><svg class="absolute left-3 top-1/2 transform -translate-y-1/2 pointer-events-none text-gray-400" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M30 28.59L22.45 21A11 11 0 1 0 21 22.45L28.59 30zM5 14a9 9 0 1 1 9 9a9 9 0 0 1-9-9z" fill="currentColor"></path></svg>
				<input disabled class="outline-hidden h-9 w-full border-none bg-transparent px-1 pl-9 pr-3 placeholder:text-gray-400 " placeholder="Search this dataset" dir="auto"></form>
			<div class="flex items-center gap-2 px-2 py-1"><button type="button" class="hover:bg-yellow-200/70 flex items-center gap-1 rounded-md border border-yellow-200 bg-yellow-100 pl-0.5 pr-1 text-[.8rem] leading-normal text-gray-700 dark:border-orange-500/25 dark:bg-orange-500/20 dark:text-gray-300 dark:hover:brightness-110 hidden"><div class="rounded-sm bg-yellow-300 px-1 font-mono text-[.7rem] font-bold text-black dark:bg-yellow-700 dark:text-gray-200">SQL
	</div>
	Console
</button></div></div>


<div class="flex flex-1 flex-col overflow-hidden min-h-64 border-t">
		

<div class="max-h-96 relative overflow-auto"><table class="w-full table-auto rounded-lg font-mono text-xs text-gray-900"><thead class="shadow-xs sticky left-0 right-0 top-0 z-1 bg-white align-top"><tr class="space-y-54 h-full min-w-fit divide-x border-b text-left"><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">subject
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">classes</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><defs><clipPath id="rounded-bar"><rect x="0" y="0" width="130" height="8" rx="4"></rect></clipPath><pattern id="hatching" patternUnits="userSpaceOnUse" patternTransform="rotate(-45)" height="1" width="5"><line y1="0" class="stroke-gray-400 dark:stroke-gray-500/80" stroke-width="3" y2="1" x1="2" x2="2"></line></pattern><pattern id="hatching-faded" patternUnits="userSpaceOnUse" patternTransform="rotate(-45)" height="1" width="5"><line y1="0" class="stroke-gray-100 dark:stroke-gray-500/20" stroke-width="3" y2="1" x1="2" x2="2"></line></pattern></defs><g height="8" style="transform: translateY(20px)" clip-path="url(#rounded-bar)"><g style="transform: scaleX(1.0153846153846153) translateX(-1px)"><g><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="1" y="0" width="25.853959547480287" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="28.853959547480287" y="0" width="12.513769854873729" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="43.367729402354016" y="0" width="11.191635241686663" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="56.55936464404068" y="0" width="10.879670894754886" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="69.43903553879557" y="0" width="10.537995657639128" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="81.9770311964347" y="0" width="10.18146497543138" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="94.15849617186608" y="0" width="10.136898640155412" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="106.29539481202148" y="0" width="8.11655810764484" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="116.41195291966632" y="0" width="5.635698777282597" height="8" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" x="124.04765169694892" y="0" width="4.95234830305108" height="8" fill-opacity="1"></rect></g></g></g><g style="transform: scaleX(1.0153846153846153) translateX(-1px)"><g><rect class="fill-white cursor-pointer" x="0" y="0" width="27.853959547480287" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="27.853959547480287" y="0" width="14.513769854873729" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="42.367729402354016" y="0" width="13.191635241686663" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="55.55936464404068" y="0" width="12.879670894754886" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="68.43903553879557" y="0" width="12.537995657639128" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="80.9770311964347" y="0" width="12.18146497543138" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="93.15849617186608" y="0" width="12.136898640155412" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="105.29539481202148" y="0" width="10.11655810764484" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="115.41195291966632" y="0" width="7.635698777282597" height="28" fill-opacity="0"></rect><rect class="fill-white cursor-pointer" x="123.04765169694892" y="0" width="6.95234830305108" height="28" fill-opacity="0"></rect></g></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 max-w-full overflow-hidden text-ellipsis whitespace-nowrap">10
				values</div></div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">year
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>int64</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="0" y="22.271428571428572" width="16.857142857142858" height="7.728571428571429" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="18.857142857142858" y="22.885714285714286" width="16.857142857142858" height="7.114285714285714" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="37.714285714285715" y="23.55" width="16.857142857142858" height="6.45" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="56.57142857142857" y="14.757142857142858" width="16.857142857142858" height="15.242857142857142" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="75.42857142857143" y="0" width="16.857142857142858" height="30" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="94.28571428571429" y="10.7" width="16.857142857142858" height="19.3" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="113.14285714285714" y="25" width="16.857142857142858" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="17.857142857142858" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="36.714285714285715" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="55.57142857142857" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="74.42857142857143" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="93.28571428571429" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="112.14285714285714" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">2.01k</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">2.02k</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">period
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>int64</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="0" y="0" width="16.857142857142858" height="30" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="18.857142857142858" y="6.277053975006648" width="16.857142857142858" height="23.72294602499335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="37.714285714285715" y="18.969423025791013" width="16.857142857142858" height="11.030576974208987" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="56.57142857142857" y="21.87981919702207" width="16.857142857142858" height="8.12018080297793" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="75.42857142857143" y="23.829300717894178" width="16.857142857142858" height="6.170699282105823" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="94.28571428571429" y="24.80404147833023" width="16.857142857142858" height="5.195958521669769" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="113.14285714285714" y="25" width="16.857142857142858" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="17.857142857142858" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="36.714285714285715" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="55.57142857142857" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="74.42857142857143" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="93.28571428571429" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="112.14285714285714" y="0" width="18.857142857142858" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">7</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">q_number
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>int64</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="0" y="1.110552763819097" width="11.2" height="28.889447236180903" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="13.2" y="2.2646566164154116" width="11.2" height="27.73534338358459" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="26.4" y="1.676716917922949" width="11.2" height="28.32328308207705" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="39.599999999999994" y="0.9363484087102165" width="11.2" height="29.063651591289783" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="52.8" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="66" y="1.8944723618090435" width="11.2" height="28.105527638190956" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="79.19999999999999" y="7.142378559463985" width="11.2" height="22.857621440536015" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="92.39999999999999" y="11.758793969849247" width="11.2" height="18.241206030150753" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="105.6" y="18.378559463986598" width="11.2" height="11.6214405360134" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="118.8" y="24.279731993299833" width="11.2" height="5.720268006700167" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">120</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">question
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="13.2" y="15.203879571630633" width="11.2" height="14.796120428369367" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="26.4" y="21.870680945645585" width="11.2" height="8.129319054354415" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="39.599999999999994" y="23.935340472822794" width="11.2" height="6.0646595271772075" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="52.8" y="24.60779955546575" width="11.2" height="5.392200444534249" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="66" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="79.19999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="92.39999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="105.6" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="118.8" y="25" width="11.2" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">646</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">A
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="13.2" y="15.844195742813254" width="11.2" height="14.155804257186746" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="26.4" y="17.932411674347158" width="11.2" height="12.067588325652842" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="39.599999999999994" y="22.046082949308754" width="11.2" height="7.953917050691244" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="52.8" y="24.870309414088215" width="11.2" height="5.129690585911784" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="66" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="79.19999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="92.39999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="105.6" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="118.8" y="25" width="11.2" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">57</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">B
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="0" width="12.666666666666666" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="14.666666666666666" y="15.623853211009175" width="12.666666666666666" height="14.376146788990825" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="29.333333333333332" y="17.992910758965806" width="12.666666666666666" height="12.007089241034196" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="44" y="23.701417848206837" width="12.666666666666666" height="6.298582151793161" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="58.666666666666664" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="73.33333333333333" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="88" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="102.66666666666666" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="117.33333333333333" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="13.666666666666666" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="28.333333333333332" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="43" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="57.666666666666664" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="72.33333333333333" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="87" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="101.66666666666666" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="116.33333333333333" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">71</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">C
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="0" width="12.666666666666666" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="14.666666666666666" y="15.066697121973505" width="12.666666666666666" height="14.933302878026495" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="29.333333333333332" y="16.57514846962083" width="12.666666666666666" height="13.424851530379168" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="44" y="21.884422110552762" width="12.666666666666666" height="8.115577889447236" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="58.666666666666664" y="24.89538602101416" width="12.666666666666666" height="5.104613978985839" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="73.33333333333333" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="88" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="102.66666666666666" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="117.33333333333333" y="25" width="12.666666666666666" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="13.666666666666666" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="28.333333333333332" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="43" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="57.666666666666664" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="72.33333333333333" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="87" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="101.66666666666666" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="116.33333333333333" y="0" width="14.666666666666666" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">72</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">D
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="13.2" y="13.121118012422361" width="11.2" height="16.87888198757764" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="26.4" y="15.375258799171842" width="11.2" height="14.624741200828158" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="39.599999999999994" y="19.917184265010352" width="11.2" height="10.082815734989648" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="52.8" y="23.638198757763973" width="11.2" height="6.361801242236025" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="66" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="79.19999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="92.39999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="105.6" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="118.8" y="25" width="11.2" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">77</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">E
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="13.2" y="12.7424206254476" width="11.2" height="17.2575793745524" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="26.4" y="16.261637622344235" width="11.2" height="13.738362377655765" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="39.599999999999994" y="22.033898305084747" width="11.2" height="7.966101694915254" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="52.8" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="66" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="79.19999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="92.39999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="105.6" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="118.8" y="25" width="11.2" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">101</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">answer
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>int64</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="0" y="5.15668922436231" width="24.4" height="24.84331077563769" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="26.4" y="3.20770432066632" width="24.4" height="26.79229567933368" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="52.8" y="2.260281103591879" width="24.4" height="27.73971889640812" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="79.19999999999999" y="0.9338885996876627" width="24.4" height="29.066111400312337" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="105.6" y="0" width="24.4" height="30" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="26.4" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="26.4" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="26.4" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="26.4" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="26.4" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">1</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">5</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">thinking
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="22.894602479941646" width="11.2" height="7.105397520058352" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="13.2" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="26.4" y="15.190371991247265" width="11.2" height="14.809628008752735" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="39.599999999999994" y="24.86214442013129" width="11.2" height="5.137855579868709" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="52.8" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="66" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="79.19999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="92.39999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="105.6" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="118.8" y="25" width="11.2" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">646</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">27.8k</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">response
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>string</span><span class="italic text-gray-400 before:mx-1 before:content-['Â·']">lengths</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="0" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="13.2" y="22.16020025031289" width="11.2" height="7.839799749687109" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="26.4" y="3.84793491864831" width="11.2" height="26.15206508135169" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="39.599999999999994" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="52.8" y="14.13892365456821" width="11.2" height="15.86107634543179" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="66" y="21.37922403003755" width="11.2" height="8.620775969962452" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="79.19999999999999" y="24.397371714643306" width="11.2" height="5.602628285356696" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="92.39999999999999" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="105.6" y="25" width="11.2" height="5" fill-opacity="1"></rect><rect class="fill-gray-400 dark:fill-gray-500/80" rx="2" x="118.8" y="25" width="11.2" height="5" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">105</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">3.33k</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th><th class="h-full max-w-sm p-2 text-left  relative w-auto"><div class="flex h-full flex-col flex-nowrap justify-between"><div><div class="flex items-center justify-between">__index_level_0__
				<form class="flex flex-col"><button id="asc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="-rotate-180 transform text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button>
						<button id="desc" class="-mr-1 ml-2 h-[0.4rem] w-[0.8rem] transition ease-in-out"><svg class="text-gray-300 hover:text-gray-500" xmlns="http://www.w3.org/2000/svg" viewBox="0 64 256 128" fill="currentColor" aria-hidden="true"><path d="M213.65674,101.657l-80,79.99976a7.99945,7.99945,0,0,1-11.31348,0l-80-79.99976A8,8,0,0,1,48,88H208a8,8,0,0,1,5.65674,13.657Z"></path></svg></button></form></div>

			<div class="mb-2 whitespace-nowrap text-xs font-normal text-gray-500"><span>int64</span></div></div>

		<div><div class="" style="height: 40px; padding-top: 2px"><svg width="130" height="28"><g><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="0" y="0" width="11.2" height="30" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="13.2" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="26.4" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="39.599999999999994" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="52.8" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="66" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="79.19999999999999" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="92.39999999999999" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="105.6" y="8.52012882447665" width="11.2" height="21.47987117552335" fill-opacity="1"></rect><rect class="fill-indigo-500 dark:fill-indigo-600/80" rx="2" x="118.8" y="8.645732689210949" width="11.2" height="21.35426731078905" fill-opacity="1"></rect></g><rect class="fill-white dark:fill-gray-900" x="0" y="26" width="130" height="2" stroke-opacity="1"></rect><line class="stroke-gray-100 dark:stroke-gray-500/20" x1="0" y1="27.5" x2="130" y2="27.5" stroke-opacity="1"></line><g><rect class="fill-indigo-500 cursor-pointer" x="-1" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="12.2" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="25.4" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="38.599999999999994" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="51.8" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="65" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="78.19999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="91.39999999999999" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="104.6" y="0" width="13.2" height="30" fill-opacity="0"></rect><rect class="fill-indigo-500 cursor-pointer" x="117.8" y="0" width="13.2" height="30" fill-opacity="0"></rect></g></svg>
	<div class="relative font-light text-gray-400" style="height: 10px; width: 130px;"><div class="absolute left-0 overflow-hidden text-ellipsis whitespace-nowrap" style="max-width: 60px">0</div>
			<div class="absolute overflow-hidden text-ellipsis whitespace-nowrap" style="right: 0px; max-width: 60px">8.34k</div>
			</div></div></div></div>
	<div class="absolute right-0 top-0 z-10 h-full w-1 cursor-col-resize hover:bg-indigo-100 active:bg-indigo-500 dark:hover:bg-indigo-800 dark:active:bg-indigo-600/80"><div class="absolute right-0 top-0 h-full w-1"></div>
								</div>
						</th></tr></thead>
			<tbody class="h-16 overflow-scroll"><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="0"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">paramedic_1</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,023</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">90</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê³¼ëŸ‰íˆ¬ì—¬ ì‹œ í”¼ë¶€ ë° ì ë§‰ì˜ ê±´ì¡°, ë™ê³µí™•ëŒ€, ê³ ì²´ì˜¨ ë“±ì˜ ì¤‘ë… ì¦ìƒì´ ë‚˜íƒ€ë‚˜ë©° í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼(í”¼ì¡°ìŠ¤í‹°ê·¸ë¯¼)ì„ í•´ë…ì œë¡œ ì‚¬ìš©í•  ìˆ˜ ìžˆëŠ” ë¬¼ì§ˆì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë‹¤ì´ì•„ì œíŒœ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì•„íŠ¸ë¡œí•€</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì‚´ì¶©ì œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëª¨ë¥´í•€</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì—íƒ„ì˜¬</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">
The question is asking for a substance that, when overdosed, causes symptoms like dry skin and mucous membranes, dilated pupils, and hyperthermia, and for which physostigmine is used as an antidote.  Let's analyze each option and see which one fits the description.

* **Symptoms described:** Dry skin and mucous membranes, dilated pupils, hyperthermia. These are classic signs of **anticholinergic toxicity**.  Anticholinergic drugs block the action of acetylcholine, a neurotransmitter responsible for various functions, including muscle contraction, gland secretions, and heart rate regulation. Blocking acetylcholine leads to these symptoms.

* **Physostigmine as an antidote:** Physostigmine is a cholinesterase inhibitor. It increases the level of acetylcholine in the synapse by preventing its breakdown.  It's used as an antidote for anticholinergic poisoning because it counteracts the effects of anticholinergic drugs by increasing acetylcholine levels, thus overcoming the blockade.

Now let's examine each option:

* **A. ë‹¤ì´ì•„ì œíŒœ (Diazepam):**  Diazepam is a benzodiazepine, primarily used as an anxiolytic, sedative, muscle relaxant, and anticonvulsant.  Overdose symptoms of diazepam include drowsiness, confusion, impaired coordination, and respiratory depression.  It's not typically associated with anticholinergic effects like dry skin, dilated pupils, and hyperthermia.  Flumazenil is the antidote for benzodiazepine overdose, not physostigmine.

* **B. ì•„íŠ¸ë¡œí•€ (Atropine):** Atropine is a classic anticholinergic drug. It's a muscarinic antagonist, meaning it blocks the muscarinic acetylcholine receptors.  Overdose of atropine would directly cause the symptoms listed: dry skin (decreased sweating), dry mucous membranes (decreased saliva), dilated pupils (mydriasis), and hyperthermia (due to decreased sweating).  Physostigmine is indeed used as an antidote for atropine poisoning to reverse these anticholinergic effects.

* **C. ì‚´ì¶©ì œ (Insecticide):**  This is a broad category.  Some insecticides, like organophosphates and carbamates, are cholinesterase inhibitors.  They *increase* acetylcholine levels, leading to cholinergic toxicity (opposite of anticholinergic). Symptoms of organophosphate/carbamate poisoning include SLUDGE (Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis) and muscle weakness, miosis (constricted pupils), bradycardia.  Other insecticides, like pyrethroids, primarily affect the nervous system through sodium channel modulation, and don't typically cause anticholinergic symptoms.  However, some older insecticides might have anticholinergic properties, but generally, insecticides are not the primary cause of anticholinergic poisoning for which physostigmine is a first-line antidote.  Organophosphate poisoning, which is more common with insecticides, is treated with atropine (ironically, to block the *excess* acetylcholine effects) and pralidoxime (to reactivate cholinesterase), not physostigmine.  This option is less likely than atropine.

* **D. ëª¨ë¥´í•€ (Morphine):** Morphine is an opioid analgesic.  Overdose symptoms of morphine include respiratory depression, pinpoint pupils (miosis), constipation, and decreased level of consciousness.  It does not cause anticholinergic symptoms like dilated pupils and hyperthermia.  Naloxone is the antidote for opioid overdose.

* **E. ì—íƒ„ì˜¬ (Ethanol):** Ethanol is alcohol.  Ethanol intoxication symptoms include impaired coordination, slurred speech, confusion, and respiratory depression in severe cases.  While it can cause vasodilation which might contribute to warmth, it doesn't typically cause hyperthermia in the same way anticholinergics do.  It also doesn't cause dilated pupils in the same way.  The primary concerns with ethanol overdose are CNS depression and respiratory depression.  There is no specific antidote in the same way as physostigmine for anticholinergics or naloxone for opioids. Treatment is supportive.

**Conclusion:**

Based on the symptoms and the antidote, **atropine (B)** is the most fitting answer.  Atropine is a known anticholinergic drug that causes the described symptoms upon overdose, and physostigmine is a well-established antidote for anticholinergic poisoning, including atropine poisoning.

Let's double check the symptoms and antidote for atropine overdose:

* **Symptoms of Atropine Overdose (Anticholinergic Toxidrome):**
    * **Mad as a hatter:** Delirium, hallucinations, confusion
    * **Blind as a bat:** Mydriasis (dilated pupils), blurred vision
    * **Red as a beet:** Vasodilation, flushed skin
    * **Hot as a hare:** Hyperthermia, anhidrosis (lack of sweating)
    * **Dry as a bone:** Dry skin, dry mucous membranes
    * **Other:** Tachycardia, urinary retention, decreased bowel sounds

The symptoms listed in the question (dry skin and mucous membranes, dilated pupils, hyperthermia) are all core components of anticholinergic toxidrome and are characteristic of atropine overdose.  And physostigmine is indeed used to treat anticholinergic poisoning, particularly in cases with severe delirium or other significant symptoms.

Therefore, the most appropriate answer is **B. ì•„íŠ¸ë¡œí•€ (Atropine)**.


Let's consider why other options are less likely:

* **Diazepam:**  Wrong symptoms, wrong antidote.
* **Insecticide:** Too broad, and while some might have anticholinergic properties, the more common insecticide poisonings (organophosphates, carbamates) cause cholinergic, not anticholinergic symptoms. Physostigmine might be contraindicated in organophosphate poisoning in some contexts (though it's complex and sometimes used with caution in specific situations), and atropine is the primary anticholinergic used as antidote for organophosphate poisoning.
* **Morphine:** Wrong symptoms, wrong antidote.
* **Ethanol:** Wrong symptoms, no specific antidote like physostigmine for this symptom profile.


Thus, Atropine is the clear best answer.
</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **B. ì•„íŠ¸ë¡œí•€**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

**ì œì‹œëœ ì¦ìƒ:**

* **í”¼ë¶€ ë° ì ë§‰ ê±´ì¡°:**  ë•€ ë¶„ë¹„ ê°ì†Œ ë° ì¹¨ ë¶„ë¹„ ê°ì†Œë¡œ ì¸í•´ ë‚˜íƒ€ë‚˜ëŠ” ì¦ìƒìœ¼ë¡œ, ë¶€êµê° ì‹ ê²½ ì–µì œ(í•­ì½œë¦° ìž‘ìš©)ì™€ ê´€ë ¨ì´ ìžˆìŠµë‹ˆë‹¤.
* **ë™ê³µ í™•ëŒ€:**  ë™ê³µ ì¡°ì ˆ ê·¼ìœ¡ì˜ ë§ˆë¹„ë¡œ ì¸í•´ ë‚˜íƒ€ë‚˜ëŠ” ì¦ìƒìœ¼ë¡œ, ë¶€êµê° ì‹ ê²½ ì–µì œ(í•­ì½œë¦° ìž‘ìš©)ì˜ ëŒ€í‘œì ì¸ ì¦ìƒìž…ë‹ˆë‹¤.
* **ê³ ì²´ì˜¨:**  ë•€ ë¶„ë¹„ ê°ì†Œë¡œ ì¸í•œ ì²´ì˜¨ ì¡°ì ˆ ìž¥ì• ë¡œ ë°œìƒí•  ìˆ˜ ìžˆìœ¼ë©°, í•­ì½œë¦° ìž‘ìš©ê³¼ ê´€ë ¨ì´ ìžˆìŠµë‹ˆë‹¤.

**í•´ë…ì œ: í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ (í”¼ì¡°ìŠ¤í‹°ê·¸ë¯¼)**

* í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì½œë¦°ì—ìŠ¤í„°ë¼ì œ ì–µì œì œìž…ë‹ˆë‹¤. ì½œë¦°ì—ìŠ¤í„°ë¼ì œëŠ” ì•„ì„¸í‹¸ì½œë¦°ì„ ë¶„í•´í•˜ëŠ” íš¨ì†Œì´ë¯€ë¡œ, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„ì„¸í‹¸ì½œë¦°ì˜ ë¶„í•´ë¥¼ ì–µì œí•˜ì—¬ ì•„ì„¸í‹¸ì½œë¦°ì˜ ë†ë„ë¥¼ ì¦ê°€ì‹œí‚µë‹ˆë‹¤.
* ì´ëŠ” **í•­ì½œë¦° ìž‘ìš© ë¬¼ì§ˆì˜ ì¤‘ë…ì„ í•´ë…í•˜ëŠ” ë° ì‚¬ìš©**ë©ë‹ˆë‹¤. í•­ì½œë¦° ìž‘ìš© ë¬¼ì§ˆì€ ì•„ì„¸í‹¸ì½œë¦°ì˜ ìž‘ìš©ì„ ì–µì œí•˜ë¯€ë¡œ, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„ì„¸í‹¸ì½œë¦° ë†ë„ë¥¼ ë†’ì—¬ í•­ì½œë¦° ìž‘ìš©ì„ ìƒì‡„ì‹œí‚¤ëŠ” íš¨ê³¼ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.

**ê° ì„ íƒì§€ ë¶„ì„:**

* **A. ë‹¤ì´ì•„ì œíŒœ:**  ë²¤ì¡°ë””ì•„ì œí•€ ê³„ì—´ì˜ ì•½ë¬¼ë¡œ, ì£¼ë¡œ ì§„ì •, ìˆ˜ë©´, í•­ë¶ˆì•ˆ ìž‘ìš©ì„ í•©ë‹ˆë‹¤. ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ ì¡¸ìŒ, í˜¼ëž€, ìš´ë™ì‹¤ì¡°, í˜¸í¡ ì–µì œ ë“±ì˜ ì¦ìƒì´ ë‚˜íƒ€ë‚˜ì§€ë§Œ, í”¼ë¶€ ê±´ì¡°, ë™ê³µ í™•ëŒ€, ê³ ì²´ì˜¨ê³¼ ê°™ì€ í•­ì½œë¦° ì¦ìƒì€ ë‚˜íƒ€ë‚˜ì§€ ì•ŠìŠµë‹ˆë‹¤. í•´ë…ì œëŠ” í”Œë£¨ë§ˆì œë‹ìž…ë‹ˆë‹¤.

* **B. ì•„íŠ¸ë¡œí•€:**  ëŒ€í‘œì ì¸ **í•­ì½œë¦° ìž‘ìš©ì œ**ìž…ë‹ˆë‹¤.  ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ ì œì‹œëœ ì¦ìƒì¸ í”¼ë¶€ ë° ì ë§‰ ê±´ì¡°, ë™ê³µ í™•ëŒ€, ê³ ì²´ì˜¨ ë“±ì´ ë‚˜íƒ€ë‚©ë‹ˆë‹¤. ë˜í•œ, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„íŠ¸ë¡œí•€ ì¤‘ë…ì˜ í•´ë…ì œë¡œ ì‚¬ìš©ë©ë‹ˆë‹¤.

* **C. ì‚´ì¶©ì œ:**  ì‚´ì¶©ì œì˜ ì¢…ë¥˜ëŠ” ë§¤ìš° ë‹¤ì–‘í•©ë‹ˆë‹¤. ìœ ê¸°ì¸ê³„ ì‚´ì¶©ì œë‚˜ ì¹´ë°”ë©”ì´íŠ¸ê³„ ì‚´ì¶©ì œëŠ” ì½œë¦°ì—ìŠ¤í„°ë¼ì œ ì–µì œì œë¡œì„œ, ì˜¤ížˆë ¤ ì½œë¦°ì„± ì¦ìƒ(ê·¼ìœ¡ ê²½ë ¨, ì¹¨ í˜ë¦¼, ë™ê³µ ì¶•ì†Œ ë“±)ì„ ìœ ë°œí•˜ë©°, í•´ë…ì œë¡œëŠ” ì•„íŠ¸ë¡œí•€ (í•­ì½œë¦°ì œ)ê³¼ ì˜¥ì‹¬ ì œì œê°€ ì‚¬ìš©ë©ë‹ˆë‹¤. ì œì‹œëœ ì¦ìƒê³¼ëŠ” ë°˜ëŒ€ë˜ëŠ” ê²½ìš°ê°€ ë§ŽìŠµë‹ˆë‹¤.

* **D. ëª¨ë¥´í•€:**  ë§ˆì•½ì„± ì§„í†µì œì¸ ì˜¤í”¼ì˜¤ì´ë“œ ê³„ì—´ ì•½ë¬¼ìž…ë‹ˆë‹¤. ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ í˜¸í¡ ì–µì œ, ë™ê³µ ì¶•ì†Œ, ë³€ë¹„ ë“±ì˜ ì¦ìƒì´ ë‚˜íƒ€ë‚˜ë©°, í•´ë…ì œëŠ” ë‚ ë¡ì†ìž…ë‹ˆë‹¤. ì œì‹œëœ ì¦ìƒê³¼ëŠ” ê±°ë¦¬ê°€ ë©‰ë‹ˆë‹¤.

* **E. ì—íƒ„ì˜¬:**  ì•Œì½”ì˜¬ìž…ë‹ˆë‹¤. ê³¼ëŸ‰ ì„­ì·¨ ì‹œ ì¤‘ì¶”ì‹ ê²½ ì–µì œ, ìš´ë™ ì‹¤ì¡°, íŒë‹¨ë ¥ ì €í•˜ ë“±ì˜ ì¦ìƒì´ ë‚˜íƒ€ë‚˜ì§€ë§Œ, í”¼ë¶€ ê±´ì¡°, ë™ê³µ í™•ëŒ€, ê³ ì²´ì˜¨ê³¼ ê°™ì€ í•­ì½œë¦° ì¦ìƒì€ ë‚˜íƒ€ë‚˜ì§€ ì•ŠìŠµë‹ˆë‹¤.

**ê²°ë¡ :**

ì œì‹œëœ ì¤‘ë… ì¦ìƒê³¼ í•´ë…ì œ(í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼)ë¥¼ ê³ ë ¤í–ˆì„ ë•Œ, ê°€ìž¥ ì í•©í•œ ë¬¼ì§ˆì€ **B. ì•„íŠ¸ë¡œí•€**ìž…ë‹ˆë‹¤. ì•„íŠ¸ë¡œí•€ì€ í•­ì½œë¦° ìž‘ìš©ì œë¡œì„œ ê³¼ëŸ‰ íˆ¬ì—¬ ì‹œ ì œì‹œëœ ì¦ìƒì„ ìœ ë°œí•˜ë©°, í”¼ì†ŒìŠ¤í‹°ê·¸ë¯¼ì€ ì•„íŠ¸ë¡œí•€ ì¤‘ë…ì˜ í•´ë…ì œë¡œ ì‚¬ìš©ë©ë‹ˆë‹¤.

**ë”°ë¼ì„œ ì •ë‹µì€ Bìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">7,494</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="1"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">paramedic_1</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,023</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">65</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì²™ì¶”ì†ìƒì´ ì˜ì‹¬ë˜ëŠ” í™˜ìžë¥¼ ì´ì†¡í•˜ê¸° ìœ„í•œ ì²™ì¶”ë³´í˜¸ì¡°ì¹˜ (ì²™ì¶”ì›€ì§ìž„ì œí•œ) ë°©ë²•ìœ¼ë¡œ ì˜³ì€ ê²ƒì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ê°€ ìœ ì§€ë˜ë„ë¡ ëª© ê³ ì •ìž¥ì¹˜ ì ìš©</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì¢Œìš°ë¡œ 45Â° ëŒë¦´ ìˆ˜ ìžˆë„ë¡ ëŠìŠ¨í•˜ê²Œ ê³ ì •</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëª©ë¼ˆì˜ êµ½íž˜ì´ë‚˜ ì••ë°•ì´ ë°œìƒí•˜ì§€ ì•Šë„ë¡ ê³¼ì‹ ì „ ìƒíƒœë¡œ ê³ ì •</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëª¸í†µì€ ìœ„ì•„ëž˜ë¡œëŠ” ì›€ì§ì´ê³  ì™¼ìª½ Â· ì˜¤ë¥¸ìª½ìœ¼ë¡œëŠ” ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì •</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">
The question is asking about the correct method of spinal motion restriction (spinal immobilization) for a patient suspected of having a spinal injury during transport.  Let's analyze each option in Korean and then translate to English for clarity.

* **Understanding the Goal:** The primary goal of spinal motion restriction is to prevent further injury to the spinal cord by minimizing movement of the spine, especially in cases of suspected spinal injury. This is crucial during patient transport to avoid exacerbating potential damage.

* **Analyzing each option:**

    * **A. ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì • (Fix the torso completely to a long spine board first, then fix the head.)**
        * **Thinking:** This sounds like a logical sequence.  Stabilizing the torso first provides a stable base before immobilizing the head. If you fix the head first and then try to move the torso onto the board, you risk moving the neck and spine. So, torso first, then head sounds correct.

    * **B. ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ê°€ ìœ ì§€ë˜ë„ë¡ ëª© ê³ ì •ìž¥ì¹˜ ì ìš© (Apply a cervical collar so that the head-tilt and chin-lift position is maintained.)**
        * **Thinking:** The head-tilt chin-lift maneuver is used to open the airway in unresponsive patients, *not* for spinal immobilization.  In spinal injury, we want to maintain a *neutral* position if possible, not necessarily head-tilt chin-lift.  Also, maintaining head-tilt chin-lift with a cervical collar sounds contradictory and potentially harmful for spinal injury.  This option seems incorrect.

    * **C. ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì¢Œìš°ë¡œ 45Â° ëŒë¦´ ìˆ˜ ìžˆë„ë¡ ëŠìŠ¨í•˜ê²Œ ê³ ì • (Fix the cervical collar loosely so that it can be turned 45Â° left and right.)**
        * **Thinking:**  The purpose of a cervical collar (ëª© ê³ ì •ìž¥ì¹˜) in spinal immobilization is to *restrict* movement, not allow it. Allowing 45Â° rotation defeats the purpose.  This is definitely incorrect.  Spinal immobilization needs to be *rigid*, not loose.

    * **D. ëª©ë¼ˆì˜ êµ½íž˜ì´ë‚˜ ì••ë°•ì´ ë°œìƒí•˜ì§€ ì•Šë„ë¡ ê³¼ì‹ ì „ ìƒíƒœë¡œ ê³ ì • (Fix in a hyperextended position to prevent flexion or compression of the cervical vertebrae.)**
        * **Thinking:** Hyperextension (ê³¼ì‹ ì „) of the neck is generally *contraindicated* in suspected spinal injury.  It can worsen the injury, especially if there's already a fracture or dislocation.  Neutral alignment is preferred.  Forcing hyperextension can cause more harm.  This is likely incorrect and dangerous.

    * **E. ëª¸í†µì€ ìœ„ì•„ëž˜ë¡œëŠ” ì›€ì§ì´ê³  ì™¼ìª½ Â· ì˜¤ë¥¸ìª½ìœ¼ë¡œëŠ” ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì • (Fix the torso so that it moves up and down but not left and right.)**
        * **Thinking:**  This option is confusing and nonsensical for spinal immobilization.  Spinal immobilization aims to restrict *all* movement of the torso and spine in all directions â€“ up/down, left/right, rotation, flexion, extension. Allowing up and down movement while restricting left/right is not a standard or recommended practice for spinal immobilization. This is incorrect and illogical.


* **Re-evaluating and confirming the best answer:**

    * Option A makes the most sense in terms of sequence and overall principle of immobilization.
    * Options B, C, D, and E are all clearly wrong based on basic principles of spinal immobilization and first aid.

* **Translating and confirming in English for clarity:**

    * A. Fix the torso completely to a long spine board first, then fix the head. (Sounds correct)
    * B. Apply a cervical collar so that the head-tilt and chin-lift position is maintained. (Incorrect - head-tilt chin-lift is for airway, not immobilization; and contraindicated for spinal injury in this context.)
    * C. Fix the cervical collar loosely so that it can be turned 45Â° left and right. (Incorrect - collar must restrict, not allow movement.)
    * D. Fix in a hyperextended position to prevent flexion or compression of the cervical vertebrae. (Incorrect and dangerous - hyperextension is generally contraindicated; neutral is preferred.)
    * E. Fix the torso so that it moves up and down but not left and right. (Incorrect and illogical - immobilization needs to restrict all torso movement.)


* **Conclusion:** Option A appears to be the only correct method for spinal motion restriction in the context of transporting a patient with suspected spinal injury.


Therefore, the answer is A.

Let's double-check typical spinal immobilization procedures:

1. **Manual stabilization:**  Immediately stabilize the patient's head and neck manually, preventing any movement.
2. **Cervical collar application:** Apply a properly sized cervical collar.
3. **Log roll (if needed):** If the patient needs to be moved (e.g., onto a spine board), perform a log roll while maintaining manual stabilization of the head and neck.
4. **Spine board application:** Center the patient onto a long spine board. Secure the torso to the board first (straps across chest, pelvis, thighs).
5. **Head immobilization:**  Secure the head to the spine board using head blocks and tape or straps. Ensure the head is in a neutral, in-line position if possible (unless resistance is met or it causes pain).
6. **Extremity immobilization (optional):**  Sometimes, straps are also used to secure the legs to the spine board.

This process aligns with option A:  torso to spine board first, then head.

</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **A. ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ì²™ì¶” ì†ìƒì´ ì˜ì‹¬ë˜ëŠ” í™˜ìžì˜ ì²™ì¶” ë³´í˜¸ ì¡°ì¹˜ (ì²™ì¶” ì›€ì§ìž„ ì œí•œ)ì˜ í•µì‹¬ì€ ì²™ì¶”ì˜ ì¶”ê°€ì ì¸ ì›€ì§ìž„ì„ ìµœì†Œí™”í•˜ì—¬ 2ì°¨ ì†ìƒì„ ì˜ˆë°©í•˜ëŠ” ê²ƒìž…ë‹ˆë‹¤.  ê° ì„ íƒì§€ë¥¼ ë¶„ì„í•´ ë³´ê² ìŠµë‹ˆë‹¤.

* **A. ëª¸í†µì„ ê¸´ì²™ì¶”ê³ ì •íŒì— ì™„ì „ížˆ ê³ ì •í•œ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •:**  **ì˜³ì€ ë°©ë²•ìž…ë‹ˆë‹¤.**  ì²™ì¶” ê³ ì •íŒì„ ì‚¬ìš©í•˜ì—¬ ëª¸í†µì„ ë¨¼ì € ì•ˆì •ì ìœ¼ë¡œ ê³ ì •í•˜ëŠ” ê²ƒì€ ì²™ì¶” ì „ì²´ë¥¼ ì•ˆì •í™”í•˜ëŠ” ë° ì¤‘ìš”í•©ë‹ˆë‹¤. ëª¸í†µì´ ê³ ì •ëœ í›„ì— ë¨¸ë¦¬ë¥¼ ê³ ì •í•´ì•¼ ì²™ì¶”ì˜ ì¶• ë°©í–¥ ì›€ì§ìž„ì„ ìµœì†Œí™”í•˜ê³ , ë¨¸ë¦¬ ê³ ì • ì‹œ ë°œìƒí•  ìˆ˜ ìžˆëŠ” ëª¸í†µì˜ ì›€ì§ìž„ì„ ë°©ì§€í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

* **B. ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ê°€ ìœ ì§€ë˜ë„ë¡ ëª© ê³ ì •ìž¥ì¹˜ ì ìš©:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° (head-tilt chin-lift) ìžì„¸ëŠ” ê¸°ë„ í™•ë³´ë¥¼ ìœ„í•´ ì‚¬ìš©í•˜ëŠ” ë°©ë²•ìœ¼ë¡œ, ì²™ì¶” ì†ìƒ í™˜ìžì—ê²ŒëŠ” ê¸ˆê¸°ìž…ë‹ˆë‹¤. ì²™ì¶” ì†ìƒ í™˜ìžì—ê²ŒëŠ” ì²™ì¶”ë¥¼ ì¤‘ë¦½ ìžì„¸ë¡œ ìœ ì§€í•˜ê³  ì›€ì§ìž„ì„ ìµœì†Œí™”í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•˜ë©°, ë¨¸ë¦¬ê¸°ìš¸ì´ê³ í„±ë“¤ê¸° ìžì„¸ëŠ” ì²™ì¶”ì— ë¶ˆí•„ìš”í•œ ì›€ì§ìž„ì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

* **C. ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì¢Œìš°ë¡œ 45Â° ëŒë¦´ ìˆ˜ ìžˆë„ë¡ ëŠìŠ¨í•˜ê²Œ ê³ ì •:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ëª© ê³ ì •ìž¥ì¹˜ (cervical collar)ëŠ” ëª©ë¼ˆì˜ ì›€ì§ìž„ì„ ìµœëŒ€í•œ ì œí•œí•˜ê¸° ìœ„í•´ ì‚¬ìš©í•˜ëŠ” ê²ƒìž…ë‹ˆë‹¤. ëŠìŠ¨í•˜ê²Œ ê³ ì •í•˜ë©´ ëª©ë¼ˆë¥¼ ì œëŒ€ë¡œ ê³ ì •í•  ìˆ˜ ì—†ê³ , ì˜¤ížˆë ¤ ì›€ì§ìž„ì´ ë°œìƒí•˜ì—¬ ì²™ì¶” ì†ìƒì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ëª© ê³ ì •ìž¥ì¹˜ëŠ” ì ì ˆí•œ í¬ê¸°ë¡œ í™˜ìžì˜ ëª©ì— ë”± ë§žê²Œ, ì›€ì§ìž„ì´ ê±°ì˜ ì—†ë„ë¡ ë‹¨ë‹¨ížˆ ê³ ì •í•´ì•¼ í•©ë‹ˆë‹¤.

* **D. ëª©ë¼ˆì˜ êµ½íž˜ì´ë‚˜ ì••ë°•ì´ ë°œìƒí•˜ì§€ ì•Šë„ë¡ ê³¼ì‹ ì „ ìƒíƒœë¡œ ê³ ì •:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ì²™ì¶”ë¥¼ ê³¼ì‹ ì „ (hyperextension) ìƒíƒœë¡œ ê³ ì •í•˜ëŠ” ê²ƒì€ ì˜¤ížˆë ¤ ì²™ì¶” ì†ìƒì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. íŠ¹ížˆ ì²™ì¶” ê³¨ì ˆì´ë‚˜ íƒˆêµ¬ê°€ ìžˆëŠ” ê²½ìš° ê³¼ì‹ ì „ì€ ì‹ ê²½ ì†ìƒì„ ìœ ë°œí•˜ê±°ë‚˜ ì•…í™”ì‹œí‚¬ ìœ„í—˜ì´ ìžˆìŠµë‹ˆë‹¤. ì²™ì¶”ëŠ” ê°€ëŠ¥í•œ í•œ ì¤‘ë¦½ ìžì„¸ (neutral position)ë¡œ ìœ ì§€í•˜ëŠ” ê²ƒì´ ì›ì¹™ìž…ë‹ˆë‹¤.

* **E. ëª¸í†µì€ ìœ„ì•„ëž˜ë¡œëŠ” ì›€ì§ì´ê³  ì™¼ìª½ Â· ì˜¤ë¥¸ìª½ìœ¼ë¡œëŠ” ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì •:** **í‹€ë¦° ë°©ë²•ìž…ë‹ˆë‹¤.** ì²™ì¶” ë³´í˜¸ ì¡°ì¹˜ëŠ” ì²™ì¶”ì˜ ëª¨ë“  ë°©í–¥ìœ¼ë¡œì˜ ì›€ì§ìž„ì„ ì œí•œí•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤. ëª¸í†µì„ ìœ„ì•„ëž˜ë¡œ ì›€ì§ì´ê²Œ í—ˆìš©í•˜ëŠ” ê²ƒì€ ì²™ì¶”ì˜ ì›€ì§ìž„ì„ ì™„ì „ížˆ ì œí•œí•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë©°, ì²™ì¶” ì†ìƒ í™˜ìžì—ê²ŒëŠ” ìœ„í—˜í•œ ì²˜ì¹˜ìž…ë‹ˆë‹¤. ëª¸í†µì€ ëª¨ë“  ë°©í–¥ìœ¼ë¡œ ì›€ì§ì´ì§€ ì•Šë„ë¡ ê³ ì •í•´ì•¼ í•©ë‹ˆë‹¤.


**ë”°ë¼ì„œ, ì²™ì¶”ì†ìƒ ì˜ì‹¬ í™˜ìž ì´ì†¡ ì‹œ ì²™ì¶” ë³´í˜¸ ì¡°ì¹˜ë¡œ ê°€ìž¥ ì ì ˆí•œ ë°©ë²•ì€ Aìž…ë‹ˆë‹¤.**

**ì •ë‹µ: A**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">7,472</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="2"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">paramedic_1</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,021</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">82</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">65ì„¸ ë‚¨ìžê°€ 20ë¶„ ì „ì— ê°‘ìžê¸° 1,000cc ì •ë„ ë‘ì°¨ë¡€ í”¼ë¥¼ í† í•œ í›„ ë‚´ì›í•˜ì˜€ë‹¤. í™˜ìžëŠ” 5ë…„ ì „ë¶€í„° ì•Œì½”ì˜¬ì„± ê°„ê²½í™”ë¡œ ì¹˜ë£Œë°›ê³  ìžˆìœ¼ë©°, ì‘ê¸‰ì‹¤ ë‚´ì› í›„ì—ë„ ê³„ì†ì ì¸ ì„ í™ìƒ‰ í† í˜ˆì„ í•˜ì˜€ë‹¤. ì˜ì‹ì€ í˜¼ìˆ˜ìƒíƒœì´ë©°, í˜ˆì•• 60/40mmHg, ë§¥ë°• 115íšŒ/ë¶„, í˜¸í¡ 28íšŒ/ë¶„ì´ê³ , í”¼ë¶€ëŠ” ì°¨ê³  ì¶•ì¶•í•˜ë‹¤. ìš°ì„  í•´ì•¼ í•  ì²˜ì¹˜ëŠ”?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì•„ì´ê²” ì‚½ìž…</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê¸°ê´€ë‚´ ì‚½ê´€</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë¹„ìœ„ê´€íŠœë¸Œ ì‚½ìž…</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í›„ë‘íŠœë¸Œê¸°ë„ê¸° ì‚½ìž…</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ ì‚½ìž…</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down this medical case step-by-step, simulating a thought process to arrive at the correct answer.

**1. Deconstructing the Patient Information:**

* **Age and Gender:** 65-year-old male.  Age is relevant as older patients might have comorbidities or less physiological reserve.
* **Chief Complaint:** Sudden onset of massive hematemesis (vomiting blood) - 1000cc twice in 20 minutes. This is a *huge* amount of blood loss in a short time.
* **Medical History:** Alcoholic liver cirrhosis (5 years).  This is *critical*.  Cirrhosis is a major risk factor for esophageal varices, a common cause of upper GI bleeding and hematemesis in these patients.
* **Current Status on Arrival:**
    * **Ongoing hematemesis:** Still vomiting bright red blood. This indicates active, ongoing bleeding and emphasizes the urgency of the situation.
    * **Consciousness:** Comatose.  This is extremely concerning and suggests significant blood loss and likely hypoperfusion of the brain. Airway compromise is a major concern.
    * **Vitals:**
        * **BP 60/40 mmHg:**  Severe hypotension.  This is shock.
        * **HR 115 bpm:** Tachycardia.  Compensatory mechanism for hypovolemia.
        * **RR 28 bpm:** Tachypnea.  Likely compensatory for metabolic acidosis and hypoxemia due to blood loss.
        * **Skin:** Cold and clammy.  Signs of peripheral vasoconstriction and poor perfusion, further indicating shock.

**2. Synthesizing the Information and Identifying the Problem:**

* **Massive Hemorrhage:** The patient is experiencing a massive upper GI bleed, most likely due to esophageal varices secondary to liver cirrhosis.
* **Hypovolemic Shock:**  The vital signs (hypotension, tachycardia, tachypnea, cold/clammy skin) and altered mental status (coma) definitively indicate hypovolemic shock due to blood loss.
* **Airway Compromise:** Comatose state and ongoing hematemesis put the patient at extremely high risk for airway obstruction due to aspiration of blood.  The patient may also have reduced respiratory drive due to shock.

**3. Prioritizing Immediate Actions - The ABCs:**

In any emergency, especially with a comatose and bleeding patient, the ABCs (Airway, Breathing, Circulation) are paramount.

* **Airway (A):**  This is *the most critical* priority in this scenario. The patient is comatose and vomiting blood.  The immediate risk is airway obstruction from aspiration. We *must* secure the airway.
* **Breathing (B):**  Tachypnea is present, but the quality of breathing is unknown and potentially compromised due to coma and shock.  Securing the airway will likely necessitate assisted ventilation.
* **Circulation (C):**  The patient is in severe shock.  While addressing circulation is crucial (IV access, fluids, blood products), it is secondary to securing the airway in this *immediate* moment because without a patent airway and adequate oxygenation, circulatory interventions will be less effective, and the patient will quickly deteriorate further.

**4. Evaluating the Answer Choices in Light of Priorities:**

* **A. ì•„ì´ê²” ì‚½ìž… (i-gel insertion):**  An i-gel is a supraglottic airway device (SGAD).  It can provide a decent airway, is relatively easy to insert, and can protect against aspiration to some extent.  It's better than nothing, but not ideal in this situation.
* **B. ê¸°ê´€ë‚´ ì‚½ê´€ (Endotracheal intubation):**  Endotracheal intubation (ETI) is the *gold standard* for airway management. It provides a definitive airway, protects against aspiration, allows for positive pressure ventilation and high FiO2 delivery.  It's more complex than SGADs, but in a comatose patient with massive hematemesis, it's the most secure and protective option.
* **C. ë¹„ìœ„ê´€íŠœë¸Œ ì‚½ìž… (Nasogastric tube insertion):** An NG tube is used to decompress the stomach and can help remove blood and gastric contents.  While helpful *later* for managing the bleeding and assessing ongoing loss, it does *not* address the immediate airway crisis.  It could even *increase* the risk of aspiration during insertion in a comatose patient.
* **D. í›„ë‘íŠœë¸Œê¸°ë„ê¸° ì‚½ìž… (Laryngeal tube insertion):** A laryngeal tube (like the King LT) is another type of SGAD.  Similar to the i-gel, it can provide an airway, but less secure than ETI, and may not be optimal for aspiration risk.
* **E. í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ ì‚½ìž… (Laryngeal mask airway (LMA) insertion):** An LMA is also an SGAD.  Similar pros and cons to i-gel and laryngeal tube.  Less secure than ETI, especially in a patient with high aspiration risk and ongoing bleeding.

**5. Choosing the Best Answer:**

Considering the patient's comatose state, massive hematemesis, and high risk of aspiration, the *most important* and *first* intervention is to secure the airway definitively.  Endotracheal intubation (B) is the best option because it provides the most secure airway, protects against aspiration, and allows for controlled ventilation and oxygenation, which are crucial in this critical situation.

While SGADs (A, D, E) might be considered in less critical airway situations or if intubation is immediately impossible, in this scenario, the patient is clearly unstable and requires the most definitive airway management. NG tube (C) is not the *priority* initial intervention and doesn't address the airway.

**Final Answer Selection and Justification:**

The best answer is **B. ê¸°ê´€ë‚´ ì‚½ê´€ (Endotracheal intubation)**.

**Reasoning Summary:**

* **Life-threatening situation:** Massive hematemesis, coma, and shock.
* **Primary concern:** Airway protection and securing breathing due to coma and aspiration risk from vomiting blood.
* **Endotracheal intubation (ETI):** Gold standard for airway management, provides definitive airway, aspiration protection, and ventilation control.
* **Other options (SGADs):** Less secure airway, higher aspiration risk, less ideal in this critical patient.
* **NG tube:** Not the priority for initial airway management and doesn't address immediate airway threats.

Therefore, securing the airway with endotracheal intubation is the most appropriate first action in this emergency situation.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">## ì •ë‹µ í•´ì„¤

ì •ë‹µì€ **B. ê¸°ê´€ë‚´ ì‚½ê´€** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

í™˜ìžëŠ” ë‹¤ìŒê³¼ ê°™ì€ ì‹¬ê°í•œ ìƒíƒœìž…ë‹ˆë‹¤.

* **ëŒ€ëŸ‰ í† í˜ˆ:** 1,000cc ë‘ ì°¨ë¡€ í† í˜ˆì€ ë§¤ìš° ë§Žì€ ì–‘ì´ë©°, í™œë ¥ ì§•í›„ë¥¼ ë¶ˆì•ˆì •í•˜ê²Œ ë§Œë“¤ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.
* **ì§€ì†ì ì¸ í† í˜ˆ:** ì‘ê¸‰ì‹¤ ë‚´ì› í›„ì—ë„ ê³„ì† í† í˜ˆì„ í•œë‹¤ëŠ” ê²ƒì€ ì¶œí˜ˆì´ ë©ˆì¶”ì§€ ì•Šê³  ìžˆë‹¤ëŠ” ê²ƒì„ ì˜ë¯¸í•˜ë©°, ë”ìš± ìœ„í—˜í•œ ìƒí™©ìž…ë‹ˆë‹¤.
* **í˜¼ìˆ˜ìƒíƒœ:** ì˜ì‹ ì €í•˜ëŠ” ë‡Œ í˜ˆë¥˜ ê°ì†Œ ë˜ëŠ” ì‹¬ê°í•œ ì „ì‹  ìƒíƒœ ì•…í™”ë¥¼ ì˜ë¯¸í•˜ë©°, ê¸°ë„ ìœ ì§€ ë° í˜¸í¡ ê´€ë¦¬ê°€ ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.
* **ì‡¼í¬ ìƒíƒœ:** í˜ˆì•• 60/40mmHgëŠ” ì‹¬ê°í•œ ì €í˜ˆì••ìœ¼ë¡œ ì‡¼í¬ ìƒíƒœë¥¼ ì˜ë¯¸í•˜ë©°, ì¦‰ê°ì ì¸ í˜ˆì•¡ëŸ‰ ë³´ì¶© ë° ì›ì¸ ì¹˜ë£Œê°€ í•„ìš”í•©ë‹ˆë‹¤.
* **ë¹ˆë§¥ ë° ë¹ˆí˜¸í¡:** ì‹¬ë°•ìˆ˜ 115íšŒ/ë¶„, í˜¸í¡ìˆ˜ 28íšŒ/ë¶„ì€ ì‡¼í¬ì— ëŒ€í•œ ë³´ìƒ ê¸°ì „ìœ¼ë¡œ ë‚˜íƒ€ë‚˜ëŠ” ë°˜ì‘ìž…ë‹ˆë‹¤.
* **ì°¨ê°€ìš´ í”¼ë¶€:** ë§ì´ˆ í˜ˆê´€ ìˆ˜ì¶•ìœ¼ë¡œ ì¸í•œ ì‡¼í¬ì˜ ì§•í›„ìž…ë‹ˆë‹¤.
* **ì•Œì½”ì˜¬ì„± ê°„ê²½í™”:** ê¸°ì € ì§ˆí™˜ìœ¼ë¡œ ì‹ë„ ì •ë§¥ë¥˜ ì¶œí˜ˆì˜ ê°€ëŠ¥ì„±ì´ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. ì‹ë„ ì •ë§¥ë¥˜ ì¶œí˜ˆì€ ê°„ê²½ë³€ í™˜ìžì—ì„œ í”í•˜ê²Œ ë°œìƒí•˜ëŠ” ëŒ€ëŸ‰ í† í˜ˆì˜ ì›ì¸ìž…ë‹ˆë‹¤.

**ìš°ì„ ì ìœ¼ë¡œ í•´ì•¼ í•  ì²˜ì¹˜:**

ê°€ìž¥ ê¸‰í•˜ê³  ì¤‘ìš”í•œ ì²˜ì¹˜ëŠ” **ê¸°ë„ í™•ë³´ ë° ìœ ì§€** ìž…ë‹ˆë‹¤. í™˜ìžëŠ” í˜¼ìˆ˜ìƒíƒœì´ê³  ì§€ì†ì ì¸ í† í˜ˆì„ í•˜ê³  ìžˆì–´ ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. ë˜í•œ ì‡¼í¬ ìƒíƒœë¡œ ìžë°œ í˜¸í¡ì´ ì¶©ë¶„í•˜ì§€ ì•Šì„ ê°€ëŠ¥ì„±ì´ ë†’ìŠµë‹ˆë‹¤.

ë”°ë¼ì„œ, **ê¸°ê´€ë‚´ ì‚½ê´€**ì„ í†µí•´ ê¸°ë„ë¥¼ í™•ë³´í•˜ê³  ì¸ê³µí˜¸í¡ì„ ì‹œìž‘í•˜ì—¬ ì‚°ì†Œ ê³µê¸‰ ë° ê¸°ë„ í¡ì¸ì„ ì˜ˆë°©í•˜ëŠ” ê²ƒì´ ìµœìš°ì„ ì ìœ¼ë¡œ í•´ì•¼ í•  ì²˜ì¹˜ìž…ë‹ˆë‹¤.

**ê° ì„ íƒì§€ë³„ ì„¤ëª…:**

* **A. ì•„ì´ê²” ì‚½ìž…:** ì•„ì´ê²”ì€ í›„ë‘ë§ˆìŠ¤í¬ê¸°ë„ê¸°(LMA)ì˜ ì¼ì¢…ìœ¼ë¡œ, ê¸°ê´€ë‚´ ì‚½ê´€ë³´ë‹¤ëŠ” ê°„ë‹¨í•˜ê²Œ ê¸°ë„ í™•ë³´ê°€ ê°€ëŠ¥í•˜ì§€ë§Œ, ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžë‚˜ í˜¼ìˆ˜ìƒíƒœ í™˜ìžì—ì„œëŠ” ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë†’ê³ , ê¸°ê´€ë‚´ ì‚½ê´€ë§Œí¼ í™•ì‹¤í•œ ê¸°ë„ ë³´í˜¸ê°€ ì–´ë µìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ë¡œëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.
* **B. ê¸°ê´€ë‚´ ì‚½ê´€:** ìœ„ì—ì„œ ì„¤ëª…í•œ ê²ƒì²˜ëŸ¼, í˜¼ìˆ˜ìƒíƒœ ë° ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžì—ê²Œ ê°€ìž¥ í™•ì‹¤í•˜ê³  ì•ˆì „í•œ ê¸°ë„ í™•ë³´ ë°©ë²•ìž…ë‹ˆë‹¤. ì¸ê³µí˜¸í¡ê¸°ë¥¼ ì—°ê²°í•˜ì—¬ ì ì ˆí•œ í™˜ê¸°ë¥¼ ì œê³µí•˜ê³ , ê¸°ë„ í¡ì¸ì„ ì˜ˆë°©í•˜ë©°, í–¥í›„ ì²˜ì¹˜ë¥¼ ìœ„í•œ ì•ˆì •ì ì¸ í™˜ê²½ì„ ì œê³µí•©ë‹ˆë‹¤. **ì •ë‹µ**ìž…ë‹ˆë‹¤.
* **C. ë¹„ìœ„ê´€íŠœë¸Œ ì‚½ìž…:** ë¹„ìœ„ê´€ íŠœë¸Œ ì‚½ìž…ì€ ìœ„ìž¥ê´€ ë‚´ ì¶œí˜ˆëŸ‰ì„ í™•ì¸í•˜ê³  ìœ„ ë‚´ìš©ë¬¼ì„ ì œê±°í•˜ì—¬ í¡ì¸ì„ ì˜ˆë°©í•˜ëŠ” ë° ë„ì›€ì´ ë  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ê¸°ë„ í™•ë³´ê°€ ìš°ì„ ì´ë©°, ë¹„ìœ„ê´€ ì‚½ìž…ì€ ê¸°ê´€ë‚´ ì‚½ê´€ í›„ ê³ ë ¤í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ëŠ” ì•„ë‹™ë‹ˆë‹¤.
* **D. í›„ë‘íŠœë¸Œê¸°ë„ê¸° ì‚½ìž…:** í›„ë‘íŠœë¸Œê¸°ë„ê¸°ëŠ” LMAì™€ ë§ˆì°¬ê°€ì§€ë¡œ ê¸°ê´€ë‚´ ì‚½ê´€ë³´ë‹¤ëŠ” ê°„ë‹¨í•˜ê²Œ ê¸°ë„ í™•ë³´ê°€ ê°€ëŠ¥í•˜ì§€ë§Œ, ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžë‚˜ í˜¼ìˆ˜ìƒíƒœ í™˜ìžì—ì„œëŠ” ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë†’ê³ , ê¸°ê´€ë‚´ ì‚½ê´€ë§Œí¼ í™•ì‹¤í•œ ê¸°ë„ ë³´í˜¸ê°€ ì–´ë µìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ë¡œëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.
* **E. í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ ì‚½ìž…:** í›„ë‘íŠœë¸Œë§ˆìŠ¤í¬ (LMA)ëŠ” ì•„ì´ê²”ê³¼ ë§ˆì°¬ê°€ì§€ë¡œ ê¸°ê´€ë‚´ ì‚½ê´€ë³´ë‹¤ëŠ” ê°„ë‹¨í•˜ê²Œ ê¸°ë„ í™•ë³´ê°€ ê°€ëŠ¥í•˜ì§€ë§Œ, ëŒ€ëŸ‰ í† í˜ˆ í™˜ìžë‚˜ í˜¼ìˆ˜ìƒíƒœ í™˜ìžì—ì„œëŠ” ê¸°ë„ í¡ì¸ì˜ ìœ„í—˜ì´ ë†’ê³ , ê¸°ê´€ë‚´ ì‚½ê´€ë§Œí¼ í™•ì‹¤í•œ ê¸°ë„ ë³´í˜¸ê°€ ì–´ë µìŠµë‹ˆë‹¤. ìš°ì„ ì ì¸ ì²˜ì¹˜ë¡œëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ,**  í˜¼ìˆ˜ìƒíƒœ ë° ëŒ€ëŸ‰ í† í˜ˆ, ì‡¼í¬ ìƒíƒœì¸ í™˜ìžì—ê²Œ ê°€ìž¥ ìš°ì„ ì ìœ¼ë¡œ í•´ì•¼ í•  ì²˜ì¹˜ëŠ” **ê¸°ê´€ë‚´ ì‚½ê´€ì„ í†µí•œ ê¸°ë„ í™•ë³´ ë° ìœ ì§€** ìž…ë‹ˆë‹¤. ì´í›„ ìˆ˜ì•¡ ë° í˜ˆì•¡ ì œì œ íˆ¬ì—¬ë¥¼ í†µí•œ í˜ˆì•• ì•ˆì •í™”, ì¶œí˜ˆ ì›ì¸ íŒŒì•… ë° ì§€í˜ˆ ë“±ì˜ ì¶”ê°€ì ì¸ ì²˜ì¹˜ë¥¼ ì§„í–‰í•´ì•¼ í•©ë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">7,146</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="3"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">doctor</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,014</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">14</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìš”ì–‘ë³‘ì›ì„ ê°œì„¤ ìš´ì˜í•˜ê³  ìžˆëŠ” ì˜ì‚¬ 'ê°‘'ì€ ì˜ë£Œê¸°ê´€ ì¸ì¦í‰ê°€ë¥¼ ë°›ì€ í›„ ì˜ë£Œê¸°ê´€ ì¸ì¦ì„œë¥¼ êµë¶€ë°›ì•˜ë‹¤. ì˜ì‚¬ 'ê°‘'ì´ ìš”ì–‘ë³‘ì› ì§„ë£Œë‚´ìš©ê³¼ ì¸ì¦ ê²°ê³¼ë¥¼ ì‹œë‚´ë²„ìŠ¤ ì°¨ëŸ‰ì˜ ì™¸ë¶€ ì˜†ë©´ì— ê´‘ê³ í•˜ê¸° ìœ„í•´ ë¯¸ë¦¬ ì‹¬ì˜ë¥¼ ë°›ìœ¼ë ¤ í•  ë•Œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì‹ ì²­ì„œë¥¼ ì œì¶œí•´ì•¼ í•˜ëŠ” ê¸°ê´€ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëŒ€í•œì˜ì‚¬í˜‘íšŒ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì›</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì›</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì›</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down this Korean medical law question step-by-step to arrive at the correct answer.

**1. Understanding the Question (Analyze the Korean Text)**

* **ìš”ì–‘ë³‘ì› (yoyangbyeongwon):**  Nursing hospital or long-term care hospital. This is the type of medical institution we are dealing with.
* **ê°œì„¤ ìš´ì˜í•˜ê³  ìžˆëŠ” ì˜ì‚¬ 'ê°‘' (gaeseol unyeonghago inneun uisa 'gap'):** Doctor 'Gap' who establishes and operates. This tells us the subject is a doctor who runs a nursing hospital.
* **ì˜ë£Œê¸°ê´€ ì¸ì¦í‰ê°€ë¥¼ ë°›ì€ í›„ ì˜ë£Œê¸°ê´€ ì¸ì¦ì„œë¥¼ êµë¶€ë°›ì•˜ë‹¤ (uiryogigwan ì¸ì¦pyeonggareul badeun hu uiryogigwan ì¸ì¦seoreul gyobubadeatda):**  Received medical institution certification after undergoing medical institution accreditation assessment and receiving a medical institution certification certificate. This is important â€“ the hospital is certified.
* **ìš”ì–‘ë³‘ì› ì§„ë£Œë‚´ìš©ê³¼ ì¸ì¦ ê²°ê³¼ë¥¼ ì‹œë‚´ë²„ìŠ¤ ì°¨ëŸ‰ì˜ ì™¸ë¶€ ì˜†ë©´ì— ê´‘ê³ í•˜ê¸° ìœ„í•´ (yoyangbyeongwon jinryonaeyonggwa ì¸ì¦ gyeolgwaleul sinaebeoseu charyang-ui oebu yeopmyeone gwang-gohagi wihae):** In order to advertise the nursing hospital's treatment details and certification results on the external side of a city bus. This is the core action: advertising.
* **ë¯¸ë¦¬ ì‹¬ì˜ë¥¼ ë°›ìœ¼ë ¤ í•  ë•Œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì‹ ì²­ì„œë¥¼ ì œì¶œí•´ì•¼ í•˜ëŠ” ê¸°ê´€ì€? (miri simuireul badeuryeo hal ttae uiryogwanggo simuisincheongseoreul jechulhaeya haneun gigwan-eun?):**  Which institution should the medical advertisement review application be submitted to when intending to receive prior review? This is the question itself - where to apply for pre-approval for the advertisement.

**In simpler English:**  A doctor operating a certified nursing hospital wants to advertise their hospital's services and certification on the side of a city bus.  Where should they submit their application for pre-approval of this medical advertisement?

**2. Identifying the Key Issue: Medical Advertisement Review**

The core of the question is *ì˜ë£Œê´‘ê³  ì‹¬ì˜ (uiryogwanggo simui)* - medical advertisement review or pre-approval.  This is the central concept to focus on. We need to know which organization is responsible for reviewing medical advertisements in Korea.

**3. Recalling Knowledge of Korean Medical Law/Regulations (or Quick Research if Unfamiliar)**

* **Medical Advertising Regulations in Korea:**  Korean medical law is quite strict about advertising medical institutions and services.  Pre-approval is generally required for many types of medical advertisements to protect patients and prevent misleading information.
* **Who Reviews Medical Ads?**  This is the crucial piece of information. In Korea, the **ì˜ë£Œê´‘ê³ ì‹¬ì˜ìœ„ì›íšŒ (uiryogwanggo simui wiwonhoe)** â€“ Medical Advertisement Review Committee â€“ is responsible for this. This committee is usually associated with or delegated to specific medical professional associations.

**4. Evaluating the Answer Choices (Analyze each option in Korean and English):**

* **A. ëŒ€í•œì˜ì‚¬í˜‘íšŒ (Daehan Uisa Hyeophoe): Korean Medical Association (KMA)** -  The KMA is the main professional organization for doctors in Korea.  They *do* play a role in medical advertisement review.  In fact, the Medical Advertisement Review Committee is often under the KMA's umbrella or delegated to them. This is a strong candidate.

* **B. êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨ (Gungmin Geongang Boheom Gongdan): National Health Insurance Service (NHIS)** - The NHIS is responsible for managing the national health insurance system. Their primary focus is on insurance, payments, and healthcare policy *financing*.  They are *not* primarily involved in advertisement review.  Less likely.

* **C. í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì› (Hanguk Bogeon Uiryo Yeonguwon): Korea Institute for Health and Social Affairs (KIHASA)** - KIHASA is a research institute focused on health and social welfare policy. They conduct research and advise the government. They are not involved in *advertisement review*. Unlikely.

* **D. ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì› (Uryogigwan Injeungpyeonggawon): Korea Institute for Healthcare Accreditation (KOIHA)** - KOIHA is the organization that conducts medical institution accreditation assessments (as mentioned in the question itself).  They *certify* hospitals. While related to hospital quality, their main role isn't *advertisement review*. Less likely.

* **E. í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì› (Hanguk Uiryo Bunjaeng Jojeong Jungjaewon): Korea Medical Dispute Mediation and Arbitration Agency (KMDMA)** - KMDMA handles medical disputes and mediation.  They are about *resolving* issues after they occur, not *preventing* misleading advertising.  Unlikely.

**5. Selecting the Most Likely Answer:**

Based on the analysis, the **Korean Medical Association (ëŒ€í•œì˜ì‚¬í˜‘íšŒ)** is the most likely organization to handle medical advertisement review applications.  They are the central professional body for doctors and are often delegated this responsibility by the Ministry of Health and Welfare.

**6. Confirmation (If Possible):**

A quick search for "ì˜ë£Œê´‘ê³  ì‹¬ì˜ ëŒ€í•œì˜ì‚¬í˜‘íšŒ" (medical advertisement review Korean Medical Association) in Korean would likely confirm that the KMA is indeed the relevant body for medical advertisement pre-approval in many cases, particularly for doctors and clinics.

**Conclusion:**

Therefore, the answer is **A. ëŒ€í•œì˜ì‚¬í˜‘íšŒ (Korean Medical Association)**.  The reasoning is based on understanding the core issue of medical advertisement review and knowing or deducing the relevant organization responsible for this in Korea.  The other options are related to healthcare but have different primary functions and are not the correct body for advertisement pre-approval.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **A. ëŒ€í•œì˜ì‚¬í˜‘íšŒ**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

* **ì˜ë£Œë²•** ì œ56ì¡° ë° ë™ë²• ì‹œí–‰ë ¹ ì œ23ì¡°ì— ë”°ë¥´ë©´, ì˜ë£Œê¸°ê´€ì˜ ê¸°ëŠ¥, ì§„ë£Œê³¼ëª©, ì§„ë£Œ ë‚´ìš© ë“±ì— ëŒ€í•œ ê´‘ê³ ëŠ” **ì‚¬ì „ì‹¬ì˜**ë¥¼ ë°›ì•„ì•¼ í•©ë‹ˆë‹¤.
* ì˜ë£Œê´‘ê³  ì‹¬ì˜ ì—…ë¬´ëŠ” ì˜ë£Œë²•ì— ë”°ë¼ **ê° ì˜ë£Œì¸ ë‹¨ì²´(ì˜ì‚¬í˜‘íšŒ, ì¹˜ê³¼ì˜ì‚¬í˜‘íšŒ, í•œì˜ì‚¬í˜‘íšŒ ë“±)**ì— ìœ„íƒë˜ì–´ ìžˆìŠµë‹ˆë‹¤.
* ë”°ë¼ì„œ ì˜ì‚¬ 'ê°‘'ì€ ì˜ì‚¬ì´ê¸° ë•Œë¬¸ì—, **ëŒ€í•œì˜ì‚¬í˜‘íšŒ**ì— ì˜ë£Œê´‘ê³  ì‹¬ì˜ì‹ ì²­ì„œë¥¼ ì œì¶œí•´ì•¼ í•©ë‹ˆë‹¤.

**ì˜¤ë‹µ ì´ìœ :**

* **B. êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨:** êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨ì€ ê±´ê°•ë³´í—˜ ë° ìž¥ê¸°ìš”ì–‘ë³´í—˜ ìš´ì˜ì„ ë‹´ë‹¹í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì™€ëŠ” ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.
* **C. í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì›:** í•œêµ­ë³´ê±´ì˜ë£Œì—°êµ¬ì›ì€ ë³´ê±´ì˜ë£Œ ê¸°ìˆ  í‰ê°€ ë° ì—°êµ¬ë¥¼ ìˆ˜í–‰í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì™€ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.
* **D. ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì›:** ì˜ë£Œê¸°ê´€ì¸ì¦í‰ê°€ì›ì€ ì˜ë£Œê¸°ê´€ ì¸ì¦í‰ê°€ë¥¼ ë‹´ë‹¹í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ, ì¸ì¦ ìžì²´ëŠ” ê´‘ê³ ì— í™œìš©ë  ìˆ˜ ìžˆì§€ë§Œ ê´‘ê³  ì‹¬ì˜ë¥¼ ë‹´ë‹¹í•˜ì§€ëŠ” ì•ŠìŠµë‹ˆë‹¤.
* **E. í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì›:** í•œêµ­ì˜ë£Œë¶„ìŸì¡°ì •ì¤‘ìž¬ì›ì€ ì˜ë£Œë¶„ìŸ ì¡°ì • ë° ì¤‘ìž¬ë¥¼ ë‹´ë‹¹í•˜ëŠ” ê¸°ê´€ìœ¼ë¡œ ì˜ë£Œê´‘ê³  ì‹¬ì˜ì™€ëŠ” ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.

**í•µì‹¬ ìš”ì•½:**

ì˜ë£Œê´‘ê³  ì‚¬ì „ì‹¬ì˜ëŠ” **í•´ë‹¹ ì˜ë£Œì¸ì˜ ì§ì—­ë³„ ì¤‘ì•™íšŒ (ì˜ì‚¬í˜‘íšŒ, ì¹˜ê³¼ì˜ì‚¬í˜‘íšŒ ë“±)**ì—ì„œ ë‹´ë‹¹í•©ë‹ˆë‹¤. ë”°ë¼ì„œ ì˜ì‚¬ì¸ 'ê°‘'ì€ **ëŒ€í•œì˜ì‚¬í˜‘íšŒ**ì— ì‹¬ì˜ì‹ ì²­ì„ í•´ì•¼ í•©ë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">61</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="4"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">nurse_assistant</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,023</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê°„í˜¸ì¡°ë¬´ì‚¬ê°€ ì§ì—…ìœ¤ë¦¬ë¥¼ ì‹¤ì²œí•˜ëŠ” ëª©ì ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë²•ì ì¸ ì±…ìž„ ë©´ì œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì—…ë¬´ ìˆ˜í–‰ ì‹œê°„ ë‹¨ì¶•</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í™˜ìžì˜ ë¹„ë°€ì„ ì¹œêµ¬ì™€ ê³µìœ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì§ë©´í•œ ìœ¤ë¦¬ì  ë”œë ˆë§ˆ íšŒí”¼</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">
The question is asking about the purpose of a nursing assistant practicing professional ethics. I need to analyze each option and choose the one that best represents the core reason for ethical practice in nursing assistance.

* **Analyze each option:**
    * **A. ë²•ì ì¸ ì±…ìž„ ë©´ì œ (Exemption from legal responsibility):** While ethical practice *can* help prevent legal issues, it's not the primary *purpose*. Ethics goes beyond just avoiding legal trouble. Legal compliance is a consequence, not the main goal.
    * **B. ì—…ë¬´ ìˆ˜í–‰ ì‹œê°„ ë‹¨ì¶• (Shortening work performance time):** Ethical practice might *sometimes* involve efficiency, but it's definitely not about shortening work time as the main purpose.  Ethical considerations can sometimes *increase* the time spent on a task (e.g., ensuring informed consent, providing emotional support).
    * **C. í™˜ìžì˜ ë¹„ë°€ì„ ì¹œêµ¬ì™€ ê³µìœ  (Sharing patient's secrets with friends):** This is the *opposite* of ethical practice.  Patient confidentiality is a core ethical principle. This option is clearly wrong.
    * **D. ì§ë©´í•œ ìœ¤ë¦¬ì  ë”œë ˆë§ˆ íšŒí”¼ (Avoiding ethical dilemmas faced):** Ethical practice isn't about avoiding dilemmas, but about *resolving* them in a principled way.  Dilemmas are inherent in healthcare, and ethics provides a framework for navigating them. This option is also incorrect.
    * **E. ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘ (Respect for human dignity and personality):** This aligns perfectly with the core principles of healthcare ethics.  Ethical practice in nursing, and nursing assistance, is fundamentally about respecting patients as individuals with inherent dignity and worth.

* **Identify the best answer:** Option E directly addresses the fundamental purpose of healthcare ethics â€“ respecting patients' dignity and personhood.  The other options are either irrelevant, incorrect, or represent side effects rather than the primary purpose.

* **Confirm the answer:**  Thinking about the core values of nursing and healthcare, patient-centered care, respect, dignity, and autonomy are central. Ethical practice is the means to uphold these values. Option E encapsulates this perfectly.

Therefore, the answer should be E.
</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **E. ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ê°„í˜¸ì¡°ë¬´ì‚¬ê°€ ì§ì—…ìœ¤ë¦¬ë¥¼ ì‹¤ì²œí•˜ëŠ” ê°€ìž¥ ì¤‘ìš”í•œ ëª©ì ì€ í™˜ìžë¥¼ ì¸ê°„ìœ¼ë¡œì„œ ì¡´ì¤‘í•˜ê³ , ê·¸ë“¤ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²©ì„ ë³´í˜¸í•˜ëŠ” ë° ìžˆìŠµë‹ˆë‹¤.  ë‹¤ë¥¸ ì„ íƒì§€ë“¤ì€ ìœ¤ë¦¬ ì‹¤ì²œì˜ ëª©ì ê³¼ëŠ” ê±°ë¦¬ê°€ ë©‰ë‹ˆë‹¤.

* **A. ë²•ì ì¸ ì±…ìž„ ë©´ì œ:** ìœ¤ë¦¬ì  ì‹¤ì²œì€ ë²•ì  ë¬¸ì œë¥¼ ì˜ˆë°©í•˜ëŠ” ë° ë„ì›€ì´ ë  ìˆ˜ ìžˆì§€ë§Œ, ë²•ì  ì±…ìž„ì„ íšŒí”¼í•˜ëŠ” ê²ƒì´ ìœ¤ë¦¬ ì‹¤ì²œì˜ ì£¼ëœ ëª©ì ì€ ì•„ë‹™ë‹ˆë‹¤. ìœ¤ë¦¬ëŠ” ë²•ë¥ ë³´ë‹¤ ë” ë†’ì€ ë„ë•ì  ê¸°ì¤€ì„ í¬í•¨í•©ë‹ˆë‹¤.
* **B. ì—…ë¬´ ìˆ˜í–‰ ì‹œê°„ ë‹¨ì¶•:** ìœ¤ë¦¬ì  ì‹¤ì²œì€ ë•Œë¡œëŠ” ì—…ë¬´ ì‹œê°„ì„ ëŠ˜ë¦´ ìˆ˜ë„ ìžˆìŠµë‹ˆë‹¤. í™˜ìžì˜ ê¶Œë¦¬ë¥¼ ì¡´ì¤‘í•˜ê³  ìœ¤ë¦¬ì  ë¬¸ì œë¥¼ í•´ê²°í•˜ëŠ” ë° ì¶©ë¶„í•œ ì‹œê°„ì„ í• ì• í•´ì•¼ í•˜ê¸° ë•Œë¬¸ìž…ë‹ˆë‹¤.
* **C. í™˜ìžì˜ ë¹„ë°€ì„ ì¹œêµ¬ì™€ ê³µìœ :** ì´ëŠ” ëª…ë°±ížˆ ìœ¤ë¦¬ ìœ„ë°˜ìž…ë‹ˆë‹¤. í™˜ìžì˜ ë¹„ë°€ ìœ ì§€ëŠ” ê°„í˜¸ ì§ì—… ìœ¤ë¦¬ì˜ í•µì‹¬ìž…ë‹ˆë‹¤.
* **D. ì§ë©´í•œ ìœ¤ë¦¬ì  ë”œë ˆë§ˆ íšŒí”¼:** ìœ¤ë¦¬ì  ë”œë ˆë§ˆë¥¼ íšŒí”¼í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ìœ¤ë¦¬ì  ì›ì¹™ì— ë”°ë¼ ë”œë ˆë§ˆë¥¼ í•´ê²°í•˜ê³  ìµœì„ ì˜ ê²°ì •ì„ ë‚´ë¦¬ëŠ” ê²ƒì´ ìœ¤ë¦¬ ì‹¤ì²œì˜ ëª©í‘œìž…ë‹ˆë‹¤.
* **E. ì¸ê°„ì˜ ì¡´ì—„ì„±ê³¼ ì¸ê²© ì¡´ì¤‘:**  í™˜ìžë¥¼ ë‹¨ìˆœížˆ ì¹˜ë£Œì˜ ëŒ€ìƒìœ¼ë¡œ ë³´ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì¡´ì—„í•œ ì¸ê°„ìœ¼ë¡œì„œ ì¡´ì¤‘í•˜ê³  ê·¸ë“¤ì˜ ê°€ì¹˜ì™€ ê¶Œë¦¬ë¥¼ ë³´í˜¸í•˜ëŠ” ê²ƒì´ ìœ¤ë¦¬ì  ì‹¤ì²œì˜ í•µì‹¬ìž…ë‹ˆë‹¤. ì´ëŠ” ê°„í˜¸ ë° ì˜ë£Œ ìœ¤ë¦¬ì˜ ê°€ìž¥ ê¸°ë³¸ì ì¸ ì›ì¹™ìž…ë‹ˆë‹¤.

**ë”°ë¼ì„œ ì •ë‹µì€ Eìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">6,586</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="5"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">pharm</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,019</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">86</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë§¥ë¥˜ê°€ ì§€ì†ë  ë•Œ ë°œìƒí•˜ëŠ” í•©ë³‘ì¦ì¸ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼(stasis dermatitis) ì˜ ë°œìƒ ê¸°ì „ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì•Œë¶€ë¯¼ì˜ í˜ˆê´€ ì™¸ ì¹¨ì°©</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë§¥ë¥˜ ë¶€ìœ„ì˜ ì„¸ê·  ê°ì—¼</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ëŒ€ì‹ì„¸í¬ì˜ ì‹ìž‘ìš©</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ë¦¼í”„êµ¬ì˜ ë©´ì—­ë°˜ì‘</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer and explanation for the question about stasis dermatitis and its mechanism.

**1. Deconstructing the Question:**

* **Keywords:** ì •ë§¥ë¥˜ (varicose veins), ì§€ì†ë  ë•Œ (persistent), í•©ë³‘ì¦ (complication), ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ (stasis dermatitis), ë°œìƒ ê¸°ì „ (pathogenesis/mechanism).
* **Core Question:** What is the underlying process that leads to stasis dermatitis when varicose veins persist?
* **Target Condition:** Stasis dermatitis (also known as venous stasis dermatitis or gravitational dermatitis).  This immediately signals a connection to venous insufficiency or poor venous return.
* **Answer Choices:**  The choices focus on different cellular/molecular events: albumin deposition, bacterial infection, red blood cell lysis, macrophage phagocytosis, lymphocyte immune response.  These are all plausible elements in various inflammatory or tissue damage scenarios, so we need to connect them specifically to venous insufficiency and stasis dermatitis.

**2.  Recalling Knowledge about Stasis Dermatitis:**

* **Etiology (Cause):** Primarily caused by chronic venous insufficiency. Varicose veins are a common manifestation of this.  The key is impaired venous return from the legs.
* **Pathophysiology (Mechanism):**  Venous hypertension (high pressure in veins) is the central issue. This leads to:
    * **Fluid leakage:** Increased pressure pushes fluid out of capillaries and venules into the surrounding tissues.
    * **Red blood cell extravasation:**  RBCs also leak out, along with other blood components.
    * **Inflammation:** The presence of leaked fluid and blood components triggers an inflammatory response.
    * **Skin changes:**  Chronic inflammation leads to the characteristic skin changes: edema, hyperpigmentation (brown discoloration), induration (hardening), and potentially ulceration.

**3.  Analyzing Each Answer Choice in Light of Stasis Dermatitis Pathophysiology:**

* **A. ì•Œë¶€ë¯¼ì˜ í˜ˆê´€ ì™¸ ì¹¨ì°© (Albumin extravascular deposition):** Albumin is a major plasma protein.  Increased vascular permeability *does* lead to albumin leakage. Albumin in the interstitial space can contribute to edema and inflammation.  This sounds *plausible*.

* **B. ì •ë§¥ë¥˜ ë¶€ìœ„ì˜ ì„¸ê·  ê°ì—¼ (Bacterial infection in varicose vein area):** While secondary bacterial infections can occur in stasis dermatitis (especially if ulcers develop), infection is *not* the primary mechanism of *developing* stasis dermatitis.  It's a complication *of* stasis dermatitis or ulcers, not the cause of the initial skin changes. This is *less likely* to be the primary mechanism.

* **C. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´ (Lysis of extravasated red blood cells):** This is a *key* point in stasis dermatitis.  Extravasated RBCs release hemoglobin.  Hemoglobin breaks down into hemosiderin, an iron-containing pigment. Hemosiderin deposition in the skin is responsible for the characteristic *brown* discoloration (hyperpigmentation) of stasis dermatitis. This sounds *very likely*.

* **D. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ëŒ€ì‹ì„¸í¬ì˜ ì‹ìž‘ìš© (Phagocytosis by extravasated macrophages):** Macrophages are involved in inflammation and tissue repair. They *will* be present in the area and *will* phagocytose debris, including RBCs and hemosiderin. However, their phagocytosis is a *response* to the underlying issue (RBC extravasation and lysis), not the primary *mechanism causing* the dermatitis. This is *less likely* to be the *primary* mechanism, although macrophages are involved in the overall process.

* **E. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ë¦¼í”„êµ¬ì˜ ë©´ì—­ë°˜ì‘ (Immune response by extravasated lymphocytes):** Lymphocytes are also involved in inflammation and immune responses. In chronic inflammation like stasis dermatitis, lymphocytes are present.  However, the *primary driver* of the skin changes isn't primarily a lymphocyte-mediated immune reaction like in allergic contact dermatitis.  While lymphocytes contribute to the inflammatory milieu, they aren't the *initiating mechanism* responsible for the characteristic skin changes. This is *less likely* to be the primary mechanism.

**4.  Comparing and Contrasting, Focusing on "Mechanism":**

We need to identify the *most direct and primary* mechanism for the *characteristic features* of stasis dermatitis, especially the brown discoloration.

* **Choice C (RBC lysis and hemosiderin deposition)** directly explains the brown discoloration, a hallmark of stasis dermatitis.  It's a direct consequence of venous hypertension and RBC extravasation.
* **Choice A (Albumin leakage)** contributes to edema but doesn't directly explain the *brown* discoloration.
* **Choices B, D, and E** are either secondary events (infection) or components of the inflammatory response but don't directly explain the *brown* pigmentation characteristic of stasis dermatitis.

**5.  Conclusion and Explanation:**

Choice C (í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´ - Lysis of extravasated red blood cells) is the most accurate and direct answer.

* **Explanation in Korean (similar to the provided example):** ì •ë§¥ë¥˜ê°€ ì§€ì†ë˜ë©´ ì •ë§¥ì•• ìƒìŠ¹ìœ¼ë¡œ ì¸í•´ í˜ˆê´€ì—ì„œ ì í˜ˆêµ¬ê°€ í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œë©ë‹ˆë‹¤. ìœ ì¶œëœ ì í˜ˆêµ¬ëŠ” ìš©í•´ë˜ì–´ í—¤ëª¨ê¸€ë¡œë¹ˆì„ ë°©ì¶œí•˜ê³ , í—¤ëª¨ê¸€ë¡œë¹ˆì€ í—¤ëª¨ì‹œë°ë¦°ìœ¼ë¡œ ì „í™˜ë©ë‹ˆë‹¤. í—¤ëª¨ì‹œë°ë¦°ì€ ê°ˆìƒ‰ ìƒ‰ì†Œì´ë¯€ë¡œ, í”¼ë¶€ì— ì¹¨ì°©ë˜ì–´ ê°ˆìƒ‰ì˜ ìƒ‰ì†Œ ì¹¨ì°©ì„ ìœ ë°œí•©ë‹ˆë‹¤. ë˜í•œ, ì í˜ˆêµ¬ ìš©í•´ ê³¼ì •ì—ì„œ ë°©ì¶œë˜ëŠ” ë¬¼ì§ˆë“¤ì€ ì—¼ì¦ ë°˜ì‘ì„ ìœ ë°œí•˜ì—¬ í”¼ë¶€ì—¼ì„ ì•…í™”ì‹œí‚µë‹ˆë‹¤. ë”°ë¼ì„œ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ ë°œìƒ ê¸°ì „ì€ í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´ìž…ë‹ˆë‹¤.

* **Explanation in English (for further clarity):**  Persistent varicose veins lead to venous hypertension, causing red blood cells to leak out of blood vessels into the surrounding tissues. These extravasated red blood cells are then lysed (broken down), releasing hemoglobin. Hemoglobin is further degraded into hemosiderin, an iron-containing pigment that is brown in color.  Hemosiderin deposition in the skin causes the characteristic brown pigmentation of stasis dermatitis.  Furthermore, the breakdown products of red blood cells contribute to inflammation, exacerbating the dermatitis. Therefore, the mechanism of stasis dermatitis is primarily the lysis of extravasated red blood cells.

This detailed thought process systematically eliminates incorrect options and reinforces why choice C is the correct answer, linking it directly to the key pathological feature of stasis dermatitis â€“ the brown discoloration and the underlying venous insufficiency mechanism.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **C. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ì˜ ìš©í•´** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼(stasis dermatitis)ì€ ë§Œì„± ì •ë§¥ ê¸°ëŠ¥ ë¶€ì „ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” í”¼ë¶€ ì§ˆí™˜ìž…ë‹ˆë‹¤.  ì •ë§¥ë¥˜ê°€ ì§€ì†ë˜ë©´ ë‹¤ìŒê³¼ ê°™ì€ ê¸°ì „ìœ¼ë¡œ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì´ ë°œìƒí•©ë‹ˆë‹¤.

1. **ì •ë§¥ì•• ìƒìŠ¹:** ì •ë§¥ë¥˜ëŠ” ì •ë§¥ì˜ íŒë§‰ ê¸°ëŠ¥ ë¶€ì „ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ë©°, ì´ëŠ” ë‹¤ë¦¬ ì •ë§¥ì˜ í˜ˆì•¡ ìˆœí™˜ ìž¥ì• ë¥¼ ì¼ìœ¼í‚¤ê³  ì •ë§¥ì••ì„ ìƒìŠ¹ì‹œí‚µë‹ˆë‹¤.
2. **í˜ˆê´€ íˆ¬ê³¼ì„± ì¦ê°€:** ì§€ì†ì ì¸ ì •ë§¥ì•• ìƒìŠ¹ì€ ëª¨ì„¸í˜ˆê´€ê³¼ ì†Œì •ë§¥ì˜ íˆ¬ê³¼ì„±ì„ ì¦ê°€ì‹œí‚µë‹ˆë‹¤.
3. **ì í˜ˆêµ¬ ë° í˜ˆìž¥ ì„±ë¶„ ìœ ì¶œ:** ì¦ê°€ëœ í˜ˆê´€ íˆ¬ê³¼ì„±ìœ¼ë¡œ ì¸í•´ ì í˜ˆêµ¬, ì•Œë¶€ë¯¼, ì„¬ìœ ì†Œì› ë“± í˜ˆìž¥ ì„±ë¶„ë“¤ì´ í˜ˆê´€ ë°– ì¡°ì§ìœ¼ë¡œ ìœ ì¶œë©ë‹ˆë‹¤.
4. **ì í˜ˆêµ¬ ìš©í•´ ë° í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©:** í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œëœ ì í˜ˆêµ¬ëŠ” íŒŒê´´(ìš©í•´)ë˜ê³ , ì í˜ˆêµ¬ ë‚´ì˜ í—¤ëª¨ê¸€ë¡œë¹ˆì€ í—¤ëª¨ì‹œë°ë¦°ì´ë¼ëŠ” ê°ˆìƒ‰ ìƒ‰ì†Œë¡œ ë³€í™˜ë©ë‹ˆë‹¤. ì´ í—¤ëª¨ì‹œë°ë¦°ì´ í”¼ë¶€ì— ì¹¨ì°©ë˜ì–´ ê°ˆìƒ‰ì˜ ìƒ‰ì†Œ ì¹¨ì°©ì„ ìœ ë°œí•©ë‹ˆë‹¤. ì´ê²ƒì´ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ íŠ¹ì§•ì ì¸ ê°ˆìƒ‰ ë³€ìƒ‰ì˜ ì›ì¸ìž…ë‹ˆë‹¤.
5. **ì—¼ì¦ ë°˜ì‘ ë° ì„¬ìœ í™”:** ìœ ì¶œëœ í˜ˆìž¥ ì„±ë¶„ê³¼ ì í˜ˆêµ¬ ìš©í•´ ì‚°ë¬¼ì€ í”¼ë¶€ì— ì—¼ì¦ ë°˜ì‘ì„ ìœ ë°œí•˜ê³ , ë§Œì„±ì ì¸ ì—¼ì¦ì€ í”¼ë¶€ì˜ ì„¬ìœ í™”ë¥¼ ì´‰ì§„í•˜ì—¬ í”¼ë¶€ë¥¼ ë‘ê»ê³  ë‹¨ë‹¨í•˜ê²Œ ë§Œë“¤ë©° (ê²½í™”), ê°€ë ¤ì›€ì¦, í†µì¦, ê¶¤ì–‘ ë“±ì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

**ì˜¤ë‹µ ì„ íƒì§€ í•´ì„¤:**

* **A. ì•Œë¶€ë¯¼ì˜ í˜ˆê´€ ì™¸ ì¹¨ì°©:** ì•Œë¶€ë¯¼ì€ í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œë  ìˆ˜ ìžˆì§€ë§Œ, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ ì£¼ëœ ë°œìƒ ê¸°ì „ì´ë¼ê¸°ë³´ë‹¤ëŠ” ë¶€ì¢…ê³¼ ê´€ë ¨ì´ ê¹ŠìŠµë‹ˆë‹¤. ì•Œë¶€ë¯¼ ìžì²´ëŠ” ê°ˆìƒ‰ ìƒ‰ì†Œ ì¹¨ì°©ì„ ìœ ë°œí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.
* **B. ì •ë§¥ë¥˜ ë¶€ìœ„ì˜ ì„¸ê·  ê°ì—¼:** ì„¸ê·  ê°ì—¼ì€ ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ í•©ë³‘ì¦ìœ¼ë¡œ ë°œìƒí•  ìˆ˜ ìžˆì§€ë§Œ, ì¼ì°¨ì ì¸ ë°œìƒ ê¸°ì „ì€ ì•„ë‹™ë‹ˆë‹¤. ê°ì—¼ì€ í”¼ë¶€ì—¼ì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆì§€ë§Œ, í”¼ë¶€ì—¼ ìžì²´ì˜ ì‹œìž‘ ì›ì¸ì€ ì•„ë‹™ë‹ˆë‹¤.
* **D. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ëŒ€ì‹ì„¸í¬ì˜ ì‹ìž‘ìš©:** ëŒ€ì‹ì„¸í¬ëŠ” í˜ˆê´€ ë°–ìœ¼ë¡œ ìœ ì¶œë˜ì–´ ì‹ìž‘ìš©ì„ í•  ìˆ˜ ìžˆì§€ë§Œ, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ ê°ˆìƒ‰ ìƒ‰ì†Œ ì¹¨ì°©ì˜ ì§ì ‘ì ì¸ ì›ì¸ì€ ì•„ë‹™ë‹ˆë‹¤. ëŒ€ì‹ì„¸í¬ëŠ” ì—¼ì¦ ë°˜ì‘ì— ê´€ì—¬í•˜ì§€ë§Œ, ì£¼ëœ ê¸°ì „ì€ ì í˜ˆêµ¬ ìš©í•´ì™€ í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©ìž…ë‹ˆë‹¤.
* **E. í˜ˆê´€ ì™¸ë¡œ ìœ ì¶œëœ ë¦¼í”„êµ¬ì˜ ë©´ì—­ë°˜ì‘:** ë¦¼í”„êµ¬ëŠ” ë©´ì—­ ë°˜ì‘ì— ê´€ì—¬í•˜ë©°, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì—ë„ ì—¼ì¦ ë°˜ì‘ì˜ ì¼ë¶€ë¡œ ë¦¼í”„êµ¬ê°€ ê´€ì—¬í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ì£¼ëœ ë°œìƒ ê¸°ì „ì€ ë¦¼í”„êµ¬ì˜ ë©´ì—­ ë°˜ì‘ë³´ë‹¤ëŠ” ì í˜ˆêµ¬ ìš©í•´ì™€ í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©ìž…ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ê°ˆìƒ‰ê²½í™”ì„± ì •ì²´í”¼ë¶€ì—¼ì˜ í•µì‹¬ ë°œìƒ ê¸°ì „ì€ ì •ë§¥ì•• ìƒìŠ¹ìœ¼ë¡œ ì¸í•œ ì í˜ˆêµ¬ì˜ í˜ˆê´€ ì™¸ ìœ ì¶œ ë° ìš©í•´, ê·¸ë¦¬ê³  ê·¸ ê²°ê³¼ë¡œ ë°œìƒí•˜ëŠ” í—¤ëª¨ì‹œë°ë¦° ì¹¨ì°©ìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3,145</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="6"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">nurse</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,019</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">45</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì§€ì—­ì‚¬íšŒê°„í˜¸ì‚¬ê°€ ì˜ì•„ë¥¼ ë‘” ë‹¤ë¬¸í™” ì—¬ì„±ì„ ëŒ€ìƒìœ¼ë¡œ ê³ í˜•ì‹ì— ëŒ€í•´ êµìœ¡í•˜ë ¤ê³  í•  ë•Œ ë¬¸í™”ì  ì°¨ì´ì ì„ í™•ì¸í•˜ê¸° ìœ„í•´ ì‚¬ì •í•´ì•¼ í•  ì‚¬í•­ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìœ ì¹˜ì˜ ê°œìˆ˜</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì•„ê¸°ì˜ ì›”ë ¹</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">
The question is asking about what a community health nurse should assess to understand cultural differences when educating a multicultural woman with an infant about solid foods.  Let's break down each option and think about its relevance to cultural differences and solid food education.

* **A. ìœ ì¹˜ì˜ ê°œìˆ˜ (Number of baby teeth):**  While the number of teeth *can* be an indicator of readiness for certain textures of food (and sometimes related to developmental stage), it's not directly tied to cultural differences in solid food introduction.  Different cultures might introduce solids at different stages regardless of teeth, and the types of solids offered could vary culturally.  Teeth are more of a biological factor than a cultural one in this context.

* **B. ì•„ê¸°ì˜ ì›”ë ¹ (Infant's age in months):**  Age is a crucial factor in determining when to start solids in general.  However, cultural practices can significantly influence *when* and *how* solids are introduced.  For example, some cultures might start earlier or later than the generally recommended age, and the types of first foods might differ based on cultural norms.  Age provides a baseline, but cultural context is essential for tailoring education.

* **C. ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€ (Whether solid foods are being given):**  Knowing if the mother is *already* introducing solids is important.  If she is, the nurse needs to understand *what* she's giving and *why*.  This can reveal cultural practices and potential misunderstandings or needs for guidance.  If she isn't, the nurse needs to understand her knowledge and beliefs about when to start, which can also be culturally influenced.  This option seems quite relevant to understanding current practices and potential cultural influences.

* **D. ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ (Infant's height and weight):**  Growth parameters are important for assessing the infant's overall health and nutritional status.  While nutrition is related to solid food introduction, height and weight themselves don't directly reveal cultural differences in *approaches* to solid foods.  They are more about the *outcome* of feeding practices, not the cultural practices themselves.  Growth monitoring is important in general, but not the primary factor for assessing cultural differences in solid food education.

* **E. ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™” (Country of origin and Korean food culture):**  This option directly addresses cultural differences.  Understanding the mother's country of origin and its food culture is crucial to understand her background beliefs and practices regarding infant feeding.  Comparing her culture's food practices with Korean food culture (the context of the nurse's practice and potentially the dominant culture the mother is navigating) is essential for culturally sensitive education.  This option appears highly relevant to assessing cultural differences.

**Comparing C and E:** Both C and E are strong contenders.

* **C (ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€):**  Focuses on current practice.  It's important to know what's happening *now*.  However, it doesn't directly address the *cultural background* driving those practices.

* **E (ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”):** Directly addresses the cultural background.  Knowing her origin and comparing it to the local culture provides the context for understanding *why* certain practices might be in place or preferred.

**The question is specifically about identifying cultural differences.**  While knowing if solids are being given (C) is useful information, understanding the cultural *context* (E) is more directly relevant to identifying and addressing cultural differences in solid food education.  Knowing the cultural background helps the nurse understand the *reasons* behind current practices and tailor education accordingly.

**Consider a scenario:** A nurse is educating a woman from a Southeast Asian country about solid foods.

* Knowing the number of teeth (A) or height/weight (D) is generally useful but not culturally specific.
* Knowing the infant's age (B) is important for general guidance but doesn't capture cultural nuances.
* Knowing if she's giving solids (C) is helpful to know current practice, but not *why* she's doing it that way.
* Knowing her country of origin and understanding its food culture (E) is *crucial*.  For example, in some cultures, rice porridge might be a very early and culturally preferred first food, while in others, pureed fruits or vegetables might be more common.  Understanding these cultural norms is essential for respectful and effective education.  Comparing it to Korean food culture can also highlight potential differences or areas where she might need support navigating the new cultural context.


**Conclusion:** Option E, "ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™” (Country of origin and Korean food culture)," is the most direct and relevant factor to assess to understand cultural differences when educating a multicultural woman about solid foods.  It provides the cultural context needed to tailor education effectively.  While C is also relevant, E is more fundamental for understanding cultural differences.


Therefore, the answer is likely **E**.

Let's re-examine the options in Korean to double-check the nuances:

* A. ìœ ì¹˜ì˜ ê°œìˆ˜: Number of deciduous teeth (baby teeth)
* B. ì•„ê¸°ì˜ ì›”ë ¹: Baby's age in months
* C. ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€: Whether solid food is being implemented/given
* D. ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ: Baby's height and weight
* E. ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”: Country of origin and Korean food culture

The question specifically asks about assessing "ë¬¸í™”ì  ì°¨ì´ì  (cultural differences)."  Option E directly addresses this.  The other options are less directly related to cultural differences in solid food education specifically.

**Final Answer: E.**

Let's confirm the logic again.  To provide culturally competent education on solid foods, a community health nurse needs to understand the mother's cultural background and how it might differ from the dominant culture (Korean in this case).  This understanding is best achieved by assessing her country of origin and the food culture of both her origin and the host country. This allows for tailoring the education to respect her cultural practices while ensuring the infant's nutritional needs are met within a safe and healthy framework.
</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">**ì •ë‹µì€ E. ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ì§€ì—­ì‚¬íšŒê°„í˜¸ì‚¬ê°€ ë‹¤ë¬¸í™” ì—¬ì„±ì—ê²Œ ì˜ì•„ ê³ í˜•ì‹ êµìœ¡ì„ í•  ë•Œ ë¬¸í™”ì  ì°¨ì´ë¥¼ í™•ì¸í•˜ê¸° ìœ„í•´ ê°€ìž¥ ë¨¼ì € ì‚¬ì •í•´ì•¼ í•  ê²ƒì€ **ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”**ìž…ë‹ˆë‹¤. ê·¸ ì´ìœ ëŠ” ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.

* **ë¬¸í™”ì  ë°°ê²½ì˜ ì¤‘ìš”ì„±:**  ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°, ì¢…ë¥˜, ë°©ë²• ë“±ì€ ë¬¸í™”ì  ë°°ê²½ì— ë”°ë¼ í¬ê²Œ ë‹¤ë¥¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ê° ë¬¸í™”ê¶Œë§ˆë‹¤ ì „í†µì ìœ¼ë¡œ ì˜ì•„ì—ê²Œ ë¨¹ì´ëŠ” ìŒì‹, ì„ í˜¸í•˜ëŠ” ì§ˆê°, ì‹ìž¬ë£Œ ë“±ì´ ë‹¤ë¥´ë©°, ì´ëŸ¬í•œ ë¬¸í™”ì  ì°¨ì´ë¥¼ ì´í•´í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.
* **íš¨ê³¼ì ì¸ êµìœ¡:**  ë‹¤ë¬¸í™” ì—¬ì„±ì˜ ì¶œì‹ êµ­ ìŒì‹ ë¬¸í™”ë¥¼ ì´í•´í•˜ë©´, í•œêµ­ ë¬¸í™”ì™€ì˜ ì°¨ì´ì ì„ íŒŒì•…í•˜ê³ , ê·¸ë…€ì˜ ë¬¸í™”ì  ë°°ê²½ì„ ì¡´ì¤‘í•˜ë©´ì„œ í•œêµ­ ë¬¸í™”ì— ì ì‘í•  ìˆ˜ ìžˆë„ë¡ ë§žì¶¤í˜• êµìœ¡ì„ ì œê³µí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì˜ˆë¥¼ ë“¤ì–´, íŠ¹ì • ë¬¸í™”ê¶Œì—ì„œëŠ” ìŒ€ë¯¸ìŒì„ ë¨¼ì € ì‹œìž‘í•˜ëŠ” ë°˜ë©´, ë‹¤ë¥¸ ë¬¸í™”ê¶Œì—ì„œëŠ” ê³¼ì¼ì´ë‚˜ ì±„ì†Œë¥¼ ë¨¼ì € ì‹œìž‘í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì´ëŸ¬í•œ ì°¨ì´ë¥¼ ì•Œê³  êµìœ¡í•´ì•¼ êµìœ¡ì˜ íš¨ê³¼ë¥¼ ë†’ì¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.
* **ì‹ ë¢° ê´€ê³„ í˜•ì„±:**  ê°„í˜¸ì‚¬ê°€ ëŒ€ìƒìžì˜ ë¬¸í™”ì  ë°°ê²½ì— ê´€ì‹¬ì„ ê°€ì§€ê³  ì´í•´í•˜ë ¤ëŠ” ë…¸ë ¥ì„ ë³´ì´ë©´, ëŒ€ìƒìžì™€ì˜ ì‹ ë¢° ê´€ê³„ë¥¼ í˜•ì„±í•˜ëŠ” ë° ë„ì›€ì´ ë©ë‹ˆë‹¤. ì‹ ë¢° ê´€ê³„ëŠ” íš¨ê³¼ì ì¸ ê°„í˜¸ ì¤‘ìž¬ì˜ ê¸°ë³¸ìž…ë‹ˆë‹¤.

**ë‹¤ë¥¸ ì„ íƒì§€ ì˜¤ë‹µ ì´ìœ :**

* **A. ìœ ì¹˜ì˜ ê°œìˆ˜:** ìœ ì¹˜ì˜ ê°œìˆ˜ëŠ” ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°ë¥¼ ê²°ì •í•˜ëŠ” ì¼ë°˜ì ì¸ ì§€í‘œê°€ ë  ìˆ˜ ìžˆì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ë¥¼ íŒŒì•…í•˜ëŠ” ë° ì§ì ‘ì ì¸ ì •ë³´ëŠ” ì•„ë‹™ë‹ˆë‹¤. ìœ ì¹˜ ë°œë‹¬ì€ ê°œì¸ì°¨ê°€ í¬ê³  ë¬¸í™”ì  ë°°ê²½ê³¼ ì§ì ‘ì ì¸ ê´€ë ¨ì€ ì ìŠµë‹ˆë‹¤.
* **B. ì•„ê¸°ì˜ ì›”ë ¹:** ì•„ê¸°ì˜ ì›”ë ¹ì€ ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°ë¥¼ ê²°ì •í•˜ëŠ” ì¤‘ìš”í•œ ìš”ì†Œì´ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ë¥¼ ì„¤ëª…í•´ì£¼ì§€ëŠ” ì•ŠìŠµë‹ˆë‹¤. ì›”ë ¹ì€ ì¼ë°˜ì ì¸ ê°€ì´ë“œë¼ì¸ì¼ ë¿, ë¬¸í™”ì— ë”°ë¼ ê³ í˜•ì‹ ì‹œìž‘ ì‹œê¸°ì— ëŒ€í•œ ê´€ì ì´ ë‹¤ë¥¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.
* **C. ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€:** ê³ í˜•ì‹ ìˆ˜í–‰ ì—¬ë¶€ë¥¼ í™•ì¸í•˜ëŠ” ê²ƒì€ í˜„ìž¬ ìƒí™©ì„ íŒŒì•…í•˜ëŠ” ë° ë„ì›€ì´ ë˜ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ì˜ ê·¼ë³¸ì ì¸ ì›ì¸ì„ ì•Œ ìˆ˜ëŠ” ì—†ìŠµë‹ˆë‹¤. ì´ë¯¸ ê³ í˜•ì‹ì„ í•˜ê³  ìžˆë‹¤ë©´ ì–´ë–¤ ì¢…ë¥˜ì˜ ìŒì‹ì„ ì£¼ê³  ìžˆëŠ”ì§€, ê·¸ ì´ìœ ëŠ” ë¬´ì—‡ì¸ì§€ ë¬¸í™”ì  ë°°ê²½ê³¼ í•¨ê»˜ íŒŒì•…í•´ì•¼ í•©ë‹ˆë‹¤.
* **D. ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²Œ:** ì•„ê¸°ì˜ í‚¤ì™€ ëª¸ë¬´ê²ŒëŠ” ì„±ìž¥ ë°œë‹¬ ìƒíƒœë¥¼ í‰ê°€í•˜ëŠ” ì¤‘ìš”í•œ ì§€í‘œì´ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ë¥¼ ì§ì ‘ì ìœ¼ë¡œ ë°˜ì˜í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ì˜ì–‘ ìƒíƒœ í‰ê°€ì— í•„ìš”í•˜ì§€ë§Œ, ë¬¸í™”ì  ì°¨ì´ ì‚¬ì •ì˜ ìš°ì„ ìˆœìœ„ëŠ” ì•„ë‹™ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ë‹¤ë¬¸í™” ì—¬ì„±ì—ê²Œ íš¨ê³¼ì ì¸ ê³ í˜•ì‹ êµìœ¡ì„ ì œê³µí•˜ê¸° ìœ„í•´ì„œëŠ” ê·¸ë…€ì˜ ë¬¸í™”ì  ë°°ê²½ì„ ì´í•´í•˜ëŠ” ê²ƒì´ ê°€ìž¥ ì¤‘ìš”í•˜ë©°, ì´ë¥¼ ìœ„í•´ ì¶œì‹ êµ­ê³¼ í•œêµ­ì˜ ìŒì‹ ë¬¸í™”ì— ëŒ€í•œ ì‚¬ì •ì´ í•„ìˆ˜ì ìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,411</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="7"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">dental_technician</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,019</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì•ˆê¶(face bow)ì— ê´€í•œ ì„¤ëª…ìœ¼ë¡œ ì˜³ì€ ê²ƒì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">êµí•©ê´€ê³„ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê¸°êµ¬ì´ë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ” ê¸°êµ¬ì´ë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë³´ì² ë¬¼ì„ ì œìž‘í•˜ëŠ” ë°ì— ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ ì´ë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer (D) for the question about face bows.

**1. Understanding the Question:**

The question is asking for the *correct* description of a face bow.  This immediately tells me I need to know what a face bow is and what it does.  The Korean term "ì•ˆê¶" is given, and it's translated as "face bow" in English.  The answer choices are all in Korean and relate to different aspects of dental procedures.  I need to translate and understand each choice in the context of a face bow.

**2.  Initial Brainstorm and Recall about Face Bows:**

My immediate thoughts about face bows are:

* **Dentistry:** It's a dental instrument.
* **Relating jaws to skull:**  It's used to transfer the relationship of the upper jaw (maxilla) to the skull.  This is the key function I recall.
* **Articulator:** It's used in conjunction with an articulator (êµí•©ê¸° in Korean), a device that simulates jaw movements for dental lab work.
* **Mounting maxillary cast:** The face bow helps mount the maxillary cast (upper jaw model) onto the articulator in a way that mimics the patient's actual jaw position relative to their skull.
* **Not about guides for movements:** It's *not* primarily about guiding jaw movements like protrusion (forward) or lateral (sideways).  Those are related to condylar guidance and incisal guidance, which are *set on the articulator* *after* mounting the casts, often *using* face bow information, but the face bow itself isn't the guide.
* **Not directly for prosthesis fabrication guide:** While the face bow information *is* crucial for accurate prosthesis fabrication, it's not *directly* a "guide" in the sense of shaping the prosthesis itself. It sets up the *articulation* which *then* guides prosthesis fabrication.

**3. Analyzing Each Answer Choice (and Translating):**

Let's translate and analyze each option:

* **A. êµí•©ê´€ê³„ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê¸°êµ¬ì´ë‹¤. (It is an instrument to reproduce occlusal relationships.)**
    * *Analysis:*  While face bows contribute to reproducing occlusal relationships on the articulator, this is a *very* broad statement and could apply to many dental instruments.  It's not *specific* to the primary function of a face bow. It's *partially* true but not the best answer.

* **B. ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤. (It is an instrument that acts as a guide for protrusive movement.)**
    * *Analysis:* Face bows do *not* directly guide protrusive movement.  Protrusive movement is guided by the condylar guidance on the articulator, set *after* face bow transfer.  This is *incorrect*.

* **C. ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤. (It is an instrument that acts as a guide for lateral movement.)**
    * *Analysis:* Similar to B, face bows do *not* directly guide lateral movement. Lateral movement is also guided by condylar guidance on the articulator. This is *incorrect*.

* **D. ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ” ê¸°êµ¬ì´ë‹¤. (It is an instrument that transfers the positional relationship of the maxilla from the skull.)**
    * *Analysis:* This is the *most accurate and specific* description of a face bow's primary function.  "ë‘ê°œê³¨" (skull), "ìƒì•…" (maxilla), "ìœ„ì¹˜ ê´€ê³„" (positional relationship), and "ì˜®ê¸°ëŠ” ê¸°êµ¬" (instrument to transfer) perfectly describe what a face bow does. This looks like the correct answer.

* **E. ë³´ì² ë¬¼ì„ ì œìž‘í•˜ëŠ” ë°ì— ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ ì´ë‹¤. (It is an instrument that acts as a guide in fabricating prostheses.)**
    * *Analysis:* Again, while face bow information is *essential* for accurate prosthesis fabrication, the face bow itself isn't a *direct guide* in the *fabrication process*. It provides the *foundation* (accurate articulation) upon which a prosthesis can be fabricated correctly.  It's too broad and not the *primary* function.  It's *indirectly* related, but not the best answer.

**4.  Confirming the Best Answer:**

Comparing the analyses, option D stands out as the most precise and accurate description of the core function of a face bow. Options A and E are too general, while B and C are factually incorrect.

**5. Final Answer Selection:**

Therefore, the best and most correct answer is **D**.

**Self-Correction/Refinement during the Process:**

* Initially, I might have considered A as *partially* correct because face bows *do* contribute to occlusal relationships.  However, realizing it's too broad and doesn't capture the *specific* function helped me refine my thinking.
* I double-checked my understanding of "guide" in the context of B, C, and E. I clarified that "guide" in these options is meant in the sense of *directly controlling movement* or *shaping the prosthesis*, which is not what a face bow does directly. It's more about establishing the *correct starting point* for articulation.
* I focused on the keyword "ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ”" (transferring the positional relationship of the maxilla from the skull) in option D and recognized this as the defining purpose of a face bow.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **D. ë‘ê°œê³¨ì—ì„œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì˜®ê¸°ëŠ” ê¸°êµ¬ì´ë‹¤.** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

* **ì•ˆê¶ (Face Bow) ì˜ ì£¼ìš” ê¸°ëŠ¥:** ì•ˆê¶ì€ í™˜ìžì˜ **ë‘ê°œê³¨**ì„ ê¸°ì¤€ìœ¼ë¡œ **ìƒì•…** ì¹˜ì•„ê¶ì˜ **3ì°¨ì›ì ì¸ ìœ„ì¹˜ ê´€ê³„**ë¥¼ ì±„ë“í•˜ì—¬ êµí•©ê¸°ë¼ëŠ” ê¸°ê³„ë¡œ ì˜®ê¸°ëŠ” ê¸°êµ¬ìž…ë‹ˆë‹¤.  ì‰½ê²Œ ë§í•´, í™˜ìžì˜ ì–¼êµ´ì—ì„œ ìœ—í„±ì˜ ìœ„ì¹˜ë¥¼ ì •í™•í•˜ê²Œ ë³¸ë– ì„œ êµí•©ê¸°ì— ìž¬í˜„í•˜ëŠ” ì—­í• ì„ í•©ë‹ˆë‹¤.

* **ê° ì„ íƒì§€ë³„ ì˜¤ë‹µ ì´ìœ :**

    * **A. êµí•©ê´€ê³„ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê¸°êµ¬ì´ë‹¤.**  (X) : êµí•©ê´€ê³„ ìž¬í˜„ì— *ì¼ì • ë¶€ë¶„* ê¸°ì—¬í•˜ì§€ë§Œ, ì•ˆê¶ì˜ *ì£¼ìš” ê¸°ëŠ¥*ì€ êµí•©ê´€ê³„ ìžì²´ë¥¼ ìž¬í˜„í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼ **ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„**ë¥¼ ì˜®ê¸°ëŠ” ê²ƒìž…ë‹ˆë‹¤. êµí•©ê´€ê³„ëŠ” êµí•©ê¸° ìƒì—ì„œ í•˜ì•… ëª¨í˜•ê³¼ í•¨ê»˜ ìž¬í˜„ë©ë‹ˆë‹¤.  ë”°ë¼ì„œ ë„ˆë¬´ í¬ê´„ì ì¸ ì„¤ëª…ìž…ë‹ˆë‹¤.

    * **B. ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.** (X) : ì „ë°©ìš´ë™ì˜ ê°€ì´ë“œ (protrusive guide) ëŠ” ì£¼ë¡œ êµí•©ê¸° ìƒì—ì„œ **ê³¼ë¡œ (condylar path)** ì„¤ì •ì„ í†µí•´ ìž¬í˜„ë©ë‹ˆë‹¤. ì•ˆê¶ì€ ì „ë°©ìš´ë™ ê°€ì´ë“œì™€ ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.

    * **C. ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ì´ë‹¤.** (X) : ì¸¡ë°©ìš´ë™ì˜ ê°€ì´ë“œ (lateral guide) ì—­ì‹œ ì£¼ë¡œ êµí•©ê¸° ìƒì—ì„œ **ê³¼ë¡œ (condylar path)** ë° **Bennet angle** ì„¤ì •ì„ í†µí•´ ìž¬í˜„ë©ë‹ˆë‹¤. ì•ˆê¶ì€ ì¸¡ë°©ìš´ë™ ê°€ì´ë“œì™€ ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.

    * **E. ë³´ì² ë¬¼ì„ ì œìž‘í•˜ëŠ” ë°ì— ê°€ì´ë“œ(guide) ì—­í• ì„ í•˜ëŠ” ê¸°êµ¬ ì´ë‹¤.** (X) : ì•ˆê¶ì€ ë³´ì² ë¬¼ ì œìž‘ ê³¼ì •ì—ì„œ **ì •í™•í•œ êµí•©**ì„ êµ¬í˜„í•˜ëŠ” ë° *í•„ìˆ˜ì ì¸ ì •ë³´*ë¥¼ ì œê³µí•˜ì§€ë§Œ, ì§ì ‘ì ìœ¼ë¡œ ë³´ì² ë¬¼ ì œìž‘ì„ *ê°€ì´ë“œ* í•˜ëŠ” ê¸°êµ¬ëŠ” ì•„ë‹™ë‹ˆë‹¤. ë³´ì² ë¬¼ ì œìž‘ ê°€ì´ë“œëŠ” ì£¼ë¡œ ì¸ìƒìž¬, ì™ìŠ¤ì—…, ë ˆì§„ ë“± ë‹¤ë¥¸ ìž¬ë£Œì™€ ê¸°êµ¬ë¥¼ í†µí•´ ì´ë£¨ì–´ì§‘ë‹ˆë‹¤.  ì•ˆê¶ì€ ê·¸ **ê¸°ì´ˆì ì¸ ìœ„ì¹˜ ì •ë³´**ë¥¼ ì œê³µí•˜ëŠ” ì—­í• ìž…ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ì•ˆê¶ì˜ ê°€ìž¥ í•µì‹¬ì ì¸ ê¸°ëŠ¥ì€ ë‘ê°œê³¨ì„ ê¸°ì¤€ìœ¼ë¡œ í•œ ìƒì•…ì˜ ìœ„ì¹˜ ê´€ê³„ë¥¼ ì •í™•í•˜ê²Œ ì˜®ê²¨ êµí•©ê¸°ì—ì„œ ìž¬í˜„í•˜ì—¬, í™˜ìžì˜ ì‹¤ì œ êµ¬ê°• ë‚´ ìƒí™©ê³¼ ìœ ì‚¬í•œ í™˜ê²½ì—ì„œ ë³´ì² ë¬¼ì„ ì œìž‘í•  ìˆ˜ ìžˆë„ë¡ ë•ëŠ” ê²ƒìž…ë‹ˆë‹¤. ë”°ë¼ì„œ Dê°€ ê°€ìž¥ ì •í™•í•œ ì„¤ëª…ìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4,750</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="8"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">pharm</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,020</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">64</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í˜„ìž¬ ìœ ë°©ì•” ì¹˜ë£Œ ì¤‘ì¸ 52ì„¸ í™˜ìžì—ê²Œ íê²½ê¸° í˜ˆê´€ìš´ë™ì¦ìƒ(vasomotor symptom) ê³¼ ìš°ìš¸ì¦ìƒì´ ë‚˜íƒ€ë‚˜ ì¹˜ë£Œë¥¼ ì‹œìž‘í•˜ë ¤ê³  í•œë‹¤. ì ì ˆí•œ ì•½ë¬¼ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë¼ë¡ì‹œíŽœ(raloxifene)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë²¤ë¼íŒì‹ (venlafaxine)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (medroxyprogesterone)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë°”ì œë…ì‹œíŽœ/ì—ìŠ¤íŠ¸ë¡œê²(bazedoxifene/conjugated equine estrogen)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì—ìŠ¤íŠ¸ë¼ë””ì˜¬/ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (estradiol/medroxyprogesterone)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer for this clinical scenario.

**1. Deconstructing the Question:**

* **Patient Profile:** 52-year-old woman, currently undergoing breast cancer treatment.  This is *critical*. Breast cancer treatment immediately raises red flags regarding hormone-sensitive therapies.
* **Symptoms:** Vasomotor symptoms (hot flashes, night sweats) and depressive symptoms. These are common menopausal symptoms, but also could be side effects of breast cancer treatment itself (like chemotherapy or endocrine therapy).
* **Goal:**  Treat vasomotor and depressive symptoms *in the context of ongoing breast cancer treatment*. This means we need to prioritize safety and avoid exacerbating the cancer or interfering with its treatment.
* **Question Type:**  "Appropriate medication." This is a medication selection question, requiring knowledge of drug classes and their contraindications/indications, particularly in the context of breast cancer.

**2. Analyzing Each Answer Option:**

* **A. Raloxifene (ë¼ë¡ì‹œíŽœ):**
    * Class: Selective Estrogen Receptor Modulator (SERM).
    * Mechanism: Estrogen agonist in bone, antagonist in breast and uterus.
    * Breast Cancer: Used for breast cancer risk reduction and treatment of osteoporosis in postmenopausal women.  However, it's *not* for vasomotor symptoms and *could* potentially have complex interactions in a patient currently *undergoing* breast cancer treatment.  While it's not directly contraindicated, it's not a primary choice for vasomotor symptoms, and we need to be cautious in a patient actively being treated.  *Initial thought: Maybe, but unlikely best option for symptoms.*

* **B. Venlafaxine (ë²¤ë¼íŒì‹ ):**
    * Class: Serotonin-Norepinephrine Reuptake Inhibitor (SNRI).
    * Mechanism: Antidepressant, also effective for vasomotor symptoms in menopausal women, especially those who cannot or should not take hormone therapy.
    * Breast Cancer: Generally considered safe in breast cancer patients.  Non-hormonal approach.  Addresses both depression and vasomotor symptoms. *Initial thought: Strong candidate.*

* **C. Medroxyprogesterone (ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ ):**
    * Class: Progestin (synthetic progesterone).
    * Mechanism: Can sometimes help with vasomotor symptoms, but less effective than estrogen. Historically used, but not preferred.
    * Breast Cancer:  Progestins *can* stimulate breast cancer growth in some cases.  Generally contraindicated or used with extreme caution in breast cancer patients.  Definitely not a first-line choice. *Initial thought:  Likely contraindicated, very risky.*

* **D. Bazedoxifene/Conjugated Equine Estrogen (ë°”ì œë…ì‹œíŽœ/ì—ìŠ¤íŠ¸ë¡œê²):**
    * Class:  Estrogen with a SERM (bazedoxifene).  "Tissue-selective estrogen complex (TSEC)".
    * Mechanism:  Estrogen component for vasomotor symptoms; bazedoxifene to protect the uterus from estrogen's proliferative effects.
    * Breast Cancer: *Estrogen is generally contraindicated in breast cancer patients*, especially those currently being treated.  Adding bazedoxifene doesn't negate the estrogen risk in breast tissue.  This combination is for menopausal symptoms, but absolutely contraindicated due to the estrogen component. *Initial thought:  Strong contraindication, definitely wrong.*

* **E. Estradiol/Medroxyprogesterone (ì—ìŠ¤íŠ¸ë¼ë””ì˜¬/ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ ):**
    * Class:  Estrogen and Progestin (Hormone Therapy - HT).
    * Mechanism: Estrogen for vasomotor symptoms; progestin to protect the uterus from estrogen.
    * Breast Cancer: *Absolutely contraindicated* in breast cancer patients, especially during active treatment.  Estrogen and progestin can fuel breast cancer growth.  This is the classic hormone therapy regimen and is the *opposite* of what's safe in this context. *Initial thought:  Strongest contraindication, definitively wrong.*

**3. Prioritization and Selection:**

* **Rule out contraindicated options:** D and E are estrogen-containing therapies, absolutely contraindicated in breast cancer. C (medroxyprogesterone alone) is also risky and less effective, not a good choice.
* **Compare remaining options:** A (raloxifene) and B (venlafaxine).
    * Raloxifene is a SERM, and while not directly contraindicated, it's not the best choice for vasomotor symptoms, and its complex estrogen agonist/antagonist profile raises concerns during active breast cancer treatment. It's more for osteoporosis prevention and breast cancer risk reduction in *high-risk* women, not symptom management in *active* breast cancer.
    * Venlafaxine is a non-hormonal SNRI, effective for both vasomotor symptoms and depression. It's considered safe and often used in breast cancer patients experiencing menopausal symptoms.

**4. Final Answer and Justification:**

Venlafaxine (ë²¤ë¼íŒì‹ ) is the most appropriate choice because:

* It effectively treats both vasomotor symptoms and depressive symptoms.
* It is a non-hormonal option, avoiding the risks associated with estrogen or progestin in a breast cancer patient.
* It is generally considered safe and well-tolerated in breast cancer patients.

Therefore, the answer is **B**.

**Self-Correction/Refinement during the process:**

Initially, I might have briefly considered raloxifene because it has some "breast-related" actions. However, upon closer examination, realizing it's not primarily for symptom relief and the context of *active* breast cancer treatment, venlafaxine emerges as the clearly superior and safer choice.  The key is always to prioritize patient safety and contraindications, especially in complex cases like this.  Thinking about *why* each option is right or wrong, and explicitly considering the patient's specific situation, leads to the correct answer.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **B. ë²¤ë¼íŒì‹ (venlafaxine)** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

**í™˜ìž ìƒíƒœ:**

* 52ì„¸ ì—¬ì„±
* í˜„ìž¬ ìœ ë°©ì•” ì¹˜ë£Œ ì¤‘
* íê²½ê¸° í˜ˆê´€ìš´ë™ì¦ìƒ (vasomotor symptom, ì•ˆë©´í™ì¡°, ì•¼ê°„ ë°œí•œ ë“±)
* ìš°ìš¸ ì¦ìƒ

**ê° ì„ íƒì§€ ë¶„ì„:**

* **A. ë¼ë¡ì‹œíŽœ(raloxifene):**  ì„ íƒì  ì—ìŠ¤íŠ¸ë¡œê² ìˆ˜ìš©ì²´ ì¡°ì ˆì œ(SERM)ë¡œ, íê²½ í›„ ì—¬ì„±ì˜ ê³¨ë‹¤ê³µì¦ ì¹˜ë£Œ ë° ìœ ë°©ì•” ì˜ˆë°©ì— ì‚¬ìš©ë©ë‹ˆë‹¤.  í•˜ì§€ë§Œ í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™” íš¨ê³¼ëŠ” ì œí•œì ì´ë©°, ìœ ë°©ì•” í™˜ìžì—ê²ŒëŠ” ì£¼ëœ ì¹˜ë£Œ ì˜µì…˜ì´ ì•„ë‹™ë‹ˆë‹¤. ì˜¤ížˆë ¤ ìœ ë°©ì•” ì¹˜ë£Œ ì¤‘ì¸ í™˜ìžì—ê²ŒëŠ” ì‹ ì¤‘í•˜ê²Œ ì‚¬ìš©í•´ì•¼ í•©ë‹ˆë‹¤.

* **B. ë²¤ë¼íŒì‹ (venlafaxine):**  ì„¸ë¡œí† ë‹Œ-ë…¸ë¥´ì—í”¼ë„¤í”„ë¦° ìž¬í¡ìˆ˜ ì–µì œì œ(SNRI) ê³„ì—´ì˜ í•­ìš°ìš¸ì œë¡œ, í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™” íš¨ê³¼ê°€ ìž…ì¦ë˜ì—ˆìŠµë‹ˆë‹¤.  íŠ¹ížˆ ìœ ë°©ì•” í™˜ìžë‚˜ í˜¸ë¥´ëª¬ ì¹˜ë£Œê°€ ê¸ˆê¸°ì¸ ì—¬ì„±ì—ê²Œ í˜ˆê´€ìš´ë™ì¦ìƒ ì¹˜ë£Œì˜ 1ì°¨ ì„ íƒ ì•½ë¬¼ë¡œ ê¶Œìž¥ë©ë‹ˆë‹¤. ìš°ìš¸ ì¦ìƒ ê°œì„ ì—ë„ íš¨ê³¼ì ì´ë¯€ë¡œ ì´ í™˜ìžì—ê²Œ ì ì ˆí•œ ì„ íƒìž…ë‹ˆë‹¤.

* **C. ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (medroxyprogesterone):**  í”„ë¡œê²ŒìŠ¤í‹´ ì œì œë¡œ, ê³¼ê±° í˜ˆê´€ìš´ë™ì¦ìƒ ì¹˜ë£Œì— ì‚¬ìš©ë˜ê¸°ë„ í–ˆì§€ë§Œ, ì—ìŠ¤íŠ¸ë¡œê²ì— ë¹„í•´ íš¨ê³¼ê°€ ë–¨ì–´ì§€ê³  ë¶€ìž‘ìš© ìœ„í—˜ì´ ìžˆìŠµë‹ˆë‹¤. íŠ¹ížˆ ìœ ë°©ì•” í™˜ìžì—ê²ŒëŠ” í”„ë¡œê²ŒìŠ¤í…Œë¡ ì´ ìœ ë°©ì•” ì„¸í¬ ì„±ìž¥ì„ ì´‰ì§„í•  ìˆ˜ ìžˆë‹¤ëŠ” ìš°ë ¤ ë•Œë¬¸ì— ì¼ë°˜ì ìœ¼ë¡œ ê¶Œìž¥ë˜ì§€ ì•ŠìŠµë‹ˆë‹¤.

* **D. ë°”ì œë…ì‹œíŽœ/ì—ìŠ¤íŠ¸ë¡œê²(bazedoxifene/conjugated equine estrogen):**  ì—ìŠ¤íŠ¸ë¡œê²ê³¼ ì„ íƒì  ì—ìŠ¤íŠ¸ë¡œê² ìˆ˜ìš©ì²´ ì¡°ì ˆì œ(SERM) ë³µí•©ì œìž…ë‹ˆë‹¤. ì—ìŠ¤íŠ¸ë¡œê²ì€ í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™”ì— íš¨ê³¼ì ì´ì§€ë§Œ, ìœ ë°©ì•” ë³‘ë ¥ì´ ìžˆê±°ë‚˜ í˜„ìž¬ ì¹˜ë£Œ ì¤‘ì¸ í™˜ìžì—ê²ŒëŠ” ê¸ˆê¸°ìž…ë‹ˆë‹¤. ì—ìŠ¤íŠ¸ë¡œê²ì€ ìœ ë°©ì•” ìž¬ë°œ ìœ„í—˜ì„ ë†’ì¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

* **E. ì—ìŠ¤íŠ¸ë¼ë””ì˜¬/ë©”ë“œë¡ì‹œí”„ë¡œê²ŒìŠ¤í…Œë¡ (estradiol/medroxyprogesterone):**  ì—ìŠ¤íŠ¸ë¡œê²ê³¼ í”„ë¡œê²ŒìŠ¤í…Œë¡  ë³µí•© í˜¸ë¥´ëª¬ ì¹˜ë£Œì œìž…ë‹ˆë‹¤.  Dì™€ ë§ˆì°¬ê°€ì§€ë¡œ ì—ìŠ¤íŠ¸ë¡œê² ì„±ë¶„ ë•Œë¬¸ì— ìœ ë°©ì•” í™˜ìžì—ê²ŒëŠ” ê¸ˆê¸°ìž…ë‹ˆë‹¤.

**ê²°ë¡ :**

ìœ ë°©ì•” ì¹˜ë£Œ ì¤‘ì¸ í™˜ìžì—ê²Œ í˜ˆê´€ìš´ë™ì¦ìƒê³¼ ìš°ìš¸ ì¦ìƒ ì¹˜ë£Œë¥¼ ìœ„í•´ ê°€ìž¥ ì ì ˆí•œ ì•½ë¬¼ì€ **B. ë²¤ë¼íŒì‹ (venlafaxine)** ìž…ë‹ˆë‹¤. ë²¤ë¼íŒì‹ ì€ ë¹„í˜¸ë¥´ëª¬ ì œì œë¡œ ìœ ë°©ì•”ì— ëŒ€í•œ ìœ„í—˜ ì—†ì´ í˜ˆê´€ìš´ë™ì¦ìƒê³¼ ìš°ìš¸ ì¦ìƒì„ ë™ì‹œì— íš¨ê³¼ì ìœ¼ë¡œ ê´€ë¦¬í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

**ì°¸ê³ :**

* ìœ ë°©ì•” í™˜ìžì˜ íê²½ê¸° ì¦ìƒ ê´€ë¦¬ëŠ” í˜¸ë¥´ëª¬ ì¹˜ë£Œë³´ë‹¤ëŠ” ë¹„í˜¸ë¥´ëª¬ ì¹˜ë£Œë¥¼ ìš°ì„ ì ìœ¼ë¡œ ê³ ë ¤í•©ë‹ˆë‹¤.
* ë²¤ë¼íŒì‹  ì™¸ì—ë„ ì„ íƒì  ì„¸ë¡œí† ë‹Œ ìž¬í¡ìˆ˜ ì–µì œì œ(SSRI) ê³„ì—´ì˜ í•­ìš°ìš¸ì œ (ì˜ˆ: íŒŒë¡ì„¸í‹´, ì‹œíƒˆë¡œí”„ëžŒ, ì—ìŠ¤ì‹œíƒˆë¡œí”„ëžŒ) ë˜í•œ í˜ˆê´€ìš´ë™ì¦ìƒ ì™„í™”ì— íš¨ê³¼ì ì´ë©° ìœ ë°©ì•” í™˜ìžì—ê²Œ ì‚¬ìš© ê°€ëŠ¥í•©ë‹ˆë‹¤.
* í™˜ìžì˜ ìƒíƒœì™€ ì„ í˜¸ë„, ì•½ë¬¼ ë¶€ìž‘ìš© ë“±ì„ ê³ ë ¤í•˜ì—¬ ê°œë³„ì ìœ¼ë¡œ ì¹˜ë£Œ ê³„íšì„ ìˆ˜ë¦½í•´ì•¼ í•©ë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3,579</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="9"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">dentist</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,020</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">28</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì´ì˜ì¹˜ ì•…ê°„ê´€ê³„ ê¸°ë¡ê³¼ì •ì—ì„œ ë‹¤ìŒ ìˆ ì‹ìœ¼ë¡œ ì±„ë“í•˜ëŠ” ê²ƒì€?
Â· ìˆ ìžì˜ ì™¼ì†ìœ¼ë¡œ í™˜ìžì˜ êµ¬ê°•ë‚´ ìƒí•˜ì•… ê¸°ë¡ìƒì„ ì¹˜ì¡°ì œì— ì •í™•í•˜ê²Œ ìœ„ì¹˜ì‹œí‚¨ë‹¤. Â· ìˆ ìžì˜ ì˜¤ë¥¸ì† ì—„ì§€ë¥¼ í™˜ìžì˜ ì´ë¶€ì— ìœ„ì¹˜ì‹œí‚¤ê³  í„±ì„ ê°€ë³ê²Œ ìž¡ëŠ”ë‹¤. Â· í™˜ìžì˜ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ ì ‘ë²ˆìš´ë™ì„ í™•ì¸ í›„ íêµ¬ì‹œí‚¨ë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¤‘ì‹¬ìœ„</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì „ë°©í™œì£¼ë¡œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìµœëŒ€ê°œêµ¬ìœ„</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìµœì „ë°©ì ‘ì´‰ìœ„</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í›„ë°©í•œê³„ê°œêµ¬ë¡œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer for the given question about interocclusal record taking in complete dentures.

**1. Deconstructing the Question:**

The question is asking about a specific technique for obtaining an interocclusal record in complete denture prosthodontics.  It provides a step-by-step procedure and asks what position this procedure is intended to record.  The key is to carefully analyze the described steps.

**2. Analyzing the Provided Steps:**

Let's go through each step and interpret its significance:

* **"ìˆ ìžì˜ ì™¼ì†ìœ¼ë¡œ í™˜ìžì˜ êµ¬ê°•ë‚´ ìƒí•˜ì•… ê¸°ë¡ìƒì„ ì¹˜ì¡°ì œì— ì •í™•í•˜ê²Œ ìœ„ì¹˜ì‹œí‚¨ë‹¤."** (The operator's left hand accurately positions the maxillary and mandibular record bases onto the alveolar ridges within the patient's mouth.)
    * *Interpretation:* This step sets the stage for recording a jaw relationship. Record bases are used in complete denture fabrication to simulate denture bases and provide a stable platform for recording jaw positions.  "ì¹˜ì¡°ì œ" (alveolar ridge) is crucial â€“ it indicates we're dealing with edentulous patients.

* **"ìˆ ìžì˜ ì˜¤ë¥¸ì† ì—„ì§€ë¥¼ í™˜ìžì˜ ì´ë¶€ì— ìœ„ì¹˜ì‹œí‚¤ê³  í„±ì„ ê°€ë³ê²Œ ìž¡ëŠ”ë‹¤."** (The operator's right thumb is positioned on the patient's chin and gently holds the jaw.)
    * *Interpretation:* This step describes how the operator is manipulating the patient's mandible.  Placing the thumb on the chin and gently holding the jaw implies controlled mandibular manipulation.

* **"í™˜ìžì˜ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ ì ‘ë²ˆìš´ë™ì„ í™•ì¸ í›„ íêµ¬ì‹œí‚¨ë‹¤."** (Gently push the patient's mandible posteriorly and superiorly, check for hinge movement, and then close the mouth.)
    * *Interpretation:* This is the *most* critical step. "í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ" (gently push posteriorly and superiorly) is the key maneuver. "ì ‘ë²ˆìš´ë™" (hinge movement) is also extremely important. This procedure is designed to guide the mandible into a specific, repeatable position.  Pushing posteriorly and superiorly, along with checking for hinge movement, strongly suggests an attempt to locate the **centric relation**.

**3. Connecting Steps to Dental Concepts:**

Now, let's link these interpreted steps to known dental concepts, especially related to interocclusal records:

* **Centric Relation (CR):**  CR is a maxillomandibular relationship where the condyles are in their most superior-anterior position in the glenoid fossae, resting against the posterior slopes of the articular eminences, with the discs interposed.  It's a hinge position, and it's considered a reproducible and physiologically acceptable starting point for denture construction.  The described technique of pushing posteriorly and superiorly *strongly* aligns with attempts to achieve CR.

* **Protrusive Record (ì „ë°©í™œì£¼ë¡œ):** This record captures the mandible in a protruded position, used for setting condylar guidance on articulators. The described technique doesn't involve protrusion; it's about posterior and superior movement.

* **Maximum Intercuspation (MI) or Maximum Opening (ìµœëŒ€ê°œêµ¬ìœ„):** MI is the position of maximum tooth contact. Maximum opening is the widest mouth opening.  The described technique isn't about either of these.  It's about a specific jaw *relationship*, not maximum opening or tooth intercuspation (which isn't relevant in edentulous patients with record bases).

* **Retruded Contact Position (RCP) or Centric Occlusion (CO) (ìµœì „ë°©ì ‘ì´‰ìœ„):** RCP/CO refers to the first tooth contact in centric relation.  While related to CR, the description emphasizes achieving the condylar position (hinge movement) rather than just the first contact.  The focus is on the *position* of the condyles, which is the definition of CR.  "ìµœì „ë°©ì ‘ì´‰ìœ„" (most anterior contact position) could be misinterpreted as CO, but in the context of the procedure described (posterior-superior guidance), it's not the best fit.  Also, "ìµœì „ë°©ì ‘ì´‰ìœ„" is a less common term, and while it might sometimes be used synonymously with CO, it doesn't capture the essence of the CR-seeking maneuver.

* **Maximum Retrusion (í›„ë°©í•œê³„ê°œêµ¬ë¡œ):** This refers to the most retruded position the mandible can achieve.  While the technique involves posterior movement, the description doesn't aim for the *extreme* retrusion.  It's about a controlled, reproducible hinge position, not just pushing the mandible as far back as possible.  Also, "í›„ë°©í•œê³„ê°œêµ¬ë¡œ" is a less direct translation and might be confusing in this context. "í›„ë°©í•œê³„ê°œêµ¬ë¡œ" might refer to the posterior limit of opening movement, which is not what the procedure is describing.

**4. Selecting the Best Answer:**

Based on the analysis, the procedure described is clearly aimed at recording **Centric Relation (ì¤‘ì‹¬ìœ„)**. The key phrases "í›„ìƒë°©ìœ¼ë¡œ ê°€ë³ê²Œ ë°€ë©´ì„œ" (gently push posteriorly and superiorly) and "ì ‘ë²ˆìš´ë™" (hinge movement) are strong indicators of a centric relation recording technique.

**5. Confirming and Refining (Self-Correction):**

Let's re-read the question and the steps to ensure no misinterpretations. The steps are consistent with a common technique for guiding the mandible into centric relation in edentulous patients. The options are:

* A. ì¤‘ì‹¬ìœ„ (Centric Relation) - **Strong candidate**
* B. ì „ë°©í™œì£¼ë¡œ (Protrusive Record) - Incorrect, procedure is posterior, not anterior.
* C. ìµœëŒ€ê°œêµ¬ìœ„ (Maximum Opening Position) - Incorrect, procedure is about jaw relation, not opening.
* D. ìµœì „ë°©ì ‘ì´‰ìœ„ (Most Anterior Contact Position) - Less precise, and the technique is focused on condylar position, not first contact.  Also, "ìµœì „ë°©ì ‘ì´‰ìœ„" is a slightly unusual term; "ì¤‘ì‹¬êµí•©ìœ„" (Centric Occlusion) would be more common and still not the best fit.
* E. í›„ë°©í•œê³„ê°œêµ¬ë¡œ (Maximum Retrusion Opening) -  Incorrect, procedure is not about maximum retrusion or opening limit.

**Conclusion:**  The most accurate answer is **A. ì¤‘ì‹¬ìœ„ (Centric Relation)**. The described technique is a classic method for guiding the mandible into centric relation for recording in complete denture prosthodontics.  The other options are not supported by the described steps.  The Korean terms also reinforce this conclusion, with "ì¤‘ì‹¬ìœ„" being the standard term for Centric Relation in Korean dentistry.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **A. ì¤‘ì‹¬ìœ„**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ì—¬ ì ‘ë²ˆìš´ë™ì„ í™•ì¸í•˜ëŠ” ê³¼ì •ìœ¼ë¡œ, ì´ëŠ” **ì¤‘ì‹¬ìœ„(Centric Relation)**ë¥¼ ì±„ë“í•˜ê¸° ìœ„í•œ ëŒ€í‘œì ì¸ ë°©ë²•ìž…ë‹ˆë‹¤.

ê° ì„ íƒì§€ë³„ ì„¤ëª…ì€ ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.

* **A. ì¤‘ì‹¬ìœ„ (Centric Relation):**  í•˜ì•… ê³¼ë‘ê°€ ê´€ì ˆì™€ì˜ ê°€ìž¥ ìƒë°©-í›„ë°© ìœ„ì¹˜ì— ë†“ì´ëŠ” ì•…ìœ„ ê´€ê³„ìž…ë‹ˆë‹¤. ì´ì˜ì¹˜ ì œìž‘ ì‹œ ê¸°ì¤€ ì•…ìœ„ë¡œ ì‚¬ìš©ë˜ë©°, ìž¬í˜„ì„±ì´ ë†’ì€ ìœ„ì¹˜ìž…ë‹ˆë‹¤. ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ì—¬ ì¤‘ì‹¬ìœ„ë¥¼ ì±„ë“í•˜ëŠ” ì „í˜•ì ì¸ ë°©ë²•ê³¼ ì¼ì¹˜í•©ë‹ˆë‹¤.

* **B. ì „ë°©í™œì£¼ë¡œ (Protrusive Record):** í•˜ì•…ì„ ì „ë°©ìœ¼ë¡œ ë‚´ë°€ì—ˆì„ ë•Œì˜ ì•…ìœ„ ê´€ê³„ë¥¼ ê¸°ë¡í•˜ëŠ” ê²ƒìž…ë‹ˆë‹¤.  ì£¼ë¡œ êµí•©ê¸° ìƒì—ì„œ ì „ë°©ìœ ë„ê°ì„ ì„¤ì •í•˜ê¸° ìœ„í•´ ì‚¬ìš©ë©ë‹ˆë‹¤. ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ ì „ë°©ìœ¼ë¡œ ë‚´ë¯¸ëŠ” ê²ƒì´ ì•„ë‹ˆë¼ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ë¯€ë¡œ ì „ë°©í™œì£¼ë¡œì™€ëŠ” ê±°ë¦¬ê°€ ë©‰ë‹ˆë‹¤.

* **C. ìµœëŒ€ê°œêµ¬ìœ„ (Maximum Opening Position):** ìž…ì„ ìµœëŒ€í•œ í¬ê²Œ ë²Œë ¸ì„ ë•Œì˜ ìœ„ì¹˜ìž…ë‹ˆë‹¤. ì•…ê´€ì ˆ ì§ˆí™˜ í‰ê°€ ë“±ì— ì‚¬ìš©ë  ìˆ˜ ìžˆì§€ë§Œ, ì•…ê°„ê´€ê³„ ê¸°ë¡ê³¼ëŠ” ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤. ì œì‹œëœ ìˆ ì‹ì€ ìž…ì„ ë²Œë¦¬ëŠ” ë™ìž‘ê³¼ëŠ” ê´€ë ¨ì´ ì—†ê³ , í•˜ì•…ì˜ íŠ¹ì • ìœ„ì¹˜ë¥¼ ìœ ë„í•˜ëŠ” ê²ƒì— ì´ˆì ì„ ë§žì¶”ê³  ìžˆìŠµë‹ˆë‹¤.

* **D. ìµœì „ë°©ì ‘ì´‰ìœ„ (Most Anterior Contact Position):** í•˜ì•…ì„ ìµœëŒ€í•œ ì „ë°©ìœ¼ë¡œ ë‚´ë°€ì–´ ì¹˜ì•„ê°€ ì²˜ìŒ ë‹¿ëŠ” ìœ„ì¹˜ë¥¼ ì˜ë¯¸í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ì¼ë°˜ì ìœ¼ë¡œ "ìµœì „ë°©ì ‘ì´‰ìœ„"ë¼ëŠ” ìš©ì–´ëŠ” ì¤‘ì‹¬ìœ„ë‚˜ ì¤‘ì‹¬êµí•©ìœ„ì™€ ê°™ì€ íŠ¹ì • ì•…ìœ„ ê´€ê³„ë¥¼ ì§€ì¹­í•˜ëŠ” í‘œì¤€ì ì¸ ìš©ì–´ëŠ” ì•„ë‹™ë‹ˆë‹¤.  ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ë¯€ë¡œ ìµœì „ë°©ì ‘ì´‰ìœ„ì™€ëŠ” ë°˜ëŒ€ ë°©í–¥ìž…ë‹ˆë‹¤.

* **E. í›„ë°©í•œê³„ê°œêµ¬ë¡œ (Maximum Retrusion Opening):** í•˜ì•…ì„ ìµœëŒ€í•œ í›„ë°©ìœ¼ë¡œ ë°€ë©´ì„œ ìž…ì„ ë²Œë¦´ ë•Œì˜ ê²½ë¡œë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.  ì•…ê´€ì ˆ í‰ê°€ ë“±ì— ì‚¬ìš©ë  ìˆ˜ ìžˆì§€ë§Œ, ì•…ê°„ê´€ê³„ ê¸°ë¡ê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.  ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ë°©ìœ¼ë¡œ ìœ ë„í•˜ì§€ë§Œ, ê°œêµ¬ ìš´ë™ë³´ë‹¤ëŠ” íêµ¬ ìƒíƒœì—ì„œ ì¤‘ì‹¬ìœ„ë¥¼ ê¸°ë¡í•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ì œì‹œëœ ìˆ ì‹ì€ í•˜ì•…ì„ í›„ìƒë°©ìœ¼ë¡œ ìœ ë„í•˜ì—¬ ì ‘ë²ˆìš´ë™ì„ í™•ì¸í•˜ëŠ” ì¤‘ì‹¬ìœ„ ì±„ë“ ë°©ë²•ê³¼ ì •í™•ížˆ ì¼ì¹˜í•˜ë¯€ë¡œ, ì •ë‹µì€ A. ì¤‘ì‹¬ìœ„ìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">16</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="10"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">doctor</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,013</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">26</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">6ê°œì›” ë‚¨ì•„ê°€ ì¶œìƒ í›„ë¶€í„° í•˜ì§€ì˜ ì›€ì§ìž„ì´ ì—†ì–´ ë³‘ì›ì— ì™”ë‹¤. ê°œêµ¬ë¦¬ ë‹¤ë¦¬ ëª¨ì–‘ì„ í•˜ê³  ëˆ„ì›Œ ìžˆì—ˆë‹¤.í˜€ì— ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•(fasciculation) ì´ ë³´ì˜€ë‹¤. ë‹¤ë¦¬ì— ìžê·¹ì„ ì£¼ì–´ë„ ì›€ì§ìž„ì´ ì—†ì—ˆê³ , ê¹Šì€íž˜ì¤„ë°˜ì‚¬ëŠ”ì—†ì—ˆë‹¤. í˜ˆì•¡ê²€ì‚¬ ê²°ê³¼ëŠ” ë‹¤ìŒê³¼ ê°™ì•˜ë‹¤. ì§„ë‹¨ì€?ì•„ìŠ¤íŒŒë¥´í…Œì´íŠ¸ì•„ë¯¸ë…¸ì „ë‹¬íš¨ì†Œ 30 U/L, ì•Œë¼ë‹Œì•„ë¯¸ë…¸ì „ë‹¬íš¨ì†Œ 20 U/L,í¬ë ˆì•„í‹´í‚¤ë‚˜ì•„ì œ 100 U/L (ì°¸ê³ ì¹˜, 5ï½ž130), ì –ì‚°íƒˆìˆ˜ì†Œíš¨ì†Œ 170 U/L (ì°¸ê³ ì¹˜, 170ï½ž580) </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë‡Œì„±ë§ˆë¹„</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¤‘ì¦ê·¼ë¬´ë ¥ì¦</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê¸¸ëž­- ë°”ë ˆì¦í›„êµ°</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down this medical case step-by-step to arrive at the most likely diagnosis.

**1. Understanding the Patient Presentation:**

* **Age:** 6 months old infant. This is crucial, as certain conditions are more common or present differently at this age.
* **Chief Complaint:** Lack of leg movement since birth. This is a significant neurological symptom.
* **Posture:** "Frog-leg position."  This posture in infants often suggests hypotonia (low muscle tone) and weakness, particularly in the hips and legs.
* **Physical Exam Findings:**
    * **Tongue fasciculations:** Involuntary muscle twitches of the tongue. This is a key finding indicating *lower motor neuron* involvement.
    * **No leg movement to stimulation:**  Strongly suggests paralysis or severe weakness in the legs.
    * **Absent deep tendon reflexes:**  This is another crucial finding pointing towards *lower motor neuron* pathology.

**2. Interpreting the Lab Results:**

* **Aspartate aminotransferase (AST) 30 U/L, Alanine aminotransferase (ALT) 20 U/L:** These are liver enzymes.  The values are within normal limits.  This is not particularly helpful for differentiating the given diagnoses.  It rules out significant liver damage, which is not directly relevant to the neurological symptoms.
* **Creatine kinase (CK) 100 U/L (Reference: 5-130 U/L):** CK is an enzyme released from muscle tissue when it's damaged. The value is *within the normal range*.  While some muscle diseases elevate CK, a normal CK level doesn't exclude all muscle disorders.  It makes rapidly progressing muscle degeneration *less likely*, but doesn't rule out slower or congenital myopathies entirely.  However, in the context of other findings, it weakens the possibility of something like Duchenne muscular dystrophy (which usually has *very* high CK levels).
* **Lactate dehydrogenase (LDH) 170 U/L (Reference: 170-580 U/L):** LDH is another enzyme found in many tissues, including muscle.  The value is at the *lower end of the normal range*. This is also not particularly helpful in differentiating the diagnoses and does not point strongly to muscle damage.

**3.  Analyzing the Differential Diagnoses and Matching with Findings:**

Let's evaluate each option based on the clinical picture:

* **A. Cerebral Palsy (ë‡Œì„±ë§ˆë¹„):**
    * **Pros:** Can present with limb weakness and abnormal posture.
    * **Cons:**  *Usually* presents with *upper motor neuron* signs (increased reflexes, spasticity).  Tongue fasciculations and absent deep tendon reflexes are *not* typical of cerebral palsy.  Cerebral palsy is caused by brain damage, not primarily lower motor neuron issues.  While hypotonia can occur in some forms of CP, the combination of hypotonia, absent reflexes, and fasciculations makes CP less likely as the *primary* diagnosis.

* **B. Myasthenia Gravis (ì¤‘ì¦ê·¼ë¬´ë ¥ì¦):**
    * **Pros:** Can cause muscle weakness, and in infants, it can present with generalized weakness ("floppy baby").
    * **Cons:**  *No fasciculations*.  Myasthenia gravis is a *neuromuscular junction* disorder, not a motor neuron disease. Deep tendon reflexes are typically *normal* or only mildly reduced.  Tongue fasciculations are not a feature.

* **C. Guillain-BarrÃ© Syndrome (ê¸¸ëž­-ë°”ë ˆì¦í›„êµ°):**
    * **Pros:** Can cause rapidly progressive weakness, areflexia (absent reflexes), and hypotonia.
    * **Cons:**  *Rare* in infants, especially at birth.  GBS is usually an *acquired* condition, often post-infectious.  Presenting *at birth* is extremely atypical.  While GBS affects peripheral nerves, tongue fasciculations are less commonly described.  However, in severe cases with bulbar involvement, cranial nerve issues could manifest. Still, less typical than the other findings.

* **D. Progressive Muscular Dystrophy (ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼):**
    * **Pros:** Can cause muscle weakness and hypotonia. Some types can present early in infancy.
    * **Cons:**  CK is usually *significantly elevated* in muscular dystrophies, especially Duchenne and Becker.  The *normal CK* makes this less likely.  Fasciculations are *not* a typical feature of muscular dystrophies. Deep tendon reflexes might be reduced later in the disease, but are not the primary early finding.

* **E. Spinal Muscular Atrophy (SMA) (ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦):**
    * **Pros:** Fits *perfectly* with the clinical picture.
        * **Onset at birth/early infancy:**  SMA Type 1 (Werdnig-Hoffmann disease) is a severe form presenting at birth or within the first few months of life.
        * **Generalized weakness, especially legs:**  "Frog-leg position" is classic for SMA Type 1.
        * **Tongue fasciculations:**  A *hallmark* of SMA due to lower motor neuron involvement.
        * **Absent deep tendon reflexes:**  Another *hallmark* of lower motor neuron disease like SMA.
        * **Normal CK (or only slightly elevated):**  Consistent with SMA.  CK might be slightly elevated due to chronic muscle atrophy, but not dramatically so in early stages.
        * **Normal liver enzymes and LDH:** Consistent with SMA.

**4. Conclusion:**

Considering all the clinical and lab findings, **Spinal Muscular Atrophy (SMA)** is the most consistent diagnosis.  The key findings of *tongue fasciculations*, *absent deep tendon reflexes*, *generalized weakness (especially legs)*, and the *infantile onset* strongly point towards SMA.  The normal CK level does not rule out SMA and is indeed typical in early SMA.

Therefore, the answer is **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Spinal Muscular Atrophy)**.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ì œì‹œëœ ì¦ìƒê³¼ ê²€ì‚¬ ê²°ê³¼ëŠ” ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Spinal Muscular Atrophy, SMA)ì˜ ì „í˜•ì ì¸ íŠ¹ì§•ì„ ë³´ìž…ë‹ˆë‹¤. ê° ì„ íƒì§€ë¥¼ í•˜ë‚˜ì”© ì‚´íŽ´ë³´ê² ìŠµë‹ˆë‹¤.

* **A. ë‡Œì„±ë§ˆë¹„ (Cerebral Palsy):** ë‡Œì„±ë§ˆë¹„ëŠ” ì¶œìƒ ì „í›„ì˜ ë‡Œ ì†ìƒìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ë©°, ìš´ë™ ë° ìžì„¸ ìž¥ì• ë¥¼ ì¼ìœ¼í‚µë‹ˆë‹¤. í•˜ì§€ë§Œ ë‡Œì„±ë§ˆë¹„ëŠ” ì¼ë°˜ì ìœ¼ë¡œ *ìƒìœ„ ìš´ë™ ì‹ ê²½ì›* ì§ˆí™˜ìœ¼ë¡œ, ì‹¬ë¶€ê±´ë°˜ì‚¬í•­ì§„, ê²½ì§ê³¼ ê°™ì€ ì¦ìƒì„ ë³´ìž…ë‹ˆë‹¤. í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ í”í•˜ì§€ ì•Šìœ¼ë©°, ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤ì€ ë‡Œì„±ë§ˆë¹„ì˜ ì£¼ìš” íŠ¹ì§•ì´ ì•„ë‹™ë‹ˆë‹¤.

* **B. ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ (Myasthenia Gravis):** ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ì€ ì‹ ê²½-ê·¼ ì ‘í•©ë¶€ì˜ ì´ìƒìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ì§ˆí™˜ìœ¼ë¡œ, ê·¼ìœ¡ì˜ í”¼ë¡œì™€ ì‡ ì•½ì´ íŠ¹ì§•ìž…ë‹ˆë‹¤. í•˜ì§€ë§Œ ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ì€ *ë³€ë™ì„±* ê·¼ë ¥ ì•½í™”ë¥¼ ë³´ì´ë©°, í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ í”í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ì‹¬ë¶€ê±´ë°˜ì‚¬ëŠ” ì¼ë°˜ì ìœ¼ë¡œ ì •ìƒìž…ë‹ˆë‹¤.

* **C. ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ° (Guillain-BarrÃ© Syndrome):** ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ°ì€ ê¸‰ì„± ì—¼ì¦ì„± íƒˆìˆ˜ì´ˆì„± ë‹¤ë°œì‹ ê²½ë³‘ì¦ìœ¼ë¡œ, ê¸‰ì„±ìœ¼ë¡œ ì§„í–‰í•˜ëŠ” ê·¼ë ¥ ì•½í™”ì™€ ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤ì„ íŠ¹ì§•ìœ¼ë¡œ í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ°ì€ ì¼ë°˜ì ìœ¼ë¡œ *ê°ê° ì´ìƒ*ì„ ë™ë°˜í•˜ë©°, í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ í”í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ë˜í•œ, ê¸¸ëž­-ë°”ë ˆ ì¦í›„êµ°ì€ ì¶œìƒ ì‹œë¶€í„° ì¦ìƒì´ ë‚˜íƒ€ë‚˜ëŠ” ê²½ìš°ëŠ” ë“œë¬¼ê³ , ì£¼ë¡œ ê°ì—¼ í›„ ìˆ˜ì¼ì—ì„œ ìˆ˜ì£¼ í›„ì— ë°œìƒí•©ë‹ˆë‹¤.

* **D. ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ (Progressive Muscular Dystrophy):** ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ëŠ” ìœ ì „ì ì¸ ê·¼ìœ¡ ì§ˆí™˜ìœ¼ë¡œ, ê·¼ìœ¡ ì„¬ìœ ì˜ í‡´í–‰ê³¼ ì‡ ì•½ì„ ì¼ìœ¼í‚µë‹ˆë‹¤. ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ ì¤‘ ì¼ë¶€ëŠ” ì˜ì•„ê¸°ì— ë°œë³‘í•  ìˆ˜ ìžˆì§€ë§Œ, ì¼ë°˜ì ìœ¼ë¡œ *í¬ë ˆì•„í‹´í‚¤ë‚˜ì•„ì œ (CK) ìˆ˜ì¹˜ê°€ ë§¤ìš° ë†’ê²Œ ìƒìŠ¹*í•©ë‹ˆë‹¤. ì œì‹œëœ ê²€ì‚¬ ê²°ê³¼ì—ì„œ CK ìˆ˜ì¹˜ëŠ” ì •ìƒ ë²”ìœ„ ë‚´ì— ìžˆìœ¼ë¯€ë¡œ ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ì˜ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤. ë˜í•œ, í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ ì§„í–‰ê·¼ë””ìŠ¤íŠ¸ë¡œí”¼ì˜ íŠ¹ì§•ì ì¸ ì¦ìƒì€ ì•„ë‹™ë‹ˆë‹¤.

* **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Spinal Muscular Atrophy, SMA):** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ ìš´ë™ ì‹ ê²½ ì„¸í¬ì˜ í‡´í–‰ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ìœ ì „ ì§ˆí™˜ìœ¼ë¡œ, ê·¼ìœ¡ì˜ ì‡ ì•½ê³¼ ìœ„ì¶•ì„ íŠ¹ì§•ìœ¼ë¡œ í•©ë‹ˆë‹¤. íŠ¹ížˆ *ì œ1í˜• ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (Werdnig-Hoffmann disease)*ì€ ì˜ì•„ê¸°ì— ë°œë³‘í•˜ë©°, ì¶œìƒ ì‹œë¶€í„° ë˜ëŠ” ìƒí›„ 6ê°œì›” ì´ë‚´ì— ì‹¬ê°í•œ ê·¼ë ¥ ì•½í™”ê°€ ë‚˜íƒ€ë‚©ë‹ˆë‹¤.

**ì œì‹œëœ ì¦ìƒê³¼ ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì˜ íŠ¹ì§•:**

* **6ê°œì›” ë‚¨ì•„, ì¶œìƒ í›„ë¶€í„° í•˜ì§€ ì›€ì§ìž„ ì—†ìŒ:** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ íŠ¹ížˆ í•˜ì§€ ê·¼ë ¥ ì•½í™”ë¥¼ ë‘ë“œëŸ¬ì§€ê²Œ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.
* **ê°œêµ¬ë¦¬ ë‹¤ë¦¬ ëª¨ì–‘:** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ í™˜ì•„ëŠ” íŠ¹ì§•ì ìœ¼ë¡œ ê°œêµ¬ë¦¬ ë‹¤ë¦¬ ìžì„¸ë¥¼ ì·¨í•©ë‹ˆë‹¤. ì´ëŠ” ê³ ê´€ì ˆ ì™¸ì „ ë° ë¬´ë¦Ž êµ´ê³¡ìœ¼ë¡œ ì¸í•œ ìžì„¸ìž…ë‹ˆë‹¤.
* **í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶• (fasciculation):** í˜€ì˜ ê·¼ì„¬ìœ ë‹¤ë°œìˆ˜ì¶•ì€ ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì˜ ë§¤ìš° íŠ¹ì§•ì ì¸ ì†Œê²¬ìž…ë‹ˆë‹¤. ì´ëŠ” ìš´ë™ ì‹ ê²½ ì„¸í¬ì˜ í‡´í–‰ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” í˜„ìƒìž…ë‹ˆë‹¤.
* **ë‹¤ë¦¬ì— ìžê·¹ì„ ì£¼ì–´ë„ ì›€ì§ìž„ ì—†ìŒ, ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤:** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ í•˜ìœ„ ìš´ë™ ì‹ ê²½ì› ì§ˆí™˜ìœ¼ë¡œ, ê·¼ë ¥ ì•½í™” ë° ì‹¬ë¶€ê±´ë°˜ì‚¬ ì†Œì‹¤ì„ ìœ ë°œí•©ë‹ˆë‹¤.
* **ì •ìƒ ë²”ìœ„ì˜ í˜ˆì•¡ ê²€ì‚¬ ê²°ê³¼ (CK, LDH):** ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ì€ ê·¼ìœ¡ ìžì²´ì˜ ì§ˆí™˜ì´ ì•„ë‹ˆë¯€ë¡œ, CK ìˆ˜ì¹˜ëŠ” ì¼ë°˜ì ìœ¼ë¡œ ì •ìƒì´ê±°ë‚˜ ê²½ë¯¸í•˜ê²Œ ìƒìŠ¹í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì œì‹œëœ CK ìˆ˜ì¹˜ëŠ” ì •ìƒ ë²”ìœ„ ë‚´ì— ìžˆìŠµë‹ˆë‹¤. LDH ë˜í•œ ì •ìƒ ë²”ìœ„ ë‚´ì— ìžˆìŠµë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ì œì‹œëœ ìž„ìƒ ì–‘ìƒê³¼ ê²€ì‚¬ ê²°ê³¼ëŠ” ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦ (íŠ¹ížˆ ì œ1í˜•)ì— ê°€ìž¥ ë¶€í•©í•©ë‹ˆë‹¤.** ë”°ë¼ì„œ ì •ë‹µì€ **E. ì²™ìˆ˜ê·¼ìœ„ì¶•ì¦** ìž…ë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">910</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="11"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">doctor</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,014</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">6</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¸ê°„ì˜ í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬(circadian rhythm) ì„ ì£¼ê´€í•˜ëŠ” ìƒë¬¼í•™ì  ì‹œê³„ì¸ í•˜ë£¨ì£¼ê¸°ì¡°ì •ìž(circadian pacemaker) ê°€ ìœ„ì¹˜í•˜ê³  ìžˆëŠ” ë¶€ìœ„ëŠ”?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì†”ê¸°í•µ(raphe nucleus)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì²­ìƒ‰ë°˜ì (locus ceruleus)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê¼¬ë¦¬í•µ(caudate nucleus)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë Œì¦ˆí•µ(lentiform nucleus)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">The question is asking about the location of the circadian pacemaker in the human brain.
- I need to identify the brain region that is responsible for regulating the circadian rhythm.
- I know that the circadian rhythm is the body's internal clock that regulates sleep-wake cycles and other physiological processes over a 24-hour period.
- I need to recall the specific brain structure known to be the master circadian pacemaker.

Let's consider each option:
A. ì†”ê¸°í•µ (raphe nucleus):  The raphe nucleus is primarily associated with serotonin production and regulation of mood, sleep, and pain. While it plays a role in sleep, it is not the primary circadian pacemaker.

B. ì²­ìƒ‰ë°˜ì  (locus ceruleus): The locus ceruleus is the main site for norepinephrine production in the brain. It is involved in arousal, attention, and stress response.  While it is related to wakefulness, it's not the master circadian pacemaker.

C. ê¼¬ë¦¬í•µ (caudate nucleus): The caudate nucleus is part of the basal ganglia and is involved in motor control, procedural learning, and habit formation. It is not directly related to circadian rhythm regulation.

D. ë Œì¦ˆí•µ (lentiform nucleus): The lentiform nucleus is also part of the basal ganglia and includes the putamen and globus pallidus. It is involved in motor control and is not the primary circadian pacemaker.

E. ì‹œì‹ ê²½êµì°¨ìƒí•µ (suprachiasmatic nucleus - SCN): The suprachiasmatic nucleus is a small nucleus in the hypothalamus, located just above the optic chiasm. It is well-established as the primary circadian pacemaker in mammals, including humans.  It receives direct input from the retina about light levels, which helps synchronize the body's internal clock with the external environment (day-night cycle).

Based on my knowledge, the suprachiasmatic nucleus (SCN) is the correct answer.  It is the master clock that regulates circadian rhythms.

Therefore, the answer is E. ì‹œì‹ ê²½êµì°¨ìƒí•µ (suprachiasmatic nucleus).</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **E. ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus)** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

* **í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬(circadian rhythm)** ì€ ì•½ 24ì‹œê°„ ì£¼ê¸°ë¡œ ë°˜ë³µë˜ëŠ” ìƒì²´ ë¦¬ë“¬ìœ¼ë¡œ, ìˆ˜ë©´-ê°ì„± ì£¼ê¸°, í˜¸ë¥´ëª¬ ë¶„ë¹„, ì²´ì˜¨ ë³€í™” ë“± ë‹¤ì–‘í•œ ìƒë¦¬ì  ê³¼ì •ì— ì˜í–¥ì„ ë¯¸ì¹©ë‹ˆë‹¤.
* **í•˜ë£¨ì£¼ê¸°ì¡°ì •ìž(circadian pacemaker)** ëŠ” ì´ëŸ¬í•œ í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì„ ì£¼ê´€í•˜ëŠ” ìƒë¬¼í•™ì  ì‹œê³„ ì—­í• ì„ í•˜ëŠ” ë‡Œ ë¶€ìœ„ìž…ë‹ˆë‹¤.

ê° ì„ íƒì§€ë¥¼ ì‚´íŽ´ë³´ë©´ ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤:

* **A. ì†”ê¸°í•µ(raphe nucleus):** ì†”ê¸°í•µì€ ì£¼ë¡œ ì„¸ë¡œí† ë‹Œì„ ìƒì„±í•˜ë©°, ê¸°ë¶„, ìˆ˜ë©´, í†µì¦ ì¡°ì ˆì— ê´€ì—¬í•©ë‹ˆë‹¤. ìˆ˜ë©´ì— ì˜í–¥ì„ ë¯¸ì¹˜ì§€ë§Œ, í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì˜ ì£¼ê´€ìžëŠ” ì•„ë‹™ë‹ˆë‹¤.
* **B. ì²­ìƒ‰ë°˜ì (locus ceruleus):** ì²­ìƒ‰ë°˜ì ì€ ë…¸ë¥´ì—í”¼ë„¤í”„ë¦°ì„ ìƒì„±í•˜ë©°, ê°ì„±, ì£¼ì˜ ì§‘ì¤‘, ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘ì— ê´€ì—¬í•©ë‹ˆë‹¤. ê°ì„±ì— ì˜í–¥ì„ ë¯¸ì¹˜ì§€ë§Œ, í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì˜ ì£¼ê´€ìžëŠ” ì•„ë‹™ë‹ˆë‹¤.
* **C. ê¼¬ë¦¬í•µ(caudate nucleus):** ê¼¬ë¦¬í•µì€ ê¸°ì €í•µì˜ ì¼ë¶€ë¡œ, ìš´ë™ ì¡°ì ˆ, ì ˆì°¨ ê¸°ì–µ, ìŠµê´€ í˜•ì„±ì— ê´€ì—¬í•©ë‹ˆë‹¤. í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.
* **D. ë Œì¦ˆí•µ(lentiform nucleus):** ë Œì¦ˆí•µ ì—­ì‹œ ê¸°ì €í•µì˜ ì¼ë¶€ë¡œ, ìš´ë™ ì¡°ì ˆì— ê´€ì—¬í•©ë‹ˆë‹¤. í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.
* **E. ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus - SCN):** ì‹œì‹ ê²½êµì°¨ìƒí•µì€ ì‹œìƒí•˜ë¶€ì— ìœ„ì¹˜í•œ ìž‘ì€ í•µìœ¼ë¡œ, **í¬ìœ ë¥˜ì˜ ì£¼ìš” í•˜ë£¨ì£¼ê¸°ì¡°ì •ìž** ë¡œ ì•Œë ¤ì ¸ ìžˆìŠµë‹ˆë‹¤. ì‹œì‹ ê²½ìœ¼ë¡œë¶€í„° ë¹› ì •ë³´ë¥¼ ì§ì ‘ ë°›ì•„ë“¤ì—¬ ì™¸ë¶€ í™˜ê²½(ë‚®ê³¼ ë°¤)ì— ìƒì²´ ì‹œê³„ë¥¼ ë™ê¸°í™”ì‹œí‚¤ëŠ” ì—­í• ì„ í•©ë‹ˆë‹¤.

ë”°ë¼ì„œ, ì¸ê°„ì˜ í•˜ë£¨ì£¼ê¸°ë¦¬ë“¬ì„ ì£¼ê´€í•˜ëŠ” ìƒë¬¼í•™ì  ì‹œê³„, ì¦‰ í•˜ë£¨ì£¼ê¸°ì¡°ì •ìžëŠ” **ì‹œì‹ ê²½êµì°¨ìƒí•µ(suprachiasmatic nucleus)** ìž…ë‹ˆë‹¤.

**ì •ë‹µ:** **E**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">982</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="12"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">doctor</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,014</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">64</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">42ì„¸ ì‚°ê³¼ë ¥ 2-0-1-2ì¸ ì—¬ìžê°€ 2ì£¼ ì „ ì‹œìž‘ëœ ì§ˆì¶œí˜ˆë¡œ ë³‘ì›ì— ì™”ë‹¤. í‰ì†Œ ì›”ê²½ì€ 30ì¼ ê°„ê²©ìœ¼ë¡œ ê·œì¹™ì ì´ì—ˆìœ¼ë©°, ìµœì¢…ì›”ê²½ì‹œìž‘ì¼ì€ 4ì£¼ ì „ì´ì—ˆë‹¤. í˜ˆì•• 110/70 mmHg, ë§¥ë°• 72íšŒ/ë¶„, ì²´ì˜¨ 36.7â„ƒì˜€ë‹¤. ì´ˆìŒíŒŒê²€ì‚¬ì—ì„œ ìžê¶ ë° ìžê¶ë¶€ì†ê¸°ëŠ” ì •ìƒì´ì—ˆë‹¤. í˜ˆì•¡ ë° ì†Œë³€ê²€ì‚¬ì™€ ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ëŠ” ë‹¤ìŒê³¼ ê°™ì•˜ë‹¤. ì§„ë‹¨ì€? í˜ˆì•¡: í˜ˆìƒ‰ì†Œ 11.6 g/dL, ë°±í˜ˆêµ¬ 8,000/mm^3, í˜ˆì†ŒíŒ 250,000/mm^3 ì†Œë³€ìž„ì‹ ë°˜ì‘: ìŒì„± ìžê¶ë‚´ë§‰: ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰(disordered proliferative endometrium) </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìžê¶ë‚´ë§‰ì•”</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìžê¶ë‚´ë§‰ì—¼</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìžê¶ë‚´ë§‰ìœ ì°©ì¦</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìžê¶ë‚´ë§‰ì¦ì‹ì¦</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the diagnosis of dysfunctional uterine bleeding (DUB) in this case.

**1.  Understanding the Patient's Presentation:**

* **Age:** 42 years old -  This is important.  Women in their 40s are in perimenopause, where hormonal fluctuations are common and can lead to irregular bleeding.
* **Parity (2-0-1-2):**  Two full-term pregnancies, one abortion, two living children.  This obstetrical history doesn't directly point to a diagnosis, but it's relevant patient history.
* **Chief Complaint:** Vaginal bleeding for 2 weeks.  This is the primary symptom and needs to be explained.
* **Menstrual History:** Regular 30-day cycles, LMP 4 weeks ago.  Initially seems normal, but the current bleeding is *outside* of her expected menstrual cycle.
* **Vitals:** Normal blood pressure, pulse, and temperature.  This rules out acute infection or significant hypovolemia for now.
* **Pelvic Ultrasound:** Normal uterus and adnexa. This is crucial. It rules out structural abnormalities like fibroids, polyps, ovarian cysts, or ectopic pregnancy as the *primary* cause of bleeding.
* **Lab Results:**
    * **Hemoglobin 11.6 g/dL:** Slightly low, indicating some blood loss, but not severely anemic.
    * **WBC 8,000/mm^3:** Normal, rules out significant infection.
    * **Platelets 250,000/mm^3:** Normal, rules out bleeding disorders related to platelets.
    * **Urine Pregnancy Test: Negative:**  Rules out pregnancy as the cause of bleeding.
    * **Endometrial Biopsy: Disordered Proliferative Endometrium:** This is the key finding.  "Proliferative" means the endometrium is growing (estrogen-driven). "Disordered" or "Dyssynchronous" implies that the growth is not happening in a coordinated, cyclical way, which is typical in a normal menstrual cycle.

**2.  Systematic Differential Diagnosis (Thinking through the options and ruling them out):**

* **A. Endometrial Cancer (ìžê¶ë‚´ë§‰ì•”):**
    * **Why consider it?**  Abnormal bleeding is a key symptom of endometrial cancer, especially in perimenopausal and postmenopausal women.
    * **Why rule it out (or at least make it less likely)?**
        * **Age:** While possible at 42, endometrial cancer is more common in older women.
        * **Endometrial Biopsy Result:** "Disordered proliferative endometrium" is *not* typical of endometrial cancer. Cancerous endometrium would show atypical cells, hyperplasia with atypia, or adenocarcinoma.  "Disordered proliferative" is a *benign* finding, albeit abnormal in its dyssynchrony.
        * **Normal Ultrasound:** While not definitive, a normal ultrasound makes structural cancer less likely (though not impossible).
    * **Conclusion:**  Less likely given the biopsy and ultrasound, but endometrial cancer *cannot* be completely ruled out without further investigation if the bleeding persists or worsens.

* **B. Endometritis (ìžê¶ë‚´ë§‰ì—¼):**
    * **Why consider it?**  Infection can cause abnormal bleeding.
    * **Why rule it out?**
        * **Normal Vitals:** No fever (36.7â„ƒ) or tachycardia (pulse 72 bpm) which are often seen in acute infection.
        * **Normal WBC:**  WBC count is within the normal range, not elevated, which would be expected in infection.
        * **"Proliferative" Endometrium:** Endometritis would typically cause inflammation and potentially a more mixed or necrotic picture on biopsy, not primarily "proliferative."
    * **Conclusion:**  Unlikely given the normal vitals, WBC, and biopsy result.

* **C. Asherman's Syndrome (ìžê¶ë‚´ë§‰ìœ ì°©ì¦):**
    * **Why consider it?** Asherman's can cause abnormal bleeding (often *reduced* or absent menstruation, but sometimes irregular bleeding).  It's associated with prior uterine procedures (D&amp;C, etc.).
    * **Why rule it out?**
        * **Patient History:** No mention of prior D&amp;C or uterine surgery.
        * **Bleeding:**  Patient has *excessive* bleeding, not reduced. Asherman's more typically presents with amenorrhea or hypomenorrhea.
        * **"Proliferative" Endometrium:**  Asherman's is characterized by *scarring* and *thinning* of the endometrium, not disordered proliferation.
    * **Conclusion:**  Unlikely given the history, bleeding pattern, and biopsy result.

* **D. Endometrial Hyperplasia (ìžê¶ë‚´ë§‰ì¦ì‹ì¦):**
    * **Why consider it?**  Endometrial hyperplasia is a precursor to endometrial cancer, and it *can* present with abnormal bleeding.
    * **Why rule it out (partially)?**
        * **Biopsy Result:**  The biopsy says "disordered proliferative endometrium," *not* "endometrial hyperplasia."  While disordered proliferation can be *a form* of simple hyperplasia *without atypia*, the term "disordered proliferative" is more often used to describe the benign hormonal imbalance of DUB, rather than a pre-cancerous lesion.  If the biopsy had mentioned "hyperplasia," especially with atypia, this would be much higher on the differential.  The absence of "hyperplasia" in the biopsy report is important.
    * **Conclusion:** Less likely given the specific biopsy term.  If the report had said "simple hyperplasia without atypia," it would be closer to DUB, but the term "disordered proliferative" is more directly associated with hormonal imbalance.

* **E. Dysfunctional Uterine Bleeding (ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ):**
    * **Why consider it?**
        * **Age:** Perimenopausal age is the classic demographic.
        * **Irregular Bleeding:**  Presents with bleeding outside normal menstruation.
        * **Normal Ultrasound:** Rules out structural causes.
        * **Negative Pregnancy Test:** Rules out pregnancy.
        * **"Disordered Proliferative Endometrium":** This is the *hallmark* biopsy finding for DUB.  It reflects anovulation or inconsistent ovulation, leading to unopposed estrogen stimulation and irregular endometrial shedding.
    * **Conclusion:**  Highly likely.  All pieces of the puzzle fit.

**3.  Final Diagnosis and Justification:**

Dysfunctional Uterine Bleeding (DUB) (ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ) is the most likely diagnosis.

* **Reasoning:**
    * The patient is perimenopausal, a typical age group for DUB.
    * She presents with abnormal vaginal bleeding.
    * Ultrasound is normal, ruling out structural lesions.
    * Pregnancy is ruled out.
    * Endometrial biopsy shows "disordered proliferative endometrium," which is the characteristic histological finding in DUB due to hormonal imbalances (often anovulation or oligo-ovulation).

**4.  Further Management (Although not asked in the question, it's good to consider):**

* **Confirm Diagnosis:**  Rule out other less likely possibilities if bleeding persists or worsens.  Repeat biopsy if needed.
* **Treatment:** Depends on severity of bleeding and patient's desire for future fertility.  Options include:
    * **Observation:** If bleeding is mild and patient is not anemic.
    * **Hormonal therapy:** Progestins (oral or IUD) to regulate cycles and reduce bleeding.  Combined oral contraceptives if contraception is also desired.
    * **NSAIDs:** To reduce bleeding during periods.
    * **Iron supplementation:** If anemic.
    * **Endometrial ablation or hysterectomy:**  For severe, refractory cases, especially if fertility is no longer desired.


By systematically going through the patient's presentation, considering the differential diagnoses, and carefully evaluating the lab results, especially the biopsy, we arrive at the most appropriate diagnosis: Dysfunctional Uterine Bleeding.  The key is to recognize that "disordered proliferative endometrium" in the context of abnormal bleeding and normal pelvic exam is highly suggestive of DUB.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **E. ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

**í™˜ìžì˜ ì¦ìƒ ë° ê²€ì‚¬ ê²°ê³¼ ë¶„ì„:**

* **42ì„¸ ì—¬ì„±, 2ì£¼ ì „ë¶€í„° ì‹œìž‘ëœ ì§ˆì¶œí˜ˆ:**  ê°€ìž¥ ì¤‘ìš”í•œ ì¦ìƒìž…ë‹ˆë‹¤.
* **ê·œì¹™ì ì¸ ì›”ê²½ë ¥, ìµœì¢…ì›”ê²½ì‹œìž‘ì¼ 4ì£¼ ì „:** í‰ì†Œ ì›”ê²½ ì£¼ê¸°ëŠ” ê·œì¹™ì ì´ì—ˆìœ¼ë‚˜, í˜„ìž¬ ì¶œí˜ˆì€ ì›”ê²½ ì£¼ê¸°ì— ë§žì§€ ì•ŠëŠ” ë¹„ì •ìƒ ì¶œí˜ˆìž…ë‹ˆë‹¤.
* **ì •ìƒ í™œë ¥ ì§•í›„ (í˜ˆì••, ë§¥ë°•, ì²´ì˜¨):** ê¸‰ì„± ê°ì—¼ì´ë‚˜ ì‹¬ê°í•œ ì „ì‹  ì§ˆí™˜ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.
* **ì •ìƒ ìžê¶ ë° ìžê¶ë¶€ì†ê¸° ì´ˆìŒíŒŒ:**  ìžê¶ê·¼ì¢…, ìžê¶ë‚´ë§‰ í´ë¦½, ë‚œì†Œ ë‚­ì¢… ë“± êµ¬ì¡°ì ì¸ ì´ìƒìœ¼ë¡œ ì¸í•œ ì¶œí˜ˆ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.
* **í˜ˆì•¡ ê²€ì‚¬:** ê²½ë¯¸í•œ ë¹ˆí˜ˆ (í˜ˆìƒ‰ì†Œ 11.6 g/dL) ì™¸ì—ëŠ” ì •ìƒìž…ë‹ˆë‹¤. ì—¼ì¦ ì†Œê²¬ (ë°±í˜ˆêµ¬ ì •ìƒ) ë„ ì—†ìŠµë‹ˆë‹¤.
* **ì†Œë³€ìž„ì‹ ë°˜ì‘ ìŒì„±:** ìž„ì‹  ê´€ë ¨ ì¶œí˜ˆì€ ì•„ë‹™ë‹ˆë‹¤.
* **ìžê¶ë‚´ë§‰ìƒê²€: ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰ (disordered proliferative endometrium):**  **í•µì‹¬ì ì¸ ì§„ë‹¨ ë‹¨ì„œìž…ë‹ˆë‹¤.**

**ê° ì„ íƒì§€ë³„ ê°€ëŠ¥ì„± í‰ê°€:**

* **A. ìžê¶ë‚´ë§‰ì•”:**
    * ìžê¶ë‚´ë§‰ì•”ì€ ë¹„ì •ìƒ ì§ˆì¶œí˜ˆì˜ ì¤‘ìš”í•œ ì›ì¸ì´ì§€ë§Œ, **ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ê°€ "ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰"ìœ¼ë¡œ ì•”ì„¸í¬ë‚˜ ë¹„ì •í˜• ì„¸í¬ê°€ ë°œê²¬ë˜ì§€ ì•Šì•˜ìœ¼ë¯€ë¡œ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.**  ìžê¶ë‚´ë§‰ì•”ì€ ë³´í†µ ì¦ì‹ì¦, ë¹„ì •í˜• ì¦ì‹ì¦, ë˜ëŠ” ì•”ì„¸í¬ ìžì²´ë¡œ ì§„ë‹¨ë©ë‹ˆë‹¤.
* **B. ìžê¶ë‚´ë§‰ì—¼:**
    * ìžê¶ë‚´ë§‰ì—¼ì€ ì—¼ì¦ìœ¼ë¡œ ì¸í•œ ì¶œí˜ˆì„ ìœ ë°œí•  ìˆ˜ ìžˆì§€ë§Œ, **ì •ìƒ ë°±í˜ˆêµ¬ ìˆ˜ì¹˜ì™€ ì •ìƒ ì²´ì˜¨**ìœ¼ë¡œ ê°ì—¼ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤. ë˜í•œ, ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ê°€ ì—¼ì¦ì„± ë³€í™”ë³´ë‹¤ëŠ” "ì¦ì‹ê¸°" ë³€í™”ë¥¼ ë³´ì´ê³  ìžˆìŠµë‹ˆë‹¤.
* **C. ìžê¶ë‚´ë§‰ìœ ì°©ì¦ (Asherman's syndrome):**
    * ìžê¶ë‚´ë§‰ìœ ì°©ì¦ì€ ìžê¶ë‚´ë§‰ ì†ìƒ í›„ ìœ ì°©ì´ ë°œìƒí•˜ì—¬ ì›”ê²½ëŸ‰ ê°ì†Œë‚˜ ë¬´ì›”ê²½ì„ ìœ ë°œí•˜ëŠ” ì§ˆí™˜ìž…ë‹ˆë‹¤. **ì§ˆì¶œí˜ˆì´ ì£¼ ì¦ìƒì¸ ì´ í™˜ìžì—ê²ŒëŠ” ì í•©í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.**
* **D. ìžê¶ë‚´ë§‰ì¦ì‹ì¦:**
    * ìžê¶ë‚´ë§‰ì¦ì‹ì¦ì€ ìžê¶ë‚´ë§‰ì´ ê³¼ë„í•˜ê²Œ ì¦ì‹í•˜ëŠ” ì§ˆí™˜ìœ¼ë¡œ, ë¹„ì •ìƒ ì¶œí˜ˆì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ, ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ê°€ "ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰"ìœ¼ë¡œ, **ì¦ì‹ì¦ìœ¼ë¡œ ëª…í™•í•˜ê²Œ ì§„ë‹¨í•˜ê¸°ì—ëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤.** "ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰"ì€ ìžê¶ë‚´ë§‰ì¦ì‹ì¦ì˜ ì´ˆê¸° ë‹¨ê³„ í˜¹ì€ ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì—ì„œ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆëŠ” ë¹„íŠ¹ì´ì ì¸ ì†Œê²¬ìž…ë‹ˆë‹¤.
* **E. ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ (Dysfunctional Uterine Bleeding, DUB):**
    * **ê°€ìž¥ ê°€ëŠ¥ì„±ì´ ë†’ì€ ì§„ë‹¨ìž…ë‹ˆë‹¤.** ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì€ ê¸°ì§ˆì ì¸ ì§ˆí™˜ ì—†ì´ í˜¸ë¥´ëª¬ ë¶ˆê· í˜•ìœ¼ë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ë¹„ì •ìƒ ìžê¶ ì¶œí˜ˆì„ ì˜ë¯¸í•©ë‹ˆë‹¤.
    * **í™˜ìžì˜ ë‚˜ì´ (42ì„¸, ê°€ìž„ê¸° í›„ë°˜), ê·œì¹™ì ì¸ ì›”ê²½ë ¥ ë³€í™”, ì •ìƒ ì´ˆìŒíŒŒ, "ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰" ì†Œê²¬ì€ ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì— í•©ë‹¹í•©ë‹ˆë‹¤.**  íŠ¹ížˆ "ë¶€ì¡°í™” ì¦ì‹ê¸° ìžê¶ë‚´ë§‰"ì€ ë°°ëž€ ìž¥ì•  ë“±ìœ¼ë¡œ ì¸í•´ í”„ë¡œê²ŒìŠ¤í…Œë¡ ì˜ ìž‘ìš© ì—†ì´ ì—ìŠ¤íŠ¸ë¡œê²ì—ë§Œ ì§€ì†ì ìœ¼ë¡œ ë…¸ì¶œëœ ìžê¶ë‚´ë§‰ì—ì„œ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆìœ¼ë©°, ì´ëŠ” ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆì˜ í”í•œ ì›ì¸ìž…ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ,** í™˜ìžì˜ ì¦ìƒ, ê²€ì‚¬ ê²°ê³¼, íŠ¹ížˆ ìžê¶ë‚´ë§‰ìƒê²€ ê²°ê³¼ë¥¼ ì¢…í•©ì ìœ¼ë¡œ ê³ ë ¤í–ˆì„ ë•Œ, **ê¸°ëŠ¥ìž¥ì• ìžê¶ì¶œí˜ˆ (E)** ì´ ê°€ìž¥ ê°€ëŠ¥ì„± ë†’ì€ ì§„ë‹¨ìž…ë‹ˆë‹¤.  ë‹¤ë¥¸ ì‹¬ê°í•œ ì§ˆí™˜ì˜ ê°€ëŠ¥ì„±ì€ ë‚®ì§€ë§Œ, ì§€ì†ì ì¸ ì¶œí˜ˆ ì‹œ ìžê¶ë‚´ë§‰ì•” ë“±ì˜ ê°€ëŠ¥ì„±ì„ ë°°ì œí•˜ê¸° ìœ„í•´ ì¶”ì  ê´€ì°°ì´ í•„ìš”í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1,083</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="13"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">doctor</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,016</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">13</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">64ì„¸ ë‚¨ìžê°€ ì˜ì‹ì´ íë ¤ì§„ ì±„ë¡œ ë°œê²¬ë˜ì–´ ì‘ê¸‰ì‹¤ì— ì‹¤ë ¤ì™”ë‹¤. ì§‘ì•ˆì¼ë¡œ ì†ì´ ìƒí•´ ì‹ì‚¬ë¥¼ í•˜ì§€ ì•Šê³  3ì¼ ë™ì•ˆ ë§¤ì¼ ì†Œì£¼ 4ë³‘ì„ ë§ˆì…¨ë‹¤ê³  í•˜ì˜€ë‹¤. ë‹¹ë‡¨ë³‘ì´ë‚˜ ê³ í˜ˆì••ì„ ì•“ì€ ì ì€ ì—†ì—ˆê³  í‰ì†Œ ë³µìš©í•˜ëŠ” ì•½ë„ ì—†ë‹¤ê³  í•˜ì˜€ë‹¤. ì˜ì‹ì€ í˜¼ë¯¸í•˜ì˜€ê³  í˜ˆì•• 110/70 mmHg, ë§¥ë°• 86íšŒ/ë¶„, í˜¸í¡ 20íšŒ/ë¶„, ì²´ì˜¨ 36.3â„ƒì˜€ë‹¤. í˜ˆì•¡ê²€ì‚¬ ê²°ê³¼ëŠ” ë‹¤ìŒê³¼ ê°™ì•˜ë‹¤. ì›ì¸ì€?í¬ë„ë‹¹ 46 mg/dL,  ì¸ìŠë¦° 1.5 Î¼U/mL (ì°¸ê³ ì¹˜, 2 ~ 20) </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë§ì´ˆ í¬ë„ë‹¹ ì´ìš© ì¦ê°€</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž ë¶„ë¹„ ì¦ê°€</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down this medical case step-by-step, mimicking a thought process for solving this clinical reasoning question.

**1. Initial Information Gathering and Problem Identification:**

* **Patient Profile:** 64-year-old male, altered consciousness, Korean (contextual for drinking habits).
* **Key History:** 3 days of heavy alcohol intake (4 bottles of Soju/day), no food intake, emotional distress related to housework. No prior diabetes, hypertension, or medications.
* **Vitals:**  Stable blood pressure (110/70 mmHg), normal heart rate (86 bpm), normal respiratory rate (20 bpm), normal temperature (36.3Â°C).  Vitals are not immediately alarming, suggesting no acute shock or infection.  However, altered consciousness *is* alarming.
* **Blood Glucose:**  **Extremely low glucose (46 mg/dL).** This is the most critical finding.
* **Insulin:** Low insulin (1.5 Î¼U/mL, normal 2-20).  This is also significant and needs to be interpreted in the context of the low glucose.

**Problem Identification:** Hypoglycemia.  The altered consciousness is highly likely due to the low blood sugar.

**2.  Considering the History and Pathophysiology of Hypoglycemia:**

* **Alcohol and Hypoglycemia:** Alcohol is a known cause of hypoglycemia, especially in the context of fasting.  Alcohol metabolism in the liver has a significant impact on glucose homeostasis.
* **Fasting:**  No food intake for 3 days depletes liver glycogen stores.  The body relies more heavily on gluconeogenesis (making glucose from non-carbohydrate sources).
* **Soju:** Soju is an alcoholic beverage.  Ethanol is the key ingredient.

**3.  Mechanism of Alcohol-Induced Hypoglycemia:**

* **Ethanol Metabolism:** Ethanol is metabolized in the liver primarily by alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH).
* **NAD+/NADH Ratio Shift:**  This metabolic pathway consumes NAD+ and produces NADH. This increases the NADH/NAD+ ratio in the liver.
* **Impact on Gluconeogenesis:**  Several key steps in gluconeogenesis are NAD+-dependent (e.g., lactate to pyruvate, malate to oxaloacetate).  The increased NADH/NAD+ ratio *inhibits* these steps.
* **Impact on Glycolysis:**  Conversely, some steps in glycolysis are NADH-producing.  The increased NADH/NAD+ ratio *favors* glycolysis, but this is less relevant in a fasted state where the goal is to *produce* glucose, not consume it.
* **Impact on Glycogenolysis:**  While alcohol can initially stimulate glycogenolysis, prolonged alcohol intake and depleted glycogen stores will make glycogenolysis less effective.

**4.  Analyzing the Answer Choices in light of the Pathophysiology:**

* **A. Glucagon ë¶„ë¹„ ì–µì œ (Glucagon secretion inhibition):** Glucagon is a counter-regulatory hormone that *raises* blood glucose. It stimulates glycogenolysis and gluconeogenesis.  If glucagon secretion is inhibited, this would worsen hypoglycemia.  Alcohol *can* suppress glucagon secretion to some extent, contributing to hypoglycemia.  This is a *possible* mechanism.

* **B. ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ (Liver glycogenolysis inhibition):** Glycogenolysis is the breakdown of glycogen into glucose.  While alcohol doesn't directly *inhibit* glycogenolysis, in a state of depleted glycogen stores (due to fasting and alcohol metabolism), glycogenolysis would be less effective anyway.  And as mentioned before, alcohol *can* initially stimulate glycogenolysis, but not for long periods especially with fasting. Indirectly, the liver's energy being focused on alcohol metabolism might reduce its capacity for glycogenolysis.  Less direct than other options, but possibly contributing.

* **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ (Liver gluconeogenesis inhibition):** Gluconeogenesis is the process of making new glucose from non-carbohydrate sources.  As discussed earlier, alcohol metabolism *directly inhibits* gluconeogenesis due to the NADH/NAD+ ratio shift. This is a *strong* mechanism.

* **D. ë§ì´ˆ í¬ë„ë‹¹ ì´ìš© ì¦ê°€ (Increased peripheral glucose utilization):**  While insulin stimulates peripheral glucose uptake, insulin is *low* in this case (1.5 Î¼U/mL).  Alcohol itself *doesn't* directly increase peripheral glucose uptake in a way that would explain this profound hypoglycemia.  This is less likely.  Furthermore, low insulin suggests decreased, not increased, peripheral glucose utilization.

* **E. ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž ë¶„ë¹„ ì¦ê°€ (Increased insulin-like growth factor secretion):** Insulin-like growth factors (IGFs) have some insulin-like effects, but they are not the primary regulator of acute glucose homeostasis.  IGF-1, for example, is more involved in long-term growth and development.  And IGFs are unlikely to be acutely increased by alcohol in a way that causes significant hypoglycemia.  This is very unlikely.

**5.  Selecting the Best Answer:**

* **Option C (ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ - Liver gluconeogenesis inhibition)** is the most direct and well-established mechanism for alcohol-induced hypoglycemia, especially in the context of fasting.  The NADH/NAD+ shift from alcohol metabolism directly impairs gluconeogenesis.

* **Option A (ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œ - Glucagon secretion inhibition)** is also a contributing factor, but perhaps less direct and less dominant than gluconeogenesis inhibition.

* **Option B (ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ - Liver glycogenolysis inhibition)** is less direct and less likely to be the primary mechanism.

* **Options D and E** are very unlikely.

**6. Final Answer and Justification:**

The most likely primary cause of hypoglycemia in this patient is **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ (Liver gluconeogenesis inhibition)**.  The combination of heavy alcohol consumption and fasting leads to a metabolic state where the liver's ability to produce glucose through gluconeogenesis is impaired due to the altered NADH/NAD+ ratio caused by ethanol metabolism.  This, coupled with depleted glycogen stores from fasting, leads to a rapid drop in blood glucose and altered consciousness.

Therefore, the answer is **C**.

**(Self-Correction/Refinement):**  Initially, I might have considered A and C both strongly. However, focusing on the *primary* mechanism in the context of the question wording ("ì›ì¸ì€?") and the pathophysiology, gluconeogenesis inhibition is the more direct and dominant effect of alcohol in this scenario. Glucagon suppression is more of a secondary/contributory factor.  Therefore, C is the most accurate and best answer.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">## ì •ë‹µ: C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ

**í•´ì„¤:**

**í™˜ìžì˜ ìƒíƒœ:**

* **64ì„¸ ë‚¨ì„±, ì˜ì‹ í˜¼ë¯¸:**  ì¤‘ì¶”ì‹ ê²½ê³„ ê¸°ëŠ¥ ì €í•˜ë¥¼ ì‹œì‚¬í•©ë‹ˆë‹¤.
* **3ì¼ê°„ ì‹ì‚¬ ì•ˆ í•˜ê³  ì†Œì£¼ 4ë³‘/ì¼:** ì‹¬í•œ ì•Œì½”ì˜¬ ì„­ì·¨ì™€ ê¸ˆì‹ ìƒíƒœìž…ë‹ˆë‹¤.
* **ë‹¹ë‡¨, ê³ í˜ˆì•• ë³‘ë ¥ ì—†ìŒ, ì•½ë¬¼ ë³µìš©ë ¥ ì—†ìŒ:** ê¸°ì¡´ ì§ˆí™˜ì´ë‚˜ ì•½ë¬¼ë¡œ ì¸í•œ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.
* **ì •ìƒ í˜ˆì••, ë§¥ë°•, í˜¸í¡, ì²´ì˜¨:**  ê¸‰ì„± ì‡¼í¬ë‚˜ ì‹¬ê°í•œ ê°ì—¼ì˜ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.
* **í˜ˆì•¡ ê²€ì‚¬:**
    * **í¬ë„ë‹¹ 46 mg/dL (ì €í˜ˆë‹¹):**  ì˜ì‹ í˜¼ë¯¸ì˜ ê°€ìž¥ ìœ ë ¥í•œ ì›ì¸ìž…ë‹ˆë‹¤.
    * **ì¸ìŠë¦° 1.5 Î¼U/mL (ë‚®ì€ ì¸ìŠë¦°):**  ì €í˜ˆë‹¹ ìƒí™©ì—ì„œ ì¸ìŠë¦° ë¶„ë¹„ê°€ ì–µì œëœ ê²ƒì€ ì •ìƒì ì¸ ë°˜ì‘ìž…ë‹ˆë‹¤.

**ê° ì„ íƒì§€ ë¶„ì„:**

* **A. ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œ:** ê¸€ë£¨ì¹´ê³¤ì€ í˜ˆë‹¹ì„ ìƒìŠ¹ì‹œí‚¤ëŠ” í˜¸ë¥´ëª¬ìž…ë‹ˆë‹¤. ì €í˜ˆë‹¹ ìƒí™©ì—ì„œëŠ” ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ê°€ **ì´‰ì§„**ë˜ì–´ì•¼ í˜ˆë‹¹ì„ ì˜¬ë¦¬ë ¤ê³  í•©ë‹ˆë‹¤. ê¸€ë£¨ì¹´ê³¤ ë¶„ë¹„ ì–µì œëŠ” ì €í˜ˆë‹¹ì„ ì•…í™”ì‹œí‚¤ë¯€ë¡œ, ì›ì¸ì´ ë  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.

* **B. ê°„ ê¸€ë¦¬ì½”ê²ë¶„í•´ ì–µì œ:** ê¸€ë¦¬ì½”ê²ë¶„í•´ëŠ” ê°„ì— ì €ìž¥ëœ ê¸€ë¦¬ì½”ê²ì„ í¬ë„ë‹¹ìœ¼ë¡œ ë¶„í•´í•˜ì—¬ í˜ˆë‹¹ì„ ì˜¬ë¦¬ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤.  ì•Œì½”ì˜¬ì€ ê°„ì—ì„œ ëŒ€ì‚¬ë˜ë©´ì„œ NADH/NAD+ ë¹„ìœ¨ì„ ì¦ê°€ì‹œì¼œ ê¸€ë¦¬ì½”ê²ë¶„í•´ë¥¼ **ì¼ì‹œì ìœ¼ë¡œ ì´‰ì§„**í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ìž¥ê¸°ê°„ ê¸ˆì‹ ìƒíƒœì—ì„œëŠ” ê°„ ê¸€ë¦¬ì½”ê² ì €ìž¥ëŸ‰ì´ ì´ë¯¸ ê³ ê°ˆë˜ì—ˆì„ ê°€ëŠ¥ì„±ì´ ë†’ê³ , ì•Œì½”ì˜¬ ëŒ€ì‚¬ë¡œ ì¸í•´ ê°„ ê¸°ëŠ¥ì´ ì €í•˜ë˜ì–´ ê¸€ë¦¬ì½”ê²ë¶„í•´ê°€ ì œëŒ€ë¡œ ì´ë£¨ì–´ì§€ì§€ ì•Šì„ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  í•˜ì§€ë§Œ **ì£¼ëœ ì›ì¸**ì´ë¼ê³  ë³´ê¸° ì–´ë µìŠµë‹ˆë‹¤.

* **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ:** í¬ë„ë‹¹ì‹ í•©ì„±ì€ ê°„ì—ì„œ ì•„ë¯¸ë…¸ì‚°, ì –ì‚°, ê¸€ë¦¬ì„¸ë¡¤ ë“± ë¹„íƒ„ìˆ˜í™”ë¬¼ ë¬¼ì§ˆë¡œë¶€í„° í¬ë„ë‹¹ì„ ìƒˆë¡œ í•©ì„±í•˜ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤.  **ì•Œì½”ì˜¬ì€ ê°„ì—ì„œ ëŒ€ì‚¬ë˜ë©´ì„œ NADH/NAD+ ë¹„ìœ¨ì„ ì¦ê°€ì‹œí‚¤ê³ , ì´ëŠ” í¬ë„ë‹¹ì‹ í•©ì„± ê³¼ì •ì˜ ì¤‘ìš”í•œ íš¨ì†Œ ë°˜ì‘ì„ ì–µì œí•©ë‹ˆë‹¤.** íŠ¹ížˆ ê¸ˆì‹ ìƒíƒœì—ì„œëŠ” í˜ˆë‹¹ ìœ ì§€ë¥¼ í¬ë„ë‹¹ì‹ í•©ì„±ì— í¬ê²Œ ì˜ì¡´í•˜ê²Œ ë˜ëŠ”ë°, ì•Œì½”ì˜¬ ì„­ì·¨ë¡œ ì¸í•´ í¬ë„ë‹¹ì‹ í•©ì„±ì´ ì–µì œë˜ë©´ ì‹¬ê°í•œ ì €í˜ˆë‹¹ì´ ë°œìƒí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. **ì´ê²ƒì´ ê°€ìž¥ ìœ ë ¥í•œ ì›ì¸ìž…ë‹ˆë‹¤.**

* **D. ë§ì´ˆ í¬ë„ë‹¹ ì´ìš© ì¦ê°€:** ì¸ìŠë¦°ì€ ë§ì´ˆ ì¡°ì§ì—ì„œ í¬ë„ë‹¹ ì´ìš©ì„ ì´‰ì§„í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ í™˜ìžì˜ ì¸ìŠë¦° ìˆ˜ì¹˜ëŠ” ë‚®ìœ¼ë¯€ë¡œ, ë§ì´ˆ í¬ë„ë‹¹ ì´ìš©ì´ ì¦ê°€í–ˆì„ ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤. ì˜¤ížˆë ¤ ì €í˜ˆë‹¹ ìƒí™©ì—ì„œëŠ” ì¸ìŠë¦° ë¶„ë¹„ê°€ ì–µì œë˜ì–´ ë§ì´ˆ í¬ë„ë‹¹ ì´ìš©ì´ ê°ì†Œí•˜ëŠ” ê²ƒì´ ì •ìƒì ì¸ ë°˜ì‘ìž…ë‹ˆë‹¤.

* **E. ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž ë¶„ë¹„ ì¦ê°€:** ì¸ìŠë¦°ìœ ì‚¬ì„±ìž¥ì¸ìž (IGF)ëŠ” ì¸ìŠë¦°ê³¼ ìœ ì‚¬í•œ ìž‘ìš©ì„ í•˜ì§€ë§Œ, ê¸‰ì„± ì €í˜ˆë‹¹ì˜ ì›ì¸ìœ¼ë¡œ ë³´ê¸° ì–´ë µìŠµë‹ˆë‹¤. IGFëŠ” ì£¼ë¡œ ì„±ìž¥ê³¼ ë°œë‹¬ì— ê´€ì—¬í•˜ë©°, í˜ˆë‹¹ ì¡°ì ˆì— ë¯¸ì¹˜ëŠ” ì˜í–¥ì€ ì¸ìŠë¦°ì— ë¹„í•´ ë¯¸ë¯¸í•©ë‹ˆë‹¤.

**ê²°ë¡ :**

í™˜ìžì˜ ê²½ìš°, 3ì¼ê°„ì˜ ê¸ˆì‹ê³¼ ê³¼ë„í•œ ì•Œì½”ì˜¬ ì„­ì·¨ë¡œ ì¸í•´ ê°„ì˜ í¬ë„ë‹¹ì‹ í•©ì„±ì´ ì–µì œë˜ì–´ ì‹¬ê°í•œ ì €í˜ˆë‹¹ì´ ë°œìƒí•œ ê²ƒìœ¼ë¡œ íŒë‹¨ë©ë‹ˆë‹¤. ë”°ë¼ì„œ ê°€ìž¥ ì ì ˆí•œ ì›ì¸ì€ **C. ê°„ í¬ë„ë‹¹ì‹ í•©ì„± ì–µì œ** ìž…ë‹ˆë‹¤.

**ì¶”ê°€ ì„¤ëª…:**

* ì•Œì½”ì˜¬ì€ ê°„ì—ì„œ ì•Œì½”ì˜¬ íƒˆìˆ˜ì†Œíš¨ì†Œ (ADH)ì™€ ì•Œë°ížˆë“œ íƒˆìˆ˜ì†Œíš¨ì†Œ (ALDH)ì— ì˜í•´ ëŒ€ì‚¬ë©ë‹ˆë‹¤. ì´ ê³¼ì •ì—ì„œ NAD+ê°€ NADHë¡œ í™˜ì›ë˜ì–´ ê°„ì„¸í¬ ë‚´ NADH/NAD+ ë¹„ìœ¨ì´ ì¦ê°€í•©ë‹ˆë‹¤.
* ë†’ì€ NADH/NAD+ ë¹„ìœ¨ì€ ê°„ì„¸í¬ ë‚´ ëŒ€ì‚¬ ê²½ë¡œì— ì˜í–¥ì„ ë¯¸ì³, íŠ¹ížˆ í¬ë„ë‹¹ì‹ í•©ì„± ê²½ë¡œë¥¼ ì–µì œí•©ë‹ˆë‹¤.
* ê¸ˆì‹ ìƒíƒœì—ì„œëŠ” ê°„ ê¸€ë¦¬ì½”ê² ì €ìž¥ëŸ‰ì´ ê°ì†Œí•˜ê³ , í¬ë„ë‹¹ì‹ í•©ì„±ì´ í˜ˆë‹¹ ìœ ì§€ì— ë”ìš± ì¤‘ìš”í•´ì§‘ë‹ˆë‹¤.
* ì•Œì½”ì˜¬ ì„­ì·¨ë¡œ ì¸í•´ í¬ë„ë‹¹ì‹ í•©ì„±ì´ ì–µì œë˜ë©´, í˜ˆë‹¹ì´ ê¸‰ê²©ížˆ ë–¨ì–´ì ¸ ì €í˜ˆë‹¹ì„± í˜¼ìˆ˜ê°€ ë°œìƒí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

**ë”°ë¼ì„œ ì •ë‹µì€ C ìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1,401</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="14"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">nurse_assistant</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,022</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">94</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìš”ì¶”ì²œìž ì§í›„ 9ì„¸ ë‚¨ì•„ê°€ ì†Œë³€ì„ ë³´ê³  ì‹¶ë‹¤ê³  í•  ë•Œ ê°„í˜¸ ë³´ì¡°í™œë™ìœ¼ë¡œ ì˜³ì€ ê²ƒì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì´ë™ì‹ ë³€ê¸°ì— ì•‰ížŒë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í™”ìž¥ì‹¤ì„ ë‹¤ë…€ì˜¤ê²Œ í•œë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìœ ì¹˜ë„ë‡¨ì„¸íŠ¸ë¥¼ ì¤€ë¹„í•œë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¹¨ëŒ€ ìœ„ì— ì„œì„œ ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">
The question is asking about the appropriate nursing assistant activity when a 9-year-old boy wants to urinate immediately after a lumbar puncture. We need to consider the potential complications and restrictions after a lumbar puncture, especially in children.

Let's analyze each option:

* **A. ì´ë™ì‹ ë³€ê¸°ì— ì•‰ížŒë‹¤. (Sit him on a portable commode.)**: This is a possibility. A portable commode is convenient for patients who have difficulty moving to the bathroom, but it still requires the patient to sit upright.

* **B. í™”ìž¥ì‹¤ì„ ë‹¤ë…€ì˜¤ê²Œ í•œë‹¤. (Let him go to the bathroom.)**:  Lumbar puncture is a procedure that involves inserting a needle into the spinal canal. One of the major concerns after a lumbar puncture is post-lumbar puncture headache (PLPH), which is often aggravated by standing or sitting upright.  Encouraging the child to walk to the bathroom might worsen potential headache and is generally not recommended immediately after the procedure.

* **C. ìœ ì¹˜ë„ë‡¨ì„¸íŠ¸ë¥¼ ì¤€ë¹„í•œë‹¤. (Prepare a Foley catheter set.)**:  A Foley catheter is an invasive procedure, and it is not a routine intervention just because a patient needs to urinate after a lumbar puncture. Catheterization is only considered if the patient is unable to void naturally and urinary retention is suspected. This is too invasive and not a first-line approach.

* **D. ì¹¨ëŒ€ ìœ„ì— ì„œì„œ ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤. (Let him stand on the bed to urinate.)**:  Standing upright after a lumbar puncture can increase the risk and severity of a post-lumbar puncture headache. Also, having a child stand on the bed to urinate is unsafe and impractical. This option is highly inappropriate.

* **E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤. (Let him urinate into a bedpan while lying down.)**:  After a lumbar puncture, patients are often advised to lie flat for a period of time to minimize the risk of post-lumbar puncture headache. Urinating in a bedpan while lying down is a common and safe practice for patients who need to void but should remain lying down. This seems like the most appropriate option given the circumstances.

Considering the need to minimize movement and maintain a lying position to prevent or reduce post-lumbar puncture headache, options B and D are clearly not suitable. Option C is too invasive and not necessary as a first step. Option A is better than B and D, but still requires sitting up, which might be less desirable than remaining lying down. Option E allows the child to urinate while remaining in a lying position, which is the recommended position after a lumbar puncture.

Therefore, option E seems to be the most appropriate nursing assistant activity.

Let's double-check the typical post-lumbar puncture care.  Post-procedure care often includes:
    * Monitoring vital signs and neurological status.
    * Encouraging fluid intake to help with CSF production and hydration.
    * Pain management, if needed.
    * **Maintaining a flat or prone position for a period of time (often 1-2 hours or more) to minimize CSF leakage and prevent headache.**

Based on this typical care, minimizing upright posture immediately after lumbar puncture is important.  Option E, using a bedpan while lying down, aligns best with this principle.


**Final Answer Selection:** E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤. (Let him urinate into a bedpan while lying down.)

**Reasoning:**
After a lumbar puncture, especially in children, minimizing movement and maintaining a lying position is crucial to prevent or reduce post-lumbar puncture headache.  Among the options, using a bedpan while lying down (option E) is the only option that allows the child to urinate without getting up or sitting upright.  The other options either involve sitting up (A), walking to the bathroom (B), standing (D), or are unnecessarily invasive (C).  Using a bedpan while lying down is a standard nursing intervention to facilitate urination for patients who need to remain in a recumbent position.

</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ìš”ì¶”ì²œìž(Lumbar puncture, spinal tap)ëŠ” ë‡Œì²™ìˆ˜ì•¡ ê²€ì‚¬ë¥¼ ìœ„í•´ ì²™ì¶”ë¼ˆ ì‚¬ì´ë¡œ ë°”ëŠ˜ì„ ì‚½ìž…í•˜ëŠ” ì‹œìˆ ìž…ë‹ˆë‹¤. ì‹œìˆ  í›„ ê°€ìž¥ í”í•œ ë¶€ìž‘ìš© ì¤‘ í•˜ë‚˜ëŠ” ë‘í†µì¸ë°, ì´ëŠ” ë‡Œì²™ìˆ˜ì•¡ì´ ëˆ„ì¶œë˜ì–´ ë°œìƒí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ë‘í†µì„ ì˜ˆë°©í•˜ê±°ë‚˜ ì™„í™”í•˜ê¸° ìœ„í•´ ìš”ì¶”ì²œìž í›„ì—ëŠ” ì¼ì • ì‹œê°„ ë™ì•ˆ **ë¨¸ë¦¬ë¥¼ ë‚®ì¶”ê³  ëˆ„ì›ŒìžˆëŠ” ìžì„¸**ë¥¼ ìœ ì§€í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.

ê° ì„ íƒì§€ë¥¼ ë¶„ì„í•´ ë³´ê² ìŠµë‹ˆë‹¤.

* **A. ì´ë™ì‹ ë³€ê¸°ì— ì•‰ížŒë‹¤.** : ì´ë™ì‹ ë³€ê¸°ëŠ” ì¹¨ìƒ ì˜†ì—ì„œ ì‚¬ìš©í•  ìˆ˜ ìžˆì–´ íŽ¸ë¦¬í•˜ì§€ë§Œ, ì•‰ëŠ” ìžì„¸ëŠ” ë¨¸ë¦¬ë¥¼ ë†’ì´ê²Œ ë˜ì–´ ë‡Œì²™ìˆ˜ì•¡ ëˆ„ì¶œë¡œ ì¸í•œ ë‘í†µì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ë”°ë¼ì„œ ìš”ì¶”ì²œìž ì§í›„ì—ëŠ” ì ì ˆí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.

* **B. í™”ìž¥ì‹¤ì„ ë‹¤ë…€ì˜¤ê²Œ í•œë‹¤.** : í™”ìž¥ì‹¤ê¹Œì§€ ê±¸ì–´ê°€ê³  ì•‰ì•˜ë‹¤ ì¼ì–´ë‚˜ëŠ” ë™ìž‘ì€ ë¨¸ë¦¬ë¥¼ ë†’ì´ëŠ” ê²ƒì€ ë¬¼ë¡ ì´ê³  ì›€ì§ìž„ ìžì²´ë„ ë‘í†µì„ ìœ ë°œí•˜ê±°ë‚˜ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ìš”ì¶”ì²œìž ì§í›„ì—ëŠ” ì›€ì§ìž„ì„ ìµœì†Œí™”í•´ì•¼ í•©ë‹ˆë‹¤.

* **C. ìœ ì¹˜ë„ë‡¨ì„¸íŠ¸ë¥¼ ì¤€ë¹„í•œë‹¤.** : ìœ ì¹˜ë„ë‡¨ëŠ” ì†Œë³€ì„ ìŠ¤ìŠ¤ë¡œ ë³¼ ìˆ˜ ì—†ëŠ” ê²½ìš°ë‚˜ ìˆ˜ìˆ  í›„ ìž¥ì‹œê°„ ì¹¨ìƒ ì•ˆì •ì´ í•„ìš”í•œ ê²½ìš° ë“±ì— ê³ ë ¤ë©ë‹ˆë‹¤. ë‹¨ìˆœ ë°°ë‡¨ë¥¼ ìœ„í•´ ìš”ì¶”ì²œìž ì§í›„ì— ìœ ì¹˜ë„ë‡¨ë¥¼ ì‹œí–‰í•˜ëŠ” ê²ƒì€ ê³¼ë„í•œ ì²˜ì¹˜ì´ë©°, ê°ì—¼ ë“±ì˜ ìœ„í—˜ë„ ìžˆìŠµë‹ˆë‹¤.

* **D. ì¹¨ëŒ€ ìœ„ì— ì„œì„œ ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.** : ì¹¨ëŒ€ ìœ„ì— ì„œëŠ” ê²ƒì€ ë§¤ìš° ìœ„í—˜í•˜ë©°, ë¨¸ë¦¬ë¥¼ ë†’ì´ëŠ” ìžì„¸ëŠ” ë‘í†µì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ì•ˆì „ ë¬¸ì œì™€ ì˜í•™ì  ì¸¡ë©´ ëª¨ë‘ì—ì„œ ë¶€ì ì ˆí•œ ë°©ë²•ìž…ë‹ˆë‹¤.

* **E. ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ê²Œ í•œë‹¤.** : ëˆ„ìš´ ìžì„¸ëŠ” ë¨¸ë¦¬ë¥¼ ë‚®ê²Œ ìœ ì§€í•˜ì—¬ ë‡Œì²™ìˆ˜ì•¡ ëˆ„ì¶œì„ ìµœì†Œí™”í•˜ê³  ë‘í†µì„ ì˜ˆë°©í•˜ëŠ” ë° ë„ì›€ì´ ë©ë‹ˆë‹¤. ì†Œë³€ê¸°ëŠ” ì¹¨ìƒì— ëˆ„ìš´ ìƒíƒœë¡œ ë°°ë‡¨í•  ìˆ˜ ìžˆë„ë¡ ë•ëŠ” ë„êµ¬ì´ë¯€ë¡œ, ìš”ì¶”ì²œìž ì§í›„ ì†Œë³€ì„ ë³´ê³  ì‹¶ì–´í•˜ëŠ” í™˜ìžì—ê²Œ ê°€ìž¥ ì ì ˆí•œ ê°„í˜¸ ë³´ì¡° í™œë™ìž…ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ìš”ì¶”ì²œìž ì§í›„ 9ì„¸ ë‚¨ì•„ì˜ ë°°ë‡¨ ìš”êµ¬ ì‹œ ê°€ìž¥ ì•ˆì „í•˜ê³  ì ì ˆí•œ ê°„í˜¸ ë³´ì¡°ëŠ” ëˆ„ì›Œì„œ ì†Œë³€ê¸°ì— ì†Œë³€ì„ ë³´ë„ë¡ ë•ëŠ” ê²ƒìž…ë‹ˆë‹¤.**

**ë”°ë¼ì„œ ì •ë‹µì€ Eìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">6,580</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="15"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">dental_technician</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,020</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">78</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ã€Œì˜ë£Œë²•ã€ìƒ ì§„ë‹¨ì„œë¥¼ êµë¶€í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì•½ì‚¬</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê°„í˜¸ì‚¬</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¡°ì‚°ì‚¬</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¹˜ê³¼ì˜ì‚¬</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë°©ì‚¬ì„ ì‚¬</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">
The question is asking about who is authorized to issue a medical certificate according to the Medical Service Act in Korea.  I need to determine which of the listed professions is legally authorized to issue a diagnosis certificate (ì§„ë‹¨ì„œ).

Let's analyze each option based on my knowledge of healthcare professions and general understanding of who can make diagnoses and issue medical certificates:

* **A. ì•½ì‚¬ (Pharmacist):** Pharmacists are experts in medications. They dispense drugs, counsel patients on drug use, and manage medication therapy.  However, they do not diagnose illnesses or issue medical certificates (ì§„ë‹¨ì„œ).  Their role is primarily related to medication management, not diagnosis.

* **B. ê°„í˜¸ì‚¬ (Nurse):** Nurses provide direct patient care, administer medications, monitor vital signs, and assist doctors.  While nurses play a crucial role in patient care and assessment,  they are generally not authorized to independently diagnose illnesses or issue medical certificates.  Their role is to assist and implement the care plans prescribed by physicians.  There might be advanced practice nurses with expanded roles in some specific contexts, but generally, in a standard medical setting, nurses don't issue ì§„ë‹¨ì„œ.

* **C. ì¡°ì‚°ì‚¬ (Midwife):** Midwives specialize in pregnancy, childbirth, and postpartum care. In Korea (and many other countries), midwives are legally recognized healthcare professionals. They can manage normal deliveries, provide prenatal and postnatal care.  Crucially, midwives, within their scope of practice (pregnancy and childbirth), are authorized to make diagnoses related to their specialty and issue certain types of medical certificates related to childbirth.  This is a potential candidate.

* **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist):** Dentists are medical professionals specialized in oral health. They diagnose and treat diseases of the teeth, gums, and related structures.  Dentists are definitely authorized to make diagnoses and issue medical certificates (ì§„ë‹¨ì„œ) related to dental conditions.  This is another strong candidate.

* **E. ë°©ì‚¬ì„ ì‚¬ (Radiologic Technologist/Radiographer):** Radiologic technologists operate medical imaging equipment like X-ray, CT, and MRI machines. They are skilled in capturing medical images, but they do not interpret these images or make diagnoses.  Diagnosis based on images is the responsibility of radiologists or other physicians. Radiographers are not authorized to issue medical certificates.


Based on this analysis:

* **Pharmacists (ì•½ì‚¬)** are not authorized.
* **Nurses (ê°„í˜¸ì‚¬)** are generally not authorized.
* **Midwives (ì¡°ì‚°ì‚¬)** might be authorized within their specialty (pregnancy and childbirth).
* **Dentists (ì¹˜ê³¼ì˜ì‚¬)** are definitely authorized, specifically for dental conditions.
* **Radiologic Technologists (ë°©ì‚¬ì„ ì‚¬)** are not authorized.


The question is about who can issue a "ì§„ë‹¨ì„œ" in general under the "ì˜ë£Œë²•" (Medical Service Act).  "ì§„ë‹¨ì„œ" usually implies a medical certificate issued by a physician for a medical condition.  Considering the options and the general understanding of medical practice, both dentists and potentially midwives could issue certain types of ì§„ë‹¨ì„œ within their respective scopes.

However, "ì§„ë‹¨ì„œ" (diagnosis certificate) is most commonly associated with physicians (ì˜ì‚¬).  Looking at the options, "ì¹˜ê³¼ì˜ì‚¬" (Dentist) is a type of physician, specifically a doctor of dental medicine.  "ì¡°ì‚°ì‚¬" (Midwife), while a recognized healthcare professional who can make diagnoses and issue certificates related to childbirth, their scope is more limited compared to a general physician or dentist.

In the context of the Medical Service Act and the general understanding of "ì§„ë‹¨ì„œ,"  the most straightforward and broadly applicable answer would be a medical doctor or a dentist.  Between Dentists and Midwives,  Dentists are more generally and commonly associated with issuing "ì§„ë‹¨ì„œ" in various medical contexts beyond just childbirth.  While midwives can issue certificates related to childbirth,  dentists' authority to issue certificates is within their domain of dental health, and "ì§„ë‹¨ì„œ" in common parlance and legal context often refers to a certificate from a doctor.

Let's consider the term "ì˜ë£Œì¸" (medical personnel/healthcare provider) in the context of the Medical Service Act.  Generally, "ì˜ë£Œì¸" under Korean law includes doctors (ì˜ì‚¬), dentists (ì¹˜ê³¼ì˜ì‚¬), oriental medicine doctors (í•œì˜ì‚¬), midwives (ì¡°ì‚°ì‚¬), and nurses (ê°„í˜¸ì‚¬).  However, the authority to issue a "ì§„ë‹¨ì„œ" is usually more restricted to doctors, dentists, and oriental medicine doctors, and potentially midwives within their specific domain.

Considering the options provided and the most common understanding of who issues "ì§„ë‹¨ì„œ" under the Medical Service Act,  **Dentists (ì¹˜ê³¼ì˜ì‚¬)** are definitely authorized to issue diagnosis certificates within their scope of practice (dental and oral health).  Midwives are likely authorized to issue certificates related to childbirth.  Between these two, dentists have a broader scope of issuing "ì§„ë‹¨ì„œ" beyond just pregnancy/childbirth.

If I have to choose the *most* appropriate and generally correct answer from the given options, considering "ì§„ë‹¨ì„œ" in a broader medical context,  **Dentist (ì¹˜ê³¼ì˜ì‚¬)** seems like the most fitting choice.  While midwives can issue certificates within their specialty, dentists' authority is more broadly recognized for issuing "ì§„ë‹¨ì„œ" related to health conditions within their domain.

Therefore, based on common medical practice, legal context, and the nature of "ì§„ë‹¨ì„œ,"  the most appropriate answer is likely **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist)**.

Let's double-check if there's any specific nuance in Korean law that might lean towards midwives more strongly than dentists for issuing "ì§„ë‹¨ì„œ."  However, generally, dentists are unequivocally authorized to issue diagnosis certificates related to dental health.  And "ì§„ë‹¨ì„œ" in a general medical context is often associated with doctors and dentists.

Given the options and the most reasonable interpretation of "ì˜ë£Œë²•" and "ì§„ë‹¨ì„œ,"  **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist)** is the most likely and correct answer.  While midwives have a role in issuing certificates related to childbirth, dentists have a more general and broader scope of issuing "ì§„ë‹¨ì„œ" within their field of expertise.  Pharmacists, nurses, and radiographers are clearly not authorized to issue "ì§„ë‹¨ì„œ."

Final Answer Selection:  **D. ì¹˜ê³¼ì˜ì‚¬ (Dentist)** appears to be the most appropriate and correct answer.
</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">**ì •ë‹µì€ D. ì¹˜ê³¼ì˜ì‚¬ìž…ë‹ˆë‹¤.**

**í•´ì„¤:**

ã€Œì˜ë£Œë²•ã€ìƒ ì§„ë‹¨ì„œë¥¼ êµë¶€í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì€ ì˜ì‚¬, ì¹˜ê³¼ì˜ì‚¬, í•œì˜ì‚¬ìž…ë‹ˆë‹¤.  ì¡°ì‚°ì‚¬ëŠ” ì œí•œì ìœ¼ë¡œ ì¶œìƒ, ì‚¬ì‚°, ì‚¬ë§ ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆì§€ë§Œ, ì¼ë°˜ì ì¸ ì§ˆë³‘ì— ëŒ€í•œ ì§„ë‹¨ì„œëŠ” ë°œê¸‰í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤. ì•½ì‚¬, ê°„í˜¸ì‚¬, ë°©ì‚¬ì„ ì‚¬ëŠ” ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì´ ì•„ë‹™ë‹ˆë‹¤.

**ê° ì„ íƒì§€ë³„ ì„¤ëª…:**

* **A. ì•½ì‚¬ (è—¥å¸«):** ì•½ì‚¬ëŠ” ì˜ì•½í’ˆ ì¡°ì œ ë° ë³µì•½ ì§€ë„ ë“±ì„ ë‹´ë‹¹í•˜ëŠ” ì˜ë£Œì¸ì´ì§€ë§Œ, ì§„ë‹¨ ë° ì§„ë‹¨ì„œ ë°œê¸‰ ê¶Œí•œì€ ì—†ìŠµë‹ˆë‹¤.
* **B. ê°„í˜¸ì‚¬ (çœ‹è­·å¸«):** ê°„í˜¸ì‚¬ëŠ” í™˜ìž ê°„í˜¸ ë° ì§„ë£Œ ë³´ì¡° ì—…ë¬´ë¥¼ ìˆ˜í–‰í•˜ì§€ë§Œ, ë…ë¦½ì ìœ¼ë¡œ ì§„ë‹¨ì„ ë‚´ë¦¬ê³  ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ê¶Œí•œì€ ì—†ìŠµë‹ˆë‹¤.
* **C. ì¡°ì‚°ì‚¬ (åŠ©ç”£å¸«):** ì¡°ì‚°ì‚¬ëŠ” ìž„ì‚°ë¶€, í•´ì‚°ë¶€ ë° ì‹ ìƒì•„ì— ëŒ€í•œ ë³´ê±´ê³¼ ì–‘í˜¸ì§€ë„ë¥¼ í•˜ë©°, ë¶„ë§Œ ì‹œ ì§„ì°°, ë¶„ë§Œ ë³´ì¡° ë° ë¶„ë§Œ í›„ ì²˜ì¹˜ ë“±ì„ ë‹´ë‹¹í•©ë‹ˆë‹¤. ã€Œì˜ë£Œë²•ã€ ì œ28ì¡°ì— ë”°ë¼ ì¡°ì‚°ì‚¬ëŠ” ìžì‹ ì´ ë¶„ë§Œí•œ ì¶œìƒ, ì‚¬ì‚°, ë˜ëŠ” ì‚¬ë§ì˜ ì¦ëª…ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤. ê·¸ëŸ¬ë‚˜ ì¼ë°˜ì ì¸ ì§ˆë³‘ì— ëŒ€í•œ ì§„ë‹¨ì„œëŠ” ë°œê¸‰í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.
* **D. ì¹˜ê³¼ì˜ì‚¬ (é½’ç§‘é†«å¸«):** ì¹˜ê³¼ì˜ì‚¬ëŠ” ì¹˜ê³¼ ì˜ë£Œë¥¼ ë‹´ë‹¹í•˜ëŠ” ì˜ë£Œì¸ìœ¼ë¡œ, ã€Œì˜ë£Œë²•ã€ìƒ ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì— í•´ë‹¹ë©ë‹ˆë‹¤. ì¹˜ê³¼ ì§ˆí™˜ì— ëŒ€í•œ ì§„ë‹¨ì„œë¥¼ ë°œê¸‰í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.
* **E. ë°©ì‚¬ì„ ì‚¬ (æ”¾å°„ç·šå¸«):** ë°©ì‚¬ì„ ì‚¬ëŠ” ë°©ì‚¬ì„  ì´¬ì˜ ë° ê´€ë ¨ ê¸°ìˆ  ì—…ë¬´ë¥¼ ìˆ˜í–‰í•˜ëŠ” ì˜ë£Œê¸°ì‚¬ì´ë©°, ì§„ë‹¨ ë° ì§„ë‹¨ì„œ ë°œê¸‰ ê¶Œí•œì€ ì—†ìŠµë‹ˆë‹¤.


**ê²°ë¡ ì ìœ¼ë¡œ, ã€Œì˜ë£Œë²•ã€ìƒ ì¼ë°˜ì ì¸ ì§„ë‹¨ì„œë¥¼ êµë¶€í•  ìˆ˜ ìžˆëŠ” ì˜ë£Œì¸ì€ ì˜ì‚¬, ì¹˜ê³¼ì˜ì‚¬, í•œì˜ì‚¬ì´ë©°, ì œì‹œëœ ì„ íƒì§€ ì¤‘ì—ì„œëŠ” ì¹˜ê³¼ì˜ì‚¬ë§Œì´ ì´ì— í•´ë‹¹ë©ë‹ˆë‹¤.**

**ë”°ë¼ì„œ ì •ë‹µì€ Dìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4,887</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="16"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">paramedic_1</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,021</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">98</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì†Œì•„ í™˜ìží‰ê°€ ì‹œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•  ìˆ˜ ìžˆëŠ” ê²½ìš°ëŠ”?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë¶€ëª¨ê°€ ì „ê³¼ìžì¸ ê²½ìš°</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í•™ì—… ì„±ì ì´ ë‚®ì€ ê²½ìš°</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í”¼ë¶€ê°ì—¼ì´ ë°œìƒí•œ ê²½ìš°</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì†ìƒê²½ìœ„ì™€ ìž„ìƒì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì€ ê²½ìš°</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì—‰ë©ì´ë‚˜ íŒ”, ë‹¤ë¦¬ì— ëª½ê³ ë°˜ì ì´ ìžˆëŠ” ê²½ìš°</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer and explanation for the Korean question about child abuse suspicion.

**1. Understanding the Question:**

The question is asking about situations where child abuse should be *suspected* during a pediatric patient evaluation.  The key word here is "suspected." It doesn't mean definitive proof, but rather indicators that should raise a red flag and warrant further investigation.

**2. Analyzing Each Option (and initial thoughts):**

* **A. ë¶€ëª¨ê°€ ì „ê³¼ìžì¸ ê²½ìš° (Parents with a criminal record):**
    * **Initial thought:**  This feels discriminatory and not directly indicative of child abuse.  Having a criminal record doesn't automatically make someone an abuser.  It's a *risk factor*, but not a direct sign.
    * **Refinement:** While statistically, individuals with certain criminal histories *might* have a higher risk, it's not a reliable indicator *in itself* to suspect abuse in a clinical setting.  We need more direct signs related to the child.  This option seems weak and possibly biased.

* **B. í•™ì—… ì„±ì ì´ ë‚®ì€ ê²½ìš° (Low academic performance):**
    * **Initial thought:**  Many factors can cause low academic performance â€“ learning disabilities, socioeconomic issues, lack of parental support, etc. Child abuse *could* be a contributing factor, but it's very non-specific.
    * **Refinement:**  Low academic performance alone is not a strong indicator of abuse.  It's a symptom of *potential* problems, but too broad.  Abuse is a *possible* cause, but many other more likely causes exist.  This is also weak.

* **C. í”¼ë¶€ê°ì—¼ì´ ë°œìƒí•œ ê²½ìš° (Skin infection):**
    * **Initial thought:**  Skin infections are common in children.  Poor hygiene *could* be linked to neglect, which is a form of abuse. However, many skin infections are just infections, especially in young children in daycare, etc.
    * **Refinement:**  While neglect *can* lead to skin infections, it's not a direct or reliable indicator of abuse *in general*.  Good hygiene practices vary across families and cultures.  This is also a weak indicator and too broad.

* **D. ì†ìƒê²½ìœ„ì™€ ìž„ìƒì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì€ ê²½ìš° (Discrepancy between the injury explanation and clinical findings):**
    * **Initial thought:**  This immediately stands out.  If a parent says "the child fell off the bed," but the injuries are inconsistent with a fall from bed height (e.g., spiral fractures, multiple bruises in various stages of healing, injuries in protected areas), that's a huge red flag.  This points to a potential attempt to conceal the true cause of injury.
    * **Refinement:**  This is a *strong* indicator.  Inconsistent stories are a classic sign of potential abuse.  It suggests someone is trying to hide what happened.  This option is very relevant to suspecting abuse.

* **E. ì—‰ë©ì´ë‚˜ íŒ”, ë‹¤ë¦¬ì— ëª½ê³ ë°˜ì ì´ ìžˆëŠ” ê²½ìš° (Mongolian spots on buttocks, arms, or legs):**
    * **Initial thought:**  Mongolian spots are common birthmarks, especially in Asian populations. They are *not* bruises and are benign.  Confusing them with bruises is a common misconception.  This option is a *distraction* and tests knowledge of normal infant skin markings vs. abuse.
    * **Refinement:**  Mongolian spots are *normal* and *not* a sign of abuse. In fact, *mistaking* them for bruises can lead to *false* accusations of abuse.  This option is definitively *wrong* as an indicator of *suspecting* abuse. It's about *differentiating* normal findings from suspicious ones.

**3. Comparing the Options and Selecting the Best Answer:**

* Options A, B, and C are weak and non-specific. They are not reliable indicators for *suspecting* child abuse in a clinical setting. They might be *correlating factors* in some studies, but not direct clinical signs.
* Option E is the opposite of an indicator of abuse; it's a normal finding that should *not* be mistaken for abuse.
* Option D is the *strongest* and most *direct* clinical indicator of *suspecting* child abuse.  Discrepancies in the story and the physical findings are a major red flag for clinicians.

**4. Formulating the Explanation:**

The explanation needs to:

* Clearly state that **D is the correct answer**.
* Explain *why* D is correct (inconsistency = suspicious).
* Briefly explain *why* the other options are incorrect, focusing on why they are not *direct* or *reliable* indicators of *suspecting* abuse.  For E, it's important to explain what Mongolian spots are and why they are *not* bruises.
* Use clear and concise language, suitable for someone learning about child abuse indicators.

**5.  Korean Language Considerations (for the target audience):**

* Ensure the explanation is in clear and grammatically correct Korean.
* Use appropriate medical terminology in Korean (ì†ìƒê²½ìœ„, ìž„ìƒì¦ìƒ, ëª½ê³ ë°˜ì , í”¼ë¶€ê°ì—¼, í•™ì—… ì„±ì , ì „ê³¼ìž).
* Maintain a respectful and informative tone.


By following these steps of analyzing each option, comparing their relevance to the question, and then constructing a clear explanation in Korean, we arrive at the correct answer (D) and the detailed explanation provided in the initial example.  The key is to focus on the *directness* and *reliability* of each option as a clinical indicator for *suspecting* child abuse.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **D. ì†ìƒê²½ìœ„ì™€ ìž„ìƒì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì€ ê²½ìš°**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ì†Œì•„ í™˜ìž í‰ê°€ ì‹œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•´ì•¼ í•˜ëŠ” ê°€ìž¥ ì¤‘ìš”í•œ ê²½ìš°ëŠ” **ì†ìƒ ê²½ìœ„ì™€ ìž„ìƒ ì¦ìƒì´ ì¼ì¹˜í•˜ì§€ ì•Šì„ ë•Œ** ìž…ë‹ˆë‹¤. ì´ëŠ” ë³´í˜¸ìžê°€ ì„¤ëª…í•˜ëŠ” ì‚¬ê³ ë‚˜ ì†ìƒì˜ ì›ì¸ê³¼ ì‹¤ì œ í™˜ìžì˜ ìƒíƒœ, ì†ìƒ ë¶€ìœ„, ì†ìƒ ì •ë„ ë“±ì´ ë§žì§€ ì•ŠëŠ” ê²½ìš°ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.  ì˜ˆë¥¼ ë“¤ì–´, "ì¹¨ëŒ€ì—ì„œ ë–¨ì–´ì¡Œë‹¤"ê³  ì„¤ëª…í•˜ì§€ë§Œ, ì•„ì´ì—ê²ŒëŠ” ë†’ì€ ê³³ì—ì„œ ì¶”ë½í•´ì•¼ ìƒê¸¸ ìˆ˜ ìžˆëŠ” ì‹¬ê°í•œ ê³¨ì ˆì´ë‚˜ ë‘ë¶€ ì†ìƒì´ ìžˆê±°ë‚˜, ì—¬ëŸ¬ ë¶€ìœ„ì— ë‹¤ì–‘í•œ ì‹œê¸°ì˜ ë©ì´ ë°œê²¬ë˜ëŠ” ê²½ìš° í•™ëŒ€ë¥¼ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.

**ë‹¤ë¥¸ ì„ íƒì§€ ì„¤ëª…:**

* **A. ë¶€ëª¨ê°€ ì „ê³¼ìžì¸ ê²½ìš°:** ë¶€ëª¨ì˜ ì „ê³¼ ê¸°ë¡ì€ ì•„ë™ í•™ëŒ€ì˜ ìœ„í—˜ ìš”ì¸ì´ ë  ìˆ˜ ìžˆì§€ë§Œ, **ì „ê³¼ ê¸°ë¡ë§Œìœ¼ë¡œ í•™ëŒ€ë¥¼ ë‹¨ì • ì§€ì„ ìˆ˜ëŠ” ì—†ìŠµë‹ˆë‹¤.**  ëª¨ë“  ì „ê³¼ìžê°€ ì•„ë™ í•™ëŒ€ìžì¸ ê²ƒì€ ì•„ë‹ˆë©°, ì „ê³¼ ê¸°ë¡ì´ ì—†ëŠ” ë¶€ëª¨ë„ í•™ëŒ€ë¥¼ ì €ì§€ë¥¼ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ì „ê³¼ ê¸°ë¡ì€ í•™ëŒ€ ì˜ì‹¬ì˜ **ì¶”ê°€ì ì¸ ê³ ë ¤ ì‚¬í•­**ì´ ë  ìˆ˜ ìžˆì§€ë§Œ, í•µì‹¬ì ì¸ ì˜ì‹¬ ì‚¬ìœ ëŠ” ì•„ë‹™ë‹ˆë‹¤.

* **B. í•™ì—… ì„±ì ì´ ë‚®ì€ ê²½ìš°:** í•™ì—… ì„±ì  ì €í•˜ëŠ” ì•„ë™ í•™ëŒ€ì˜ ê°„ì ‘ì ì¸ ì˜í–¥ì¼ ìˆ˜ ìžˆì§€ë§Œ, **í•™ì—… ì„±ì ë§Œìœ¼ë¡œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ê¸°ëŠ” ì–´ë µìŠµë‹ˆë‹¤.**  í•™ì—… ë¶€ì§„ì˜ ì›ì¸ì€ ë‹¤ì–‘í•˜ë©° (í•™ìŠµ ìž¥ì• , ê°€ì • í™˜ê²½ ë¬¸ì œ, ë°œë‹¬ ë¬¸ì œ ë“±), í•™ëŒ€ê°€ ì•„ë‹Œ ë‹¤ë¥¸ ìš”ì¸ì¼ ê°€ëŠ¥ì„±ì´ ë” ë†’ìŠµë‹ˆë‹¤.

* **C. í”¼ë¶€ê°ì—¼ì´ ë°œìƒí•œ ê²½ìš°:** í”¼ë¶€ ê°ì—¼ì€ ìœ„ìƒ ìƒíƒœ ë¶ˆëŸ‰ì´ë‚˜ ë‹¤ë¥¸ ì§ˆí™˜ìœ¼ë¡œ ì¸í•´ ë°œìƒí•  ìˆ˜ ìžˆìœ¼ë©°, **í”¼ë¶€ ê°ì—¼ë§Œìœ¼ë¡œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ê¸°ëŠ” ì–´ë µìŠµë‹ˆë‹¤.**  ë¬¼ë¡  ì‹¬ê°í•œ ë°©ìž„ì€ í”¼ë¶€ ê°ì—¼ì„ ìœ ë°œí•  ìˆ˜ ìžˆì§€ë§Œ, í”¼ë¶€ ê°ì—¼ ìžì²´ëŠ” í”í•œ ì†Œì•„ ì§ˆí™˜ìž…ë‹ˆë‹¤. ë°©ìž„ìœ¼ë¡œ ì¸í•œ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ë ¤ë©´ ë‹¤ë¥¸ ì¦ìƒë“¤ê³¼ í•¨ê»˜ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤.

* **E. ì—‰ë©ì´ë‚˜ íŒ”, ë‹¤ë¦¬ì— ëª½ê³ ë°˜ì ì´ ìžˆëŠ” ê²½ìš°:** ëª½ê³ ë°˜ì ì€ ë™ì–‘ì¸ì—ê²Œ í”í•˜ê²Œ ë‚˜íƒ€ë‚˜ëŠ” **ì •ìƒì ì¸ í”¼ë¶€ ë³€í™”**ì´ë©°, **í•™ëŒ€ì™€ ì „í˜€ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.**  ì˜¤ížˆë ¤ ëª½ê³ ë°˜ì ì„ ë©ìœ¼ë¡œ ì˜¤ì¸í•˜ì—¬ í•™ëŒ€ë¡œ ìž˜ëª» ì‹ ê³ ë˜ëŠ” ê²½ìš°ê°€ ìžˆìŠµë‹ˆë‹¤. ëª½ê³ ë°˜ì ì€ ì¶œìƒ ì‹œë¶€í„° ë‚˜íƒ€ë‚˜ë©°, ì‹œê°„ì´ ì§€ë‚˜ë©´ì„œ ìžì—°ì ìœ¼ë¡œ ì‚¬ë¼ì§‘ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ,** ì•„ë™ í•™ëŒ€ë¥¼ ì˜ì‹¬í•˜ëŠ” ê°€ìž¥ ì¤‘ìš”í•œ ë‹¨ì„œëŠ” **ì†ìƒ ê²½ìœ„ì™€ ìž„ìƒ ì¦ìƒì˜ ë¶ˆì¼ì¹˜**ìž…ë‹ˆë‹¤.  ë‹¤ë¥¸ ì„ íƒì§€ë“¤ì€ í•™ëŒ€ì™€ ê´€ë ¨ë  ìˆ˜ ìžˆì§€ë§Œ, ì§ì ‘ì ì¸ ì˜ì‹¬ ì‚¬ìœ ëŠ” ì•„ë‹ˆë©°, ì˜¤ížˆë ¤ ì˜¤í•´ë¥¼ ë¶ˆëŸ¬ì¼ìœ¼í‚¬ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.  ì˜ë£Œì§„ì€ ì†ìƒ ê²½ìœ„ì™€ ìž„ìƒ ì¦ìƒì„ ë©´ë°€ížˆ ë¹„êµí•˜ê³ , ì•„ë™ì˜ ì•ˆì „ì„ ìµœìš°ì„ ìœ¼ë¡œ ê³ ë ¤í•˜ì—¬ ì‹ ì¤‘í•˜ê²Œ íŒë‹¨í•´ì•¼ í•©ë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">7,159</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="17"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">nurse</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,021</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">51</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í‰ë¶€ì™¸ìƒìœ¼ë¡œ í‰ë§‰ê°• ë‚´ í˜ˆì•¡ì´ ì¶•ì ë˜ì—ˆì„ ë•Œ ìš°ì„ ì ì¸ ì‚¬ì •ê²°ê³¼ëŠ”?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë§ì´ˆë¶€ì¢…</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë§ì´ˆê°ê° ì €í•˜</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê°•í•˜ê³  ëŠë¦° ë§¥ë°•</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í™˜ì¸¡ ë¶€ìœ„ íƒ€ì§„ ì‹œ ê³¼ê³µëª…ìŒ</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">
The question is asking about the priority assessment finding when blood accumulates in the pleural space due to chest trauma. This condition is called hemothorax.  Let's analyze each option and see which one is the most relevant and indicative of hemothorax.

* **Hemothorax:** Blood in the pleural space. Pleural space is the space between the visceral and parietal pleura, normally containing a small amount of lubricating fluid. Blood accumulation in this space is usually due to trauma, surgery, or sometimes spontaneously.

* **Consequences of Hemothorax:**
    * **Reduced Lung Expansion:** Blood in the pleural space takes up space, compressing the lung and preventing full expansion. This leads to impaired gas exchange and respiratory distress.
    * **Hypovolemia (if significant blood loss):** Depending on the amount of blood lost, it can lead to hypovolemia and shock.

Let's evaluate each option:

* **A. ë§ì´ˆë¶€ì¢… (Peripheral edema):** Peripheral edema is usually caused by fluid overload, heart failure, kidney problems, or venous insufficiency.  It's not a primary or direct consequence of hemothorax.  While severe hypovolemic shock *could* eventually lead to kidney issues and potentially edema, it's not a *priority* finding or the most direct result.  This is unlikely to be the *primary* or *priority* finding.

* **B. ë§ì´ˆê°ê° ì €í•˜ (Decreased peripheral sensation):**  Decreased peripheral sensation can be caused by various conditions, including nerve damage, circulatory problems, or certain neurological conditions.  While severe hypovolemic shock *could* lead to decreased peripheral perfusion and potentially sensory changes, it's not the *most direct* and *priority* finding related to hemothorax itself.  It's a less direct consequence compared to respiratory findings.

* **C. ê°•í•˜ê³  ëŠë¦° ë§¥ë°• (Strong and slow pulse):**  A strong and slow pulse (bradycardia) is not typically associated with hemothorax.  In fact, in response to blood loss and hypovolemia (if significant), the body usually tries to compensate with an *increased* heart rate (tachycardia) to maintain cardiac output.  Bradycardia might be seen in certain situations like increased intracranial pressure, but not typically in hemothorax. This option is unlikely.

* **D. ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ (Decreased breath sounds on auscultation):**  Hemothorax directly affects the lungs. Blood in the pleural space compresses the lung, preventing it from expanding properly.  When auscultating the lungs, the breath sounds over the affected area will be diminished or absent due to the reduced air movement into that part of the lung. This is a *direct* and *primary* physical finding expected in hemothorax.

* **E. í™˜ì¸¡ ë¶€ìœ„ íƒ€ì§„ ì‹œ ê³¼ê³µëª…ìŒ (Hyperresonance on percussion of the affected side):**  Hyperresonance on percussion indicates increased air in the pleural space, such as in pneumothorax (air in the pleural space).  In hemothorax, the pleural space is filled with blood, which is a fluid. Fluid in the pleural space would generally lead to *dullness* or *flatness* on percussion, not hyperresonance. Hyperresonance is the opposite of what you'd expect in hemothorax.

**Comparing D and others:**

Option D (decreased breath sounds) is the most direct and immediate physical finding expected in hemothorax.  The other options are either less directly related, less likely, or even contradictory to the pathophysiology of hemothorax.

Therefore, the most appropriate answer is D.

**Final Answer Selection Process:**

1. **Understand the condition:** Hemothorax = blood in the pleural space.
2. **Consider the direct effects:** Blood occupies space, compressing the lung.
3. **Evaluate each option based on direct effects and typical findings:**
    * A. Peripheral edema - Indirect, less likely, not priority.
    * B. Decreased peripheral sensation - Indirect, less likely, not priority.
    * C. Strong and slow pulse - Contradictory to typical response to blood loss.
    * D. Decreased breath sounds - Direct result of lung compression, primary finding.
    * E. Hyperresonance on percussion - Opposite of what's expected in fluid accumulation.

4. **Select the best fit:** Option D (decreased breath sounds) is the most direct, relevant, and priority assessment finding in hemothorax.

Therefore, the answer is D.

Let's translate the options and the question to English for clarity:

**Question:** What is the priority assessment finding when blood accumulates in the pleural space due to chest trauma (hemothorax)?

A. Peripheral edema
B. Decreased peripheral sensation
C. Strong and slow pulse
D. Decreased breath sounds on auscultation
E. Hyperresonance on percussion of the affected side

**Conclusion:** The most appropriate answer is D.
</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **D. ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

í‰ë¶€ì™¸ìƒìœ¼ë¡œ ì¸í•´ í‰ë§‰ê°• ë‚´ì— í˜ˆì•¡ì´ ì¶•ì ë˜ëŠ” í˜ˆí‰(hemothorax)ì€ íë¥¼ ì••ë°•í•˜ì—¬ íí™œëŸ‰ì„ ê°ì†Œì‹œí‚¤ê³  ê°€ìŠ¤ êµí™˜ì„ ë°©í•´í•©ë‹ˆë‹¤.  ë”°ë¼ì„œ ê°€ìž¥ ìš°ì„ ì ìœ¼ë¡œ ë‚˜íƒ€ë‚˜ëŠ” ì‚¬ì • ê²°ê³¼ëŠ” í˜¸í¡ê¸°ê³„ ë³€í™”ì™€ ê´€ë ¨ëœ ì¦ìƒìž…ë‹ˆë‹¤.

ê° ì„ íƒì§€ë¥¼ ë¶„ì„í•´ ë³´ê² ìŠµë‹ˆë‹¤.

* **A. ë§ì´ˆë¶€ì¢…:** ë§ì´ˆë¶€ì¢…ì€ ì£¼ë¡œ ì‹¬ë¶€ì „, ì‹ ìž¥ ì§ˆí™˜, ì •ë§¥ ë¶€ì „ ë“± ìˆœí™˜ê¸°ê³„ ë¬¸ì œì™€ ê´€ë ¨ì´ ìžˆìœ¼ë©°, í˜ˆí‰ì˜ ì§ì ‘ì ì¸ ìš°ì„  ì‚¬ì • ê²°ê³¼ëŠ” ì•„ë‹™ë‹ˆë‹¤. í˜ˆì•¡ëŸ‰ ê°ì†Œë¡œ ì¸í•´ ë°œìƒí•  ìˆ˜ ìžˆì§€ë§Œ, ìš°ì„ ì ì¸ ì¦ìƒì€ ì•„ë‹™ë‹ˆë‹¤.

* **B. ë§ì´ˆê°ê° ì €í•˜:** ë§ì´ˆê°ê° ì €í•˜ëŠ” ì‹ ê²½ ì†ìƒ, ë§ì´ˆí˜ˆê´€ ì§ˆí™˜ ë“± ì‹ ê²½ê³„ ë˜ëŠ” í˜ˆê´€ ë¬¸ì œì™€ ê´€ë ¨ì´ ê¹ŠìŠµë‹ˆë‹¤. í˜ˆí‰ìœ¼ë¡œ ì¸í•œ í˜ˆì•¡ëŸ‰ ê°ì†Œë¡œ ë§ì´ˆ ìˆœí™˜ì´ ê°ì†Œí•˜ì—¬ ê°ê° ì €í•˜ê°€ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆì§€ë§Œ, í˜¸í¡ê¸°ê³„ ì¦ìƒë³´ë‹¤ ìš°ì„ ì ì¸ ì‚¬ì • ê²°ê³¼ëŠ” ì•„ë‹™ë‹ˆë‹¤.

* **C. ê°•í•˜ê³  ëŠë¦° ë§¥ë°•:** ê°•í•˜ê³  ëŠë¦° ë§¥ë°• (ì„œë§¥)ì€ ì¼ë°˜ì ìœ¼ë¡œ í˜ˆí‰ê³¼ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤. ì˜¤ížˆë ¤ í˜ˆì•¡ëŸ‰ ê°ì†Œ ì‹œ ì‹¬ë°•ìˆ˜ê°€ ì¦ê°€í•˜ëŠ” ë¹ˆë§¥ì´ ë‚˜íƒ€ë‚  ê°€ëŠ¥ì„±ì´ ë†’ìŠµë‹ˆë‹¤. ì„œë§¥ì€ ë‘ê°œë‚´ì•• ìƒìŠ¹, ë¯¸ì£¼ì‹ ê²½ ìžê·¹ ë“± ë‹¤ë¥¸ ìƒí™©ì—ì„œ ë‚˜íƒ€ë‚  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

* **D. ì²­ì§„ ì‹œ í˜¸í¡ìŒ ê°ì†Œ:** í˜ˆí‰ìœ¼ë¡œ ì¸í•´ í‰ë§‰ê°• ë‚´ í˜ˆì•¡ì´ ì°¨ë©´ íê°€ ì••ë°•ë˜ì–´ íí¬ë¡œì˜ ê³µê¸° ì´ë™ì´ ê°ì†Œí•©ë‹ˆë‹¤.  ë”°ë¼ì„œ ì²­ì§„ ì‹œ í™˜ì¸¡ í‰ë¶€ì—ì„œ í˜¸í¡ìŒì´ ê°ì†Œí•˜ê±°ë‚˜ ì†Œì‹¤ë˜ëŠ” ê²ƒì€ í˜ˆí‰ì˜ ê°€ìž¥ ì§ì ‘ì ì´ê³  ìš°ì„ ì ì¸ ì‚¬ì • ê²°ê³¼ìž…ë‹ˆë‹¤.

* **E. í™˜ì¸¡ ë¶€ìœ„ íƒ€ì§„ ì‹œ ê³¼ê³µëª…ìŒ:** ê³¼ê³µëª…ìŒì€ í‰ê°• ë‚´ ê³µê¸°ê°€ ì¦ê°€í–ˆì„ ë•Œ ë‚˜íƒ€ë‚˜ëŠ” íƒ€ì§„ìŒìœ¼ë¡œ, ê¸°í‰(pneumothorax)ì˜ íŠ¹ì§•ì ì¸ ì†Œê²¬ìž…ë‹ˆë‹¤. í˜ˆí‰ì€ í‰ê°• ë‚´ í˜ˆì•¡ì´ ì°¨ëŠ” ê²ƒì´ë¯€ë¡œ, íƒ€ì§„ ì‹œ ë‘”íƒìŒ(dullness)ì´ë‚˜ íŽ¸í‰ìŒ(flatness)ì´ ë‚˜íƒ€ë‚˜ëŠ” ê²ƒì´ ì¼ë°˜ì ìž…ë‹ˆë‹¤. ê³¼ê³µëª…ìŒì€ í˜ˆí‰ê³¼ëŠ” ë°˜ëŒ€ë˜ëŠ” ì†Œê²¬ìž…ë‹ˆë‹¤.


**ê²°ë¡ ì ìœ¼ë¡œ, í‰ë¶€ì™¸ìƒìœ¼ë¡œ ì¸í•œ í˜ˆí‰ ì‹œ ê°€ìž¥ ìš°ì„ ì ìœ¼ë¡œ ì‚¬ì •í•´ì•¼ í•  ê²°ê³¼ëŠ” íì˜ ì••ë°•ìœ¼ë¡œ ì¸í•œ í˜¸í¡ìŒ ê°ì†Œìž…ë‹ˆë‹¤.**

**ë”°ë¼ì„œ ì •ë‹µì€ Dìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,845</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="18"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">dental_technician</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,020</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">73</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì˜ ì–¸ë”ì»·(undercut)ì„ ë©”ì›Œì£¼ëŠ” ê³¼ì •ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë¦´ë¦¬í”„(relief)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë“±ê³ ì (tripoding)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í˜•ì„± ë¸”ë¡ì•„ì›ƒ(shaped block out)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìž„ì˜ ë¸”ë¡ì•„ì›ƒ(arbitrary block out)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">í‰í–‰ ë¸”ë¡ì•„ì›ƒ(paralleled block out)</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down this Korean question and arrive at the correct answer.

**1. Deconstructing the Question:**

* **ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ (sujik bu-yeon-gyeol-jang-chi):**  This translates to "vertical minor connector."  In dentistry, this refers to a part of a removable partial denture that connects the major connector (like a palatal bar or lingual bar) to other components like clasps or rests.  Think of it as a supporting arm extending vertically.

* **ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ (jinaganeun buwi):**  "Area it passes through" or "area it crosses."  This implies the minor connector is traversing a certain area in the mouth.

* **ì–¸ë”ì»· (undercut):**  This is a crucial dental term. An undercut is a recessed area of a tooth or alveolar ridge that is *below* the height of contour. In simpler terms, it's a "cave" or "indentation" that can prevent the insertion and removal of a denture if not properly addressed.  Imagine a tooth with a bulge near the gumline; the area *below* that bulge toward the root is an undercut.

* **ë©”ì›Œì£¼ëŠ” ê³¼ì • (mewo-juneun gwajeong):**  "Process of filling in" or "process of blocking out." This indicates we need to eliminate or reduce the undercut.

* **Question summary:** The question is asking for the process of filling in or eliminating undercuts in the area where a vertical minor connector of a removable partial denture will pass.  This is necessary to ensure the denture can be inserted and removed without interference or damage to the tissues.

**2. Analyzing the Answer Choices:**

* **A. ë¦´ë¦¬í”„ (relief):** Relief in dentistry refers to creating space *under* a denture base or connector to prevent pressure on soft tissues.  It's about *reducing* pressure, not necessarily filling undercuts.  While relief is important in denture fabrication, it's not directly related to *filling* undercuts specifically for minor connector placement. Itâ€™s more about preventing tissue impingement and ensuring proper seating.

* **B. ë“±ê³ ì  (tripoding):** Tripoding is a technique used in surveying and dentistry to establish a stable and repeatable reference plane.  In dentistry, it's used on casts to orient them consistently on an articulator.  It has nothing to do with filling undercuts for minor connectors.

* **C. í˜•ì„± ë¸”ë¡ì•„ì›ƒ (hyeongseong beulloka-ut):**  "Shaped block out." Block out, in general, means to eliminate undercuts on a cast to facilitate the fabrication of a removable partial denture. "Shaped" implies a specific, contoured block out.  This sounds highly relevant to the question.  We are dealing with a specific structure (minor connector) and need a specific block out shape to accommodate it.

* **D. ìž„ì˜ ë¸”ë¡ì•„ì›ƒ (imui beulloka-ut):** "Arbitrary block out." "Arbitrary" means random or not specifically defined. While block out in general is about removing undercuts, "arbitrary" suggests a less precise or uncontrolled method.  For a vertical minor connector, which needs to be accurately positioned and have proper tissue contact, an arbitrary block out is unlikely to be the correct approach.  It might be used in simpler situations or initial blocking out before more refined steps.

* **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ (pyeonghaeng beulloka-ut):** "Paralleled block out."  Paralleled block out is done using a dental surveyor with the cast oriented on a specific path of insertion.  It aims to create parallel surfaces to guide the denture insertion and removal.  This is a more precise and controlled form of block out.  It sounds very relevant to the placement of a vertical minor connector, which needs to be properly aligned with the path of insertion and avoid interference.

**3. Comparing and Contrasting C and E:**

Both "Shaped block out" and "Paralleled block out" seem related to blocking out undercuts for a minor connector. Let's refine the distinction.

* **Shaped block out (C):**  Focuses on the *shape* of the block out needed to accommodate the minor connector.  This could involve creating a specific contour or form to ensure the minor connector fits smoothly and functions correctly.

* **Paralleled block out (E):**  Emphasizes the *parallelism* of the block out to the path of insertion. This ensures the minor connector is aligned with the overall denture insertion path and avoids creating new undercuts or interferences during insertion/removal.

**4.  Connecting to Minor Connector Function:**

Vertical minor connectors need to be accurately placed and have appropriate tissue contact for support, stability, and retention of the denture.  They also need to be non-interfering during insertion and removal.  Therefore, a precise and controlled block out is necessary.

**5.  Choosing the Best Answer:**

While "shaped block out" (C) is generally relevant, "paralleled block out" (E) is more specific and accurate in the context of vertical minor connectors.  Paralleled block out is performed using a surveyor and takes into account the path of insertion, which is crucial for the function and comfort of a removable partial denture.  It's a more refined and standard procedure for creating space for components like minor connectors.

**6. Conclusion:**

The most appropriate answer is **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ (paralleled block out)** because it's the most precise and relevant technique for eliminating undercuts in the path of insertion for a vertical minor connector, ensuring proper denture fit and function.  While shaped block out is a broader term, paralleled block out is the more specific and technically correct method in this scenario.

**Final Answer: E**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ(paralleled block out)** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

* **ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜:** ê°€ì² ì„± êµ­ì†Œ ì˜ì¹˜(í‹€ë‹ˆ)ì˜ ì£¼ìš” ì—°ê²° ìž¥ì¹˜(ì˜ˆ: êµ¬ê°œë¶€ ì—°ê²°ìž¥ì¹˜, ì„¤ì¸¡ ì—°ê²°ìž¥ì¹˜)ì™€ ë‹¤ë¥¸ êµ¬ì„± ìš”ì†Œ(ì˜ˆ: ìœ ì§€ ìž¥ì¹˜, ì§€ì§€ ìž¥ì¹˜)ë¥¼ ì—°ê²°í•˜ëŠ” ìˆ˜ì§ìœ¼ë¡œ ë»—ì€ ìž‘ì€ ì—°ê²° ìž¥ì¹˜ìž…ë‹ˆë‹¤.

* **ì–¸ë”ì»·(Undercut):** ì¹˜ì•„ë‚˜ ì¹˜ì¡°ê³¨ì˜ íŠ¹ì • ë¶€ìœ„ê°€ ê°€ìž¥ ë³¼ë¡í•œ ë¶€ë¶„(height of contour) ì•„ëž˜ë¡œ ì›€í‘¹ ë“¤ì–´ê°„ ë¶€ë¶„ìž…ë‹ˆë‹¤. ì–¸ë”ì»·ì€ ê°€ì² ì„± ì˜ì¹˜ì˜ ì‚½ìž… ë° ì œê±° ê²½ë¡œë¥¼ ë°©í•´í•˜ì—¬ ì˜ì¹˜ê°€ ì œëŒ€ë¡œ ìž¥ì°©ë˜ì§€ ëª»í•˜ê²Œ í•˜ê±°ë‚˜, ë¬´ë¦¬í•˜ê²Œ ì‚½ìž…/ì œê±° ì‹œ êµ¬ê°• ì¡°ì§ì— ì†ìƒì„ ì¤„ ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

* **ë¸”ë¡ì•„ì›ƒ(Block out):**  ìž‘ì—… ëª¨í˜• ìƒì—ì„œ ì–¸ë”ì»·ì„ ì œê±°í•˜ê±°ë‚˜ ë©”ì›Œì£¼ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤. ì´ëŠ” ì˜ì¹˜ì˜ ì‚½ìž… ë° ì œê±° ê²½ë¡œë¥¼ ìš©ì´í•˜ê²Œ í•˜ê³ , ì˜ì¹˜ ì œìž‘ ê³¼ì •ì—ì„œ ë¶ˆí•„ìš”í•œ ë³€í˜•ì´ë‚˜ ì†ìƒì„ ë°©ì§€í•˜ê¸° ìœ„í•´ í•„ìˆ˜ì ìž…ë‹ˆë‹¤.

ì´ì œ ê° ì„ íƒì§€ë¥¼ ì‚´íŽ´ë³´ê² ìŠµë‹ˆë‹¤.

* **A. ë¦´ë¦¬í”„(Relief):** ë¦´ë¦¬í”„ëŠ” ì˜ì¹˜ìƒ ë˜ëŠ” ì—°ê²° ìž¥ì¹˜ ì•„ëž˜ì— ê³µê°„ì„ ë‘ì–´ íŠ¹ì • ë¶€ìœ„ì— ì••ë ¥ì´ ì§‘ì¤‘ë˜ëŠ” ê²ƒì„ ë°©ì§€í•˜ëŠ” ê³¼ì •ìž…ë‹ˆë‹¤. ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ê²ƒê³¼ëŠ” ì§ì ‘ì ì¸ ê´€ë ¨ì´ ì ìŠµë‹ˆë‹¤.

* **B. ë“±ê³ ì (Tripoding):** ë“±ê³ ì ì€ ìž‘ì—… ëª¨í˜•ì„ íŠ¹ì •í•œ ìœ„ì¹˜ì— ì•ˆì •ì ìœ¼ë¡œ ê³ ì •í•˜ê³ , ëª¨í˜•ì˜ ìœ„ì¹˜ë¥¼ ìž¬í˜„í•˜ê¸° ìœ„í•œ ê³¼ì •ìž…ë‹ˆë‹¤. ì–¸ë”ì»· ì œê±°ì™€ëŠ” ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.

* **C. í˜•ì„± ë¸”ë¡ì•„ì›ƒ(Shaped block out):** í˜•ì„± ë¸”ë¡ì•„ì›ƒì€ íŠ¹ì • í˜•íƒœë¥¼ ë¶€ì—¬í•˜ì—¬ ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ë¸”ë¡ì•„ì›ƒ ë°©ë²•ìž…ë‹ˆë‹¤.  ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì— ì í•©í•  ìˆ˜ ìžˆì§€ë§Œ, ì¢€ ë” í¬ê´„ì ì¸ ê°œë…ìž…ë‹ˆë‹¤.

* **D. ìž„ì˜ ë¸”ë¡ì•„ì›ƒ(Arbitrary block out):** ìž„ì˜ ë¸”ë¡ì•„ì›ƒì€ íŠ¹ë³„í•œ ê¸°ì¤€ ì—†ì´ ìž„ì˜ë¡œ ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ë°©ë²•ìž…ë‹ˆë‹¤. ì •ë°€í•œ ì˜ì¹˜ ì œìž‘ì—ëŠ” ì í•©í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.

* **E. í‰í–‰ ë¸”ë¡ì•„ì›ƒ(Paralleled block out):** í‰í–‰ ë¸”ë¡ì•„ì›ƒì€ ì˜ì¹˜ì˜ ì‚½ìž… ë° ì œê±° ê²½ë¡œì™€ í‰í–‰í•˜ê²Œ ì–¸ë”ì»·ì„ ë©”ìš°ëŠ” ë°©ë²•ìž…ë‹ˆë‹¤.  ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ëŠ” ì˜ì¹˜ì˜ ì‚½ìž… ê²½ë¡œì™€ í‰í–‰í•˜ê²Œ ì„¤ê³„ë˜ëŠ” ê²½ìš°ê°€ ë§Žìœ¼ë¯€ë¡œ, **í‰í–‰ ë¸”ë¡ì•„ì›ƒì´ ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì˜ ì–¸ë”ì»·ì„ ë©”ì›Œì£¼ëŠ” ê°€ìž¥ ì ì ˆí•œ ê³¼ì •**ìž…ë‹ˆë‹¤.  í‰í–‰ ë¸”ë¡ì•„ì›ƒì„ í†µí•´ ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì–¸ë”ì»·ì— ê±¸ë¦¬ì§€ ì•Šê³  ì›í™œí•˜ê²Œ ì‚½ìž… ë° ì œê±°ë  ìˆ˜ ìžˆë„ë¡ ê³µê°„ì„ í™•ë³´í•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ìˆ˜ì§ ë¶€ì—°ê²°ìž¥ì¹˜ê°€ ì§€ë‚˜ê°€ëŠ” ë¶€ìœ„ì˜ ì–¸ë”ì»·ì„ ë©”ì›Œì£¼ëŠ” ê³¼ì •ì€ ì˜ì¹˜ì˜ ì‚½ìž… ê²½ë¡œë¥¼ ê³ ë ¤í•˜ì—¬ í‰í–‰í•˜ê²Œ ì–¸ë”ì»·ì„ ì œê±°í•˜ëŠ” "í‰í–‰ ë¸”ë¡ì•„ì›ƒ"ì´ ê°€ìž¥ ì í•©í•©ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4,949</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="19"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">nurse_assistant</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,022</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">47</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¸ì²´ì—ì„œ ë¹„íƒ€ë¯¼Dê°€ í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³ , ë„ë¥´ë…¸ì„ (ê±´ê°•ì„ )ì´ ìžˆëŠ” ê´‘ì„ ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Î±ì„ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Xì„ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì ì™¸ì„ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìžì™¸ì„ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê°€ì‹œê´‘ì„ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to answer the question about vitamin D synthesis and the Dorno ray (health ray).

**1. Understanding the Question (Korean to English and Key Terms):**

The question is in Korean and asks: "ì¸ì²´ì—ì„œ ë¹„íƒ€ë¯¼Dê°€ í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³ , ë„ë¥´ë…¸ì„ (ê±´ê°•ì„ )ì´ ìžˆëŠ” ê´‘ì„ ì€?"

Let's translate and break down the key terms:

* **ì¸ì²´ì—ì„œ (inche-eseo):** in the human body
* **ë¹„íƒ€ë¯¼D (bitamin-D):** Vitamin D
* **í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³  (hyeongseongdoerok jagyonghago):** works to form/synthesize/enable formation
* **ë„ë¥´ë…¸ì„  (doreuno-seon):** Dorno ray (also known as *ê±´ê°•ì„ * - geon-gang-seon)
* **(ê±´ê°•ì„ ) ((geon-gang-seon)):** (health ray) - clarification of Dorno ray
* **ìžˆëŠ” ê´‘ì„ ì€? (inneun gwangseon-eun?):** which light ray is it?  (The "-eun" is a topic marker, and "-eun?" is a question marker)

So, the question is essentially asking:  "Which light ray acts in the human body to form Vitamin D and is also known as the Dorno ray (health ray)?"

**2. Recalling Knowledge about Vitamin D and Sunlight:**

My knowledge base immediately connects vitamin D synthesis with sunlight.  I recall learning that exposure to sunlight is crucial for the body to produce vitamin D.  More specifically, I know it's a certain *type* of sunlight.

**3. Considering the Options and Eliminating Incorrect Choices:**

Now let's go through each option and analyze if it fits the criteria (Vitamin D synthesis and Dorno ray):

* **A. Î±ì„  (alpha-seon): Î±-rays:**  Alpha rays are a type of particle radiation, not electromagnetic radiation (light). They are associated with radioactive decay.  They are *not* involved in vitamin D synthesis and are not the Dorno ray.  **Eliminate A.**

* **B. Xì„  (X-seon): X-rays:** X-rays are high-energy electromagnetic radiation. They are used for medical imaging because they can penetrate soft tissues. While they are part of the electromagnetic spectrum, they are *not* the primary type of sunlight responsible for vitamin D synthesis.  X-rays are also generally considered harmful in excessive amounts and not associated with "health rays."  **Eliminate B.**

* **C. ì ì™¸ì„  (jeok-oe-seon): Infrared rays:** Infrared rays are associated with heat.  While sunlight contains infrared, it's primarily responsible for warming us.  Infrared is not directly involved in vitamin D synthesis. It is also not known as the Dorno ray. **Eliminate C.**

* **D. ìžì™¸ì„  (ja-oe-seon): Ultraviolet rays:** Ultraviolet (UV) rays *are* the part of sunlight strongly linked to vitamin D synthesis. I recall learning that UVB rays, specifically, are crucial for the photochemical reaction in the skin that produces vitamin D.  The term "Dorno ray" or "health ray" is less common in modern scientific language but historically, and sometimes still, refers to UV rays, specifically the beneficial aspects. **This is a strong candidate.**

* **E. ê°€ì‹œê´‘ì„  (gasi-gwangseon): Visible light:** Visible light is what we can see â€“ the colors of the rainbow.  While sunlight *contains* visible light, it's not the primary driver of vitamin D synthesis. Visible light is essential for vision and photosynthesis in plants, but not directly for vitamin D in humans in the same way UV is.  It's not the Dorno ray in the context of vitamin D and health. **Eliminate E.**

**4. Confirming the Dorno Ray (ê±´ê°•ì„ ) Connection:**

To be absolutely certain, I can mentally (or actually if needed) search for "Dorno ray" or "ê±´ê°•ì„ " and "vitamin D."  A quick search confirms that the Dorno ray, or *ê±´ê°•ì„ * (health ray), is indeed an older term referring to the beneficial UV rays, specifically those responsible for vitamin D production.  It's sometimes used in more holistic or alternative health contexts.  While not a strictly scientific term in mainstream modern science, it's historically and colloquially linked to the beneficial effects of UV.

**5. Selecting the Best Answer:**

Based on the above reasoning, **D. ìžì™¸ì„  (Ultraviolet rays)** is the correct answer. It is the light ray responsible for vitamin D synthesis in the human body, and it is also historically associated with the term "Dorno ray" or "health ray."

**Final Answer Selection and Confidence:**

I am confident that **D. ìžì™¸ì„ ** is the correct answer.  The question is clearly designed to test knowledge of vitamin D synthesis and the historical/alternative health term "Dorno ray," both of which point directly to ultraviolet radiation.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **D. ìžì™¸ì„ **ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

* **ë¹„íƒ€ë¯¼ D í˜•ì„±:** ìžì™¸ì„ , íŠ¹ížˆ UVBëŠ” í”¼ë¶€ì—ì„œ ë¹„íƒ€ë¯¼ Dë¥¼ í•©ì„±í•˜ëŠ” ë° í•„ìˆ˜ì ì¸ ì—­í• ì„ í•©ë‹ˆë‹¤. ìžì™¸ì„ ì´ í”¼ë¶€ì— ë‹¿ìœ¼ë©´ í”¼ë¶€ ì† 7-ë””í•˜ì´ë“œë¡œì½œë ˆìŠ¤í…Œë¡¤ì´ë¼ëŠ” ë¬¼ì§ˆì´ ë¹„íƒ€ë¯¼ D3ë¡œ ë³€í™˜ë©ë‹ˆë‹¤.
* **ë„ë¥´ë…¸ì„  (ê±´ê°•ì„ ):** ë„ë¥´ë…¸ì„ ì€ ìžì™¸ì„ ì„ ê°€ë¦¬í‚¤ëŠ” ë‹¤ë¥¸ ì´ë¦„ìž…ë‹ˆë‹¤. ê³¼ê±°ì—ëŠ” ìžì™¸ì„ ì˜ ê±´ê°• ì¦ì§„ íš¨ê³¼ (ë¹„íƒ€ë¯¼ D í•©ì„±, ì‚´ê·  ìž‘ìš© ë“±)ë¥¼ ê°•ì¡°í•˜ë©° ë„ë¥´ë…¸ì„  ë˜ëŠ” ê±´ê°•ì„ ì´ë¼ê³  ë¶ˆë €ìŠµë‹ˆë‹¤.

**ê° ì„ íƒì§€ë³„ ì„¤ëª…:**

* **A. Î±ì„  (ì•ŒíŒŒì„ ):** ë°©ì‚¬ì„ ì˜ ì¼ì¢…ìœ¼ë¡œ, ì¸ì²´ íˆ¬ê³¼ë ¥ì´ ë§¤ìš° ì•½í•˜ë©° ë¹„íƒ€ë¯¼ D í•©ì„±ê³¼ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.
* **B. Xì„  (ì—‘ìŠ¤ì„ ):** ë†’ì€ ì—ë„ˆì§€ë¥¼ ê°€ì§„ ì „ìžê¸°íŒŒë¡œ, ì˜ë£Œ ì˜ìƒ ì´¬ì˜ ë“±ì— ì‚¬ìš©ë˜ì§€ë§Œ ë¹„íƒ€ë¯¼ D í•©ì„±ê³¼ ê´€ë ¨ì´ ì—†ìœ¼ë©°, ê³¼ë‹¤ ë…¸ì¶œ ì‹œ ì¸ì²´ì— í•´ë¡­ìŠµë‹ˆë‹¤.
* **C. ì ì™¸ì„  (ì €ì™¸ì„ ):** ì—´ ìž‘ìš©ì„ í•˜ëŠ” ì „ìžê¸°íŒŒë¡œ, ì˜¨ì—´ ì¹˜ë£Œ ë“±ì— ì‚¬ìš©ë˜ì§€ë§Œ ë¹„íƒ€ë¯¼ D í•©ì„±ê³¼ ê´€ë ¨ì´ ì—†ìŠµë‹ˆë‹¤.
* **D. ìžì™¸ì„  (ìžì™¸ì„ ):** ë¹„íƒ€ë¯¼ D í•©ì„±ì— í•„ìˆ˜ì ì´ë©°, ë„ë¥´ë…¸ì„  (ê±´ê°•ì„ )ìœ¼ë¡œ ë¶ˆë¦¬ê¸°ë„ í•©ë‹ˆë‹¤. ê³¼ë‹¤ ë…¸ì¶œ ì‹œ í”¼ë¶€ì•”, í™”ìƒ ë“±ì˜ ìœ„í—˜ì´ ìžˆì§€ë§Œ ì ì ˆí•œ ì–‘ì˜ ë…¸ì¶œì€ ê±´ê°•ì— ìœ ìµí•©ë‹ˆë‹¤.
* **E. ê°€ì‹œê´‘ì„  (ê°€ì‹œê´‘ì„ ):** ìš°ë¦¬ê°€ ëˆˆìœ¼ë¡œ ë³¼ ìˆ˜ ìžˆëŠ” ë¹›ìœ¼ë¡œ, ë¹„íƒ€ë¯¼ D í•©ì„±ì— ì§ì ‘ì ì¸ ì—­í• ì„ í•˜ì§€ëŠ” ì•ŠìŠµë‹ˆë‹¤.

**ë”°ë¼ì„œ, ì¸ì²´ì—ì„œ ë¹„íƒ€ë¯¼Dê°€ í˜•ì„±ë˜ë„ë¡ ìž‘ìš©í•˜ê³ , ë„ë¥´ë…¸ì„ (ê±´ê°•ì„ )ì´ ìžˆëŠ” ê´‘ì„ ì€ ìžì™¸ì„ ìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">6,543</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="20"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">dental_technician</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,019</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">7</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë‚©í˜•(wax pattern)ì„ ì œìž‘í•  ë•Œ ì¹˜ì•„ì˜ ìµœëŒ€ í’ìœµë¶€ê°€ ê³¼í’ìœµ (over contouring)ë  ê²½ìš°ì— ë‚˜íƒ€ë‚˜ëŠ” í˜„ìƒì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìžì •ìž‘ìš©ì´ ìž˜ëœë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¹˜ì£¼ì¡°ì§ì„ ê°•í™”í•œë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì´ ë°œìƒí•œë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ìƒë¦¬ì  ë§ˆì‚¬ì§€ì˜ íš¨ê³¼ê°€ ìžˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¹˜ê²½ë¶€ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì €ë¥˜ë˜ëŠ” ê²ƒì„ ë§‰ëŠ”ë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer and explanation for the question about over-contoured wax patterns in dentistry.

**1. Understanding the Question:**

The question is asking about the *consequences* of *over-contouring* the maximum convexity (greatest bulge or widest point) of a tooth when creating a wax pattern.  This is in the context of dental restorations (like crowns, bridges, etc.) where wax patterns are used to create the final prosthetic.

**2. Defining Key Terms:**

* **Wax Pattern (ë‚©í˜•):**  A wax replica of the tooth or teeth being restored. It's used as a mold to create the final restoration in metal, ceramic, or other materials.
* **Maximum Convexity (ìµœëŒ€ í’ìœµë¶€):** The widest part of the tooth's crown, both buccolingually (cheek-to-tongue) and mesiodistally (front-to-back). This is crucial for proper function, esthetics, and periodontal health.
* **Over-Contouring (ê³¼í’ìœµ):** Making the maximum convexity *too* prominent or bulging.  This means the restoration (if based on this wax pattern) will be wider than the natural tooth should be at that point.
* **Self-Cleansing Action (ìžì •ìž‘ìš©):** The natural cleaning of the teeth by saliva, tongue, cheeks, and chewing forces.  Proper contours are essential for this.
* **Periodontal Tissue (ì¹˜ì£¼ì¡°ì§):** The tissues surrounding and supporting the teeth: gums (gingiva), periodontal ligament, cementum, and alveolar bone.
* **Free Gingiva (ìœ ë¦¬ì¹˜ì€):** The unattached portion of the gingiva, forming a collar around the tooth. It's the most susceptible part of the gingiva to inflammation.
* **Physiological Massage (ìƒë¦¬ì  ë§ˆì‚¬ì§€):** The gentle stimulation of the gingiva during chewing, which promotes healthy blood circulation and keratinization of the gingiva.  Proper contours contribute to this.
* **Food Impaction (ìŒì‹ë¬¼ ìž”ì‚¬ ì €ë¥˜):** Food getting trapped between teeth and the gingiva, often due to improper contours.
* **Cervical Area (ì¹˜ê²½ë¶€):** The neck of the tooth, where the crown meets the root, and where the gingiva attaches.

**3. Analyzing Each Answer Choice in Relation to Over-Contouring:**

* **A. ìžì •ìž‘ìš©ì´ ìž˜ëœë‹¤. (Self-cleansing is good.):**  *Incorrect.* Over-contouring creates areas where saliva and the tongue can't easily reach to clean.  Food debris and plaque will accumulate more easily.  Therefore, self-cleansing will be *impaired*, not improved.

* **B. ì¹˜ì£¼ì¡°ì§ì„ ê°•í™”í•œë‹¤. (Strengthens periodontal tissue.):** *Incorrect.* Over-contouring is detrimental to periodontal tissue.  It can lead to food impaction, plaque accumulation, and gingival inflammation.  It *weakens*, not strengthens, periodontal tissues.

* **C. ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì´ ë°œìƒí•œë‹¤. (Inflammation occurs in the free gingiva.):** *Correct.* This is the most direct and common consequence of over-contouring. The excess contour presses on the free gingiva, creating a sheltered area for plaque and bacteria to accumulate. This leads to gingivitis (inflammation of the gingiva).

* **D. ìƒë¦¬ì  ë§ˆì‚¬ì§€ì˜ íš¨ê³¼ê°€ ìžˆë‹¤. (Has the effect of physiological massage.):** *Incorrect.*  Proper contours, not over-contours, contribute to physiological massage. Over-contouring can actually hinder this natural massaging action as the tongue and cheeks may not properly stimulate the gingiva during function. Instead, it can lead to trauma from food impaction and improper forces.

* **E. ì¹˜ê²½ë¶€ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì €ë¥˜ë˜ëŠ” ê²ƒì„ ë§‰ëŠ”ë‹¤. (Prevents food debris from accumulating at the cervical area.):** *Incorrect.*  Over-contouring, especially at the cervical area, actually *promotes* food impaction.  It creates ledges and areas where food can get trapped and compressed against the gingiva.  Proper contours, on the other hand, are designed to direct food away from the gingival margin.

**4.  Connecting Over-Contouring to Periodontal Health (The Core Concept):**

The central theme here is the relationship between tooth contours and periodontal health.  Proper tooth contours are crucial for:

* **Gingival Health:**  Allowing for proper gingival adaptation and preventing irritation.
* **Self-Cleansing:** Facilitating natural cleaning by saliva, tongue, and cheeks.
* **Food Deflection:** Directing food away from the gingival sulcus (the space between the tooth and gingiva).
* **Occlusal Harmony:**  Ensuring proper bite forces and distribution.

Over-contouring disrupts all of these. It leads to:

* **Gingival Irritation/Inflammation:**  Direct pressure and plaque accumulation.
* **Impaired Self-Cleansing:**  Areas difficult to clean.
* **Food Impaction:**  Trapping food against the gingiva.
* **Potential Occlusal Problems:**  Interference with proper bite.

**5.  Formulating the Explanation:**

Based on the above analysis, the correct answer is C.  The explanation should clearly articulate *why* over-contouring leads to gingival inflammation.  This involves:

* **Direct Pressure:** The over-contoured area pushes against the free gingiva.
* **Plaque Accumulation:**  The over-contour creates a protected area where plaque and bacteria thrive because self-cleansing is reduced.
* **Gingivitis:** This plaque accumulation and irritation cause inflammation of the gingiva (gingivitis).

**6.  Review and Refine:**

Reread the question, answer choices, and explanation to ensure everything is clear, concise, and accurate.  Confirm that the explanation directly addresses why C is correct and why the other options are incorrect.  Make sure the terminology is appropriate for a dental context.

This systematic approach, starting from understanding the question and key terms, analyzing each option, and focusing on the core concept of periodontal health and tooth contours, leads to the correct answer and a comprehensive explanation.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **C. ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì´ ë°œìƒí•œë‹¤.** ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ë‚©í˜• ì œìž‘ ì‹œ ì¹˜ì•„ì˜ ìµœëŒ€ í’ìœµë¶€ë¥¼ ê³¼í’ìœµ(over contouring)í•˜ê²Œ ë˜ë©´ ë‹¤ìŒê³¼ ê°™ì€ í˜„ìƒì´ ë‚˜íƒ€ë‚©ë‹ˆë‹¤.

* **ìœ ë¦¬ì¹˜ì€ ì—¼ì¦ ë°œìƒ:** ê³¼ë„í•˜ê²Œ ë³¼ë¡í•˜ê²Œ í˜•ì„±ëœ ìµœëŒ€ í’ìœµë¶€ëŠ” ìž‡ëª¸(ìœ ë¦¬ì¹˜ì€)ì— ì••ë°•ì„ ê°€í•˜ê²Œ ë©ë‹ˆë‹¤. ì´ëŠ” ì¹˜íƒœì™€ ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì‰½ê²Œ ì¶•ì ë˜ëŠ” í™˜ê²½ì„ ì¡°ì„±í•˜ê³ , ìž‡ëª¸ì„ ìžê·¹í•˜ì—¬ ì—¼ì¦ì„ ìœ ë°œí•©ë‹ˆë‹¤. íŠ¹ížˆ ìœ ë¦¬ì¹˜ì€ì€ ì¹˜ì•„ì™€ ì§ì ‘ ë§žë‹¿ì•„ ìžˆì–´ ë”ìš± ë¯¼ê°í•˜ê²Œ ë°˜ì‘í•©ë‹ˆë‹¤.

**ì˜¤ë‹µ í•´ì„¤:**

* **A. ìžì •ìž‘ìš©ì´ ìž˜ëœë‹¤:** ê³¼í’ìœµì€ ì˜¤ížˆë ¤ ìžì •ìž‘ìš©ì„ ë°©í•´í•©ë‹ˆë‹¤.  ì •ìƒì ì¸ ì¹˜ì•„ í˜•íƒœëŠ” í˜€ì™€ ë³¼, ìž…ìˆ ì˜ ì›€ì§ìž„, ê·¸ë¦¬ê³  íƒ€ì•¡ì˜ íë¦„ì„ í†µí•´ ìžì—°ìŠ¤ëŸ½ê²Œ ì¹˜ì•„ê°€ ì„¸ì²™ë˜ëŠ” ìžì •ìž‘ìš©ì„ ë•ìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ ê³¼í’ìœµì€ ì´ëŸ¬í•œ ìžì—°ì ì¸ ì„¸ì²™ ìž‘ìš©ì„ ì–´ë µê²Œ ë§Œë“¤ì–´ ì¹˜íƒœì™€ ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì‰½ê²Œ ì¶•ì ë©ë‹ˆë‹¤.

* **B. ì¹˜ì£¼ì¡°ì§ì„ ê°•í™”í•œë‹¤:** ê³¼í’ìœµì€ ì¹˜ì£¼ì¡°ì§ì— ì˜¤ížˆë ¤ í•´ë¡œìš´ ì˜í–¥ì„ ë¯¸ì¹©ë‹ˆë‹¤. ì§€ì†ì ì¸ ì••ë°•ê³¼ ì—¼ì¦ì€ ì¹˜ì£¼ì¡°ì§ì„ ì•½í™”ì‹œí‚¤ê³ , ì¹˜ì£¼ ì§ˆí™˜ì„ ìœ ë°œí•  ìˆ˜ ìžˆìŠµë‹ˆë‹¤.

* **D. ìƒë¦¬ì  ë§ˆì‚¬ì§€ì˜ íš¨ê³¼ê°€ ìžˆë‹¤:**  ì •ìƒì ì¸ ì¹˜ì•„ í˜•íƒœëŠ” ì €ìž‘ ìš´ë™ ì‹œ ìž‡ëª¸ì— ì ì ˆí•œ ìƒë¦¬ì  ë§ˆì‚¬ì§€ íš¨ê³¼ë¥¼ ì œê³µí•˜ì—¬ í˜ˆì•¡ ìˆœí™˜ì„ ì´‰ì§„í•˜ê³  ìž‡ëª¸ ê±´ê°•ì„ ìœ ì§€í•˜ëŠ” ë° ë„ì›€ì„ ì¤ë‹ˆë‹¤. í•˜ì§€ë§Œ ê³¼í’ìœµì€ ì˜¤ížˆë ¤ ìž‡ëª¸ì— ê³¼ë„í•œ ì••ë°•ì„ ê°€í•˜ê±°ë‚˜, ì •ìƒì ì¸ ìžê·¹ì„ ë°©í•´í•˜ì—¬ ìƒë¦¬ì  ë§ˆì‚¬ì§€ íš¨ê³¼ë¥¼ ì €í•´í•©ë‹ˆë‹¤.

* **E. ì¹˜ê²½ë¶€ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ì €ë¥˜ë˜ëŠ” ê²ƒì„ ë§‰ëŠ”ë‹¤:** ê³¼í’ìœµì€ ì˜¤ížˆë ¤ ì¹˜ê²½ë¶€(ì¹˜ì•„ì™€ ìž‡ëª¸ ê²½ê³„ ë¶€ìœ„)ì— ìŒì‹ë¬¼ ìž”ì‚¬ê°€ ë” ì‰½ê²Œ ì €ë¥˜ë˜ë„ë¡ ë§Œë“­ë‹ˆë‹¤. ê³¼ë„í•˜ê²Œ ëŒì¶œëœ ë¶€ìœ„ëŠ” ìŒì‹ë¬¼ì´ ê±¸ë¦¬ê¸° ì‰½ê³ , ì¹«ì†”ì§ˆë¡œë„ ê¹¨ë—í•˜ê²Œ ì œê±°í•˜ê¸° ì–´ë ¤ì›Œ ì¶©ì¹˜ë‚˜ ì¹˜ì£¼ ì§ˆí™˜ì˜ ìœ„í—˜ì„ ë†’ìž…ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ, ë‚©í˜• ì œìž‘ ì‹œ ìµœëŒ€ í’ìœµë¶€ì˜ ê³¼í’ìœµì€ ì¹˜ì£¼ ê±´ê°•ì— ë¶€ì •ì ì¸ ì˜í–¥ì„ ë¯¸ì¹˜ë©°, íŠ¹ížˆ ìœ ë¦¬ì¹˜ì€ì— ì—¼ì¦ì„ ìœ ë°œí•˜ëŠ” ì£¼ìš” ì›ì¸ì´ ë©ë‹ˆë‹¤.** ë”°ë¼ì„œ ë‚©í˜• ì œìž‘ ì‹œì—ëŠ” ì ì ˆí•œ ì¹˜ì•„ í˜•íƒœì™€ í’ìœµë„ë¥¼ ìž¬í˜„í•˜ëŠ” ê²ƒì´ ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">4,752</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="21"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">dental_technician</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,021</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">45</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¹˜ê³¼ìš© ì„ê³ ì œí’ˆ ì¤‘ ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë‚®ì€ ê²ƒì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê²½ì„ê³ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë³´í†µì„ê³ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¸ìƒìš©ì„ê³ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³ </span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">3</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer to the question "ì¹˜ê³¼ìš© ì„ê³ ì œí’ˆ ì¤‘ ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë‚®ì€ ê²ƒì€?" (Among dental gypsum products, which has the lowest compressive strength?).

1. **Understanding the Question:** The question is asking about the compressive strength of different types of dental gypsum.  "ê°€ìž¥ ë‚®ì€" (lowest) is the key phrase.  We need to identify the gypsum product with the *weakest* compressive strength.

2. **Translating and Identifying Key Terms:**  Let's translate and understand the options:
    * ì¹˜ê³¼ìš© ì„ê³ ì œí’ˆ (chigwa-yong seokgo-jepum): Dental gypsum products
    * ì••ì¶•ê°•ë„ (apchuk-gangdo): Compressive strength
    * ê°€ìž¥ ë‚®ì€ (gajang najeun): Lowest, weakest
    * A. ê²½ì„ê³  (gyeong-seokgo):  Dental Stone (Type III) - often translated as "hard stone" or "dental stone, hard" in English.
    * B. ë³´í†µì„ê³  (botong-seokgo): Plaster (Type II) - often translated as "model plaster" or "dental plaster".
    * C. ì¸ìƒìš©ì„ê³  (insang-yong seokgo): Impression Plaster (Type I) - specifically for dental impressions.
    * D. ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (jeo-paengchang-yong cho-gyeong-seokgo): Low-expansion die stone (Type IV).  "ì´ˆê²½ì„ê³ " (cho-gyeong-seokgo) means "super hard stone" or "die stone." "ì €íŒ½ì°½ìš©" (jeo-paengchang-yong) means "low expansion."
    * E. ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (go-paengchang-yong cho-gyeong-seokgo): High-expansion die stone (Type V). "ê³ íŒ½ì°½ìš©" (go-paengchang-yong) means "high expansion."

3. **Recalling Knowledge about Dental Gypsum Types:**  My knowledge base about dental materials immediately brings to mind the classification of dental gypsum products based on ADA (American Dental Association) specifications (or similar international standards).  These are categorized by type, roughly related to their strength and application:

    * **Type I: Impression Plaster:**  Weakest.  Designed for taking impressions, where detail reproduction is more important than high strength.  Easy to separate from the impression.
    * **Type II: Model Plaster:**  Slightly stronger than impression plaster. Used for study models, mounting casts on articulators, etc. Still relatively weak.
    * **Type III: Dental Stone (or Hard Stone):** Stronger than plaster. Used for working casts, diagnostic casts, and denture bases.  More durable and resistant to abrasion than plaster.
    * **Type IV: Die Stone (Low Expansion):**  Significantly stronger than dental stone.  High compressive strength and abrasion resistance. Low setting expansion for accurate dies used in crown and bridge fabrication.
    * **Type V: Die Stone (High Expansion):**  Similar to Type IV in strength but with controlled, higher setting expansion to compensate for the shrinkage of certain casting alloys.

4. **Relating Knowledge to the Options:** Now, let's match the options to the types and their relative strengths:

    * A. ê²½ì„ê³  (Dental Stone) - Type III -  Moderate strength.
    * B. ë³´í†µì„ê³  (Plaster) - Type II -  Weaker strength than stone.
    * C. ì¸ìƒìš©ì„ê³  (Impression Plaster) - Type I -  Weakest strength.
    * D. ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (Low-expansion die stone) - Type IV -  Highest strength (among these options).
    * E. ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³  (High-expansion die stone) - Type V -  Highest strength (similar to Type IV, among these options).

5. **Determining the Weakest:**  Based on the classification and understanding of the properties, Impression Plaster (Type I) is clearly the weakest among the given options.

6. **Selecting the Answer:**  Therefore, the answer is **C. ì¸ìƒìš©ì„ê³  (Impression Plaster)**.

7. **Verification (Self-Correction/Confirmation):**  To double-check, I quickly review the characteristics of each gypsum type again.  Impression plaster is indeed formulated to be weak and easily broken, facilitating removal from the mouth and model separation.  Plaster is stronger, stone stronger still, and die stones are the strongest.  The question specifically asks for the *lowest* compressive strength, so Impression Plaster fits perfectly.  The other options are all stronger gypsum products.

This systematic process of translation, recall, comparison, and verification leads confidently to the correct answer, C.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **C. ì¸ìƒìš© ì„ê³ **ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

ì¹˜ê³¼ìš© ì„ê³  ì œí’ˆì€ ìš©ë„ì— ë”°ë¼ ë‹¤ì–‘í•œ ì¢…ë¥˜ê°€ ìžˆìœ¼ë©°, ì••ì¶•ê°•ë„ëŠ” ê° ì œí’ˆì˜ ì£¼ìš” íŠ¹ì„± ì¤‘ í•˜ë‚˜ìž…ë‹ˆë‹¤. ì••ì¶•ê°•ë„ëŠ” ì„ê³ ê°€ ì••ë ¥ì— ì–¼ë§ˆë‚˜ ìž˜ ê²¬ë””ëŠ”ì§€ë¥¼ ë‚˜íƒ€ë‚´ëŠ” ì§€í‘œë¡œ, ë†’ì„ìˆ˜ë¡ ë‹¨ë‹¨í•˜ê³  ê°•í•œ ì„ê³ ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.

ê° ì„ê³  ì œí’ˆë³„ ì••ì¶•ê°•ë„ë¥¼ ë¹„êµí•˜ë©´ ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.

* **ì¸ìƒìš© ì„ê³  (Impression Plaster):**  **ê°€ìž¥ ë‚®ì€ ì••ì¶•ê°•ë„**ë¥¼ ê°€ì§‘ë‹ˆë‹¤.  ì¸ìƒ ì±„ë“ ì‹œ êµ¬ê°• ë‚´ì—ì„œ ì‰½ê²Œ ì œê±°ë  ìˆ˜ ìžˆë„ë¡ ì•½í•˜ê²Œ ë§Œë“¤ì–´ì¡Œìœ¼ë©°, ì •ë°€í•œ ìž¬í˜„ì„±ë³´ë‹¤ëŠ” ìš©ì´í•œ ì œê±°ì— ì´ˆì ì„ ë§žì¶¥ë‹ˆë‹¤.

* **ë³´í†µ ì„ê³  (Model Plaster):** ì¸ìƒìš© ì„ê³ ë³´ë‹¤ëŠ” ê°•í•˜ì§€ë§Œ, ê²½ì„ê³ ë‚˜ ì´ˆê²½ì„ê³ ë³´ë‹¤ëŠ” **ì••ì¶•ê°•ë„ê°€ ë‚®ìŠµë‹ˆë‹¤**. ì£¼ë¡œ ì§„ë‹¨ ëª¨í˜• ì œìž‘ì´ë‚˜ êµì • ëª¨í˜• ì œìž‘ ë“± ë¹„êµì  ê°•ë„ê°€ ëœ ìš”êµ¬ë˜ëŠ” ìš©ë„ì— ì‚¬ìš©ë©ë‹ˆë‹¤.

* **ê²½ì„ê³  (Dental Stone):** ë³´í†µ ì„ê³ ë³´ë‹¤ **ì••ì¶•ê°•ë„ê°€ ë†’ìŠµë‹ˆë‹¤**. ìž‘ì—… ëª¨í˜•, ì™ìŠ¤ì—…, ì˜ì¹˜ìƒ ì œìž‘ ë“± ì–´ëŠ ì •ë„ ê°•ë„ê°€ í•„ìš”í•œ ìš©ë„ì— ì‚¬ìš©ë©ë‹ˆë‹¤.

* **ì´ˆê²½ì„ê³  (Die Stone):**  **ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë†’ìŠµë‹ˆë‹¤**.  ì •ë°€í•œ ë³´ì² ë¬¼ ì œìž‘ì„ ìœ„í•œ ë‹¤ì´ ëª¨í˜• ì œìž‘ì— ì‚¬ìš©ë˜ë©°, ë†’ì€ ê°•ë„ì™€ ë‚´ë§ˆëª¨ì„±ì´ ìš”êµ¬ë©ë‹ˆë‹¤. ì €íŒ½ì°½ìš© ì´ˆê²½ì„ê³ ì™€ ê³ íŒ½ì°½ìš© ì´ˆê²½ì„ê³  ëª¨ë‘ ê²½ì„ê³ ë³´ë‹¤ í›¨ì”¬ ë†’ì€ ì••ì¶•ê°•ë„ë¥¼ ê°€ì§‘ë‹ˆë‹¤.

**ë”°ë¼ì„œ, ì¹˜ê³¼ìš© ì„ê³  ì œí’ˆ ì¤‘ ì••ì¶•ê°•ë„ê°€ ê°€ìž¥ ë‚®ì€ ê²ƒì€ ì¸ìƒìš© ì„ê³ ìž…ë‹ˆë‹¤.**

**ì¶”ê°€ ì„¤ëª…:**

* **ì••ì¶•ê°•ë„ ìˆœì„œ (ë‚®ì€ ìˆœ -> ë†’ì€ ìˆœ):**  ì¸ìƒìš© ì„ê³  &lt; ë³´í†µ ì„ê³  &lt; ê²½ì„ê³  &lt; ì´ˆê²½ì„ê³  (ì €íŒ½ì°½ìš©, ê³ íŒ½ì°½ìš©)

ì´ëŸ¬í•œ ì••ì¶•ê°•ë„ì˜ ì°¨ì´ëŠ” ì„ê³  ì œì¡° ê³¼ì •ì—ì„œ ì‚¬ìš©ë˜ëŠ” ì„ê³  ìž…ìžì˜ í˜•íƒœ, í¬ê¸°, ë¬¼-ì„ê³  ë¹„ìœ¨ ë“±ì— ì˜í•´ ê²°ì •ë©ë‹ˆë‹¤.

**ê²°ë¡ ì ìœ¼ë¡œ ì •ë‹µì€ C ìž…ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5,013</div></div>
							</td>
					</tr><tr class="group cursor-pointer space-x-4 divide-x border-b outline-offset-[-2px] odd:bg-gray-50 hover:bg-gray-100 dark:odd:bg-gray-925 dark:hover:bg-gray-850  last:border-none" tabindex="0" data-row-idx="22"><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">dental_technician</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2,022</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">1</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ëŠ” ì‹ ê²½ì€?</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ëŒ€êµ¬ê°œì‹ ê²½</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ë¹„êµ¬ê°œì‹ ê²½</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì†Œêµ¬ê°œì‹ ê²½</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì „ìƒì¹˜ì¡°ì‹ ê²½</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì¤‘ìƒì¹˜ì¡°ì‹ ê²½</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">2</div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">Let's break down the thought process to arrive at the correct answer for the Korean question about nerves innervating the anterior hard palate via the incisive canal.

**1. Deconstructing the Question (Korean to English Translation and Key Terms)**

* **ì ˆì¹˜ê³µ (jeolchi-gong):**  This translates to "incisive foramen" or "incisive canal."  This is a crucial anatomical landmark.
* **í†µê³¼í•˜ì—¬ (tong-gwaha-yeo):**  "Passing through" or "going through." This indicates the nerve passes through the incisive canal.
* **ê²½êµ¬ê°œ (gyeong-gu-gae):** "Hard palate."  This is the area of innervation.
* **ì „ë°© ë¶€ìœ„ (jeon-bang bu-wi):** "Anterior portion" or "front part." This specifies the region of the hard palate.
* **ì§€ë°°í•˜ëŠ” ì‹ ê²½ (ji-bae-ha-neun sin-gyeong):** "Nerve that innervates" or "nerve controlling." This is asking for the nerve's name.
* **ì‹ ê²½ (sin-gyeong):** "Nerve."

**Putting it together in English:**  "Which nerve passes through the incisive canal to innervate the anterior portion of the hard palate?"

**Key Anatomical Concepts:**

* **Incisive Canal/Foramen:**  A passageway in the anterior midline of the hard palate, located just behind the central incisors.  It connects the nasal cavity and the oral cavity.
* **Hard Palate Innervation:** The hard palate is primarily innervated by branches of the maxillary nerve (V2), a branch of the trigeminal nerve (V).

**2. Analyzing the Answer Choices and Eliminating Incorrect Options**

Let's go through each option and consider its anatomical relevance:

* **A. ëŒ€êµ¬ê°œì‹ ê²½ (dae-gu-gae sin-gyeong): Greater palatine nerve**
    * "ëŒ€" (dae) means "large" or "greater."
    * "êµ¬ê°œ" (gu-gae) means "palate."
    * The greater palatine nerve emerges from the greater palatine foramen, located in the posterior hard palate (near the molars).  It innervates the *posterior* hard palate and gingiva.  Therefore, this is *unlikely* to be the answer as the question specifies the *anterior* hard palate.

* **B. ë¹„êµ¬ê°œì‹ ê²½ (bi-gu-gae sin-gyeong): Nasopalatine nerve**
    * "ë¹„" (bi) relates to "nose" or "nasal."
    * "êµ¬ê°œ" (gu-gae) means "palate."
    * The nasopalatine nerve is known to pass through the incisive canal/foramen. It originates from the sphenopalatine ganglion and travels along the nasal septum before entering the incisive canal to reach the anterior hard palate. This is a *strong candidate*.

* **C. ì†Œêµ¬ê°œì‹ ê²½ (so-gu-gae sin-gyeong): Lesser palatine nerve**
    * "ì†Œ" (so) means "small" or "lesser."
    * "êµ¬ê°œ" (gu-gae) means "palate."
    * The lesser palatine nerve emerges from the lesser palatine foramen, located *posterior* to the greater palatine foramen. It primarily innervates the *soft palate* and tonsillar area.  It does *not* innervate the anterior hard palate and does not pass through the incisive canal.  This is *unlikely*.

* **D. ì „ìƒì¹˜ì¡°ì‹ ê²½ (jeon-sang-chi-jo sin-gyeong): Anterior superior alveolar nerve (ASA)**
    * "ì „ìƒ" (jeon-sang) means "anterior superior."
    * "ì¹˜ì¡°" (chi-jo) refers to the "alveolar process" (the bone supporting the teeth).
    * The ASA nerve innervates the anterior maxillary teeth (incisors, canines) and the *buccal* gingiva (cheek side) in the anterior maxilla. It runs within the maxillary bone and emerges onto the face. It does *not* pass through the incisive canal and primarily innervates teeth and buccal gingiva, not the palatal mucosa directly.  This is *unlikely*.

* **E. ì¤‘ìƒì¹˜ì¡°ì‹ ê²½ (jung-sang-chi-jo sin-gyeong): Middle superior alveolar nerve (MSA)**
    * "ì¤‘ìƒ" (jung-sang) means "middle superior."
    * "ì¹˜ì¡°" (chi-jo) refers to the "alveolar process."
    * The MSA nerve innervates the premolars, and sometimes the mesiobuccal root of the maxillary first molar, along with the buccal gingiva in the premolar region.  Like the ASA, it runs within the maxillary bone and doesn't pass through the incisive canal to innervate the hard palate.  This is *unlikely*.

**3. Confirmation and Conclusion**

Based on the anatomical knowledge and elimination process:

* **Nasopalatine nerve (ë¹„êµ¬ê°œì‹ ê²½)** is the only nerve that correctly matches the description of passing through the incisive canal and innervating the anterior hard palate.

Therefore, the answer is **B. ë¹„êµ¬ê°œì‹ ê²½**.

**Final Answer Justification (in Korean, as requested):**

ì ˆì¹˜ê³µì€ ê²½êµ¬ê°œì˜ ì „ë°© ì¤‘ì•™ë¶€ì— ìœ„ì¹˜í•˜ë©°, ë¹„êµ¬ê°œì‹ ê²½ì´ ì´ êµ¬ë©ì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„, íŠ¹ížˆ ì•žë‹ˆ ë¶€ìœ„ì˜ ì ë§‰ê³¼ ê³¨ë§‰ì„ ì§€ë°°í•©ë‹ˆë‹¤.  ëŒ€êµ¬ê°œì‹ ê²½ì€ í›„ë°© ê²½êµ¬ê°œë¥¼, ì†Œêµ¬ê°œì‹ ê²½ì€ ì—°êµ¬ê°œë¥¼ ì§€ë°°í•˜ë©°, ìƒì¹˜ì¡°ì‹ ê²½ë“¤ì€ ì¹˜ì•„ì™€ ì¹˜ì¡°ê³¨, ê·¸ë¦¬ê³  ëº¨ìª½ ìž‡ëª¸ì„ ì§€ë°°í•©ë‹ˆë‹¤. ë”°ë¼ì„œ ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ëŠ” ì‹ ê²½ì€ ë¹„êµ¬ê°œì‹ ê²½ì´ ê°€ìž¥ ì ì ˆí•©ë‹ˆë‹¤.</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="" dir="auto"><span class="">ì •ë‹µì€ **B. ë¹„êµ¬ê°œì‹ ê²½**ìž…ë‹ˆë‹¤.

**í•´ì„¤:**

* **ì ˆì¹˜ê³µ (Incisive foramen):**  ê²½êµ¬ê°œì˜ ì •ì¤‘ì„ , ì•žë‹ˆ ë°”ë¡œ ë’¤ì— ìœ„ì¹˜í•œ êµ¬ë©ìž…ë‹ˆë‹¤.
* **ë¹„êµ¬ê°œì‹ ê²½ (Nasopalatine nerve):**  ì ‘í˜•êµ¬ê°œì‹ ê²½ì ˆì—ì„œ ê¸°ì›í•˜ì—¬ ë¹„ê°•ì„ í†µí•´ ë‚´ë ¤ì™€ ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„, íŠ¹ížˆ ì•žë‹ˆ ë¶€ìœ„ì˜ ì ë§‰ê³¼ ê³¨ë§‰ì„ ì§€ë°°í•˜ëŠ” ê°ê° ì‹ ê²½ìž…ë‹ˆë‹¤.

**ë‹¤ë¥¸ ì„ íƒì§€ ì„¤ëª…:**

* **A. ëŒ€êµ¬ê°œì‹ ê²½ (Greater palatine nerve):**  ëŒ€êµ¬ê°œê³µì„ í†µí•´ ê²½êµ¬ê°œë¡œ ë‚˜ì™€ êµ¬ì¹˜ ë¶€ìœ„ì˜ ê²½êµ¬ê°œ ì ë§‰ê³¼ ìž‡ëª¸ì„ ì§€ë°°í•©ë‹ˆë‹¤. ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì§€ ì•Šìœ¼ë©° ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.
* **C. ì†Œêµ¬ê°œì‹ ê²½ (Lesser palatine nerve):**  ì†Œêµ¬ê°œê³µì„ í†µí•´ ë‚˜ì™€ ì—°êµ¬ê°œì™€ íŽ¸ë„ ë¶€ìœ„ë¥¼ ì§€ë°°í•©ë‹ˆë‹¤. ê²½êµ¬ê°œë¥¼ ì§€ë°°í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.
* **D. ì „ìƒì¹˜ì¡°ì‹ ê²½ (Anterior superior alveolar nerve):**  ìƒì•…ë™ ì „ë²½ ë‚´ì—ì„œ ì£¼í–‰í•˜ë©° ìƒì•… ì „ì¹˜ì™€ ê²¬ì¹˜, ê·¸ë¦¬ê³  í•´ë‹¹ ë¶€ìœ„ì˜ ëº¨ìª½ ìž‡ëª¸ê³¼ ìƒì•…ë™ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•©ë‹ˆë‹¤. ê²½êµ¬ê°œë¥¼ ì§ì ‘ ì§€ë°°í•˜ì§€ ì•Šìœ¼ë©° ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.
* **E. ì¤‘ìƒì¹˜ì¡°ì‹ ê²½ (Middle superior alveolar nerve):**  ìƒì•…ë™ ì™¸ë²½ ë‚´ì—ì„œ ì£¼í–‰í•˜ë©° ìƒì•… ì†Œêµ¬ì¹˜ì™€ ì œ1ëŒ€êµ¬ì¹˜ì˜ ê·¼ì‹¬í˜‘ì¸¡ì¹˜ê·¼, ê·¸ë¦¬ê³  í•´ë‹¹ ë¶€ìœ„ì˜ ëº¨ìª½ ìž‡ëª¸ê³¼ ìƒì•…ë™ ì¸¡ë²½ ë¶€ìœ„ë¥¼ ì§€ë°°í•©ë‹ˆë‹¤. ê²½êµ¬ê°œë¥¼ ì§ì ‘ ì§€ë°°í•˜ì§€ ì•Šìœ¼ë©° ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.

**ë”°ë¼ì„œ ì ˆì¹˜ê³µì„ í†µê³¼í•˜ì—¬ ê²½êµ¬ê°œì˜ ì „ë°© ë¶€ìœ„ë¥¼ ì§€ë°°í•˜ëŠ” ì‹ ê²½ì€ ë¹„êµ¬ê°œì‹ ê²½ì´ ê°€ìž¥ ì •í™•í•©ë‹ˆë‹¤.**</span></div></div>
							</td><td class="min-w-fit max-w-sm break-words p-2 "><div class="line-clamp-2 "><div class="text-right" dir="auto">5,135</div></div>
							</td>
					</tr></tbody></table>
		<div class="bg-linear-to-b sticky left-0 border-t border-dashed border-gray-300 from-gray-100 to-white py-3 text-center font-mono text-xs dark:border-gray-700 dark:from-gray-950 dark:to-gray-900">End of preview. <a href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/viewer/default/train" class="group"><span class="underline decoration-gray-300 group-hover:decoration-gray-400 dark:decoration-gray-500 dark:group-hover:decoration-gray-300">Expand</span>
						in <svg class="text-lg mr-0.5 inline -translate-y-px text-red-500" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 12 12"><path fill="currentColor" d="M2.5 2h7a1 1 0 0 1 1 1v6a1 1 0 0 1-1 1h-7a1 1 0 0 1-1-1V3a1 1 0 0 1 1-1Zm0 2v2h3V4h-3Zm4 0v2h3V4h-3Zm-4 3v2h3V7h-3Zm4 0v2h3V7h-3Z"></path></svg>Data Studio
					</a></div></div>




			<div class="bg-linear-to-b from-gray-100 to-white dark:from-gray-950 dark:to-gray-900 "><hr class="flex-none -translate-y-px border-t border-dashed border-gray-300 bg-white dark:border-gray-700 dark:bg-gray-950">
					<nav><ul class="flex select-none items-center justify-between space-x-2 text-gray-700 sm:justify-center py-1 text-center font-mono text-xs rounded-b-lg"><li><a class="flex items-center rounded-lg px-2.5 py-1 hover:bg-gray-50 dark:hover:bg-gray-800 pointer-events-none cursor-default text-gray-400 hover:text-gray-700" href=""><svg class="mr-1.5" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M10 16L20 6l1.4 1.4l-8.6 8.6l8.6 8.6L20 26z" fill="currentColor"></path></svg>
		Previous</a></li>
			<li class="hidden sm:block"><a class="rounded-lg px-2.5 py-1 bg-gray-50 font-semibold ring-1 ring-inset ring-gray-200 dark:bg-gray-900 dark:text-yellow-500 dark:ring-gray-900 hover:bg-gray-50 dark:hover:bg-gray-800" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/viewer/default/train?p=0">1</a>
				</li><li class="hidden sm:block"><a class="rounded-lg px-2.5 py-1  hover:bg-gray-50 dark:hover:bg-gray-800" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/viewer/default/train?p=1">2</a>
				</li><li class="hidden sm:block"><a class="rounded-lg px-2.5 py-1  hover:bg-gray-50 dark:hover:bg-gray-800" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/viewer/default/train?p=2">3</a>
				</li><li class="hidden sm:block"><a class="rounded-lg px-2.5 py-1  pointer-events-none cursor-default" href="#">...</a>
				</li><li class="hidden sm:block"><a class="rounded-lg px-2.5 py-1  hover:bg-gray-50 dark:hover:bg-gray-800" href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/viewer/default/train?p=87">88</a>
				</li>
			<li><a class="flex items-center rounded-lg px-2.5 py-1 hover:bg-gray-50 dark:hover:bg-gray-800 " href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/viewer/default/train?p=1">Next
		<svg class="ml-1.5 transform rotate-180" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M10 16L20 6l1.4 1.4l-8.6 8.6l8.6 8.6L20 26z" fill="currentColor"></path></svg></a></li></ul></nav></div></div>






</div></div></div></div></div></div></div>

				
					<div class="SVELTE_HYDRATER contents" data-target="RepoCodeCopy" data-props="{}"><div></div></div>
					

					<div class="SVELTE_HYDRATER contents" data-target="SideNavigation" data-props="{&quot;titleTree&quot;:[],&quot;classNames&quot;:&quot;top-6&quot;}">

</div>
					<div class="2xl:pr-6"><div class="prose pl-6 -ml-6 hf-sanitized hf-sanitized-pfYj6XeKgrbqYSaNVaOOz">
	<!-- HTML_TAG_START --><h1 class="relative group flex items-center">
	<a rel="nofollow" href="#information" class="block pr-1.5 text-lg md:absolute md:p-1.5 md:opacity-0 md:group-hover:opacity-100 md:right-full" id="information">
		<span class="header-link"><svg viewBox="0 0 256 256" preserveAspectRatio="xMidYMid meet" height="1em" width="1em" role="img" aria-hidden="true" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" class="text-gray-500 hover:text-black dark:hover:text-gray-200 w-4"><path fill="currentColor" d="M167.594 88.393a8.001 8.001 0 0 1 0 11.314l-67.882 67.882a8 8 0 1 1-11.314-11.315l67.882-67.881a8.003 8.003 0 0 1 11.314 0zm-28.287 84.86l-28.284 28.284a40 40 0 0 1-56.567-56.567l28.284-28.284a8 8 0 0 0-11.315-11.315l-28.284 28.284a56 56 0 0 0 79.196 79.197l28.285-28.285a8 8 0 1 0-11.315-11.314zM212.852 43.14a56.002 56.002 0 0 0-79.196 0l-28.284 28.284a8 8 0 1 0 11.314 11.314l28.284-28.284a40 40 0 0 1 56.568 56.567l-28.285 28.285a8 8 0 0 0 11.315 11.314l28.284-28.284a56.065 56.065 0 0 0 0-79.196z"></path></svg></span>
	</a>
	<span>
		Information
	</span>
</h1>
<p>This data includes the training data from KorMedMCQA, as well as a portion of the trainind data from the <strong>additional KorMedMCQA support set (private)</strong>.
This dataset is based on the responses generated by <em>gemini-flash-thinking-exp-01-21</em> model and has undergone <strong>MANUAL rejection sampling</strong>.</p>
<!-- HTML_TAG_END --></div>
</div></section>
			
			<section class="pt-6 border-gray-100 md:pb-24 md:pl-6 md:w-64 lg:w-80 xl:w-96 flex-none order-first md:order-none md:border-l pt-3! md:pt-6!"><dl class="flex items-baseline justify-between"><dt class="text-sm text-gray-500">Downloads last month</dt><div class="mx-4 flex-1 border-b border-dotted"></div><dd class="font-semibold">22</dd></dl>
				
				<div class="divider-column-vertical"></div>
				<div class="grid grid-cols-2 gap-x-2 md:flex md:flex-row md:flex-wrap"><div class="SVELTE_HYDRATER contents" data-target="DatasetAndModelActionsDropdown" data-props="{&quot;classNames&quot;:&quot;order-last&quot;,&quot;discussionsDisabled&quot;:false,&quot;repo&quot;:{&quot;type&quot;:&quot;dataset&quot;,&quot;name&quot;:&quot;ChuGyouk/medical-o1-train-kormedmcqa&quot;},&quot;canWrite&quot;:false,&quot;canDisable&quot;:false,&quot;repoIsPrivate&quot;:false,&quot;repoIsGated&quot;:false,&quot;repoIsDisabled&quot;:false,&quot;repoIsAdminFlaggedNFAA&quot;:false,&quot;repoHasBlockedOids&quot;:false}"><div class="order-last"><div class="relative ">
	<button class="btn px-1.5 py-1.5 " type="button">
		
			<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" class="p-0.5" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><circle cx="16" cy="7" r="3" fill="currentColor"></circle><circle cx="16" cy="16" r="3" fill="currentColor"></circle><circle cx="16" cy="25" r="3" fill="currentColor"></circle></svg>
		
		</button>
	
	
	</div></div>













</div>
					<div class="SVELTE_HYDRATER contents" data-target="DatasetLibrary" data-props="{&quot;classNames&quot;:&quot;md:w-full xl:w-auto xl:flex-none&quot;,&quot;libraries&quot;:[{&quot;language&quot;:&quot;python&quot;,&quot;library&quot;:&quot;datasets&quot;,&quot;function&quot;:&quot;load_dataset&quot;,&quot;loading_codes&quot;:[{&quot;config_name&quot;:&quot;default&quot;,&quot;arguments&quot;:{},&quot;code&quot;:&quot;from datasets import load_dataset\n\n# Login using e.g. `huggingface-cli login` to access this dataset\nds = load_dataset(\&quot;ChuGyouk/medical-o1-train-kormedmcqa\&quot;)&quot;}]},{&quot;language&quot;:&quot;python&quot;,&quot;library&quot;:&quot;pandas&quot;,&quot;function&quot;:&quot;pd.read_parquet&quot;,&quot;loading_codes&quot;:[{&quot;config_name&quot;:&quot;default&quot;,&quot;arguments&quot;:{&quot;splits&quot;:{&quot;train&quot;:&quot;data/train-00000-of-00001.parquet&quot;}},&quot;code&quot;:&quot;import pandas as pd\n\n# Login using e.g. `huggingface-cli login` to access this dataset\ndf = pd.read_parquet(\&quot;hf://datasets/ChuGyouk/medical-o1-train-kormedmcqa/data/train-00000-of-00001.parquet\&quot;)&quot;}]},{&quot;language&quot;:&quot;python&quot;,&quot;library&quot;:&quot;mlcroissant&quot;,&quot;function&quot;:&quot;Dataset&quot;,&quot;loading_codes&quot;:[{&quot;config_name&quot;:&quot;default&quot;,&quot;arguments&quot;:{&quot;record_set&quot;:&quot;default&quot;,&quot;partial&quot;:false},&quot;code&quot;:&quot;import requests\nfrom huggingface_hub.file_download import build_hf_headers\nfrom mlcroissant import Dataset\n\n# Login using e.g. `huggingface-cli login` to access this dataset\nheaders = build_hf_headers()  # handles authentication\njsonld = requests.get(\&quot;https://huggingface.co/api/datasets/ChuGyouk/medical-o1-train-kormedmcqa/croissant\&quot;, headers=headers).json()\nds = Dataset(jsonld=jsonld)\nrecords = ds.records(\&quot;default\&quot;)&quot;}]},{&quot;language&quot;:&quot;python&quot;,&quot;library&quot;:&quot;polars&quot;,&quot;function&quot;:&quot;pl.read_parquet&quot;,&quot;loading_codes&quot;:[{&quot;config_name&quot;:&quot;default&quot;,&quot;arguments&quot;:{&quot;splits&quot;:{&quot;train&quot;:&quot;data/train-00000-of-00001.parquet&quot;}},&quot;code&quot;:&quot;import polars as pl\n\n# Login using e.g. `huggingface-cli login` to access this dataset\ndf = pl.read_parquet('hf://datasets/ChuGyouk/medical-o1-train-kormedmcqa/data/train-00000-of-00001.parquet')\n&quot;}]}]}"><div class="relative md:w-full xl:w-auto xl:flex-none">
	<button class="from-gray-800! to-black! max-xl:mb-2 text-white! gap-1! border-gray-800! dark:border-gray-900!  btn w-full cursor-pointer text-sm" type="button">
		<svg class="mr-1.5 mr-0.5! " xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32" style="transform: rotate(360deg);"><path d="M31 16l-7 7l-1.41-1.41L28.17 16l-5.58-5.59L24 9l7 7z" fill="currentColor"></path><path d="M1 16l7-7l1.41 1.41L3.83 16l5.58 5.59L8 23l-7-7z" fill="currentColor"></path><path d="M12.419 25.484L17.639 6l1.932.518L14.35 26z" fill="currentColor"></path></svg>
			Use this dataset
		<svg class="-mr-1 text-gray-500" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 24 24"><path d="M16.293 9.293L12 13.586L7.707 9.293l-1.414 1.414L12 16.414l5.707-5.707z" fill="currentColor"></path></svg></button>
	
	
	</div>

</div>
					
					</div>
				<div class="divider-column-vertical"></div>
					<div class="flex flex-col flex-wrap xl:flex-row"><a class="bg-linear-to-r dark:via-none group mb-1.5 flex max-w-full flex-col overflow-hidden rounded-lg border border-gray-100 from-white via-white to-white px-2 py-1 hover:from-gray-50 dark:from-gray-900 dark:to-gray-925 dark:hover:to-gray-900 md:mr-1.5 pointer-events-none" rel="nofollow" target="_blank"><div class="truncate text-xs text-gray-400">Size of downloaded dataset files:</div>
		<div class="truncate text-sm ">
			<!-- HTML_TAG_START -->38.6 MB<!-- HTML_TAG_END --></div></a><a class="bg-linear-to-r dark:via-none group mb-1.5 flex max-w-full flex-col overflow-hidden rounded-lg border border-gray-100 from-white via-white to-white px-2 py-1 hover:from-gray-50 dark:from-gray-900 dark:to-gray-925 dark:hover:to-gray-900 md:mr-1.5 " href="/datasets/ChuGyouk/medical-o1-train-kormedmcqa/tree/refs%2Fconvert%2Fparquet/" rel="nofollow" target="_blank"><div class="truncate text-xs text-gray-400">Size of the auto-converted Parquet files:</div>
		<div class="truncate text-sm group-hover:underline">
			<!-- HTML_TAG_START -->38.6 MB<!-- HTML_TAG_END --></div></a><a class="bg-linear-to-r dark:via-none group mb-1.5 flex max-w-full flex-col overflow-hidden rounded-lg border border-gray-100 from-white via-white to-white px-2 py-1 hover:from-gray-50 dark:from-gray-900 dark:to-gray-925 dark:hover:to-gray-900 md:mr-1.5 pointer-events-none" rel="nofollow" target="_blank"><div class="truncate text-xs text-gray-400">Number of rows:</div>
		<div class="truncate text-sm ">
			<!-- HTML_TAG_START -->8,751<!-- HTML_TAG_END --></div></a></div>
				
				
				
				

				<div class="divider-column-vertical"></div>
					<h2 class="text-smd mb-5 flex items-baseline overflow-hidden whitespace-nowrap font-semibold text-gray-800"><svg class="mr-1 inline self-center flex-none" width="1em" height="1em" aria-hidden="true" focusable="false" role="img" viewBox="0 0 12 13" fill="none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><rect x="2" y="2.49902" width="8" height="3.76425" rx="1.16774" fill="currentColor" fill-opacity="0.4"></rect><rect x="6.21875" y="6.7334" width="3.78055" height="3.76425" rx="1.16774" fill="currentColor" fill-opacity="0.7"></rect><rect x="2" y="6.73438" width="3.78055" height="3.76425" rx="1.16774" fill="currentColor" fill-opacity="0.5"></rect></svg>
						Collection including
						<span class="ml-1 truncate font-mono text-[0.86rem] font-medium">ChuGyouk/medical-o1-train-kormedmcqa</span></h2>
					<div class="flex flex-col gap-3">

<div class="flex flex-col"><article class="overview-card-wrapper group/collection rounded-md! from-white! to-white! dark:from-gray-900! dark:to-gray-900! relative  peer"><a href="/collections/ChuGyouk/korean-medical-dataset-66bc742e78a0239bbfd56216" class="block p-2"><header class="mb-0.5 flex items-center" title="Korean Medical Dataset"><h4 class="text-md text-smd truncate font-semibold group-hover/collection:underline">Korean Medical Dataset</h4>
				<div class="ml-2 flex items-center rounded-sm sm:ml-2.5 bg-green-500/10 py-0.5 pl-1 pr-1.5 text-xs leading-none text-gray-700"><svg class="mr-0.5 flex-none text-green-700" width="1em" height="1em" aria-hidden="true" focusable="false" role="img" viewBox="0 0 12 13" fill="none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><rect x="2" y="2.49902" width="8" height="3.76425" rx="1.16774" fill="currentColor" fill-opacity="0.4"></rect><rect x="6.21875" y="6.7334" width="3.78055" height="3.76425" rx="1.16774" fill="currentColor" fill-opacity="0.7"></rect><rect x="2" y="6.73438" width="3.78055" height="3.76425" rx="1.16774" fill="currentColor" fill-opacity="0.5"></rect></svg>
					Collection
				</div></header>

			<div class="mr-1 flex items-center overflow-hidden whitespace-nowrap text-sm leading-tight text-gray-400"><span class="max-w-64 truncate">í•œêµ­ì–´ ì˜ë£Œ ê´€ë ¨ ë°ì´í„°</span>
					<span class="px-1.5 text-gray-300">â€¢ </span>
				<span>23 items</span>
				<span class="px-1.5 text-gray-300">â€¢ </span>
				<span class="truncate">Updated
					<time datetime="2025-03-21T06:08:28" title="2025-03-21T06:08:28.143Z">4 days ago</time></span>
				<span class="px-1.5 text-gray-300">â€¢</span>

					<svg class="flex-none w-3 mr-1 text-gray-400" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" aria-hidden="true" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 12 12" fill="transparent"><path d="M9.30013 9.29152H9.3H2.7H2.69987C2.62308 9.29154 2.54762 9.27146 2.481 9.23328C2.41437 9.1951 2.3589 9.14015 2.32009 9.07389C2.28128 9.00763 2.26048 8.93237 2.25977 8.85558C2.25907 8.7798 2.27796 8.70513 2.31458 8.63882L5.62238 2.9426L5.67518 2.85168C5.7059 2.81806 5.74178 2.78928 5.78164 2.76649C5.84813 2.72848 5.9234 2.70848 6 2.70848C6.0766 2.70848 6.15187 2.72848 6.21836 2.76649C6.28441 2.80425 6.33953 2.85848 6.37836 2.92389L9.68527 8.63855C9.72199 8.70493 9.74093 8.7797 9.74023 8.85558C9.73952 8.93237 9.71872 9.00763 9.67991 9.07389C9.6411 9.14015 9.58563 9.1951 9.519 9.23328C9.45238 9.27146 9.37692 9.29154 9.30013 9.29152Z" stroke="currentColor"></path></svg>

					5</div></a></article>
	<div class="overview-card-wrapper rounded-md! bg-linear-to-t! -z-1  from-gray-50! to-gray-50! shadow-none! dark:from-gray-925! dark:to-gray-925! -mt-[1.60rem] h-8 scale-x-[98%] transition-transform peer-hover:-translate-y-[2px] peer-hover:from-gray-100/80 dark:peer-hover:from-black"></div></div></div>
				<div class="divider-column-vertical md:hidden"></div></section></div></main>

	<footer class="b-12 mb-2 flex border-t border-gray-100 md:h-14"><nav class="container relative flex flex-col justify-between space-y-2 py-6 text-gray-500 max-md:*:self-start md:flex-row md:items-center md:space-y-0 md:py-0 md:text-sm"><div class="SVELTE_HYDRATER contents" data-target="ThemeSwitcher" data-props="{&quot;theme&quot;:&quot;system&quot;,&quot;isLoggedIn&quot;:false,&quot;menuClassNames&quot;:&quot;md:-top-24&quot;,&quot;classNames&quot;:&quot;max-md:mb-5 max-md:*:self-start&quot;}">
<div class="relative inline-block max-md:mb-5 max-md:*:self-start">
	<button class="rounded-full border border-gray-100 pl-2 py-1 pr-2.5  flex items-center text-sm text-gray-500 bg-white hover:bg-purple-50 hover:border-purple-200 dark:hover:bg-gray-800 dark:hover:border-gray-950 dark:border-gray-800 " type="button">
		<svg class="mr-1.5 text-gray-500" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" fill="currentColor" focusable="false" role="img" width="1em" height="1em" preserveAspectRatio="xMidYMid meet" viewBox="0 0 32 32"><path d="M29 25H3a1 1 0 1 0 0 2h26a1 1 0 1 0 0-2Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M6 22.5h20a2 2 0 0 0 2-2V7a2 2 0 0 0-2-2H6a2 2 0 0 0-2 2v13.5a2 2 0 0 0 2 2ZM7 7a1 1 0 0 0-1 1v11a1 1 0 0 0 1 1h18a1 1 0 0 0 1-1V8a1 1 0 0 0-1-1H7Z" fill="currentColor"></path><path d="M6 8a1 1 0 0 1 1-1h18a1 1 0 0 1 1 1v11a1 1 0 0 1-1 1H7a1 1 0 0 1-1-1V8Z" fill="currentColor" fill-opacity=".4"></path><path d="M29 25H3a1 1 0 1 0 0 2h26a1 1 0 1 0 0-2Z" fill="currentColor"></path></svg>
			System theme
		</button>
	
	
	</div></div>
		<div class="font-semibold text-black md:hidden">Company</div>
		<a class="hover:underline" href="/terms-of-service">TOS</a>
		<a class="hover:underline" href="/privacy">Privacy</a>
		<a class="hover:underline" href="/huggingface">About</a>
		<a class="hover:underline" href="https://apply.workable.com/huggingface/">Jobs</a>
		<a href="/" class="max-md:mb-4! max-md:mt-8! group flex-none max-md:order-last"><svg class="h-7 w-7 transition-transform group-hover:-translate-y-px" viewBox="0 0 95 88" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M47.2119 76.5C66.4037 76.5 81.9619 60.9419 81.9619 41.75C81.9619 22.5581 66.4037 7 47.2119 7C28.02 7 12.4619 22.5581 12.4619 41.75C12.4619 60.9419 28.02 76.5 47.2119 76.5Z" fill="#FFD21E"></path><path d="M81.9619 41.75C81.9619 22.5581 66.4037 7 47.2119 7C28.02 7 12.4619 22.5581 12.4619 41.75C12.4619 60.9419 28.02 76.5 47.2119 76.5C66.4037 76.5 81.9619 60.9419 81.9619 41.75ZM8.46185 41.75C8.46185 20.349 25.8108 3 47.2119 3C68.6129 3 85.9619 20.349 85.9619 41.75C85.9619 63.151 68.6129 80.5 47.2119 80.5C25.8108 80.5 8.46185 63.151 8.46185 41.75Z" fill="#FF9D0B"></path><path d="M58.5024 32.2915C59.7768 32.7415 60.2839 35.3615 61.5713 34.6769C64.0095 33.3805 64.9351 30.353 63.6387 27.9148C62.3423 25.4767 59.3148 24.5511 56.8766 25.8475C54.4384 27.1439 53.5128 30.1714 54.8092 32.6096C55.4211 33.7604 57.3632 31.8892 58.5024 32.2915Z" fill="#3A3B45"></path><path d="M34.9454 32.2915C33.671 32.7415 33.164 35.3615 31.8766 34.6769C29.4384 33.3805 28.5128 30.353 29.8092 27.9148C31.1056 25.4767 34.1331 24.5511 36.5713 25.8475C39.0095 27.1439 39.9351 30.1714 38.6387 32.6096C38.0268 33.7604 36.0846 31.8892 34.9454 32.2915Z" fill="#3A3B45"></path><path d="M46.9619 56.289C56.7903 56.289 59.9619 47.5261 59.9619 43.0262C59.9619 40.6875 58.3898 41.4236 55.8718 42.6702C53.5449 43.8222 50.4102 45.4101 46.9619 45.4101C39.7822 45.4101 33.9619 38.5263 33.9619 43.0262C33.9619 47.5261 37.1334 56.289 46.9619 56.289Z" fill="#3A3B45"></path><mask id="mask0" style="mask-type:alpha" maskUnits="userSpaceOnUse" x="33" y="41" width="27" height="16"><path d="M46.9619 56.289C56.7903 56.289 59.9619 47.5261 59.9619 43.0262C59.9619 40.6875 58.3898 41.4236 55.8718 42.6702C53.5449 43.8222 50.4102 45.4101 46.9619 45.4101C39.7822 45.4101 33.9619 38.5263 33.9619 43.0262C33.9619 47.5261 37.1334 56.289 46.9619 56.289Z" fill="white"></path></mask><g mask="url(#mask0)"><path d="M47.2119 66.5C52.0018 66.5 55.8848 62.617 55.8848 57.8271C55.8848 54.0962 53.5291 50.9156 50.224 49.6915C50.1023 49.6464 49.9794 49.604 49.8553 49.5643C49.0219 49.2979 48.1337 52.1623 47.2119 52.1623C46.3506 52.1623 45.5186 49.2797 44.7332 49.5135C41.151 50.5799 38.5389 53.8984 38.5389 57.8271C38.5389 62.617 42.4219 66.5 47.2119 66.5Z" fill="#F94040"></path></g><path d="M70.7119 37C72.5068 37 73.9619 35.5449 73.9619 33.75C73.9619 31.9551 72.5068 30.5 70.7119 30.5C68.9169 30.5 67.4619 31.9551 67.4619 33.75C67.4619 35.5449 68.9169 37 70.7119 37Z" fill="#FF9D0B"></path><path d="M24.2119 37C26.0068 37 27.4619 35.5449 27.4619 33.75C27.4619 31.9551 26.0068 30.5 24.2119 30.5C22.4169 30.5 20.9619 31.9551 20.9619 33.75C20.9619 35.5449 22.4169 37 24.2119 37Z" fill="#FF9D0B"></path><path class="origin-bottom-right transition-transform group-hover:-rotate-6" d="M17.5238 48C15.9048 48 14.4578 48.665 13.4488 49.871C12.8248 50.618 12.1728 51.822 12.1198 53.625C11.4408 53.43 10.7878 53.321 10.1778 53.321C8.6278 53.321 7.2278 53.915 6.2378 54.994C4.9658 56.379 4.4008 58.081 4.6468 59.784C4.7638 60.595 5.0348 61.322 5.4398 61.995C4.5858 62.686 3.9568 63.648 3.6528 64.805C3.4148 65.712 3.1708 67.601 4.4448 69.547C4.3638 69.674 4.2878 69.806 4.2168 69.941C3.4508 71.395 3.4018 73.038 4.0778 74.568C5.1028 76.887 7.6498 78.714 12.5958 80.675C15.6728 81.895 18.4878 82.675 18.5128 82.682C22.5808 83.737 26.2598 84.273 29.4448 84.273C35.2988 84.273 39.4898 82.48 41.9018 78.944C45.7838 73.25 45.2288 68.042 40.2058 63.022C37.4258 60.244 35.5778 56.148 35.1928 55.249C34.4168 52.587 32.3648 49.628 28.9538 49.628H28.9528C28.6658 49.628 28.3758 49.651 28.0898 49.696C26.5958 49.931 25.2898 50.791 24.3568 52.085C23.3498 50.833 22.3718 49.837 21.4868 49.275C20.1528 48.429 18.8198 48 17.5238 48ZM17.5238 52C18.0338 52 18.6568 52.217 19.3438 52.653C21.4768 54.006 25.5928 61.081 27.0998 63.833C27.6048 64.755 28.4678 65.145 29.2448 65.145C30.7868 65.145 31.9908 63.612 29.3858 61.664C25.4688 58.733 26.8428 53.942 28.7128 53.647C28.7948 53.634 28.8758 53.628 28.9538 53.628C30.6538 53.628 31.4038 56.558 31.4038 56.558C31.4038 56.558 33.6018 62.078 37.3778 65.851C41.1538 69.625 41.3488 72.654 38.5968 76.69C36.7198 79.442 33.1268 80.273 29.4448 80.273C25.6258 80.273 21.7108 79.379 19.5168 78.81C19.4088 78.782 6.0658 75.013 7.7558 71.805C8.0398 71.266 8.5078 71.05 9.0968 71.05C11.4768 71.05 15.8058 74.592 17.6668 74.592C18.0828 74.592 18.3758 74.415 18.4958 73.983C19.2888 71.138 6.4388 69.942 7.5218 65.821C7.7128 65.092 8.2308 64.796 8.9588 64.797C12.1038 64.797 19.1598 70.328 20.6388 70.328C20.7518 70.328 20.8328 70.295 20.8768 70.225C21.6178 69.029 21.2118 68.194 15.9888 65.033C10.7658 61.871 7.0998 59.969 9.1848 57.699C9.4248 57.437 9.7648 57.321 10.1778 57.321C13.3488 57.322 20.8408 64.14 20.8408 64.14C20.8408 64.14 22.8628 66.243 24.0858 66.243C24.3668 66.243 24.6058 66.132 24.7678 65.858C25.6348 64.396 16.7148 57.636 16.2118 54.847C15.8708 52.957 16.4508 52 17.5238 52Z" fill="#FF9D0B"></path><path class="origin-bottom-right transition-transform group-hover:-rotate-6" d="M38.5967 76.6898C41.3487 72.6538 41.1537 69.6248 37.3777 65.8508C33.6017 62.0778 31.4037 56.5578 31.4037 56.5578C31.4037 56.5578 30.5827 53.3518 28.7127 53.6468C26.8427 53.9418 25.4697 58.7328 29.3867 61.6638C33.3037 64.5938 28.6067 66.5848 27.0997 63.8328C25.5927 61.0808 21.4777 54.0058 19.3437 52.6528C17.2107 51.2998 15.7087 52.0578 16.2117 54.8468C16.7147 57.6358 25.6357 64.3958 24.7677 65.8588C23.8997 67.3208 20.8407 64.1398 20.8407 64.1398C20.8407 64.1398 11.2687 55.4288 9.18465 57.6988C7.10065 59.9688 10.7657 61.8708 15.9887 65.0328C21.2127 68.1938 21.6177 69.0288 20.8767 70.2248C20.1347 71.4208 8.60465 61.6998 7.52165 65.8208C6.43965 69.9418 19.2887 71.1378 18.4957 73.9828C17.7027 76.8288 9.44465 68.5978 7.75565 71.8048C6.06565 75.0128 19.4087 78.7818 19.5167 78.8098C23.8267 79.9278 34.7727 82.2968 38.5967 76.6898Z" fill="#FFD21E"></path><path class="origin-bottom-left transition-transform group-hover:rotate-6" d="M77.3999 48C79.0189 48 80.4659 48.665 81.4749 49.871C82.0989 50.618 82.7509 51.822 82.8039 53.625C83.4829 53.43 84.1359 53.321 84.7459 53.321C86.2959 53.321 87.6959 53.915 88.6859 54.994C89.9579 56.379 90.5229 58.081 90.2769 59.784C90.1599 60.595 89.8889 61.322 89.4839 61.995C90.3379 62.686 90.9669 63.648 91.2709 64.805C91.5089 65.712 91.7529 67.601 90.4789 69.547C90.5599 69.674 90.6359 69.806 90.7069 69.941C91.4729 71.395 91.5219 73.038 90.8459 74.568C89.8209 76.887 87.2739 78.714 82.3279 80.675C79.2509 81.895 76.4359 82.675 76.4109 82.682C72.3429 83.737 68.6639 84.273 65.4789 84.273C59.6249 84.273 55.4339 82.48 53.0219 78.944C49.1399 73.25 49.6949 68.042 54.7179 63.022C57.4979 60.244 59.3459 56.148 59.7309 55.249C60.5069 52.587 62.5589 49.628 65.9699 49.628H65.9709C66.2579 49.628 66.5479 49.651 66.8339 49.696C68.3279 49.931 69.6339 50.791 70.5669 52.085C71.5739 50.833 72.5519 49.837 73.4369 49.275C74.7709 48.429 76.1039 48 77.3999 48ZM77.3999 52C76.8899 52 76.2669 52.217 75.5799 52.653C73.4469 54.006 69.3309 61.081 67.8239 63.833C67.3189 64.755 66.4559 65.145 65.6789 65.145C64.1369 65.145 62.9329 63.612 65.5379 61.664C69.4549 58.733 68.0809 53.942 66.2109 53.647C66.1289 53.634 66.0479 53.628 65.9699 53.628C64.2699 53.628 63.5199 56.558 63.5199 56.558C63.5199 56.558 61.3219 62.078 57.5459 65.851C53.7699 69.625 53.5749 72.654 56.3269 76.69C58.2039 79.442 61.7969 80.273 65.4789 80.273C69.2979 80.273 73.2129 79.379 75.4069 78.81C75.5149 78.782 88.8579 75.013 87.1679 71.805C86.8839 71.266 86.4159 71.05 85.8269 71.05C83.4469 71.05 79.1179 74.592 77.2569 74.592C76.8409 74.592 76.5479 74.415 76.4279 73.983C75.6349 71.138 88.4849 69.942 87.4019 65.821C87.2109 65.092 86.6929 64.796 85.9649 64.797C82.8199 64.797 75.7639 70.328 74.2849 70.328C74.1719 70.328 74.0909 70.295 74.0469 70.225C73.3059 69.029 73.7119 68.194 78.9349 65.033C84.1579 61.871 87.8239 59.969 85.7389 57.699C85.4989 57.437 85.1589 57.321 84.7459 57.321C81.5749 57.322 74.0829 64.14 74.0829 64.14C74.0829 64.14 72.0609 66.243 70.8379 66.243C70.5569 66.243 70.3179 66.132 70.1559 65.858C69.2889 64.396 78.2089 57.636 78.7119 54.847C79.0529 52.957 78.4729 52 77.3999 52Z" fill="#FF9D0B"></path><path class="origin-bottom-left transition-transform group-hover:rotate-6" d="M56.3271 76.6898C53.5751 72.6538 53.7701 69.6248 57.5461 65.8508C61.3221 62.0778 63.5201 56.5578 63.5201 56.5578C63.5201 56.5578 64.3411 53.3518 66.2111 53.6468C68.0811 53.9418 69.4541 58.7328 65.5371 61.6638C61.6201 64.5938 66.3171 66.5848 67.8241 63.8328C69.3311 61.0808 73.4461 54.0058 75.5801 52.6528C77.7131 51.2998 79.2151 52.0578 78.7121 54.8468C78.2091 57.6358 69.2881 64.3958 70.1561 65.8588C71.0241 67.3208 74.0831 64.1398 74.0831 64.1398C74.0831 64.1398 83.6551 55.4288 85.7391 57.6988C87.8231 59.9688 84.1581 61.8708 78.9351 65.0328C73.7111 68.1938 73.3061 69.0288 74.0471 70.2248C74.7891 71.4208 86.3191 61.6998 87.4021 65.8208C88.4841 69.9418 75.6351 71.1378 76.4281 73.9828C77.2211 76.8288 85.4791 68.5978 87.1681 71.8048C88.8581 75.0128 75.5151 78.7818 75.4071 78.8098C71.0971 79.9278 60.1511 82.2968 56.3271 76.6898Z" fill="#FFD21E"></path></svg></a>
		<div class="max-md:mt-8! font-semibold text-black md:hidden">Website</div>

		<a class="hover:underline" href="/models">Models</a>
		<a class="hover:underline" href="/datasets">Datasets</a>
		<a class="hover:underline" href="/spaces">Spaces</a>
		<a class="hover:underline" href="/pricing">Pricing</a>
		<a class="hover:underline" href="/docs">Docs</a></nav></footer></div>

		<script>
			import("\/front\/build\/kube-68d7aa0\/index.js");
			window.moonSha = "kube-68d7aa0\/";
			window.__hf_deferred = {};
		</script>

		<!-- Stripe -->
		<script>
			if (["hf.co", "huggingface.co"].includes(window.location.hostname)) {
				const script = document.createElement("script");
				script.src = "https://js.stripe.com/v3/";
				script.async = true;
				document.head.appendChild(script);
			}
		</script>
	</body>
</html>
